Evaluating the impact of environmental tobacco smoke on biological age markers: a canine model by Hutchinson, Natalie
  
 
 
 
 
 
 
Hutchinson, Natalie (2017) Evaluating the impact of environmental tobacco 
smoke on biological age markers: a canine model. PhD thesis. 
 
 
 
http://theses.gla.ac.uk/8371/  
 
 
 
 
Copyright and moral rights for this work are retained by the author 
A copy can be downloaded for personal non-commercial research or study, without prior 
permission or charge 
This work cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
Enlighten:Theses 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk 
  
Evaluating the impact of environmental tobacco 
smoke on biological age markers: 
a canine model 
 
 
Natalie Hutchinson 
MRes, MSc, MBChB 
 
 
 
Submitted in fulfilment of the requirements for the  
Degree of Doctor of Philosophy 
 
School of Veterinary Medicine 
College of Medical, Veterinary and Life Sciences 
University of Glasgow 
 
August 2017  
2 
 
Abstract 
This thesis aimed to examine the impact of environmental tobacco smoke on 
biological markers of ageing in pet dogs.  In order to achieve this, community-
based dogs and owners were recruited, approximately half of whom lived in 
smoking homes and half non-smoking homes.  Owners were asked to attend 2 
appointments, 12 months apart.  Questionnaire assessments of dog 
environmental tobacco smoke exposure were compared to biomarkers in hair of 
the dogs (Chapter 3).  This gave an objective measure of exposure and hair 
nicotine concentrations reliably reflected information provided by owners.  A 
qPCR technique was optimised to measure telomere lengths (Chapter 4).  This 
was utilised to measure telomere lengths in leukocytes, buccal cells, cremaster 
muscle, vas deferens and epididymis samples from the study dogs.  Owners were 
offered free-of-charge neutering for their pet, and the spare tissues used for 
these analyses.  A negative relationship in leukocyte telomere length with hair 
nicotine was observed, among other changes (Chapter 5).  mRNA levels of 
further biomarkers of ageing were measured in testes, as well as leukocyte 
global DNA methylation percentage (Chapter 6).  Again, several significant 
relationships were found between tobacco smoke exposure markers and the 
biomarkers of ageing, including a significant negative relationship with CDKN2A 
expression with increased tobacco smoke exposure. Plasma testosterone and hair 
cortisol concentrations were measured.  In addition, factors which related to 
weight gain after neutering were examined (Chapter 7).  Increased cotinine 
concentrations in fur were significantly related to increased percentage weight 
gain.  Several avenues for future research were generated, and many areas 
warrant further investigation.     
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ng Nanogram 
nM Nanomolar 
p450 SCC Cytochrome p450 cholesterol side chain cleavage 
PCR Polymerase chain reaction 
pg Picogram 
qPCR Quantitative polymerase chain reaction  
qRT PCR Quantitative reverse transcription polymerase chain reaction 
ROC Receiver operating characteristic 
RNA Ribonucleic acid 
RTL Relative telomere length 
SIMD Scottish Index of Multiple Deprivation 
sqrt Square root 
StAR Steroidogenic acute regulatory protein 
TRF Telomere restriction fragment 
TRF1 Telomeric repeat-binding factor 1 
TRF2 Telomeric repeat-binding factor 2 
V Volt 
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 Smoking as a Public Health Issue 
According to the World Health Organisation Global Report on Trends in Prevalence 
of Tobacco Smoke 2015, tobacco use is the most common preventable cause of 
death worldwide, with an estimated 6 million people dying from it each year.  This 
includes 600,000 people estimated to die as a result of second hand smoke effects.  
In Scotland in 2009, 24.2% of all deaths were from causes attributable to smoking 
(ScotPHO, 2016).  Among UK women, smokers lose at least 10 years of their 
lifespan compared to non-smokers (Pirie et al., 2013). 
 
 
The rates of smoking in the UK have declined over the past century.  In 1948, the 
rate of tobacco use (including pipe and rolled tobacco) was as high as 80% in men 
(Forey et al., 2012).  Studies such as those by Doll and Hill, 1950 and English, 
Willius and Berkson, 1940 established links between smoking and lung cancer and 
coronary heart disease, respectively, around this period and numerous further 
disease associations have been found since (examined in Section 1.2.2).  Currently, 
21% of people aged 16 and over smoke in Scotland and 6% of children aged 0-15 
years are exposed to environmental tobacco smoke (ETS) in their own home (The 
Scottish Government, 2015c).  The Scottish Government has set a target to reduce 
the rate of smoking to less than 5% in Scotland by 2034.  They want young people 
to not start smoking, for people to be protected from second hand smoke and to 
help people to stop smoking (The Scottish Government, 2013).  While 68% of 
Scottish adults stated they wished to quit smoking, the Scottish Smoking Cessation 
Services report stated that only 5% of service users were known to have 
successfully quit at 12 months (many were lost to follow up), so there is a 
challenge to find ways to engage people and enable them to maintain their quit 
status (Information Service Division, 2015).  
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 Tobacco smoke 
When a cigarette is smoked, “mainstream smoke” (first hand smoke) is formed and 
inhaled by the smoker.  Between puffs, the cigarette still produces smoke which is 
released into the environment.  This smoke is known as “sidestream smoke” 
(Woodward and Al-Delaimy, 1999).  The mainstream smoke (MS) exhaled by the 
smoker plus the sidestream smoke (SS) inhaled by other individuals (including pets) 
is known as “second hand smoke”.  However, individuals do not stop being exposed 
to tobacco smoke constituents when the cigarette is extinguished.  The MS and SS 
remain in the environment, and chemicals are adsorbed onto surfaces from which 
they may be re-emitted over time.  This source of exposure is referred to as “third 
hand smoke”.  Therefore, the exposure of non-smokers and pets to tobacco smoke 
is a combination of second hand and third hand smoke, which together is known as 
“environmental tobacco smoke” (ETS) (Baker and Proctor, 1990). 
 
 
Cigarette smoke is a combination of an aerosol of liquid droplets (the particulate 
phase), semi-volatile components and a mix of gases.  Figure 1.1 shows the general 
composition of cigarette smoke by percentage, and Table 1-1 gives the general 
composition of the particulate and vapour phases, by percentage. 
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Figure 1.1 Cigarette smoke components by percentage 
Adapted from Thielen, Klus and Mueller (2008) 
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Table 1-1 Components of the particulate and vapour phases of tobacco smoke 
Adapted from Thielen, Klus and Mueller (2008) 
Particulate phase Vapour phase 
Component Percentage Component Percentage 
Water 16 Carbon dioxide 57 
Alcohols and 
humectants 
15.5 Carbon monoxide 18 
Carboxyl acids 13 Water 18 
Aldehydes and 
ketones 
11 Hydrocarbons 3.5 
Nicotine 6 Aldehydes and 
ketones 
2 
Alkanes 5 Nitriles 0.5 
Terpenoid 
hydrocarbons 
5 Miscellaneous 1 
Pigments 4   
Phenols 3.5   
Esters 3.5   
Other alkaloids 3.5   
Miscellaneous and 
unidentified 
14   
 
 
Over 5000 individual chemicals in cigarette smoke have been identified.  Of these, 
the International Agency for Research on Cancer has classed 69 as animal 
carcinogens.  These carcinogens include polycyclic aromatic hydrocarbons (PAHs) 
and tobacco specific nitrosamines (TSNAs).  12 of the PAHs in cigarette smoke are 
known carcinogens.  The TSNAs NNN (N′-nitrosonornicotine) and NNK 
(4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) are classed as animal carcinogens 
and possible human carcinogens (WHO, 1986). 
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 Biomarkers 
Questionnaires are the most common method of assessing exposure to ETS 
(Woodward and Al-Delaimy, 1999).  By using a biomarker, the absorbed dose of ETS 
in an individual can be measured.  To be a successful biomarker, the measured 
variable should show a clear dose-response relationship, be able to demonstrate 
accurate exposure over a range of concentrations, and remain stable over time in 
a collected biological sample.  In addition, the tissue sample for measurement 
should be easy to collect (Schick et al., 2017).  Many published studies involve 
measurement of biomarkers as an objective measure of a smoker’s own exposure.  
The biomarker in this thesis needed to be present in tobacco smoke in sufficient 
quantity to be measured in non-smokers.  Table 1-2 summarises examples of 
tobacco smoke biomarkers and example references using these. 
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Table 1-2 Tobacco smoke exposure biomarkers 
Examples of tobacco smoke biomarkers in publications, with references split according to 
whether these were measured as a means of assessing the exposure of smokers or as an ETS 
biomarker (table structure adapted from Schick et al. (2017)) 
Tobacco 
smoke 
constituent 
Example 
biomarkers 
Example 
tissues used 
for 
measurement 
in publications 
Example 
references: 
in smokers 
Example 
references: ETS 
biomarker 
Nicotine and 
metabolites 
Nicotine 
 
Cotinine 
Blood 
Urine 
Saliva 
Hair 
Nails 
Amniotic fluid 
Kyerematen 
et al., 
1990; 
Eliopoulos, 
1996;  
Jarvis et 
al., 2008; 
Schütte-
Borkovec et 
al., 2009 
Jarvis et al., 
1984;  
Al-Delaimy, 
Crane and 
Woodward, 2000; 
Al-Delaimy et al., 
2002;  
Kamer et al., 
2013;  
Stiby et al., 2013 
TSNAs NNK 
 
NNAL 
Urine 
Hair 
Nails 
Stepanov et 
al., 2007; 
Hu et al., 
2013 
Anderson et al., 
2001;  
Hecht et al., 
2006;  
Pérez-Ortuño et 
al., 2016 
Volatile 
organic 
compounds 
Benzene 
 
1,3-Butadiene 
Breath 
Urine 
Carmella et 
al., 2009; 
Kotapati et 
al., 2011 
Gordon et al., 
2002 
PAHs Pyrene 
 
1-
Hydroxypyrene 
Urine Astenf et 
al., 2001; 
Feng and 
Liang Q, 
Kinser R, 
Suwan-ampai et 
al., 2009 
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Jin Y, 
Scherer G, 
Urban M, 
Engl J, 
Riedel K, 
2006; 
Scherer et 
al., 2007 
Metals Cadmium Blood 
Urine 
McElroy et 
al., 2007 
Willers, 
Gerhardsson and 
Lundh, 2005; 
Leung et al., 
2013 
Carbon 
monoxide 
Carbon 
monoxide 
 
Carboxyhaemo- 
globin 
Breath 
Blood 
Jarvis, 
Russell and 
Saloojee, 
1980; 
Pojer, 
Whitfield 
and 
Richmond, 
1984; 
Bailey, 
2013 
Jarvis, Russell 
and Feyerabend, 
1983;  
Deveci et al., 
2004;  
Leitch et al., 
2005 
 
 
 Nicotine and metabolites 
Only a small fraction of the many studies utilising nicotine and its metabolites are 
displayed in Table 1-2 (which only shows examples of studies in humans).  Section 
3.1.1 examines studies where these biomarkers have been measured in companion 
animals.  Figure 1.2 displays the metabolism pathway of nicotine. 
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Nicotine is rapidly absorbed through the small airway in smokers and blood 
concentrations rise rapidly.  Approximately 75% of nicotine is metabolised to 
cotinine by the enzyme P450 2A6 (Hukkanen, Jacob and Benowitz, 2005).  Nicotine 
half-life in the blood of humans is 2 hours, whereas it was 53 minutes in Beagles 
exposed to cigarette smoke through a tracheostomy (Nightingale et al., 1981).  
Nicotine is also readily absorbed in individuals exposed to ETS.  SS is less acidic 
than MS, due to higher ammonia concentrations in SS, resulting in a higher 
proportion of nicotine being in its unionised form in SS (Woodward and Al-Delaimy, 
1999). 
 
 
A negative of using nicotine as a biomarker of ETS is that it is not carcinogenic, 
and therefore not necessarily measuring reflecting the risk of cancer in exposed 
individuals (Hecht, 2002).  In addition, there are also various factors which affect 
the rate of nicotine metabolism, including age, renal function and medications 
affecting the activity of P450 2A6.  In addition, both nicotine and cotinine 
metabolism are increased in females compared to males (Hukkanen, Jacob and 
Benowitz, 2005). 
 
 
Due to the half-life of nicotine, measurements of concentrations of nicotine and 
derivates in blood, urine and saliva represent short-term exposure.  Hair and nails 
have been used as tissues for measurement of multiple substances, with 
compounds entering the hair via the follicle, apocrine glands and sebaceous 
glands, and being present on the shaft through external environmental exposure 
(Henderson, 1993).  Hair has been described as a “tape-recorder” for dosage 
history, with a 1cm length of hair representing 1 months’ exposure in humans 
(Uematsu, 1993).  The rate of growth of 1cm per month is similar to that of dogs 
(Gunaratnam and Wilkinson, 1983), with some potential variability with breed.  
Examples of utilisation of hair nicotine and metabolites as a biomarker for ETS 
exposure, and comparison with concentrations in other tissues are described in 
Chapter 3.  
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Figure 1.2 Nicotine metabolism pathways  
Diagram adapted from Hukkanen, Jacob and Benowitz, (2005) 
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 TSNAs 
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) is a metabolite of NNK, and 
is a carcinogen.  The half-life of NNAL in humans is 10-18 days, so this marker 
maintains a steady level for biomarker analysis.  However, the concentration of 
NNAL is very low, which may prove problematic for ETS exposure measurement.   
Hu et al. (2014) measured the concentration of NNK and NNAL in the urine of 101 
smokers and 40 non-smokers.  NNK and NNAL were not detectable in any of the 
samples from non-smokers and NNK was not detectable in the urine of the 
smokers.  NNAL was detectable in 100 of the smokers’ urine samples, and was 
significantly correlated with nicotine and cotinine concentrations.  In order to 
measure long term exposure to NNN, NNK and NNAL, Pérez-Ortuño et al. (2016) 
measured concentrations in 48 hair samples, 24 from people exposed to ETS at 
home, 24 not exposed.  NNAL was not quantifiable in any of the samples and NNN 
was only quantifiable in 7 ETS exposed and 2 non-exposed samples.  NNK was 
quantifiable in 15 of the hair samples from ETS exposed people and 11 from non-
exposed, and was highly correlated with nicotine and cotinine concentrations.  In 
addition, nicotine, cotinine and NNK concentrations were all significantly higher in 
samples from ETS exposed than non-ETS exposed people.  However, concentrations 
of NNK was very low.  In ETS-exposed samples, median NNK was 1.3pg/mg, 
compared to 2040pg/mg nicotine and 49pg/mg cotinine.  In non-ETS exposed 
samples, median NNK concentration was only 0.74pg/mg. 
 
 
 Volatile organic compounds 
Volatile organic compounds (VOCs) are formed from incomplete combustion of 
organic materials, and physiologically from inflammation and lipid peroxidation 
(Gordon et al., 2002; Statheropoulos, Spiliopoulou and Agapiou, 2005).  Therefore, 
tobacco smoke is only one source of exposure.  Several VOCs are harmful to 
health, and have been demonstrated to be increased in smokers compared to non-
smokers.  Kotapati et al. (2011) measured the concentration of a urinary 
metabolite of 1,3-Butadiene, a known carcinogen, in 27 smokers and 19 non-
smokers.  The concentration was 21.6ng/mg in smokers compared to 13.7ng/mg in 
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non-smokers.  While the concentrations in the groups were significantly different, 
the data suggested that the non-smokers were being exposed from another source 
than tobacco smoke, for example car exhaust fumes.  
 
 
 Polycyclic aromatic hydrocarbons 
PAHs are formed during incomplete combustion.  They are found in tobacco 
smoke, air pollution, food, pesticides and industrial workplaces (Van Delft et al., 
2001; Lodovici et al., 2004).  Some of the higher molecular weight PAHs are known 
carcinogens, so measurement of these may provide useful information of the 
health risk of exposed individuals.  However, concentrations in the body are low 
and the half-life of the metabolites is short, so concentration reflects short-term 
exposure.  In addition, non-carcinogenic PAHs have been shown to be more 
strongly associated with reported tobacco smoke exposure than carcinogenic PAHs 
(Suwan-ampai et al., 2009). 
 
 
 Metals 
Metals in cigarette smoke include aluminium, cadmium, chromium, copper, lead 
and mercury (Bernhard, Rossmann and Wick, 2005).  Lead exposure has been 
linked to illnesses such as cataracts and hypertension (Korrick et al., 1999; 
Schaumberg et al., 2004).  Cadmium has been associated with renal disease and 
increased risk of various malignancies including lung cancer and breast cancer 
(Savolainen, 1995; McElroy et al., 2006; Nawrot et al., 2006).  Leung et al. (2013) 
measured concentration of lead, cadmium and cotinine in urine samples from 893 
children aged 2 to 7 in Hong Kong.  38% of children were exposed to ETS at home.  
Lead concentration was measurable in 3.9% of samples, whereas cadmium was 
measurable in 92.4%.  Cotinine concentration was significantly higher in exposed 
compared to non-exposed children, and correlated with increasing number of 
cigarettes smoked at home.  There was no significant difference in cadmium 
concentration between the exposure groups, and cadmium did not correlate with 
cotinine concentration.  Whereas, in a study of 23 Swedish children of mean age 
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8.4, concentration of urinary cadmium was significantly correlated with urinary 
cotinine, and there was a non-significant positive correlation between urinary lead 
and cotinine (Willers, Gerhardsson and Lundh, 2005). 
 
 
 Carbon Monoxide 
Carbon monoxide (CO) is formed as a result of biological processes and incomplete 
combustion of organic materials.  CO competes with oxygen for haemoglobin 
binding and CO has a higher affinity for haemoglobin than oxygen.  CO shifts the 
oxygen-haemoglobin dissociation curve to the left, impairing release of oxygen into 
tissues.  Chronic exposure to CO from smoking has been linked to cardiovascular 
disease (Astrup and Kjeldsen, 1979). 
 
 
Published studies examining CO as a biomarker for tobacco smoke exposure either 
involve measuring the concentration of CO in expired air or the concentration of 
carboxyhaemoglobin (COHb) in blood. COHb has a short half-life (2 to 3 hours in 
humans) and the vast majority of studies using this biomarker are as a means of 
quantifying exposure in the smoker rather than as a biomarker of ETS (e.g. Jarvis, 
Russell and Saloojee, 1980; Deveci et al., 2004; Bailey, 2013).  The measurement 
of CO in breath in human studies required the user to inhale deeply and exhale on 
command, so would not be practical for studies in this thesis. 
 
 
 Tobacco smoking and health 
In the 15th century, Christopher Columbus brought the first tobacco leaves to 
Europe.  Tobacco use was recommended by doctors for managing a range of 
ailments including toothache and worms (Musk and De Klerk, 2003).  Associations 
between snuff, pipe smoking and cancer were suggested by individuals during the 
following centuries, but were disregarded by the wider community.  Evidence 
began to mount for a link between morbidity and smoking in the first half of the 
20th century.  These reports were generally of incidental findings, such as that 
33 
 
patients with oral or respiratory cancers were often heavy smokers.  For example, 
Abbe (1915) reported that in 100 private patients with cancer of the mouth, 89 
were heavy smokers. 
 
 
Case controls studies were needed to provide evidence beyond incidental findings 
that smoking was associated with increased risk of morbidity.  The first case-
control study regarding lung cancer mortality was credited to Müller in 1939.  The 
findings of the study together with the rising incidence of lung cancer in the 
general population at the time, led Müller to conclude that tobacco smoking was 
the most important cause of the disease.  Further case-control studies were 
undertaken to demonstrate the carcinogenic nature of smoking.  Schrek et al. 
(1950), for example, found a higher incidence of smoking in a group of men with 
cancer of the lung or larynx compared to control patients with miscellaneous 
tumours. 
 
 
Doll and Hill in 1950 presented a key paper in the British Medical Journal linking 
smoking to the increased number of deaths from lung cancer in the preceding 25 
years, which had been recorded to increase from 612 to 9,287 per year.  Following 
this article, Doll organised a prospective cohort study of smoking and mortality in 
UK doctors.  Questionnaires were sent to doctors on the medical registry.  As early 
as 2.5 years in to the study, a link was apparent between mortality due to lung 
cancer and smoking (Doll and Hill, 1954).  Cause-specific mortality was followed up 
for 50 years, displaying a link between smoking and mortality due to vascular, 
neoplastic and respiratory diseases (Doll et al., 2004). 
 
 
Current estimates are that tobacco smoking is responsible for a third of cancer 
deaths in Western countries (Sasco, Secretan and Straif, 2004).  The International 
Agency for Research on Cancer Working Groups have agreed that there is evidence 
for an increased risk of cancer associated with tobacco smoking in humans in the 
following tissue sites: lung, oral cavity, oro- and hypo-pharynx, oesophagus, 
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larynx, nasal cavity, paranasal sinuses, stomach, liver, pancreas, kidney, urinary 
tract, uterine cervix and myeloid leukaemia (WHO, 1986). 
 
Alongside with the link between smoking and malignancy, in the early 20th century 
associations were being formed between coronary disease and smoking.  Hoffman 
(1920) examined statistics of causes of death between 1900 and 1918, using data 
from the United States census office.  An increase in the annual rate of death from 
heart disease was noted, on a background of a stable overall rate of mortality.  
English, Willius and Berkson in 1940 examined records of 1000 patients with 
coronary heart disease in relation to smoking, and found a link between the 
development of disease under the age of 50 with smoking.    
 
 
Chronic obstructive pulmonary disease (COPD) is characterised by airflow 
limitation, which is progressive.  There is an abnormal inflammatory response to 
noxious particles or gases.  Smokers have more respiratory symptoms and lung 
function abnormalities than non-smokers, and an increased risk of mortality from 
COPD (Pauwels and Rabe, 2004).  A prospective study of COPD in London working 
men was performed by Fletcher and Peto (1977).  They found that in some 
smokers, an airflow limitation plus hypersecretory disorder was present, including 
infective processes.  More recently, COPD has been cited as the fifth most common 
cause of death in high income countries, equating to 3.8% of deaths.  Tobacco 
smoking is the most important cause of COPD, with smoking causing 73% of COPD-
related mortality in high income countries. 
 
 
With the rise of coronary heart disease and strokes in the 20th century, multiple 
cohort studies were established in attempt to discover the causes of the disease.  
The Framingham Heart Study is an American study which began in 1948.  A cohort 
of 4,255 men and women aged 36 to 68 from this study were examined.  In a 26 
year follow up, 459 strokes occurred, with smoking being significantly related to 
the risk of stroke after age and hypertension were taken into account.  The risk of 
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stroke increased with daily cigarette consumption (Wolf et al., 1988).  In a further 
study, 1,838 men from the Framingham Heart Study and another cohort study, the 
Albany Cardiovascular Health Center Study, were followed for 8 years.  The men 
who smoked at least 20 cigarettes per day had a three times risk of myocardial 
infarction compared to non-smokers or former smokers (Doyle et al., 1964). 
 
 
Smoking has been associated with multiple other disorders of various body 
systems, for example, peptic ulcer (Kurata and Nogawa, 1997) psoriasis (Fortes et 
al., 2005), vascular dementia (Anstey et al., 2007), cataracts (Ye et al., 2012), 
periodontitis (Bergström, 2006), and male and female infertility (Vine, 1996; 
Augood, Duckitt and Templeton, 1998).  Birth defects have also been associated 
with maternal smoking in pregnancy.  Hackshaw, Rodeck and Boniface (2011) 
examined birth data from 1959 to 2010, including 173,687 cases of birth defects 
and 11,674,332 unaffected controls.  Significant positive associations were found 
between maternal smoking and orofacial clefts, clubfoot, cardiovascular/heart 
defects and gastrointestinal defects in the infant. 
 
 
 ETS exposure and dog health 
Studies regarding examples of increased risk of poor health in dogs exposed to ETS 
are few in number.  While it would be assumed that dogs are at risk from ill health 
from ETS the same way that humans are, there are few studies documenting 
associations between exposure and disease in dogs. 
 
 
Hawkins et al. 2010 used questionnaire and historical data from clinical records to 
try to ascertain risk factors associated with chronic cough in dogs.  The dogs in 
question had presented to a veterinary hospital with at least a 2-month history of 
cough.  The authors did not find a relationship between ETS exposure and cough.  
In addition, none of the 6 cases that were diagnosed as having cancer were from 
smoking homes.  Whereas, when 43 dogs with chronic cough were studied in a 
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Japanese veterinary centre, indices of airway limitation were significantly higher 
in dogs exposed to ETS (Yamaya, Sugiya and Watari, 2014).  When 30 Yorkshire 
terriers, half of which lived in a smoking home, underwent bronchiolar lavage, 
macrophage and lymphocyte numbers were observed to be significantly higher in 
the fluid obtained from dogs in smoking homes, and anthracosis was present in 
macrophage cytoplasm in 8 of the 15 ETS exposed dogs (Roza and Viegas, 2007). 
 
 
Reif et al. (1998) conducted a case-control study in nasal cancer of dogs, 
examining whether there was a difference in risk of developing nasal cancer in 
smoking homes compared to a control group, which had other types of cancer.  
They found an increased risk of nasal cancer with ETS exposure, but only in long 
nosed breeds with the highest level of exposure, as determined from questionnaire 
data.  A case control study on lung cancer in dogs relating to ETS exposure, again 
using other cancer cases as the control group, concluded that the effect of ETS on 
risk of lung cancer was restricted to short and medium length nosed dogs.  
However, the quoted 95% confidence interval quoted for the odds ratio result on 
which they based their claim crosses 1.00, so the conclusions they reach read as 
somewhat confusing (Reif et al., 1992).  Glickman et al. (1989) interviewed owners 
of 59 dogs with transitional cell carcinoma of the bladder and owners of 71 dogs 
with chronic diseases.  The odds ratio of having bladder cancer if the dog lived in a 
smoking home was not significant.   
 
 
In addition to the effects of ETS, dogs may consume whole cigarettes, cigarette 
butts discarded on the floor or the contents of ashtrays in the home.  Novotny et 
al. (2011) collected data from the Pet Poison Help Line, Bloomington MN and 
ASPCA Animal Poison Control Center, Urbana IL and found over the period of 2005-
2010 there were 801 calls related to dogs consuming cigarettes or butts.   55% of 
the dogs experienced vomiting and 25% ataxia.  There was one reported case of 
death, however it was unclear if the dog was euthanized for reasons related to 
cigarette consumption. 
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 Dogs as sentinels of exposure 
Pet dogs share their owner’s home environment, without engaging in behaviours 
such as alcohol consumption which may confound epidemiological studies.  They 
often spend nearly all their lives in one home, which may be a better example of 
“real world” exposure than that which is regulated within a laboratory.  Dogs have 
been used as sentinels for exposure to many potentially harmful agents in previous 
studies, including mercury (Dunlap et al., 2007), and herbicides (Glickman et al., 
2004).  In addition, dogs spend a lot of their time at home, so potentially would be 
exposed to third-hand smoke in a similar nature to young children.  Like small 
children, they often explore their environment with their mouths, potentially 
ingesting third-hand smoke and increasing their exposure.  In addition, being 
quadrupeds, they spend a lot of time close to the floor.  Matt et al. (2004) 
conducted a study to examine ETS contamination in household air, dust and on 
surfaces in homes of non-smokers, smokers and smokers who try to protect their 
families by only smoking outside or away from others (indirect exposure group).  
The study found that in the living room of the houses, the indirect exposure group 
had significantly higher air nicotine, surface nicotine and nicotine dust levels than 
the non-exposure group and the direct exposure group had significantly higher 
levels than the indirect.  This showed that while people in the indirect group 
reduced the exposure of their families to nicotine compared to those who smoke 
inside, they did not protect them completely.  In fact, average nicotine levels in 
the homes of the indirect group were 5-7 times higher than the non-exposure 
group.  The study also examined the levels of nicotine in the mothers and children 
in the households.  No nicotine was detected on the fingers of mothers in the non-
exposure group, but nicotine was detected on 100% and 92% of the fingers of 
mothers in the indirect and direct groups, respectively.  A higher concentration of 
nicotine was found on the fingers of mothers than the household surfaces.  
Exposure to ETS in the children was confirmed using concentrations of nicotine and 
cotinine in urine and hair samples.  This confirmed that there were significantly 
higher levels of exposure in the indirect group compared to no exposure, and 
significantly higher levels in the direct compared to indirect group.  
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Dogs are also a useful sentinel for ETS exposure due to there being an estimated 
8.5 million dogs in UK households (24% of households), with 46% of households in 
the UK owning any type of pet (Pet Food Manufacturers’ Association, 2015).  Many 
elderly people live alone, save the company of a pet and may wish to protect their 
pet from smoke (Hovell and Irvin, 2007).  Such people, and younger single childless 
pet owners, are not targeted in campaigns against child exposure to ETS.    A web-
based survey of 3293 adult pet owners in Michigan with questions about smoking 
behaviour of owners and their cohabitants was conducted.  21% of people in the 
survey were smokers, which as previously mentioned is the current rate of smoking 
in Scotland.  In addition, 76% of respondents were dog owners.  28.4% of smoking 
pet owners stated that information on the dangers of second hand smoke to their 
pets would motivate them to quit smoking, and 14.2% said they would potentially 
only smoke outside.  Provided with similar information, 16.4% of non-smoking 
respondents said they would ask their co-habitants to quit smoking, and 24.2% 
would ask people to go outside to smoke (Milberger, Davis and Holm, 2009). 
 
 
 What is a biomarker of age? 
Age usually refers to the chronological length of time since birth, with older age 
leading to a progressive decline in physiological function and higher risks of age-
related morbidity and mortality.  Whereas, “biological” age refers to the 
physiological function of an individual relative to normal physiological progression 
throughout lifespan (Flatt, 2012; Jarman et al., 2015). 
 
 
Baker III and Sprott (1988) proposed a case for identifying biomarkers which would 
better represent physiological function than chronological age.  They laid out a set 
of criteria which the biomarker should meet: 
➢ The rate of change of the biomarker should reflect a parameter which can 
be predicted at a later stage 
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➢ The biomarker should reflect a biological process of ageing rather than a 
predisposition to disease 
➢ The biomarker should be reproducible cross-species 
➢ The biomarker should change independently with chronological age 
➢ The biomarker should be non-lethal to measure 
➢ The biomarker should be measurable over a short time relative to the 
lifespan of the animal 
 
 
Molecular age biomarkers (MABs) were evaluated in this thesis.  MABs measure 
aspects of DNA and RNA abundance or sequence over the animal’s lifespan (Jarman 
et al., 2015). 
 
 Telomeres 
In the late 1930s, work performed by Hermann Muller on fruit flies and studies by 
Barbara McClintock on maize led to the discovery of natural ends at chromosomes 
which prevented the joining of the end of chromosomes to each other.  Muller 
named these ends “telomeres” (McClintock, 1931; Muller, 1938).  Yet it was some 
time after this that the true structure and function of telomeres was discovered.  
In the 1970s, the sequence of telomeres in Tetrahymena yeast was described, a 
series of TTGGGG repeats, and subsequent work led to the finding of telomerase, 
an enzyme which could synthesise telomeric repeats de novo in this yeast in 1984 
by Elizabeth Blackburn (Blackburn and Szostak, 1984).  It was already known that 
DNA polymerase could only extend preformed DNA and so could not extend the 
very end of linear DNA (“the end replication problem”) (Watson, 1972).  While the 
majority of DNA is double-stranded, the distal end contains a 3’ overhang in the 
telomere region.    Blackburn found that telomerase which could extend this 
overhang.  It is now known that the overhang or “G-tail” is folded back on itself to 
form a “t-loop” to prevent enzymatic degradation and end-fusion events (Griffith 
et al., 1999).   
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By the late 1980s, the human telomere sequence was established to be repeats of 
TTAGGG (Moyzis et al., 1988), only slightly different to that of yeast, and 
telomerase was found in human cells, opening up a whole avenue of new research 
into cellular senescence and cancer.  Harley, Futcher and Greider (1990) examined 
human cells in culture and found that telomere shortening occurred with each cell 
division due to the end replication problem with a lack of telomerase expression.  
Senescence by activation of the p53 checkpoint system occurred when a critically 
short telomere length was reached, which defined a finite number of times a cell 
can divide, the so called “Hayflick Limit” (Hayflick and Moorhead, 1961).  If 
telomerase was expressed, telomeres did not shorten and the cells did not show 
senescence.  Although cells after passing the Hayflick limit can still live for a long 
time, they cannot be stimulated to proliferate again except by transformation.  
However, in the presence of somatic mutations or viral oncogenes, the cellular 
senescence triggered by telomere shortening may be bypassed, so the cell can 
continue to divide and the telomeres continue to shorten.  Continued telomere 
erosion can lead to the activation of telomerase, maintaining the remaining 
telomere and the cell can continue to proliferate.  An alternative method of 
evasion of telomere induced senescence in tumours and cell lines has been 
observed, the Alternative Lengthening of Telomeres (ALT) (Shay and Wright, 1996; 
Bryan and Reddel, 1997). 
 
 
Telomeres have a protective function.  The loss of telomeres has been 
demonstrated to be invariably associated with Robertsonian chromosome 
rearrangements in mice.  Robertsonian rearrangements involve centromere fusion 
of two telocentric or acrocentric chromosomes to form a single metacentric 
chromosome.  In telocentric chromosomes, the centromere is located at the 
terminal end of the chromosome, and these type of chromosomes are present in 
mice (Hemann et al., 2001).  All autosomal chromosomes in the dog are 
acrocentric, where the P-arm (short arm) of the chromosome is very short, but 
longer than in telocentric chromosomes (Oshimura, Sasaki and Makino, 1973).  In 
the telocentric chromosomes of mice, most Robertsonian fusion events involve two 
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P-arms, emphasising the importance of telomere function at P-arms to prevent 
these fusion events from occurring (Slijepcevic, 1998). 
 
 
Telomeres must avoid having the 3’ overhang being recognised by the cell as a 
broken DNA end and therefore stimulating DNA damage pathways.  A group of 
telomere associated proteins collectively known as shelterin provides this function.  
Shelterin proteins form t-loops at the end of telomeres which result in the end in 
the end of the telomere being tucked in and the 3’ overhang invading the double 
stranded region forming a D-loop (Figure 1.3) (de Lange et al., 1990; O’Sullivan 
and Karlseder, 2010). 
 
 
Figure 1.3 Telomeres have a t-loop and D-loop at the end 
Copied from Greider (1999) with permission 
 
 
Shelterin includes the following proteins: telomeric repeat binding factors 1 and 2 
(TRF1 and TRF2), TRF1 interacting protein 1 (TIN2), repressor/activator protein 1 
(RAP1), protection of telomeres 1 (POT1) and TPP1 (also known as 
TINT1/PIP1/PTOP1).  TRF1 and TRF2 bind the double stranded repeat, POT1 
attaches to the 3’ overhang, and these proteins are then bridged by TPP1, TIN2 
and RAP1 (De Lange, 2005; O’Sullivan and Karlseder, 2010).  In vitro study of TRF2 
demonstrated that a dominant negative allele of TRF2 induced end-to-end 
chromosome fusions (Van Steensel, Smogorzewska and De Lange, 1998).  In 
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addition, in vitro targeting TRF1 and TRF2 individually lead to telomere 
shortening, demonstrating that these proteins act together (Ancelin et al., 2002).  
 
 
Following the observations by Harley, Futcher and Greider (1990) that telomeres 
shortened in human fibroblasts with increasing population doublings, telomere 
length was measured in human blood samples to test if there was a negative 
relationship with age.  Hastie and Dempster (1990) measured telomere length in 47 
human blood samples.  There was a significant negative relationship with age 
observed, equivalent to 33bp per year.  In a further study using blood samples 
from 140 humans aged 0 to 107 years, telomere length declined by 41bp per year 
(Vaziri et al., 1993).  A negative relationship between telomere length in blood 
samples and age has been found in many human studies, and the shortening of 
telomeres with each cell division has been said to act as a “biological clock” (Von 
Zglinicki, 1998). 
 
 
As with studies in human fibroblasts, when canine dermal fibroblasts were cultured 
in vitro, telomere length declined with population doublings, from 20.5kb at 
passage 1 to 17.5kb at passage 16 (Nasir et al., 2001).  Also, as with humans, the 
relationship between telomere length in leukocytes and age has been examined in 
dogs.  For example, Fick et al. (2012) measured leukocyte telomere length (LTL) in 
175 dogs of various breeds and found a significant decline with age, at a rate of 
360bp per year.  McKevitt et al. (2002) measured LTL in 47 dogs aged 6 months to 
13 years.  There was a negative non-significant trend with age. 
 
 
 Telomeres and oxidative stress 
In telomerase-negative cells, telomeres shorten with each cell division.  However, 
the rate of telomere shortening is not constant.  The rate is influenced by the 
degree of oxidative stress and the level of antioxidant defence.  Some of the 
oxidative damage inflicted upon telomeres cannot be repaired and the damaged 
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DNA is lost in the next replication (von Zglinicki, 2002).  As telomeres contain high 
levels of guanine residues, they are particularly sensitive to oxidative stress 
damage.  Guanine residues have the lowest oxidation potential of the 4 bases in 
DNA, so are most likely to be damaged by reactive oxygen species (ROS) and they 
are even more vulnerable to oxidative reactions when in triplicate as occurs in 
telomeres.  ROS can modify guanine bases into 8-oxo-7, 8-dihydroguanine8 (8-
oxodG), which can induce single strand breaks.  Oxidative damage cumulates over 
the life span of a cell.  Senescent cells have 30% more oxidatively changed guanine 
bases and higher levels of 8-oxodG.  A single 8-oxo-dG lesion can reduce the 
percentage of bound TRF1 and TRF2 proteins by at least 50%, and the effect 
increases with more lesions (Opresko et al., 2005).   
 
 
By looking at the rate of loss of telomere bases, inferences can be made as to the 
level of oxidative stress upon the whole genome (von Zglinicki, 2002), and thus the 
environmental influences upon the individual.  Research has demonstrated that 
cigarette smoking induces oxidative stress.  In vitro experiments by Carnevali et al. 
(2003) showed that cigarette smoke extract induced oxidative stress and apoptosis 
in human lung fibroblasts.  This relationship was dose-dependent. Keaney Jr et al. 
(2003) demonstrated that in humans cigarette smoking was significantly associated 
with increased urinary 8-epi-PGF2α, a marker of systemic oxidative stress.  
Demissie et al. (2006) found that this marker of oxidative stress in urine was 
inversely related to telomere length in humans.  In addition, passive smoking has 
been shown to cause oxidative stress in children (Demissie et al., 2006).  Plasma 
peroxide levels were found to be significantly higher and measures of antioxidant 
levels significantly lower in children exposed to passive smoking compared to those 
who were not (Kosecik et al., 2005). 
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 Factors in individuals related to telomere length 
 Lifespan and telomere length 
Dogs are a unique species in that there is such a wide variety of life expectancy 
and size within the species.  Fick et al. (2012) found that in 175 dogs, LTL was 
strongly positively predictive of breed life span. However, across species, telomere 
length was negatively correlated with life span in an analysis of over 60 
mammalian species (Gomes et al., 2011).  This was not simply due to a 
relationship with size, as there was no independent association between body size 
and telomere length observed.  Gomes et al also examined differences in patterns 
of telomerase activity across species.  In smaller mammals, such as the house 
mouse and Norway rat, telomerase was active across a range of tissues.  Whereas, 
in larger mammals, such as dogs and humans, telomerase was repressed in tissues, 
and active in only a small number of cell types, such as germ cells.  Telomerase is 
highly active in testes in humans, and unlike many tissues, telomeres have been 
found to increase in length in sperm (Eisenberg, Hayes and Kuzawa, 2012).  
Examples of species telomere length and telomerase pattern are shown in Table 1-
3. 
 
 
Larger mammals tend to have repressed telomerase, short telomeres and use 
“replicative ageing”, where short telomeres result in growth arrest in vitro.  
Species not using replicative ageing have a higher replicative capacity, but are at 
increased risk of tumorigenesis.  The response to damaged telomeres also varies 
between small and large species.  In humans, critically short telomeres induce 
senescence through the p53 or p16/retinoblastoma pathway.  Suppression of both 
of these pathways is required to suppress senescence (Ben-Porath and Weinberg, 
2005).  In in vitro experiments of mouse cells, telomere damage also resulted in 
senescence but this senescence could be prevented by the loss of p53 function, 
indicating that the p16/retinoblastoma pathway is not linked to telomere 
dysfunction in mice (Smogorzewska and de Lange, 2002).   
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A relationship between telomere bases lost per year of age and lifespan has also 
been observed, with greater yearly losses being associated with shorter lifespans 
(Haussmann et al., 2003).  In addition, with the same species of bird, the Alpine 
swift, it was demonstrated by examining telomere length over a 6 year period that 
those with long telomeres and slow rate of yearly loss had higher rates of survival 
and longer lifespans (Bize et al., 2009).   
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Table 1-3 Examples of telomere restriction fragment lengths and telomerase in various species 
The species, published telomere length and whether telomerase is restricted in somatic 
tissues is given.  * indicates the telomere lengths in the study went above the limits of the 
authors’ assay, so the true upper length is not known. 
Species Telomere 
length 
Telomerase 
restricted 
Reference(s) 
House mouse 
(DBA/2, CBA/Ca, 
C57BL/6J 
laboratory strains) 
Up to 150kb* No Kipling and Cooke, 
1990; Broccoli et al., 
1996 
Chicken 8 to 20kb No Venkatesan and Price, 
1998 
European White 
rabbit (inbred 
laboratory strain) 
10 to over 
80kb* 
No Forsyth et al., 2005 
Domestic cat 4.7 to 26.3kb Yes McKevitt et al., 2003 
Domestic dog 10.9 to 23.5kb Yes Nasir et al., 2001; 
Yazawa et al., 2001; 
McKevitt et al., 2002; 
Cadile et al., 2007; 
Benetos et al., 2011 
Cynomolgus 
monkey 
15.4 to 17.5kb Yes Gardner et al., 2007 
Human 4.5 to 18.9kb Yes Kim et al., 1994; 
Iwama et al., 1998; 
Melk et al., 2000; 
Okuda et al., 2002; 
Kimura et al., 2008 
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 Breed, weight and neutering as determinants of longevity 
Several studies have found a link between increased average dog breed weight and 
decreased life expectancy (Li et al., 1996; Patronek, Waters and Glickman, 1997; 
Galis et al., 2007; Greer, Canterberry and Murphy, 2007; Adams et al., 2010; 
Dreschel, 2010; O’Neill et al., 2013).  For example, when data was collected from 
over 700 dogs of 77 breeds, there was a significant negative correlation between 
longevity and both height and weight, with weight being a strong predictor of 
lifespan (Greer et al, 2006).  Interestingly, (Galis et al., 2007) observed that while 
there was a negative correlation between size and longevity overall, within breeds 
there was a positive correlation between weight and longevity.  In addition, a 
further study found that within weight categories, cross breed dogs had a longer 
median lifespan than purebred dogs (Patronek, Waters and Glickman, 1997).  Cross 
breeds lived longer on average than pure breeds overall in two surveys of British 
mortality data (Michell, 1999; O’Neill et al., 2013).  Dreschel (2010) replicated the 
weight and lifespan negative correlation and also found that neutered dogs lived 
significantly longer than entire dogs.  Neutering was also found to give increased 
lifespan in a study using over 80,000 mortality records of animals presenting to 
North American veterinary teaching hospitals.  This was the case for both sexes, 
with an increase of life expectancy of 13.8% in males and 26.3% in females 
(Hoffman, Creevy and Promislow, 2013).   
 
 
 Risk of mortality and telomere length 
There is mixed evidence in humans as to whether an individual’s telomere length is 
a predictor of likelihood of mortality.  For example, when LTL was measured in 
2744 men of mean age 75.5 and 20% died in the 6 year follow up period, there was 
no association between initial LTL and subsequent mortality (Svensson et al., 
2014).  In addition, Bendix et al. (2014) found no association between LTL and 
mortality in the 10 year follow up in 1356 individuals aged 30 to 70.  Whereas, 
when Fitzpatrick et al. (2011) measured LTL in 1136 participants of mean age 73.9, 
those with the shortest quartile of LTL were 60% more likely to die during the 6 
year follow up than those with the longest quartile.  In a further study, in 143 
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individuals aged over 60, shorter telomeres were significantly related to mortality 
in the following 15 years.  This was found to be in part attributed to a 3 times 
higher mortality rate from heart disease and an 8.5 times higher mortality rate 
from infectious disease in those with the shortest quartile of LTL (Cawthon et al., 
2003). 
 
 
Aside from predicting human mortality, telomere length was seen to be 
significantly associated with mortality in a closed wild population of Seychelles 
Warblers.  This was in a well sampled population, where age was known for the 
birds.   When 62 of 200 individuals died in the same year as last having a blood 
sample taken, telomere length, but not age, was a significant predictor of 
mortality, with those which subsequently died having shorter telomere length 
(Barrett et al., 2013). 
 
 
 Morbidity and telomere length 
Telomere length has been shown to be significantly shorter in humans with various 
diseases across multiple body systems compared to healthy counterparts.  For 
example, rheumatoid arthritis, type 2 diabetes mellitus, liver cirrhosis, chronic 
heart failure, chronic obstructive pulmonary disease and multiple sclerosis patients 
were all shown to have shorter telomere lengths than healthy controls (Wiemann 
et al., 2002; Steer et al., 2007; van der Harst et al., 2007; Albrecht et al., 2014; 
Liu et al., 2014; Guan et al., 2015). 
 
 
Cadile et al. (2007) measured the telomere length of 57 solid-tissue tumour 
samples, 40 normal tissue samples from 12 healthy dogs and 4 blood samples from 
blood donor dogs.  The mean telomere length was 19.0kb in both the tumour 
samples and healthy tissue samples, however there was a larger variability in 
telomere length in the tumour samples.  Yazawa et al. (2001) compared telomere 
length in 27 mammary gland tumour samples to 12 normal mammary gland samples 
and found there was no significant difference between the two groups.  However, 
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in normal tissue, age was significantly negatively related to telomere length, 
whereas there was no significant association between age and telomere length in 
the tumour samples. 
 
 
Aside from telomere length in tumours, no studies regarding telomere length and 
chronic disease in dogs could be found.  However, an association between 
telomere length and chronic kidney disease (CKD) in cats has been documented 
(Quimby et al., 2013).  Telomere length was measured in samples of proximal and 
distal tubular epithelial cells from 12 cats with CKD, 12 young healthy cats of mean 
age 2.7, and 6 old healthy cats, with a mean age of 11.5.  Reduced telomere 
length was observed in CKD cats compared to both the young and old healthy cats. 
 
 
No studies could be found regarding telomere length and canine obesity.  
Although, with 20.4% of dogs being obese and 38.9% being overweight in 696 dogs 
attending five veterinary practices in the UK (Courcier et al., 2010), it is worth 
considering adiposity as a potential factor for telomere length variation.  Examples 
of the relationship between obesity and telomere length are described in Chapter 
7. 
 
 
 Heritability of telomere length 
Studies have been undertaken in humans examining to what extent telomere 
length is inherited and how much environmental factors influence, using twin 
studies and parent/offspring studies.  Paternal age has been shown to positively 
relate to offspring telomere length (e.g. Eisenberg, Hayes and Kuzawa, 2012; Broer 
et al., 2013).  However, in terms of heritability of telomere length there is mixed 
evidence as to whether maternal or paternal telomere length has a stronger 
influence.  Nawrot et al. (2004) found a strong correlation between father’s and 
daughter’s telomere length but not father’s and son’s, but a strong correlation 
between mother’s telomere length and both son’s and daughter’s telomere length.  
This lead them to suggest an X-linked inheritance of telomere length.  Whereas, 
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Njajou et al. (2007) observed a stronger relationship between paternal and 
offspring telomere length, than maternal and offspring telomere length.  They also 
observed a positive relationship between daughter’s telomere length and paternal 
lifespan, but not maternal lifespan.  
 
 
In a study of 123 human monozygotic and dizygotic twins, results indicated that 
78% heritability for LTL (Slagboom, Droog and Boomsma, 1994).  Hjelmborg et al. 
(2015) measured LTL in 355 monozygotic and 297 dizygotic same-sex twins.  They 
found a lower heritability estimate that Slagboom et al of 64%, and 22% due to 
shared environment effects.  Heritability of telomere attrition rate was estimated 
to be 28%, and 72% of attrition was estimated to be linked to individual 
environment effects.  This may indicate that a large proportion of telomere length 
would be determined in the dogs in this thesis by genetic factors such as breed, 
but environmental factors like ETS exposure may have a larger determining role in 
telomere length attrition.  
 
 
Aside from parental inheritance, dog breeds are genetically divergent and 
telomere length may vary between breeds.  When LTL was measured in 22 
Labrador retrievers, 17 miniature schnauzers and 8 beagles, a significant breed 
effect was observed (McKevitt et al., 2002). 
 
 
 Sex and telomere length 
A sex effect on telomere length has been found in many studies.  Female human 
newborn LTL was significantly longer than male newborn LTL in 490 infants 
(Factor-Litvak et al., 2016), and non-significantly longer in females in a further 
study on 168 infants (Okuda et al., 2002).  Female human adults are commonly 
found to have longer LTL than their male counterparts (e.g. Nordfjäll et al., 2008; 
Ahola et al., 2012; Steenstrup et al., 2013; Chen et al., 2014; Berglund et al., 
2016).   
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Two studies have described the relationship between sex and telomere length in 
dogs.  Fick et al. (2012) found a significant negative relationship between LTL and 
age.  However, when stratified by sex, the relationship was no longer significant in 
females, but was still significant in males.  In contrast, in a recent study measuring 
LTL in 89 Chihuahuas, when the significant negative relationship with age was 
stratified by sex, the relationship only remained significant in females (Buddhachat 
et al., 2017). 
 
 
 Cephalic Index 
The cephalic index (CI) is a ratio of skull width to skull length.  Brachycephalic 
dogs, i.e. those with a short muzzle, have a high cephalic index.  For example, in 
breed data gathered at dog shows in Australia, pugs had a mean CI of 98.54, 
whereas greyhounds, a long nosed or dolichocephalic breed, had an average CI of 
46.34 (McGreevy et al., 2013). 
 
 
No data could be found on telomere length and cephalic index.  However, in a 
survey of purebred dogs in the UK, dogs with very high cephalic indexes appeared 
to have a lower median age of death, when compared to other dogs in their own 
weight category (five weight groups were used: toy, small, medium, large, giant).  
Pugs and French bulldogs, who have a high CI, were in the “small” weight group 
and were found to have a median age of death of 11 and 9 years, respectively.  
Other dogs in this weight category without a high cephalic index and corresponding 
median age of death included: dachshund, 12.67 years, Border terrier, 14 years, 
and Lhasa Apso- 14.33 years.  In the medium weight group, the English bulldog, 
another high CI breed, had a median age of death of only 6.29 years of the 180 
deaths surveyed, compared to 12.25 years in 106 Border collies (Adams et al., 
2010).   
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Brachycephalic dogs have been shown to be prone to upper respiratory disorders, 
specifically brachycephalic airway obstructive syndrome and gastrointestinal 
disorders, namely reflux oesophagitis and hiatus hernia (Koch et al., 2003; 
Lecoindre and Richard, 2004).  Chronic disease states have been linked to 
shortened telomere length.  Dolichocephalic dogs have also been demonstrated to 
be prone to their own issues.  As described in Section 1.3, dolichocephalic dogs 
were found to be at higher risk of nasal cancer when exposed to very high levels of 
environmental tobacco smoke, whereas short and mid length muzzle dogs were not 
(Reif, Bruns and Lower, 1998).  It could be speculated that this may equate to 
these dogs being more sensitive to telomere erosion due to airborne environmental 
factors.   
 
 
 Inbreeding 
In pure breed dogs, there is a limited sized population and therefore an inevitable 
degree of inbreeding.  Selecting within breeds on the basis of certain desirable 
traits leads to further inbreeding, as two individuals are selected for this purpose 
are more likely to be related than two dogs selected at random (Lewis, 
Abhayaratne and Blott, 2015).  Leroy et al. (2015) used French Kennel Club data to 
investigate the effect of inbreeding on 7 dog breeds.  They found a negative 
correlation between degree of inbreeding and percentage who survived to 2 years 
of age.  
 
  
In mice, when several in-bred and out-bred lines were compared, in-bred mice had 
significantly longer LTL than out-bred mice.  If the mice were crossed, the 
offspring had LTL intermediate to that of the parents (Manning et al., 2002).  No 
correlation between LTL and inbreeding was found in a group of human subjects by 
Mansour et al. (2011), when DNA polymorphisms and family history were used to 
determine inbreeding.   
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The effective population size was a concept in genetics first discussed by Wright 
(1931).  The population number is rarely directly proportional to the amount of 
genetic drift.  The amount of genetic drift in a population is proportional to the 
effective population size.  The population loses genetic diversity when the 
effective population size is less than 100 and the measure can be used as a marker 
of inbreeding level (Lewis, Abhayaratne and Blott, 2015).  Registration data has 
been used to generate the estimated effective population size (EEPS) for many UK 
dog breeds, and these are available on the Kennel Club UK website (The Kennel 
Club Limited, 2016). 
 
 
 Intraindividual synchrony of telomere length 
While wide inter-individual variations in telomere length exist, intra-individual 
synchrony in telomere length among cells from different tissues has been 
demonstrated in several studies across species and ages.  Intra-individual 
synchrony in telomere length was observed in human newborns among leukocytes, 
umbilical artery cells and skin cells (Okuda et al., 2002), in 11 tissues from 
foetuses aged 15 to 19 weeks (Youngren et al., 1998), in cerebral cortex, 
myocardium, liver and renal cortex of human autopsy cases which were neonates 
to over 100 years old (Takubo et al., 2002), in skeletal muscle, fat, leukocytes and 
skin of rhesus macaques (Smith Jr et al., 2011) and in leukocytes, fat and skeletal 
muscle of 83 dogs aged 4 to 42 months (Benetos et al., 2011). 
 
 
 Longitudinal measurements 
As well as telomere length varying between individuals, the rate of telomere 
attrition is also dependent on the individual.  In addition, the rate of attrition 
varies across the lifespan within individuals.  Telomere length change in leukocytes 
has been demonstrated to vary with age, with there being a faster rate of loss 
early in life during growth and development, followed by a slow in the dynamic 
later in life.  This may be explained by that, in humans, haematopoietic stem cells 
replicate around 17 times in the first year of life, roughly 2.5 times a year between 
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ages 3 and 13, and only 0.6 times a year in adults (Sidorov et al., 2009).  For 
example, Zeichner et al. (1999) demonstrated that in 9 different infants the rate 
of loss of LTL was 270 base pairs per year, roughly 4 times that of human adults.  
In addition, this was demonstrated in lymphocytes and granulocytes from cats.  
Samples were taken at 2 week intervals in newborn kittens, a 2 year old and 10 
year old cats.  Telomere shortening was most rapid in the newborn kittens 
(Brümmendorf et al., 2002). 
 
 
Baseline telomere length in longitudinal studies can also affect subsequent 
measures in individuals.  Telomere attrition rate has been shown to be inversely 
correlated with telomere length at baseline (e.g. Nordfjäll et al., 2009), with 
those with the longest initial telomere lengths undergoing a larger attrition.  
Verhulst et al. (2013) investigated whether this pattern stemmed from a statistical 
artefact, namely regression to the mean.  Regression to the mean (RTM) occurs 
where repeated measures are made on the same subject.  Simply put, if an 
observation is made which is relatively very high or low, it is likely to be followed 
by an observation closer to the subject’s true mean  (Barnett, Pols and Dobson, 
2005).  Velhurst et al found that the rate of telomere attrition was based on the 
first LTL measure, but correcting for RTM reduced the slope of the relationship by 
57%. 
 
 
 Telomere length in minimally proliferative tissues 
Telomere length in cells of minimally proliferative or post mitotic tissues have 
been shown to be longer than those of highly proliferative cells in several species 
(e.g. Takubo et al., 2002; Gardner et al., 2007; Smith Jr et al., 2011).  It has been 
hypothesised that by comparing telomere length in post mitotic tissues, such as 
those that form the brain, heart and skeletal muscle (Campisi and d’Adda di 
Fagagna, 2007), to telomere length in a highly proliferative tissue in an individual, 
this could provide information on telomere length dynamics over the individual’s 
life course.  This model has been applied to macaques (Smith Jr et al., 2011), 
humans (Daniali et al., 2013) and dogs (Benetos et al., 2011). 
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In 71 rhesus macaques, skeletal muscle telomere length was not related to age, 
but the difference between leukocyte and muscle telomere lengths was 
significantly related to the age of the individual.  The difference in telomere 
length between the two tissues increased with age (Smith Jr et al., 2011).  
Whereas, in the study using human samples, in 87 individuals aged 19 to 77, while 
telomere length was longest in skeletal muscle and shortest in leukocytes 
(telomere lengths of skin and subcutaneous fat cells were also measured), the 
difference between leukocyte and skeletal muscle was not related to age.  In 
addition, they found a similar level of decline in telomere length in all tissues with 
age (Daniali et al., 2013). 
 
 
The Benetos et al (2011) study involved 83 dogs aged 4 to 42 months of a wide 
range of breeds.  58% were female.  The dogs underwent a neutering surgical 
procedure, and samples of blood, subcutaneous fat and skeletal muscle (cremaster 
muscle in the males, rectus abdominis muscle in the females) were collected.  
Telomere length was measured in the 3 tissues by TRF analysis (see Section 4.3.1 
for details of this method).  Telomere length was significantly shorter in 
leukocytes than skeletal muscle and fat, but it was not significantly different in fat 
and skeletal muscle samples.  Telomere lengths varied by approximately 6kb 
within individuals, but were highly synchronised within individuals (i.e. those with 
long skeletal muscle telomere length also had long leukocyte and fat telomere 
lengths and vice versa).  Skeletal muscle and fat telomere lengths were not 
significantly related to age, but LTL was significantly negatively related to dog 
age, with age explaining 6% of the variation in LTL.  The difference between 
leukocyte and muscle telomere lengths by age was then examined.  As can be seen 
in Figure 1.4A, the difference significantly increased with age.  The data are 
displayed as leukocyte minus skeletal muscle telomere length on the y axis to 
generate an equivalent graph to the single tissue telomere length by age plots.  
Age explained 43% of the variation in leukocyte minus skeletal muscle telomere 
length.  Repeating this analysis using fat in place of skeletal muscle, resulted in 
age only explaining 14.2% of the variation in telomere length difference.  In 
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addition, the rate of change between skeletal muscle and leukocyte telomere 
lengths with age was examined (Figure 1.4B).  The relationship showed a faster 
rate of change in telomere length between the tissues at younger ages.   
 
 
There has been criticism about this model as skeletal muscle is capable of some 
repair and regeneration, which may impact telomere length.  However, this repair 
is undertaken by satellite cells, which are distinct from the muscle cells 
themselves (Dellavalle et al., 2007).  In addition, some studies have found 
telomere shortening in skeletal muscle.  For example, in male CAST/Ei mice, 
oxidative stress resulted in significant telomere shortening in isolated muscle 
fibres (Ludlow et al., 2014).  Venturelli et al. (2014) measured telomere length in 
arm and leg skeletal muscle in young, old mobile and old immobile human 
subjects.  They found no relationship between age and arm skeletal muscle 
telomere length.  However, leg skeletal muscle telomere length was negatively 
associated with age.  Free radical concentration was highest in leg muscle of the 
old immobile group, and free radical concentration was significantly negatively 
associated with age. 
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A 
B 
Figure 1.4 Difference in tissue telomere length by age 
A significant negative association was observed between leukocyte minus 
muscle TRF and age in months (A), and a negative curvilinear relationship was 
observed between muscle minus leukocyte TRF divided by age in months and 
age (B).  The plot in B displays the slowing in rate of change between TRF in the 
two tissues with age.  Copied with permission from Benetos et al. (2011) 
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 Biochemical and haematological measures and telomere 
length 
 Renal function and electrolytes 
Blood sodium, potassium, chloride, calcium, phosphate, urea and creatinine 
concentrations are routinely measured in dogs attending the University of Glasgow 
Small Animal Hospital.  Estimated glomerular filtration rate (eGFR) is regularly 
used as a means of assessing renal function in human medicine, with a smaller 
eGFR indicating poorer renal function level (Cockcroft and Gault, 1976).  The 
majority of studies examining renal function and telomere length use this measure.  
Raschenberger et al (2013) found a significant positive correlation between LTL 
and eGFR, whereas Huzen et al (2014) found no correlation.  In addition, Melk et 
al. (2000) found no association between GFR and telomere length measured in 
human kidney samples.  Neuner et al. (2015) and Huzen et al. (2014) found no 
significant correlation between LTL and creatinine concentration, which was also 
the case for a study by Maeda et al (2011), who in addition found no correlation 
between sodium or potassium concentration and LTL.   
 
 
While no information could be found regarding phosphate levels and telomere 
length, it has been shown that there is a strong negative correlation between 
species average serum phosphate and life expectancy in a wide range of mammals 
(Kuro-o, 2010). 
 
 
 Liver function 
The liver enzymes routinely measured in dog blood samples at the Small Animal 
Hospital are alkaline phosphatase (ALKP), aspartate transaminase (AST), alanine 
transaminase (ALT) and gamma-glutamyl transaminase (GGT).  In a group of human 
patients with hepatitis C, ALT and AST were significantly negatively correlated 
with CD4+ and CD8+ telomere lengths (LTL) when the patients were not receiving 
pegylated-interferon-alpha plus ribavirin treatment, but no correlation was found 
in a second group of patients who did receive the treatment (O’Bryan et al., 
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2011).  In a group of female human patients with hypertension, there was no 
significant correlation between LTL and AST, ALT or GGT levels (Maeda et al., 
2011). 
 
 
 Albumin and globulin 
No significant correlation was found between LTL and albumin in a group of 500 
male Caucasians (Raschenberger et al., 2013), whereas in a group of female 
patients there was a significant positive correlation LTL and both albumin and 
albumin:globulin ratio, and a significant negative correlation between LTL and 
globulin (Maeda et al., 2011). 
 
 
 Cholesterol, triglycerides and glucose 
In the same study as previously mentioned, Maeda et al. (2011) elicited no 
significant correlation between LTL and LDL or HDL cholesterol, nor with 
triglycerides or fasting blood glucose.  In the study of 500 male Caucasians, there 
was a significant positive correlation between LTL and HDL-cholesterol, but no 
correlation between LTL and total cholesterol.  There was a significant negative 
correlation with glucose levels (Raschenberger et al., 2013).  In a group of 343 
adults, cholesterol and glucose were significantly negatively correlated with LTL, 
but not with triglycerides (Neuner et al., 2015).  In a further group of 8074 adults, 
glucose, cholesterol and also triglycerides were significantly negatively correlated 
with LTL (Huzen et al., 2014).  In contrast, in a cohort study of 382 Glaswegian 
adults, there was a significant positive correlation between LTL and blood 
cholesterol level (Shiels et al., 2011). 
 
 
 Haemoglobin and erythrocytes 
In a group of over 3000 adults, there was a significant negative correlation found 
between LTL and haemoglobin concentration, mean cell volume (MCV) and red cell 
distribution width (RDW) (Kozlitina and Garcia, 2012).  De Meyer et al. (2008) also 
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observed a negative correlation between LTL and MCV, but a significant positive 
correlation between LTL and red blood cell count (RBC).  Neuner et al. (2015) 
noted a significant positive correlation between LTL and RBC as well, in addition, 
they observed a significant positive correlation between LTL and haemoglobin 
concentration and haematocrit percentage.  No correlation was found between LTL 
and MCV, mean cell haemoglobin (MCH) or mean cell haemoglobin concentration 
(MCHC).  Meyer et al. (2016) adjusted the haematological parameters for age and 
BMI, in their study using samples from humans aged 60 to 84 years, and then found 
a significant negative correlation between both MCH and MCHC and LTL, but in 
men only.  RBC was found not to correlate with LTL in a group of laboratory mice 
(Hao et al., 2005). 
 
 
 Leukocytes 
Multiple studies have observed a significant positive correlation between LTL and 
leukocyte count (Hao et al., 2005; Gutmajster et al., 2013; Neuner et al., 2015).  
When the white cell differential was examined by Gutmajster et al. (2013), the 
only type of white cell which significantly correlated with LTL was basophils.  In 
contrast, several studies found no correlation between LTL and white cell count 
(Satoh et al., 1996; De Meyer et al., 2008; Maeda et al., 2011; Kozlitina and 
Garcia, 2012; Meyer et al., 2016). 
 
 
It has been observed that the rate of telomere shortening varies between types of 
leukocyte.  Brümmendorf et al. (2002) examined feline lymphocytes and 
granulocytes, measuring telomere length by flow-FISH.  They found age-dependent 
telomere attrition was faster in lymphocytes than in granulocytes.  This finding 
was also seen in human samples by Rufer et al. (1999).  In contrast, in another 
study in humans, across a range of ages telomere length declined at a similar rate 
in neutrophils and T lymphocytes.  In addition, telomere lengths in T cells were on 
average 372 base pairs longer than in neutrophils (Robertson et al., 2000).  This 
difference in length was similar to that found by Terasaki et al. (2002), who 
observed an average 310 base pair difference.  They also noted a similar attrition 
61 
 
rate in telomere length between the two cell populations.  Differences in 
lymphocyte subpopulations have also been observed (e.g. Lin et al., 2010), 
however data on lymphocyte subpopulation levels will not be available in the dogs 
in this thesis, so the details will not be given here.   
 
 
With the differences in telomere length of leukocyte cell populations in mind, the 
neutrophil to lymphocyte and lymphocyte to monocyte ratios was examined 
against telomere length in this thesis.  In addition to the differences noted in 
telomere length between the cell types in previous studies, both neutrophil to 
lymphocyte ratio and lymphocyte to monocyte ratios have been found in multiple 
human studies to predict cancer survival rate (e.g. Walsh et al., 2005; Porrata et 
al., 2012; Proctor et al., 2012).  A recent study in dogs showed that neutrophil to 
lymphocyte ratio was significantly increased in dogs with soft tissue sarcoma 
compared to benign soft tissue tumours (M. J. Macfarlane et al., 2016). 
 
 
 Platelets 
Significant positive correlations were observed between LTL and platelet count by 
Hao et al. (2005) and Kozlitina and Garcia (2012).  No correlation was observed 
between LTL and platelet count in two further studies (Maeda et al., 2011; 
Gutmajster et al., 2013).  
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 Psychological stress and telomere length 
Psychological stress has been found to be associated with increased levels of 
oxidative stress in multiple species.  For example, increased levels of oxidative 
stress markers were found in mice subjected to whisker removal and male 
Sprague-Dawley rats exposed to “conditioned emotional stimuli” by being housed 
next to rats being intermittently electrically shocked (Adachi, Kawamura and 
Takemoto, 1993; Wang et al., 2007).  However, no significant differences were 
found in oxidative stress or inflammation markers between humans diagnosed with 
major depressive disorder and controls.  Yet, the duration of the illness was 
significantly inversely related to LTL, as was oxidative stress markers in both 
controls and cases (Wolkowitz et al., 2011). 
 
 
In humans, significantly shorter LTLs have been demonstrated in association with 
psychological stressors such as intimate partner violence (Humphreys et al., 2012), 
being diagnosed with a mood disorder (Simon et al., 2006), and being a caregiver 
to a chronically ill child (Epel et al., 2004).  In addition, in the Epel et al study, a 
numerated level of perceived stress and years of caregiving for a chronically ill 
child were both significantly positively related to oxidative stress index.  However, 
Parks et al. (2009) found no significant association between perceived stress level 
and LTL in women aged 35 to 74.  Yet, there was a significant relationship with 
LTL in those with both higher perceived stress and above average urine 
catecholamine concentration, indicating there was an interaction between 
biological and psychological factors at play. 
 
 
Psychological stressors have also been found to be related to telomere length in 
other species.  For example, significantly shorter telomere lengths were found in 
singly-housed than pair-housed African grey parrots, a highly sociable bird 
(Aydinonat et al., 2014).  Offspring of wild caught house mice that were kept in 
crowded conditions by not removing subsequently produced offspring had 
significantly shorter telomere length than controls kept in non-crowded conditions 
(Kotrschal, Ilmonen and Penn, 2007).  No studies could be found regarding 
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psychological factors and telomere length in dogs.  However, in a study examining 
relationships between anxiety, fear and health and lifespan in dogs, stranger 
directed fear was related to shorter lifespan (Dreschel, 2010).  
 
 
 Socioeconomic status and telomere length 
 Examples of the association between socioeconomic status and 
telomere length 
While measures such as employment status may not be measurable in dogs, there 
have been studies looking at the effect of parental socioeconomic factors on child 
telomere length and the effects found in children may potentially be similar in 
dogs.  The West of Scotland Twenty-07 Study is a cohort study examining the social 
factors which potentially contribute to health inequalities, with individuals divided 
into group based on if they were born in the 1970s, 1950s or 1930s (Benzeval et 
al., 2009).  The study investigated if social factors from when the participants 
were age 15 impacted adult LTL.  In the 1970s cohort only, there was a significant 
positive association between parental social class and adult LTL.  For the 1970s 
and 1950s groups, if the family owned a car when they were 15 they had a 
significantly longer adult telomere length (Robertson et al., 2012).   Theall et al., 
(2013) found that children living in neighbourhoods perceived to have high levels 
of disorder had significantly shorter salivary telomere length than those who did 
not live in such a neighbourhood.  Factors contributing to a label of “high disorder” 
included presence of strewn garbage, broken glass, vacant buildings and graffiti.  
Mitchell et al. (2014) examined saliva telomere length and social factors in forty 9 
year old boys who participated in the Fragile Families and Child Wellbeing Study.  
Living in a disadvantaged environment resulted in significantly shorter telomere 
length, while increased parental income and having a mother with at least some 
postsecondary education (versus less than a high school education) resulted in 
significantly longer telomere length.   
 
 
64 
 
In contrast, other studies did not find a link between family socioeconomic factors 
and child telomere length.  In the Newcastle Thousand Families Study, adult LTL  
was not associated with social class at birth (Adams et al., 2007).  Asok et al. 
(2013) found no association between buccal cell telomere length in children and 
household income. 
 
 
 Scottish Index of Multiple Deprivation 
The Scottish Index of Multiple Deprivation (SIMD) is a measure produced by the 
Scottish government which ranks areas of Scotland from most deprived (rank 1) to 
least deprived (rank 6,505).  It is based on a combination of measures of income, 
employment, health, education, skills and training, housing, geographic access and 
crime (The Scottish Government, 2012).  The Scottish Neighbourhood Statistics 
government website, www.sns.gov.uk, can be used to obtain measures of 
deprivation at a postcode level.  In addition, in 2013, in the 20% most deprived 
areas of Scotland as measured by SIMD, 39% of people smoked, compared to 11% of 
people in the 20% least deprived (The Scottish Government, 2015a). 
 
 
 Alternative tissues to blood in telomere length studies 
 Why an alternative to blood is required 
To take a blood sample specifically for a study from a dog, a Home Office licence 
is required.  Dogs, along with primates, cats and equidae, have additional 
protection over other vertebrates (Home Office, 2015) making a project licence 
harder to obtain in these animals.  In addition, there are risks associated with 
blood sampling.  These risks are uncommon, but include injuries to the limb or 
neck, stress to the patient, haematoma at the puncture site, thrombophlebitis, 
bite injuries to the team performing the procedure and failing to obtain a 
sufficient sample (British Small Animal Veterinary Association, 2010; Judah, 2014).  
Clipping fur to expose the vein may lead to dermatitis, so called “clipper rash” 
(Mason, 2004). 
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 Potential alternative tissues to blood for telomere studies 
For a tissue to be a viable alternative to blood for the needs of this study, it 
needed to be able to be obtained without the need for a Home Office licence, to 
be acceptable to owners, the DNA extracted needed to be of sufficient quantity 
and quality for telomere length analysis (see Chapter 4) and preferably to have 
been used in previous studies to successfully demonstrate age-related telomere 
changes.  
 
 
  Buccal mucosa and saliva 
Buccal and saliva samples have previously been used in human telomere studies 
(e.g. Broberg et al., 2005).  The different methods of obtaining oral DNA include: 
oral rinse, whole-saliva, saliva sponge, buccal swab and cytobrush (Rogers et al., 
2007; Mitsouras and Faulhaber, 2009).  Oral rinse and whole-saliva methods would 
not be possible to implement in our study, as oral rinse involves the participant 
“swishing” with mouthwash and whole saliva requires the participant to deposit 
saliva into a cup (Rogers et al., 2007), both of which would be rather difficult to 
get a dog to do. 
 
 
Cytobrushes were used to collect DNA from 3 dogs by Oberbauer et al. (2003).   
The resulting DNA amplified uniformally in PCR of 8 canine microsatellite markers, 
demonstrating the quality of DNA extracted.  Each swab gave enough DNA for at 
least 200 PCR reactions.  In addition, they found owners were more willing to 
include their dogs in a study when buccal samples were requested than when blood 
was asked for.  Mitsouras and Faulhaber (2009) compared DNA yield and quality 
between saliva and buccal swabs in 15 dogs, 3 of whom also had blood samples 
taken for DNA extraction.  To obtain the saliva, they used a specially designed 
sponge which is marketed as being for use in animals.  They found DNA yield from 
saliva was higher than from blood or buccal samples.  Buccal swabs produced, on 
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average, poorer quality DNA as measured by spectrophotometry, compared to 
saliva samples.  Buccal samples have previously been used to measure canine 
telomere length, however the author did not state the method of sampling and did 
not report if age correlated with telomere length or not (Cadile et al., 2007).  
 
 
One disadvantage of using oral samples is the presence of bacteria in the mouth, 
which would be co-extracted with the dog’s cells.  When human saliva and buccal 
swab samples were tested, the percentage of human DNA content ranged from 5.7 
to 100% of the total DNA.  The buccal swabs had a higher proportion of human DNA 
than the saliva samples.  In dogs, this is of particular concern given that when 162 
dogs were examined at post mortem, 63.6% had periodontitis and this rose to 80% 
in dogs aged 6 or over (Hamp et al., 1984).  The plaque seen in this disease 
consists mainly of bacteria in a biofilm (Harvey, 1998). 
 
 
 Nails and fur 
Nails and fur are another potential minimally invasive source of DNA.  However, in 
the case of nails, some dogs dislike and resist having their feet handled, others 
may previously have had their nails cut too short, resulting in pain and bleeding 
(Judah, 2014).  In addition, many dogs would not have long enough claws to collect 
sufficient clippings.  Telomerase is present in high levels in hair follicles (Ramirez 
et al., 1997) and no information could be found on telomerase activity, or 
telomere length, in hair itself or in nails.  Oberbauer et al. (2003) performed DNA 
extractions on dog toenail clippings and found the resulting DNA provided variable 
results when used in PCR, so the DNA quality was poor. 
 
 
 Buccal mucosa and saliva telomere length correlation with age 
Some studies were able to demonstrate a negative correlation between age and 
telomere length using oral DNA samples, others not.  All studies found on a 
literature search were on human samples only.  Hou et al. (2013) measured 
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telomere length in samples collected from 1,234 individuals by an oral-rinse 
method, and found a significant negative correlation between mean telomere 
length and age group.  Shalev et al. (2013) measured telomere length in buccal 
swab samples collected from children at two time points: at age 5 and age 10.  
The mean telomere length of all children at age 10 was significantly shorter than 
the mean telomere length at age 5.  A significant negative correlation was also 
found between age and saliva telomere length by Lahnert (2005), but the author 
did not state the method of saliva collection.  Broberg et al. (2005) measured 
telomere length in samples collected by oral rinse by qPCR in a group of patients 
with bladder cancer and a control group.  An inverse relationship was found 
between age and telomere length only in the bladder cancer cases, not the 
controls.  A similar result was found by Thomas, O’ Callaghan and Fenech (2008), 
who measured telomere length in samples collected using a small headed 
toothbrush against the inside of the cheek.  A significant negative correlation 
between age and telomere length was found in individuals with Alzheimer’s 
disease, but not the study control group. 
 
 
 Telomerase reverse transcriptase 
 TERT function 
Telomerase is an enzyme found universally in eukaryotes.  It is a ribonucleoprotein 
which depends on two parts: telomerase reverse transcriptase (TERT) and 
telomerase RNA (TERC), in order to synthesise telomere repeats and lengthen 
telomeres (Liu et al., 2000; Li and Liu, 2002).  The TERC sequence is 
complementary to the telomere repeat sequence of TTAGGG. 
 
 
TERT is required for development.  TERT deficient embryonic mouse stem cells 
exhibited genome instability, aneuploidy and telomeric fusions (Liu et al., 2000).  
TERT and TERC are both expressed in human embryonic stem cells, but then are 
downregulated during the differentiation process (Yang et al., 2008).   
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In non-embryonic cells, TERT expression is associated with cell survival and 
proliferation.  In a study of TERT knockout zebrafish, impaired cell proliferation 
was present, as demonstrated by the S-phase marker PCNA (proliferating cell 
nuclear antigen) and a lack of spermatogenesis in testes.  In addition, an increase 
in cell senescence marker β-galactosidase in testes, kidney marrow and gut was 
seen relative to wild type fish.  The lack of TERT and therefore telomerase 
resulted in a p53 mediated DNA damage dependent pathway being activated, 
leading to cell cycle arrest and apoptosis.  The knockout fish died prematurely 
compared to wild-type fish (Henriques et al., 2013).  MYC proto-oncogene encodes 
the c-MYC transcription factor and is involved in cell proliferation and 
differentiation.  The TERT promoter contains multiple c-MYC binding sites, and 
therefore c-MYC can increase telomerase activity through TERT binding (Greenberg 
et al., 1999; Wu et al., 1999).  In addition, in vitro TERT is activated by both 
epidermal growth factor and insulin growth factor-1 (Maida et al., 2002; Wetterau 
et al., 2003).  Furthermore, telomerase activity is regularly found in tumours.  In 
27 canine mammary gland tumours, 26 had detectable telomerase activity, 
compared to 4 out of 12 normal mammary tissue samples (Yazawa et al., 2001). 
 
 
 TERT and age 
No studies could be found on TERT and age, however the whole telomerase protein 
has been shown to decline with age in normal human T and B cells (Hiyama et al., 
1995; Lin et al., 2015).  In addition, when telomerase activity was measured in 
leukocytes obtained from 124 healthy humans aged 4 to 95, a progressive decline 
in activity was seen between ages 4 and 39, and those 40 and over either showed 
stable but very low activity or had no detectable activity (Iwama et al., 1998). 
 
 
 TERT and breed 
While it has been suggested that dog breed influences telomere length (Section 
1.8.3), breed may not influence TERT.  When the TERT gene of 10 dogs each of 
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four breeds, Shih Tzu, Dachshund, Irish wolfhound and Newfoundland were 
sequenced, polymorphisms did not segregate by breed, and therefore the authors 
suggested that polymorphic diversification of TERT preceded breed derivation 
(McAloney et al., 2014). 
 
 
 CDKN2A 
 CDKN2A and the cell cycle 
 
Figure 1.5 Cell cycle 
Copied from Harper and Brooks (2005) with permission.  The cycle is split into mitosis (M), the 
two gap phases (G1/G2) and synthesis phase (S).  3 checkpoints exist, represented by the 
shaded bars. 
 
 
Figure 1.5 shows the stages of the cell cycle, which is split into interphase, 
consisting of G1, S and G2, and mitosis.  Progression through the cycle is regulated 
through cyclin-dependent kinases (CDKs) (Lees, 1995; Vermeulen, Van Bockstaele 
and Berneman, 2003).  Of the nine identified CDKs, five have been demonstrated 
to be active during the cell cycle: CDK4, CDK6 and CDK2 in G1, CDK2 in S and CDK1 
in M phase.  Different cyclins bind to the CDKs at set points in the cycle.  One of 
the ways the CDKs are regulated is the binding of CDK inhibitors, either to a CDK 
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alone, or to a CDK-cyclin complex.  The INK4 (inhibitor of CDK4) family includes 
p15(INK4b), p16(INK4a), p18(INK4c) and p19(INK4d) (Harper and Brooks, 2005).  
p16(INK4a) is also known as CDKN2A (cyclin dependent kinase inhibitor 2A) and was 
examined in this thesis. 
 
 
When active, CDKs phosphorylate downstream proteins, the most widely studied of 
which is the product of the retinoblastoma tumour suppressor gene (Rb) (Kato et 
al., 1993; Morgan, 1995).  The activation of cyclin D-CDK4 and cyclin D-CDK6 
complexes results in phosphorylation of Rb protein pockets, which is essential for 
G1 progression.  Cells in G1 can enter G0 resting state.  Cells in G0 may be 
quiescent, senescent or postmitotic.  Quiescent cells can resume proliferation in 
response to cellular signals.  Both senescent and postmitotic cells have lost the 
ability to divide (Campisi and d’Adda di Fagagna, 2007; Gewirtz, 2013).  As 
CDKN2A inhibits CDK4, upregulation of this inhibitor prevents cells from 
progressing past G1.  CDKN2A normally has minimal expression in adult tissues, but 
levels rise when cellular stress occurs and in senescence, but not in quiescent or 
post mitotic cells (Alcorta et al., 1996; Hara et al., 1996).  Ectopic expression of 
CDKN2A in human lung fibroblasts in vitro resulted in cell cycle arrest and 
senescence (Zhu et al., 1998).  In addition, inactivation of CDKN2A in vitro human 
fibroblasts caused a delay in senescence compared to dermal fibroblast controls 
(Brookes et al., 2004). 
 
 CDKN2A, age and morbidity 
There is a measurable increase in senescent cells in vivo with age (Dimri et al., 
1995), and thus an increase in CDKN2A with age.  As well as age, increasing 
CDKN2A levels have been associated reduced organ function and presence of 
disease.  For example, in human kidney tissues from adults aged 21 to 80, CDKN2A 
expression increased with age and was higher in rejected kidney grafts than 
healthy kidneys (Chkhotua et al., 2003).  In human skin biopsies from groups of 
ages (0 to 20, 21 to 70, 71 to 95) there was a significant upregulation of CDKN2A in 
the elderly group (Ressler et al., 2006).  In human whole blood, expression of 
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CDKN2A exponentially increased with donor age, and also was associated with 
plasma interleukin-6, a marker of human frailty (Y. Liu et al., 2009).  Furthermore, 
when apoptosis was induced in CDKN2A-expressing cells of wild type mice, lifespan 
was extended, tumorigenesis was delayed and age-related deterioration of several 
organs was attenuated (Baker et al., 2016). 
 
 
No studies could be found examining age-related changes in CDKN2A in dogs.  
However, links have been demonstrated between CDKN2A and canine cancer.  For 
example, CDKN2A expression was absent or reduced compared to normal tissue in 
6 of 7 canine melanoma cell lines and 21 of 26 spontaneous canine melanoma 
tissue samples (Koenig et al., 2002).  In addition, cancer associated loci have been 
found near CDKN2A in 96% of histiocytic sarcoma affected Bernese Mountain Dogs 
(Shearin et al., 2012). 
 
 
 Aryl hydrocarbon receptor 
The aryl hydrocarbon receptor (AHR) is part of the pathway responsible for the 
mediation of toxicological effects of selected halogenated and polycyclic aromatic 
hydrocarbons, which are found in, for example, cigarette smoke and smog.  When 
unbound, the AHR remains in the cytoplasm as part of a complex.  Binding of a 
hydrocarbon ligand results in the release of AHR from the complex, and the AHR 
then associates with the AHR nuclear translocator protein (ARNT) (Hankinson, 
1995).  The AHR/ARNT dimer can bind to xenobiotic-responsive elements (XRE) in 
DNA, which leads to transcription of AHR target genes (Abel and Haarmann-
Stemmann, 2010).  
 
  
When a chemical activates the AHR, this leads to upregulation of AHR-mediated 
genes, which are primarily genes involved in the detoxification of the chemical 
(Puga, Ma and Marlowe, 2009).  Although, one of the genes governed by the AHR-
ARNT dimer is the AHR repressor (Ahrr) gene, activation of which leads to negative 
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feedback of AHR expression (Baba et al., 2001).  In addition, depending on the 
particular ligand which is taken up by the receptor can affect whether the AHR 
itself is upregulated or downregulated, which can also vary by tissue and by 
organism.  For example, benzo[a]pyrene was observed to downregulate AHR in 
cultured mouse embryo fibroblasts, but AHR mRNA was increased in the liver of 
mice exposed to the hydrocarbon 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene 
(Maglich et al., 2002; Kann et al., 2005). 
 
 
Two of the target genes of AHR, P4501A1 and P4501A2, are part of the cytochrome 
P450 family.  When substrates such as 2,3,7,8-Tetrachlorodibenzodioxin (TCDD) are 
metabolised by these enzymes, there is subsequent reactive oxygen metabolite 
mediated oxidative stress.  This was demonstrated by Park, Shigenaga and Ames 
(1996), who found a marked elevation in excretion of 8-oxoguanine when CYP1A1 
was induced in a hepatoma cell line (Hepa1c1c7).   
 
 
While the AHR is involved in the mediation of hydrocarbons, the levels of AHR are 
actually affected more by biological factors than chemical ligands.  Studies have 
shown links between AHR and the cell cycle, with changes being associated with 
ageing and cancer.   
 
 
When exposed to TCDD, AHR has been demonstrated to form complexes with the 
retinoblastoma (Rb) protein.  AHR appears to act synergistically with Rb to slow 
cell cycle progression, by repressing E2F-dependent transcription (Puga et al., 
2000).  Hepatoma cells from AHR-negative mice and human hepatoma cells 
transfected with AHR siRNA demonstrate a delay between G1 and S phases of the 
cell cycle (Ma and Whitlock, 1996; Abdelrahim, Smith and Safe, 2003).  In the 
absence of a ligand, functional AHR plays a role in cell cycle progression, not 
slowing.  Transgenic mice with constitutively active AHR have been seen to 
develop stomach and liver tumours (Andersson et al., 2002; Moennikes et al., 
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2004).  In addition, AHR was upregulated in canine mast cell tumours, mammary 
tumours and osteosarcomas compared to control tissues (Giantin et al., 2013). 
 
 
In Caenorhabditis elegans, AHR-deficiency resulted in an increased mean life span 
compared to wild-type strains (Eckers et al., 2016).  In terms of age-related 
change, AHR mRNA expression significantly decreased in C3H/a male mice at 26 
month old of age compared to 3 months olds (Mikhailova, Gulyaeva and Filipenko, 
2005).  In Sprague-Dawley rats, hepatic and lung AHR protein levels increased 
rapidly after birth until day 21 of life, then slowly declined with age (Carlstedt-
Duke et al., 1979; Gasiewicz, Ness and Rucci, 1984).  No studies could be found 
regarding AHR and age in dogs. 
 
 
 Sirtuin 1 
The sirtuins are a group of proteins found in all organisms, all of which are 
orthologues of the yeast protein, silent inflammatory regulator 2 (Sir2) (Rine et 
al., 1979).  Seven have been defined in humans, named numerically sirtuin 1 to 7 
(Michishita et al., 2005).  Sir2 activity is regulated by changes in cellular ratio of 
nicotinamide adenine dinucleotide (NAD+) to the reduced form, NADH, or level of 
nicotinamide (Blander and Guarente, 2004).  The conversion of NAD+ to NADH is 
important in metabolic pathways, with NADH serving as an energy transfer 
intermediate (Verdin, 2015).  NAD+ levels reduce with age.  In C. elegans, 
reduction of NAD+ results in a loss of worm lifespan (Mouchiroud et al., 2013).  
 
 
Calorie restriction has been demonstrated to increase lifespan in several species, 
including mice (Weindruch and Walford, 1982), rhesus monkeys (Colman et al., 
2009) and dogs, namely Labrador retrievers (Kealy et al., 2002).  Transgenic mice 
that overexpressed sirtuin 1 (SIRT1) displayed similar phenotypes to mice on a 
calorie-restricted diet.  They were leaner than control mice and displayed better 
glucose control (Bordone et al., 2007).  Theories suggest the link between calorie 
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restriction and increased lifespan is due to a decrease in NADH, which increases 
the ratio of NAD+ to NADH and activates SIRT1 as a result (Lin et al., 2004).  In 
yeast, it was demonstrated that Sir2 alone does not increase lifespan, NAD+ is also 
required (Lin, Defossez and Guarente, 2000).  
 
 
Sirtuins are involved in several cellular pathways.  They act to deacylate lysines 
from proteins and peptides, so their effects are wide reaching.  For example, DNA 
damage leads to acetylation of p53, causing p53 to be activated and subsequent 
cellular growth arrest or apoptosis.  SIRT1 was shown to deacetylate p53 in vitro, 
thus preventing apoptosis in the cell (Vaziri et al., 2001; Kume et al., 2006).  The 
ability of SIRT1 to aid in cell survival is also seen in some cancers.  In a 
hepatocellular carcinoma cell line, SIRT1 was demonstrated to be overexpressed 
compared to normal liver, and interacted with TERT to maintain telomeres.  When 
SIRT1 was silenced, TERT levels reduced and telomere dysfunction was apparent 
(J. Chen et al., 2011).  Although, in an English setter dog, when SIRT1 was 
measured in samples from 5 different tumours and peripheral blood mononuclear 
cells (PBMCs), SIRT1 was lower in the tumour samples compared to the PBMCs 
(Marfe et al., 2012). 
 
 
SIRT1 decreased with age in mice aorta samples (Donato et al., 2011) and in testis 
and thymus samples, but not brain (Sasaki et al., 2006).  Protein levels of SIRT1 
were measured in serum of 250 health human adults.  In women, there was a 
statistically significant pattern with age: an increase from their twenties to 
thirties, followed by a significant decrease in their forties.  However, there was no 
significant pattern with age in the male subjects (Lee and Yang, 2017). 
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 Clusterin 
 Clusterin function 
Clusterin was first described in 1983, and was found to be the major glycoprotein 
in ram rete testis fluid.  It was reported to cause clustering of suspensions of rat 
sertoli cells, mouse testis TM-4 cells and erythrocytes (Blaschuk, Burdzy and Fritz, 
1983; Fritz et al., 1983).  Clusterin has been found in many species under a variety 
of functions, often at the time being named by the biological association by which 
it was recognised.  The many alternative names have included SGP-2 (sulphated 
glycoprotein 2), apoJ (apolipoprotein J) and TRPM-2 (transient receptor cation 
channel, subfamily M, member 2) (Grassilli et al., 1992; Wong et al., 1993; Jordan-
Starck et al., 1994).  Despite the many names and functions, clusterin has an 
estimated 70 to 80% sequence homology between mammals.  An inaugural 
international workshop on the protein agreed on the name clusterin (Wilson and 
Easterbrook-Smith, 2000), and for simplicity in this thesis all alternative names will 
be converted to clusterin in the text.   
 
The clusterin (CLU) gene encodes for two types of clusterin protein: an 
extracellular form (sCLU) and an intracellular form (nCLU).  The majority of 
clusterin protein is in the sCLU form, but in some cell types nCLU occurs in times 
of apoptosis induction (Trougakos and Gonos, 2009).  sCLU has two key functions: 
firstly, as an apolipoprotein associated with high density lipoprotein (De Silva et 
al., 1990), and secondly, to stabilise misfolded proteins under a variety of stresses 
to inhibit protein precipitation (Humphreys et al., 1999; Poon et al., 2000).  This 
second function has resulted in sCLU being considered as a homologue for heat 
shock proteins (Gudi and Gupta, 1993).  Viard et al. (1999) exposed a human 
epidermoid carcinoma cell line (A431) to a variety of stresses: heat shock using 
temperature-controlled water baths, chemical stress using hydrogen peroxide or 
hypoxanthine-xanthine oxide, hyperoxia and ultraviolet A.  A strong increase in 
CLU mRNA following these exposures was reported.  Anti-sense clusterin clones 
were then produced. The clones were very sensitive to apoptotic cell death 
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following exposure to the same stressors, further demonstrating the role of 
clusterin in cellular stress response.  Overexpression of clusterin has repeatedly 
been shown in in vitro studies to increase cell survival after stress exposure (e.g. 
Dumont et al., 2002).  Furthermore, in vitro clusterin was found to interfere with 
Bax activation in mitochondria to prevent apoptosis (Zhang et al., 2005). 
 
Petropoulou et al. (2001) demonstrated that in human fibroblasts clusterin mRNA 
and protein levels were upregulated with cell senescence.  They suggested that 
clusterin did not induce senescence but the increase was a secondary consequence 
of the senescent phenotype.  In addition, contrary to previous reports, clusterin 
provided no apoptosis protection when the cells were exposed to hydrogen 
peroxide. 
 
 
 Clusterin and morbidity 
Clusterin has been proposed as a biomarker of disease.  In dogs presenting at the 
University of Glasgow Small Animal Hospital for clinical investigation, mRNA levels 
of clusterin were elevated in cerebrospinal fluid of dogs with degenerative 
myelopathy and chronic intervertebral disc disease, but not idiopathic epilepsy or 
meningoencephalitis (Shafie et al., 2014).  Clusterin protein levels were raised in 
sputum of children with asthma compared to healthy controls, and concentration 
was associated with severity of disease (Sol et al., 2016).  In addition, when serum 
clusterin was measured in serum of 183 humans undergoing coronary angiography, 
clusterin concentration was significantly higher in patients with significant 
coronary artery stenosis than those without (Poulakou et al., 2008). 
 
 
 Clusterin and age 
In terms of age-related change, clusterin has been demonstrated to increase with 
age in rat brain (Senut et al., 1992), rat ventral prostate (Bettuzzi et al., 1994), 
and rat kidney (Laping et al., 1998).  In Norway Brown rat epididymis, caput-
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corpus clusterin did not change with age, whereas cauda clusterin increased from 
age 6 to 18 months, then declined at 24 months (Viger and Robaire, 1995).  No 
studies could be found regarding the relationship between clusterin and canine 
age.   
 
 
 DNA methylation 
 Methylation of DNA in the genome 
Cytosine can be modified by the covalent attachment of a methyl group to the C5 
position of its ring to form 5-methylcytosine (5-mc) (Razin and Riggs, 1980).  5-mc 
has been found in DNA of animals including in mammals, amphibians and reptiles 
(Vanyushin et al., 1973).  The majority of 5-mc residues are found in the sequence 
5’-CG (also known as CpG).  There are portions of the genome known as CpG 
islands where there is a higher frequency of CpG than the rest of the genome.  
CpG islands are found at the 5’ end of all housekeeping genes (Gardiner-Garden 
and Frommer, 1987).  More than 90% of 5-mc residues in the genome lie within 
CpG islands located in transposable repetitive elements such as Alu elements and 
LINE-1 (long interspersed nucleotide element-1) sequences (Bollati et al., 2009).  
34% of the canine genome is made up of such repetitive elements, which is a lower 
percentage than in many other mammals including humans (Smit, 1999; Whitelaw 
and Martin, 2001; Lindblad-Toh et al., 2005).  When investigating 5-mc, the 
percentage of 5-mc residues in the genome may be measured, or as so many of the 
5-mc residues are located in repetitive elements, measurement of proportion of 
5mc in LINE-1, for example, has been shown to represent the whole genome (Yang 
et al., 2004).   
 
 
Methylation is a necessary process for life.  When mutation in the enzyme 
responsible for the reaction transferring the methyl group onto cytosine was 
introduced into the germline of mice, the result was a lethal phenotype.  Embryos 
were stunted and did not live past mid gestation (Li, Bestor and Jaenisch, 1992).  
Methylation and changes in methylation status affect gene expression and 
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function.  For example, an increase in 5-mc was observed with T cell 
differentiation, then methylation decreased slowly with age following terminal 
differentiation.  The increase in methylation as part of differentiation likely served 
to silence genes (Golbus, Palellan and Richardson, 1990).  A further example of 
methylation affecting genes, is methylation being widely reported to be a key part 
of X chromosome inactivation (e.g. Allen et al., 1992). 
 
 
 DNA methylation and age 
Changes in methylation state occur over time.  Loci in CpG have been observed to 
gain methylation with age, whereas loci not in CpG islands tend to lose 
methylation with age (Christensen et al., 2009).  In mice and humans, the overall 
5-mc content in the genome decreases with age (e.g. Wilson et al., 1987; 
Christensen et al., 2009).  One study relating global DNA methylation to age in 
dogs was found on literature searching.  Using an ELISA, percentage global 5-mc 
was measured in 16 dogs, weighing between 3.2 and 70kg, aged from 2 months to 
14 years.  %5-mc increased with age and was not related to weight.  Reported 
mean %5-mc was 43.5 in dogs under 9 months and 81.3% in dogs over 8 years, 
which is surprising as a previous estimate of mammalian DNA %5-mc was between 2 
and 7%, depending on species (Razin and Riggs, 1980; Gryzinska et al., 2016). 
 
 
The changes in 5-mc content in human genome over time have been used to 
generate an “epigenetic age”, which can then be compared to chronological age 
with a view to predict risk of age related mortality or morbidity.  In a study of 
leukocyte DNA from 442 human adults, an increase in epigenetic age compared to 
chronological age was associated with a higher risk of cancer and mortality (Zheng 
et al., 2016).  In a further study of 1334 humans aged between 70 and 90, one 
standard deviation increase in baseline epigenetic age was linked to a 22% increase 
in risk of mortality in the 6-year follow-up period (Marioni et al., 2016).  This 
methodology of producing an epigenetic age was very recently replicated in a 
study of 42 domestic dogs and 62 grey wolves.  The epigenetic age was generated 
using the methylation frequency of 41 CpG islands in dogs and 67 CpG islands in 
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the wolves.  There was a strong positive correlation between epigenetic age and 
chronological age in both species.  A mix of different pure breeds of dog were 
included in the study.  A non-significant positive correlation was seen in the 
difference between epigenetic age and chronological age with maximum weight of 
the dog breed, which the authors suggested may have been a significant 
relationship with a larger sample size (Thompson et al., 2017). 
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Figure 1.6 Steroidogenic pathway in Leydig cells of the testis 
Adapted from Luetjens and Weinbauer (2012) 
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 Testosterone biosynthesis 
Figure 1.6 summarises the steroidogenic pathways in the Leydig cells of the 
testis.  Steroidogenesis is reliant on cholesterol.  Cholesterol enters the Leydig 
cell, most commonly by receptor-mediated endocytosis.  Steroidogenic acute 
regulatory protein (StAR) then plays the essential role of transferring cellular 
cholesterol from the outer mitochondrial membrane to the inner mitochondrial 
membrane, where the p450 SCC (cholesterol side chain cleavage) enzyme is 
located (Black et al., 1994; Bauer et al., 2000).  Cholesterol is converted to 
pregnenolone in a single step (Shikita and Hall, 1973).  Pregnenolone diffuses 
across the mitochondrial membrane and is converted to testosterone at the 
smooth endoplasmic reticulum via several intermediary steps (Simard et al., 
2005). 
 
 
One study regarding change with age of mRNA expression of genes of pathway 
enzymes in male dogs was published very recently.  Three 4-5 month old dogs, 
seven 6 month old dogs and eight 1 year old dogs of a variety of breeds 
underwent routine castration.  mRNA levels of p450 SCC, p450 C17, 3βHSD 
(hydroxysteroid dehydrogenase), p450 aro (aromatase) and StAR were measured.  
p450 SCC, 3βHSD and StAR decreased non-significantly between the 3 age 
groups, whereas there was a significant decrease in p450 C17.  p450 aro 
increased with age.  While several of the genes did not significantly change with 
age, only 18 dogs with a narrow age range were in the study, and patterns of 
potential biological interest were apparent in their data plots (Ogawa et al., 
2017). 
 
 
Four further studies in age related changes of the testosterone pathway genes 
were in Brown Norway rats, using groups aged between 4 and 24 months.  StAR 
and p450 SCC mRNA and protein levels were seen to decrease with age in 
multiple studies with reductions starting at “middle age” (14/15 months old) 
(Luo, Chen and Zirkin, 1996, 2001, 2005; Leers-Sucheta, Stocco and Azhar, 
1999).  Only one of the studies examined 3βHSD and 17βHSD.  No reduction in 
3ΒHSD mRNA was seen between 4 months and 22 months of age (17βHSD mRNA 
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expression was not reported).  However, there was a significant decrease in 
enzyme activity of both 3βHSD and 17βHSD in 22 month old compared to 4 
month old rats (Luo, Chen and Zirkin, 1996).  
 
 
 Overall aims and hypothesis of thesis 
The principal key aim of this thesis was to assess the impact of ETS exposure in 
dogs, with the view of both dog welfare and as a model for human exposures.  
This was conducted through the measurement of biomarkers of ageing, with the 
hypothesis that ETS exposure would result in an increased biological age.  In 
order to do this, biomarkers of ageing needed to be measured and examined to 
explore which would be appropriate for use in dogs and methodologies were 
developed for their measurement.  An objective assessment of ETS exposure was 
tested in the form of hair nicotine and cotinine concentrations in the dogs, 
which were then compared to the biomarkers of ageing to examine potential 
relationships. 
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2 Chapter 2: Materials and methods 
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 Materials 
Reagents, kits and solutions used in experiments from all chapters will be 
detailed in this section, along with consumables and equipment. 
 
 
 General Reagents & Purchased Solutions 
For ease of reference, the reagents have been divided into sections according to 
their use. 
 
Reagents used across multiple experiment types 
Reagent Supplier 
Ethanol (molecular biology grade) VWR, Lutterworth UK 
PCR water Invitrogen, Paisley UK 
Phosphate buffered saline (PBS) 
tablets 
Sigma Aldrich, Gillingham UK 
 
Reagents for DNA extraction, RNA extraction and cDNA synthesis 
3M Sodium Acetate pH 5.2 Sigma Aldrich, Gillingham UK 
Chloroform Sigma Aldrich, Gillingham UK 
dNTP mix Sigma Aldrich, Gillingham UK 
Oligo(dT)12-18 Invitrogen, Paisley UK 
Phenol Sigma Aldrich, Gillingham UK 
Phenol/Chloroform/IAA Sigma Aldrich, Gillingham UK 
Proteinase K Macherey Nagel, Düren Germany  
RNAlater-Ice Invitrogen, Paisley UK 
RNAzap Applied Biosystems, Paisley UK 
Tris EDTA buffer pH 8.0 Sigma Aldrich, Gillingham UK 
Trizol Invitrogen, Paisley UK 
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Reagents for qPCR & RT-qPCR 
Absolute blue low ROX SYBR green 
qPCR mix 
Thermo Scientific, Loughborough UK 
DNAzap Applied Biosystems, Paisley UK 
pBR322 plasmid DNA from E.coli Sigma Aldrich, Gillingham UK 
Primers (sequences in results 
chapters) 
Integrated DNA Technologies, Leuven 
Belgium  
Primers arrived lyophilised and were reconstituted to a concentration of 1µg µl-1 
using ddH2O, then stored in aliquots at −20°C. 
 
Reagents for Southern blotting 
Agarose (molecular biology grade) Invitrogen, Paisley UK 
Citric acid VWR, Lutterworth UK 
Ethylenediaminetetraacetic acid 
(EDTA) disodium salt 
VWR, Lutterworth UK 
Ethidium bromide 10mg/ml solution Sigma Aldrich, Gillingham UK 
Glacial acetic acid VWR, Lutterworth UK 
Hydrochloric acid 6M VWR, Lutterworth UK 
pH standards: pH 4, 7 and 10 Hanna instruments, Leighton Buzzard 
UK 
Sodium chloride VWR, Lutterworth UK 
Sodium dodecyl sulphate (SDS) Sigma Aldrich, Gillingham UK 
Sodium hydroxide pellets VWR, Lutterworth UK 
Tris base Sigma Aldrich, Gillingham UK 
Tri-Sodium citrate VWR, Lutterworth UK 
 
Reagents for cell culture 
DMEM High glucose media Invitrogen, Paisley UK 
Foetal calf serum Invitrogen, Paisley UK 
Penicillin-Streptomycin Invitrogen, Paisley UK 
Trypsin-EDTA Invitrogen, Paisley UK 
 
Reagents for cortisol ELISA 
HPLC grade methanol Fisher scientific, Loughborough UK 
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 Kits 
Kit Name Company Kit Contents 
QIAamp Blood 
Midi & Maxi kits 
Qiagen, 
Manchester UK 
Spin columns, collection tubes, lysis 
buffer, 2 wash buffers, elution buffer, 
protease 
Nucleospin Blood 
Mini Kit 
Macherey Nagel, 
Düren Germany  
Spin columns, collection tubes, 
proteinase K, proteinase buffer, lysis 
buffer, 2 wash buffers, elution buffer 
PureLink RNA 
Mini Kit 
Invitrogen,  
Paisley UK 
Spin columns, collection tubes, lysis 
buffer, 2 wash buffers, RNase-free 
water, recovery tubes 
PureLink DNase 
Set 
Invitrogen,  
Paisley UK 
DNase, reaction buffer, RNase-free 
water 
Superscript II Invitrogen,  
Paisley UK 
Reverse transcriptase, first-strand 
buffer, DTT 
TeloTAGGG 
Telomere Length 
Assay 
Roche, Basel 
Switzerland 
Restriction enzymes (Hinf I and Rsa I), 
digestion buffer, nuclease-free water, 
control DNA, DIG molecular weight 
marker, loading buffer, DIG easy hyb 
granules, telomere probe, washing 
buffer, maleic acid buffer, blocking 
buffer, anti-DIG-AP, detection buffer, 
substrate solution 
Cortisol 
parameter assay 
kit 
R&D systems, 
Minneapolis USA 
Goat anti-mouse microplate, cortisol 
conjugate, cortisol standard, primary 
antibody solution, calibrator diluents, 
wash buffer, colour reagents, stop 
solution, plate sealers 
5-mC DNA ELISA 
Kit 
Cambridge 
Bioscience, 
Cambridge UK 
Microplate, coating buffer, ELISA 
buffer, primary antibody, second 
antibody, HRP developer, negative 
control, positive control 
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 Solutions & Buffers 
Solution/Buffer Constituents 
Tissue lysis buffer 10ml of 5M sodium chloride solution, 10ml of 1M 
Tris pH 8.0 solution, 25ml of 0.5M pH 8.0 solution 
and 2.5g SDS solution were added together and 
the total volume brought to 500ml with deionised 
water.  The buffer was mixed well with a 
magnetic stirrer and autoclaved prior to use. 
6M guanidine hydrochloride 143.31g of guanidine hydrochloride was dissolved 
in 250ml deionised water to make a 6M solution. 
Protein extraction wash 
solution 
10ml of 6M guanidine hydrochloride solution was 
added to 190ml of 100% ethanol and mixed to 
make 200ml of solution.  This resulted in a 
concentration of 0.3M guanidine hydrochloride. 
1% SDS solution SDS solution was prepared in a fume hood.  5g of 
SDS powder was dissolved in 500ml of deionised 
water to make a 1% solution. 
2.5M Sodium hydroxide 50g of sodium hydroxide pellets were dissolved in 
500ml of deionised water, resulting in a 2.5M 
solution.   
1M Tris solution, pH 8.0 121.1g of Tris was dissolved in 700ml of deionised 
water, then the pH adjusted using concentrated 
hydrochloric acid to pH 8.0, stirring continuously 
with a magnetic stirrer.  The volume of the 
solution was then made up to 1L with deionised 
water. 
2M Tris solution, pH 7.5  242.2g of Tris was dissolved in 700ml of deionised 
water, then the pH adjusted using concentrated 
hydrochloric acid to pH 7.5, stirring continuously 
with a magnetic stirrer.  The volume of the 
solution was then made up to 1L with deionised 
water. 
5M sodium chloride 292.2g of sodium chloride was dissolved in 
deionised water to make 1L of solution. 
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0.5M EDTA solution, pH 8.0 To make 500ml of solution, 93.06g of disodium 
salt EDTA was added to 400ml deionised water.  
Sodium hydroxide pellets were slowly added until 
the pH of the solution reached 8.0, the solution 
was made up to 500ml with deionised water and 
mixed well with a magnetic stirrer. 
50X TAE buffer To make 1000ml buffer 242g Tris base, 57.1ml 
glacial acetic acid and 100ml 0.5M EDTA solution 
pH 8.0 were combined, then the solution was 
made up at 1000ml with deionised water and 
mixed well with a magnetic stirrer. 
1X TAE buffer 50X TAE buffer was diluted 1 in 50 to make a 1X 
working solution, with a concentration of 40mM 
Tris, 20mM acetic acid and 1mM EDTA. 
0.25M Hydrochloric acid 6M hydrochloric acid was diluted 1 in 24 with 
deionised water to make 0.25M hydrochloric acid 
solution. 
Denaturation solution To make 500ml of solution, 100ml of 2.5M sodium 
hydroxide and 150ml of 5M sodium chloride were 
added to 250ml deionised water and mixed, 
resulting in a final concentration of 0.5M sodium 
hydroxide and 1.5M sodium chloride. 
Neutralisation solution 300ml of 5M sodium chloride solution were added 
to 125ml 2M Tris solution pH 7.5 and 75ml 
deionised water to make 500ml neutralisation 
solution, resulting in a final concentration of 
0.5M Tris and 3M NaCl. 
20X SSC 600ml of 5M sodium chloride solution were added 
to 300ml of 1M sodium citrate pH 7.0 solution and 
100ml deionised water to make 1L of 20X SSC, 
resulting in a final concentration of 3M sodium 
chloride and 0.3M sodium citrate. 
2X SSC 20X SSC was diluted 1 in 10 with deionised water 
to make 2X SSC. 
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DIG Easy Hyb Granules Granules supplied in the TeloTaGGG kit were 
reconstituted in 64ml of deionised water and the 
bottle incubated in a 37°C water bath until 
reconstitution was complete. 
Stringent wash buffer I To make 1L of buffer, 100ml of 20X SSC was 
added to 100ml of 1% SDS solution and 800ml 
deionised water, giving a final concentration of 
2X SSC and 0.1% SDS. 
Stringent wash buffer II 100ml of 2X SSC and 100ml of 1% SDS solution 
were added to 800ml of deionised water to make 
1L of buffer, with a concentration of 0.2X SSC 
and 0.1% SDS. 
1X Washing buffer The washing buffer is provided in the TeloTaGGG 
kit at a 10X stock concentration.  To create a 
working concentration buffer, the stock was 
diluted 1 in 10 with deionised water. 
1X Blocking buffer The blocking buffer is provided in the TeloTaGGG 
kit at a 10X stock concentration.  To create a 
working concentration buffer, the stock was 
diluted 1 in 10 with 1X maleic acid buffer. 
1X Maleic acid buffer The maleic acid buffer is provided in the 
TeloTaGGG kit at a 10X stock concentration.  To 
create a working concentration buffer, the stock 
was diluted 1 in 10 with deionised water. 
1X Detection buffer The detection buffer is provided in the 
TeloTaGGG kit at a 10X stock concentration.  To 
create a working concentration buffer, the stock 
was diluted 1 in 10 with deionised water. 
Anti-DIG-AP solution The anti-DIG-AP antibody was prepared by 
centrifuging the vial for 5 minutes at 12,000 x g, 
which reduces background caused by aggregated 
antibody.  7.5μl of anti-DIG-AP was added to 
75ml blocking solution for each blot.  The final 
concentration of antibody was 1 in 10,000 
(75mU/ml). 
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Stripping buffer for 
Southern blots 
To make 500ml of buffer, 40ml of 2.5M NaOH 
solution, 50ml of 1% SDS solution and 410ml 
deionised water were mixed together.  The final 
concentrations of reagents in the buffer were 
0.2M NaOH and 0.1% SDS.   
 
 
 Consumables 
Item Supplier 
2ml borosilicate glass vial Wheaton, Millville USA 
10cm plastic dishes Corning, Flintshire UK 
15 ml falcon tubes Greiner, Stonehouse UK 
15ml borosilicate test tubes Fisher Scientific, Loughborough UK 
175cm2 Tissue culture flasks Greiner, Stonehouse UK 
20ml scintillation vials Sigma Aldrich, Gillingham UK 
25ml sterile reagent reservoirs VWR, Lutterworth UK 
3mm Whatman filter paper GE Healthcare Life Sciences, 
Buckinghamshire UK 
50ml falcon tubes Greiner, Stonehouse UK 
96-well PCR plates, semi-skirted, 
white 
Starlab, Milton Keynes UK 
Amersham Hybond-N+ blotting 
membrane 
VWR, Lutterworth UK 
Cell scrapers VWR, Lutterworth UK 
Cover slips Chance Propper, Leicester UK 
Disposable scalpels Swann Morton, Sheffield UK 
EDTA blood collection tubes BD Life Sciences, Erembodegem Belgium 
Filter pipette tips- 2μl, 20μl, 
200μl, 1000μl 
Starlab, Milton Keynes UK 
Hybridisation bags Roche, Basel Switzerland 
Microamp Optical Cap Strips Applied Biosystems, Paisley UK 
Microcentrifuge tubes: 0.2ml, 
1.5ml, 2ml 
Greiner, Stonehouse UK and Starlab, Milton 
Keynes UK 
Parafilm Fisher Scientific, Loughborough UK 
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Pestle tips VWR, Lutterworth UK 
Pipettes: 10ml, 25ml Corning, Flintshire UK 
Plate seals Thermo scientific, Paisley UK 
qPCR plates clear Thermo scientific, Paisley UK 
RNase free 1.5ml microcentrifuge 
tubes 
VWR, Lutterworth UK 
SK-1S DNA Buccal swabs Isohelix, Kent UK 
X-ray film Thermo scientific, Paisley UK 
 
 
 Equipment 
Equipment Manufacturer 
AB 7500 fast qPCR machine Applied Biosystems, Paisley UK 
Agarose gel kit Bio rad, Hemel Hempstead UK 
Balance Fisher Scientific, Loughborough UK 
Benchtop centrifuge Beckman Coulter, High Wycombe UK 
Electronic multichannel pipette Thermo scientific, Paisley UK 
Film cassette GRI Medical Products, Cave Creek Arizona 
Flatbed scanner Hewlett Packard, California 
Haemocytometer Hawksley, Worthing UK 
Heat sealer TEW, Taipei Taiwan 
Incubator New Brunswick, Hamburg Germany  
Kontes electric pestle Kimble-Chase, Vineland New Jersey 
Magnetic stirrer  Stuart scientific, Staffordshire UK 
Micro plate spinner Thermo Scientific, Paisley UK 
Microcentrifuge Technico, Punjab Pakistan 
Microcentrifuge with temperature 
control 
Eppendorf, Hamburg Germany 
Microplate reader MTX Lab systems, Virginia USA 
Microscope Leica Microsystems, Milton Keynes UK 
Microwave Sanyo, Osaka Japan 
Mini gel kit Bio rad, Hemel Hempstead UK 
MM400 Ball mill Retsch, Düsseldorf Germany 
MxPro 3000P qPCR machine Stratagene, San Diego, California USA 
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Nanodrop 1000 ThermoScientific, Paisley UK 
pH meter Fisher scientific, Loughborough UK 
Pipette controller BrandTech Scientific, Essex Connecticut 
Pipettes: ≤20μl, ≤200μl, ≤1000μl Gilson, Luton UK 
Power pack Bio rad, Hemel Hempstead UK 
Rocking platform Stuart scientific, Staffordshire UK 
Safety hood Medical Air Technology, Manchester UK 
Shaking incubator Gallenkamp, London UK 
Techne HB-1D Hybridisation oven 
and bottles 
Bibby Scientific, Staffordshire UK 
Techne Heat block Bibby Scientific, Staffordshire UK 
Techne Sample concentrator Bibby Scientific, Staffordshire UK 
Thermocycler AB2720 Applied Biosystems, Paisley UK 
Timer Fisher scientific, Paisley UK 
Tube roller Starlab, Milton Keynes UK 
UV cross linker Stratagene, Paisley UK 
Vortex Heidolph Instruments, Schwabach 
Germany 
Water bath Grant Instruments, Cambridge UK 
X ray developer Xograph Imaging Systems, Gloucestershire 
UK 
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 Methods 
 DNA Extraction from Tissue using Phenol 
A ~20mg section was removed from the tissue sample using a disposable scalpel.  
The section was diced into small pieces on a 10cm plastic dish.  A fresh scalpel 
and dish were used for each sample.  The diced sample was placed in a 2ml 
microcentrifuge tube and 900μl tissue lysis buffer added, along with 100μl 
proteinase K (10mg/ml).  The tube was inverted to mix and incubated for 16 to 
72 hours with occasional vigorous mixing, until the tube contents were entirely 
liquid.  1000μl of phenol was added, the tube was vortexed briefly and then 
centrifuged at 12,000 x g for 10 minutes at room temperature.  Two layers were 
formed: an upper, aqueous layer and a lower, organic layer.  The aqueous layer 
was removed and put into a new, clean microcentrifuge tube.  Care was taken 
not to disturb the interface or organic phase to avoid transferring these into the 
new tube.  The organic phase and tube were discarded as per the protocol for 
hazardous waste in the laboratory.  An equal volume of phenol was added to the 
new tube and the process repeated as before.  Then this process was repeated 
twice more, using phenol/chloroform/isoamyl alcohol (25:24:1) in place of 
phenol.  The resulting solution was split into two microcentrifuge tubes.  One 
tenth volume of 3M sodium acetate and two volumes 100% molecular biology 
grade ethanol were added to precipitate the DNA.  The tubes were placed at 
−20°C overnight.  The next day, the tubes were centrifuged at 12,000 x g for 15 
minutes at 4°C to form a DNA pellet.  The aqueous supernatant was removed 
and the pellet washed in 70% molecular biology grade ethanol.  The pellet was 
air dried for 20 minutes, then resuspended in 200μl TE solution.  The quality and 
concentration of the DNA was measured as described in section 2.2.5, then 
stored at −20°C.  
 
 
 DNA Extraction using Columns 
Blood, buccal and cell culture samples were DNA extracted using column based 
kits.  The kits used were Macherey Nagel Nucleospin® Blood Mini Kit and Qiagen 
QIAamp® Blood Midi Kit.  The mini size was used for sample volumes up to 200μl 
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and the midi for sample volumes greater than 200µl up to 2ml.  The 
manufacturers’ protocols were followed with minor adjustments. 
 
 
 Blood DNA Extraction 
Blood samples collected in EDTA tubes were used for the extractions and 
equilibrated to room temperature prior to starting the protocol.  For a 
proportion of the samples used in Chapter 4, the Qiagen QIAamp midi kit was 
used to obtain larger amounts of DNA using a single column.  For all other blood 
DNA extractions, the Macherey Nagel kit was used.  For brevity, the Macherey 
Nagel kit protocol will be described only, as the Qiagen kit protocol is largely 
equivalent bar the use of larger volumes of liquid. 
 
 
200μl blood was pipetted into a 1.5ml microcentrifuge tube and 25μl Proteinase 
K added, followed by 200μl of Buffer B3 (kit lysis buffer).  The tube was 
vortexed vigorously for 10-20 seconds to mix the contents.  The samples were 
incubated at 70°C using a heat block for 1 hour.  210μl of molecular biology 
grade ethanol was added to each sample and the tube vortexed again.   The 
sample was then loaded into a Nucleospin® Blood column placed in a collection 
tube.  The tube was centrifuged at 11,000 x g for 1 minute.  The collection tube 
and follow through were discarded.  DNA was now bound to the silica membrane 
of the column and next the membrane was washed twice.  For the first wash, 
the column was placed in a new collection tube and 500μl of Buffer BW (kit wash 
buffer) added into the column and then centrifuged for 1 minute at 11,000 x g.  
Again, the collection tube and follow through were discarded.  The column was 
placed into a new collection tube and 600μl of Buffer B5, the second kit wash 
buffer, was added and the sample centrifuged at 11,000 x g for 1 minute.  The 
follow through only was discarded, the column placed back into the collection 
tube and centrifuged for 1 minute at 11,000 x g, to remove residual ethanol.  
The collection tube was discarded and the column placed in a 1.5ml 
microcentrifuge tube.  100μl of 70°C preheated Buffer BE (kit elution buffer) 
was added directly onto the silica membrane.  After 1 minute of incubation at 
room temperature, the tube was centrifuged for 1 minute and 11,000 x g.  In 
order to increase the DNA yield, the elute was placed back onto the column and 
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the incubation and centrifugation repeated.  The DNA was then in the 
microcentrifuge tube.  The quality and quantity were measured and the DNA 
stored at −20°C. 
 
 
 Buccal Swab DNA Extraction 
Buccal samples were obtained using Isohelix SK1 swabs.  The swab was removed 
from its tube, placed inside the mouth of the dog and rubbed firmly against the 
inside of the cheek.  The swab was rubbed inside both cheeks for a total of up to 
one minute.  Sampling for one minute increases DNA yield, however, this was 
sometimes impractical if it was difficult to control the dog or the dog showed 
signs of aggression.  The swab was placed back in the tube and the handle 
snapped at the provided groove.  The swab head with remaining stick was 
dropped into the tube and the tube sealed with the screw cap provided.  The 
swabs were DNA extracted within 24 hours of sample collection to minimise time 
for microbial growth. 
 
 
The swab head was removed from the tube using sterile tweezers and the swab 
head was cut off from the stick with scissors and placed into a 2ml round bottom 
microcentrifuge tube.  400μl of PBS, 20μl of Proteinase K and 600μl Buffer B3 
(lysis buffer) were added.  The tube was vortexed vigorously for 20 seconds and 
then incubated at 70°C for one hour.  From this point, either a phenol-
chloroform based protocol or a column based protocol was performed.   
For the column protocol, firstly, 400μl of molecular biology grade ethanol was 
added.  The tube was then vortexed.  600μl of the mixture was loaded into a 
Nucleospin® column placed in a collection tube and centrifuged for 1 minute at 
11,000 x g.  The flow through and collection tube were discarded.  The column 
was placed in a new collection tube and the remaining mix loaded into the 
column, the tube centrifuged for 1 minute at 11,000 x g and the collection tube 
and flow through discarded.  The column was placed in a new collection tube 
and wash steps and elution procedure were followed as per the blood DNA 
extraction methodology (section 2.2.2.1). 
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To follow the phenol protocol, the microcentrifuge tube was centrifuged for 15 
minutes at 11,000 x g.  The swab was removed and 1000µl phenol was added.  
The tissue extraction protocol was then followed from the initial addition of 
phenol step (section 2.2.1).  
 
 
 Cultured Cells DNA Extraction 
5x106 cells in medium were transferred into a 1.5ml microcentrifuge tube and 
the tube centrifuged for 5 minutes at 300 x g.  The supernatant was removed 
and the cell pellet resuspended in 200μl PBS.  The methodology was then 
followed as per the blood DNA extraction methodology from the lysis stage (see 
section 2.2.2.1).       
   
 
 RNA Extraction from Tissue 
A section of tissue of approximately 50mg was removed from each sample.  The 
section was placed in an RNase-free 1.5ml microcentrifuge tube and 400μl Trizol 
added.  The section was homogenised using an electric pestle.  A further 600μl 
Trizol was added and the tube was left at room temperature for 5 minutes.  
200μl of chloroform was then added and the tube shaken vigorously for 15 
seconds.  Then followed a 3-minute incubation at room temperature, after 
which the sample was centrifuged at 12,000 x g for 15 minutes at 4°C.  The 
liquid split into 3 phases: a lower, phenol-chloroform phase, an interphase and 
an upper aqueous phase containing the RNA.  400μl of the upper phase was 
transferred into a new RNase-free 1.5ml microcentrifuge tube.  The remaining 
liquid was kept and stored at −80°C, in order to be protein extracted at a later 
date.  400μl of 70% molecular biology grade ethanol was added to the upper 
phase tube and the tube was vortexed to mix.  The sample was then processed 
using a PureLink RNA mini kit including an on-column DNase treatment.  600μl of 
sample was transferred to a Spin Cartridge with a collection tube, the tube was 
centrifuged for 15 seconds at 12,000 x g and the flow through discarded.  The 
column was replaced into the collection tube and the remaining sample loaded 
into the column.  The tube was centrifuged for 15 seconds at 12,000 x g and the 
flow through discarded again.  350μl of Wash Buffer I was added to the Spin 
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Cartridge and centrifuged for 15 seconds at 12,000 x g.  The flow through and 
collection tube were discarded and the Spin Cartridge was inserted into a new 
collection tube.  A DNase treatment on column mix was made using 8μl of 10X 
DNase I Reaction Buffer, 10μl of 3U/μl DNase and 62μl RNase free water and this 
was added directly onto the surface of the Spin Cartridge membrane.  It was 
incubated at room temperature for 15 minutes.  350μl of Wash Buffer I was 
added to the Spin Cartridge and it was centrifuged at 12,000 x g for 15 seconds.  
The flow through and collection tube were discarded and the Spin Cartridge was 
inserted into a new collection tube.  500μl of Wash Buffer II with ethanol was 
added to the Spin Cartridge, centrifuged for 15 seconds at 12,000 x g and the 
flow through discarded.  The Spin Cartridge was reinserted into the collection 
tube and was washed again with Wash Buffer II twice using the same method.  
The Spin Cartridge was centrifuged at 12,000 x g for 1 minute, which dried the 
membrane.  The collection tube was discarded and the Spin Cartridge was 
inserted into a Recovery Tube.  30μl of RNase free water was added to the 
centre of the Spin Cartridge membrane.  It was incubated at room temperature 
for 1 minute and centrifuged at 12,000 x g for 1 minute.  The elute was placed 
back onto the Spin Cartridge membrane, incubated for another minute and 
centrifuged for 1 minute at 12,000 x g.  The elute contained the RNA sample.  
The quantity and quality of the RNA was measured, then stored at −80°C.  
 
 
 cDNA Synthesis 
cDNA was synthesised from RNA as DNA is required for PCR assays, using the 
method as follows.  For each RNA sample, 2μg of RNA was added to a 0.2ml 
nuclease-free microcentrifuge tube, along with 1μl oligo(dT)12-18 and 1μl dNTP 
mix (10mM each).  Sterile, distilled water was added to the contents to make a 
total volume of 12μl.  A “blank” tube was made by adding no RNA but with all 
other reagents.  The tubes were placed in a thermal cycler, heated to 65°C for 5 
minutes then immediately placed on ice.  The tubes were briefly centrifuged to 
collect the contents at the bottom of the tube and then 4μl first-strand buffer 
and 2μl of 0.1M DTT were added.  The contents were mixed by pipetting up and 
down, then the tubes incubated at 42°C for 2 minutes.  1μl of Superscript™II 
Reverse Transcriptase was added to each tube and then mixed in by pipetting up 
and down.  The tubes were placed at 42°C for 50 minutes, then the reaction was 
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inactivated by heating at 70°C for 15 minutes.  The concentration and quality of 
cDNA was measured, using the “blank” tube as the blank, and then stored at 
−20°C. 
 
 
 Spectrophotometry 
The quantity and quality of sample post DNA and RNA extractions, cDNA and 
single stranded DNA oligonucleotides were assessed using a Nanodrop® 1000 
spectrophotometer. 
 
 
 DNA and RNA quantification 
The software uses a modified version of the Beer-Lambert equation for nucleic 
acid quantification.  The correct settings were chosen on the software, such that 
the extinction coefficient for double-stranded DNA was 50 ng-cm/μl, for single-
stranded DNA 33ng-cm/μl and for RNA 40 ng-cm/μl.  Absorbance is measured at 
230nm, 260nm and 280nm, and 260/280 and 260/230 ratios are calculated by 
the software.   The absorbance values are also corrected relative to a blank.  
The blank used was the elute buffer for DNA column extractions, TE buffer for 
DNA phenol-chloroform extractions, RNase-free water for RNA extractions, 
nuclease-free water for single stranded DNA and, for cDNA, the “blank” tube as 
described in section 2.2.4.  Sample concentration calculations are based on the 
260nm absorbance and the extinction coefficient.  The 260/280 value is used to 
assess the purity of the nucleic acid.  For our purposes, a value of 1.8 or greater 
was accepted for DNA and 2.0 or greater for RNA.  The 260/230 ratio also 
assesses purity and a low value indicates the presence of co-purified 
contaminants, such as phenol.  A 260/230 of over 2.0 was seen as ideal, but a 
value of over 1.8 was accepted.  Rules were enforced for these numbers as 
residual contaminants can lead to overestimation of concentration of nucleic 
acid and potentially inhibit downstream procedures. 
 
 
If values for purity measurements in the DNA extractions fell below the required 
standards, purification steps were repeated until the required standard was met, 
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or repeat extraction was performed if there was sufficient sample available.   To 
purify DNA, a Macherey Nagel Nucleospin® Blood Mini kit was used.  1 volume of 
Buffer B3 (kit lysis buffer) and 1 volume molecular biology grade ethanol were 
added, then vortexed for 20 seconds.  This mixture was loaded into a 
Nucleospin® column and the protocol followed as described in section 2.2.2.1, 
DNA extraction using columns. 
 
 
If values for purity of RNA fell beneath the required standards, a repeat 
extraction was performed using the original tissue.  
 
 
 Quantitative PCR 
PCR is a method of generating copies of a specific template spanning from a set 
of primers, using a repetitive cycle of reactions.  When the reaction efficiency is 
100%, the amount of product doubles with each cycle, until factors such as 
depletion of reactants results in a plateauing of product accumulation.  As 
different PCRs can reach plateau at different cycle numbers, traditional “end 
point” PCR cannot be used for quantification purposes.  Quantitative PCR (qPCR, 
also known as “real time” PCR) enables the user to measure the amount of PCR 
product as it accumulates, using fluorescent dyes.  SYBR green was used in this 
thesis, which emits fluorescence when bound to double stranded DNA.   
A “ΔR” or “dR” value is calculated by the qPCR machine software, which is the 
difference between the reaction fluorescence and the background fluorescence.  
This is plotted against the cycle number, giving the amplification plot.  An 
example plot is shown in Figure 2.1 Example of qPCR amplification plot In the 
initial cycles, the ΔR remains at baseline until sufficient signal is generated for 
machine detection (Heid et al., 1996).  When the signal generated is 
significantly greater than the background, the intensity increases in an 
exponential manner.  During this exponential phase, the fluorescent signal is 
directly proportional to DNA concentration (Raso and Biassoni, 2014).  An 
arbitrary threshold is assigned in the exponential phase, which is the point at 
which all samples are compared to each other.  The number of PCR cycles 
required to reach this threshold is known as the cycle threshold, or “CT”.  The CT 
values are directly related to the starting concentration of template and are the 
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basis for calculations of telomere length (Chapter 4 and 5) or mRNA expression 
level (Chapter 6).  Differences in CT are used to compare samples.  As the 
reaction is exponential at this point, a difference in CT of, for instance, 2 is 
equivalent to a fourfold difference in starting material (Ginzinger, 2002). 
 
 
There are two key types of qPCR analysis: relative quantitation and standard-
curve based “absolute” quantitation.  Relative quantitation examines the 
differences in CT to the power of 2 (due to doubling of PCR product) and the 
data generates represents fold difference between items of interest.  Both 
absolute and relative quantitation were explored for telomere experiments.  
mRNA expression levels were calculated using the relative method, comparing 
test samples to an internal control sample (Ginzinger, 2002).   
 
 
As the amount of starting material directly influences CT, results are usually 
normalised to a control gene to correct for quantity of DNA added to each plate 
well (Livak and Schmittgen, 2001).  In addition, by including a passive reference 
dye, such as ROX (6-carboxy-X-rhodamine), in the reaction mix, non-PCR related 
changes in fluorescence can be accounted for using the settings on the machine 
software.  The ΔR value in the amplification plot can then be normalised to the 
signal from the passive reference dye (Schuelke, 2000; Wong and Medrano, 
2005).
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Figure 2.1 Example of qPCR amplification plot 
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 Gel Electrophoresis 
Prior to using DNA samples for Southern blotting, the integrity of the DNA was 
checked by electrophoresis using a 1% agarose gel.  The samples were prepared 
for loading by diluting the DNA to 5ng/μl with TE buffer and adding 8μl to 2μl 5X 
loading buffer.  The samples were then loaded onto the gel and the gel run at 
100V for approximately 20 minutes.  The DNA bands were visualised using a UV 
transilluminator and photographed.  Figure 2.2 shows an example of a gel 
photograph of DNA samples tested for integrity prior to Southern blot analysis.  
If a band did not move in parallel with the others or appeared as a smear, then 
the corresponding DNA was not used for any further analysis.  This is because the 
use of degraded DNA in Southern blot analysis can lead to inaccurately short 
telomere measurements. 
 
 
Figure 2.2 Representative gel of genomic DNA  
Gel run to check DNA integrity prior to starting Southern blot protocol 
 
 
 Cell Culture 
 Cell Lines 
Lines used in this thesis were MDCK cells and HeLa cells.  The MDCK cell line was 
established by S.H. Madin and N.B. Darby in 1958 from the kidney of an 
apparently normal female Cocker Spaniel (Madin, 1958).  The HeLa cell line 
originated from cervical cancer cells derived in 1951 from a human patient, 
Henrietta Lacks (Gey, Coffman and Kubicek, 1952).  MDCK cells (passage 25) 
were kindly provided by Prof L Nasir, School of Veterinary Medicine, University 
of Glasgow, and HeLa cells (passage 26) were kindly provided by Mr A Stevenson, 
Centre for Virus Research, University of Glasgow.  Both lines were cultured in 
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DMEM High Glucose media supplemented with 10% FCS, 100IU/ml penicillin and 
100IU/ml streptomycin.  They were kept in 5% CO2 in a 37°C incubator.   
 
 
Both HeLa and MDCK were cultured in 10cm dishes and, once confluent, the cell 
lysate was used for Western blot experiments as described in Appendix 9.  MDCK 
cells were also cultured in 175cm2 flasks and aliquots of cells were collected for 
DNA extraction purposes. 
 
 
 Passage of Cells 
MDCK cells cultured in 175cm2 flasks were split into multiple flasks to generate 
large numbers of cells for DNA extraction.  The cells were grown until 80% 
confluency was reached, then the media removed and discarded from the flask.  
The cells were washed with 15ml PBS and then covered with 5ml pre-warmed 
37°C trypsin-EDTA.  The flask was placed in the incubator for 5 minutes and then 
examined under a microscope to check the cells had detached.  10ml of pre-
warmed medium was dispersed over the cell layer and the cells then transferred 
into a 15ml tube.  The tube was centrifuged at 200 x g for 5 minutes, producing 
a cell pellet, and the supernatant removed.   The cell pellet was resuspended in 
5ml of media, 1ml of cell suspension was added to 25ml of fresh media in a new 
flask and the other 4ml used for DNA extraction, after quantifying the cell 
concentration as described below. 
 
 
 Cell Counting 
10μl of cell suspension was introduced into a haemocytometer.  The chamber 
was viewed under a microscope using a 10X objective and the cells in the central 
gridded square counted.  The count was multiplied by 105 to estimate the 
number of cells per ml.  The count was repeated twice and the average between 
the counts taken.  
 
Chapter 2  104 
 
 Environmental Tobacco Smoke Exposure in Pet Dogs Study 
Outline 
 Initial project outline 
The aim was to recruit 40 dogs to the study, 20 from smoking homes and 20 from 
non-smoking homes.  For the sample size power calculation, see section 5.2.1.  
The dogs were to participate in the study for one year, with 3 monthly 
appointments.  Given that other studies have found differences in telomere 
length between breeds, it was decided that only one breed would be targeted 
for recruitment.  Staffordshire Bull Terriers are a popular breed in the west of 
Scotland, however many end up in the care of rescue charities.  The Scottish 
Society for the Prevention of Cruelty to Animals (SSPCA) runs events to help 
promote the adoption of the breed, due to the numbers in their care and the 
negative reputation of the behaviour of dogs of this breed.  Staffordshire Rescue 
Scotland is one of many charities that run initiatives to help owners to cover the 
cost of neutering, as a preventive measure to help “stem the tide” of these dogs 
ending up in rescue centres.  For these reasons, it was decided to focus 
recruitment on this breed.  As there have been studies in humans showing 
telomere shortening in individuals with chronic illnesses, dogs with longstanding 
illnesses were excluded from the study.  Dogs were required not to have been 
neutered previously, as neutering and retention of the removed tissues formed 
part of the study.  The dogs could be of any age and either sex, provided they 
were old enough to undergo neutering surgery. 
 
 
To establish the environmental tobacco smoke exposure of each dog, a 
questionnaire was distributed to its owners at 3 monthly intervals and repeat fur 
samples were taken from the neck of the dog for quantification of nicotine and 
cotinine concentrations by mass spectrometry.   
 
 
The dogs had health checks and pre-anaesthetic blood samples taken at a 
recruitment appointment to ensure they were fit for the study and surgical 
anaesthesia.  The samples were sent to the University of Glasgow Veterinary 
Diagnostic Service for haematology and biochemistry tests.  Results from these 
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tests were checked by a qualified veterinary surgeon.  Discarded blood in the 
EDTA coated tube following the pre-anaesthetic haematology testing was 
retained.  DNA was extracted from 200μl of the discarded blood as described in 
section 2.2.2.1.  The remainder was centrifuged at 1,500 x g for 10 minutes to 
separate out the plasma, which was then stored at ‒20°C.  If the dog was 
deemed fit to partake in the study, it was admitted for a neutering procedure.  
On the day of the procedure, a buccal swab was collected from the dog.  Males 
underwent a closed prescrotal castration and females an ovariohysterectomy 
(procedures as described in Fossum 2013).  Pre-anaesthetic, acepromazine and 
opioid analgesia were administered.  General anaesthesia was induced with 
propofol and maintained with isoflurane.  Skin sutures used depended on 
surgeon preference.  If non-absorbable sutures were used, an appointment for 
suture removal was provided 10 to 14 days after the procedure.  Meloxicam was 
administered during the procedure and the owners were provided with a bottle 
to take home for post-operative oral analgesia.  The meloxicam was kindly 
donated by Boehringer (Ingelheim an Rhein, Germany).  If a young male dog was 
deemed to not be ready for castration (judged by examination by a veterinary 
surgeon) at the health check appointment, the castration was not performed 
until its testicles were sufficiently developed.  
  
 
Surgically removed ovaries and testes were cut into approximately 1cm3 pieces.  
Pieces from one of the testes or ovaries were then placed in formalin and pieces 
from the other were snap frozen in liquid nitrogen, then stored at ‒80°C.  
Samples were collected from the uterus, in the case of the females, and from 
cremaster muscle, vas deferens and epididymis, in the case of the males, for 
DNA extraction purposes.  After sampling, the remaining tissue was stored at 
−80°C.  It was planned to take 3 further buccal swabs over the course of the 
following 12 months, for DNA extraction and telomere length measurement, 
alongside the owner questionnaire and fur sampling.  The aim was to establish 
whether there was a pattern in telomere length dynamics in the buccal samples 
with the environmental tobacco smoke exposure across the year.  At the end of 
12 months, a blood sample was taken as part of a routine annual health screen 
and sent to the university’s veterinary clinical pathology department as 
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previously.  Again, the spare blood after testing was retained, 200μl used for 
DNA extraction, then plasma separated from the remaining.   
 
 
 Revised project outline 
5 months after recruiting the first dog to the study, only 8 dogs had been signed 
up to the study.  Therefore, it was decided that the study plan should be 
changed in order to recruit the further 30 dogs wanted within a shorter time 
frame.  Firstly, the breed criteria were changed.  While keeping to one breed 
was seen as ideal due to literature stating that there are telomere length 
differences between breeds, only using one breed was limiting for recruitment 
purposes.  The dogs which had been recruited had other issues which may have 
also had an impact on telomere length, such as obesity and previous 
psychological stress due to abandonment and rehoming, so focussing on breed 
seemed short sighted after encountering a few cases.  In fact, two of the first 8 
dogs recruited were relinquished by their owners during the study period due to 
issues with aggression in these animals.  It was decided that dogs under 5kg and 
over 50kg should be excluded, as these extremes in size may have had an as yet 
unknown impact on telomere length.  Also non-shedding breeds were excluded, 
as it was queried whether this coat type may be different in terms of hair 
nicotine measurements in work previously conducted in pet dogs (Knottenbelt et 
al., 2012).  Finally, it was decided to only use male dogs and exclude females, 
after the final female booked to attend was seen, for three key reasons.  First, 
because differences in telomere biology have been seen between sexes in both 
dogs and humans (Okuda et al., 2002; Mayer et al., 2006; Zhu et al., 2011; Fick 
et al., 2012).   Secondly, ovarian pathology was present in all bitches spayed as 
part of the study and, thirdly, it was not possible to obtain skeletal muscle from 
the female dogs while working under the Veterinary Surgeons Act (1966).  
Skeletal muscle was required to replicate the model of telomere dynamics 
described by Benetos et al. (2011).     
 
 
In addition to the changes in recruitment criteria, the number of appointments 
over the 12-month study period was reduced due to poor attendance of 
appointments by owners.  The visits were reduced to the pre-operative 
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screening, the neutering and the 12 month follow up appointments.  The owners 
were asked to respond to e-mails, phone calls or letters (depending on their 
preference) during the year to establish if the dog’s tobacco smoke exposure had 
remained the same, and if the dog had any illnesses, injuries, psychological 
trauma or developed any new behavioural problems.  It was also hoped that by 
remaining in contact with the owners that they may be more likely to respond to 
a request for them to return to the hospital at the 12-month time point.  The 
steps of the revised outline and samples collected at each time point are 
summarised in Figure 2.3.   
 
        
 Recruitment methods 
9 of the dogs were recruited with the kind help of Staffordshire Rescue Scotland, 
who liaised with owners on our behalf prior to the dogs’ first visits to the Small 
Animal Hospital.  A request was sent to the local People’s Dispensary for Sick 
Animals (PDSA) hospital for client referrals; however, this yielded no recruits.  
Information was disseminated to local first opinion veterinary practices in the 
area, but again this provided no further participants.  However, when one 
practice was informed that a client of theirs was taking part, this did result in 
one further dog being recruited.  One dog belonged to a veterinary student who 
found out about the study through word-of-mouth.  After the breed criteria were 
changed, an e-mail was sent to all staff and students at the University of 
Glasgow, which led to many requests to join the study and the remaining dogs 
needed being signed up. 
 
 
To thank owners for participating, the neutering and associated aftercare and 
health check blood tests were provided free of charge.   In addition, they were 
entitled to two doses of worming tablets over the 12-month period for providing 
up to date information about their dog’s health and ETS exposure.  At the 12-
month appointment (or after depending on the dog’s vaccination history) owners 
were entitled to a free booster vaccination for their dog.  The vaccines and 
wormers were kindly donated by Zoetis (New Jersey, USA).   
 
 Recruitment appointment 
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Figure 2.3 Outline of study 
Flowchart displaying steps taken at each time point.  C indicates the chapter that the 
relevant data is examined. 
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The owners were not given any financial payment for their time or travel 
expense, so the free veterinary services provided were a means of offsetting 
these factors for the owners and the items provided were of benefit for the 
health and wellbeing of the dogs.   
   
 
After the study was completed, the owners were informed of the results 
generated.  Many owners had stated they would like this information, and it 
provided another opportunity to thank them for taking part. 
 
 
 Study documentation and record keeping 
Before agreeing to take part in the study, owners were provided with an 
information sheet (Appendix 1) and details of what would take place over the 
course of the 12 months (Appendix 2).  This information was reiterated at the 
initial health check appointment prior to the owner signing the study consent 
form (Appendix 3).  Owners were also required to sign the hospital’s own 
consent form prior to the neutering procedure.   Their local first opinion 
veterinary practice was sent documentation to inform them when a dog signed 
up to the study (Appendix 4), when they were neutered, the results of clinical 
pathology blood tests and vaccine batch numbers.  This was to ensure continuity 
of care for the dog.  The owner signed a consent form if they were happy for this 
communication to take place (Appendix 5).    A questionnaire regarding ETS 
exposure and dog health was distributed to owners (Appendix 6).  
 
 
The dogs were each assigned a study number and their information, including 
demographics and questionnaire responses from their owners, were stored in a 
Microsoft Access database.  The database was only available to view by the 
author and supervisors.  Collaborators were provided only with information 
required and not allowed database access.  However, the owner and pet details 
were available to staff within the small animal hospital and were stored as a 
standard clinical record.  This was to ensure that staff caring for each dog in the 
hospital had the information needed to perform their job efficiently.  Study 
documentation completed by the owners was stored in a locked cabinet.   
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 The study group and retention rate 
42 dogs took part in total.  2 extra dogs (beyond the intended 40) were recruited 
as it was known that 2 of the dogs who joined the study early on had been 
relinquished by their owners.  There were 5 females and 37 males.  Age at the 
initial health check appointment ranged from 5.5 months to 7 years, with a 
median age of 1 year 5 months.  After the breed criteria changed, many 
different breeds of dog were recruited.  The breeds with more than one dog in 
the study were: Staffordshire bull terrier (n=12), Staffordshire bull terrier X 
lurcher (n=2), Border collie (n=4), Yorkshire terrier (n=2), cavalier King Charles 
spaniel (n=2) and English springer spaniel (n=2).  Breeds with one dog in the 
study were: bearded collie, miniature schnauzer, boxer, cocker spaniel, 
Patterdale terrier, beagle, Jack Russell terrier, German shorthaired pointer, 
Rottweiler, Shar-pei, Basset hound, Pomeranian X Border terrier, German 
shepherd dog X collie, Border terrier X pug, Patterdale terrier X Lakeland 
terrier, English springer spaniel X German shepherd dog, collie X Labrador 
retriever and a retriever/Rottweiler X bull mastiff. 
 
 
Of the 42 dogs, 17 (40.5%) did not return for the 12 month follow up 
appointment.  11 of the dogs that did not return were Staffordshire bull terriers 
and one was a Staffordshire bull terrier X lurcher.  The other dogs who did not 
return were a boxer, a Rottweiler, a Yorkshire terrier, an English springer 
spaniel X German shepherd dog and a Shar-pei.  Only 1 of the 5 female dogs 
returned.  
 
 
 Ethics 
The project was reviewed by the Home Office veterinary surgeon and the 
decision was reached to keep the project as part of routine veterinary practice.  
Ethical approval for the study was obtained from the University of Glasgow 
School of Veterinary Medicine Ethics Committee.  
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 Haematology and biochemistry testing of blood 
samples 
Haematology and biochemistry analyses were performed by the University of 
Glasgow Veterinary Diagnostics Service.  An Advia 120 analyser (Siemens, 
Erlangen Germany) with veterinary software was used for haematology analysis 
from whole blood in EDTA.  Data were verified by making a blood smear stained 
with Pappenheim stain, which was assessed by a clinical pathologist.  
Concentration of biochemistry measures was measured in serum using a Beckman 
Coulter AU640 automated analyser (Beckman Coulter, High Wycombe UK). 
 
 
 Nicotine and cotinine concentration measurement 
Hair samples were sent to the University of Glasgow Forensic Toxicology Service.  
Samples envelopes were uniquely identified, but no information was provided as 
to the reported exposure by the dog owners to the laboratory, so the operator 
would be blind to the history of the dog.  The procedure was performed using 
the methodology by Bawazeer et al. (2012).  Briefly, 30mg of hair was weighed 
into 20ml Chromacol environmental vials.  Hair was finely snipped and 
extraction of nicotine and cotinine performed using 2ml methanol and 1% formic 
acid.  20µl of supernatant was injected into LC-MS/MS system.  Chromatographic 
separation was performed using a ZIC-HILIC column.  Triple quadruple tandem 
mass spectrometry and Agilent Masshunter software (Aglient, Santa Clara USA) 
were used for identification and quantitative analyses.  The lower limit of 
quantification for nicotine was 0.01ng/mg and 0.05ng/mg for cotinine.  Repeat 
measures were highly correlated (R2>0.99).   
 
 
In previous studies, hair was initially washed to remove surface nicotine and 
cotinine, then only nicotine and cotinine in the hair lysate were measured (e.g. 
Pichini et al., 1997; Apelberg et al., 2012).  However, as described in Bawazeer, 
Watson and Knottenbelt (2012), it is worth including surface hair nicotine and 
cotinine as dogs may absorb these through self-grooming.  Therefore, no initial 
wash step was included and data were reported as the total hair nicotine and 
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cotinine concentrations, incorporating surface and hair lysate concentrations 
together. 
 
 
 Statistical analysis 
Statistical analyses were conducted using Stata, version 13.1 (StataCorp USA, 
2013) and R, version 3.2.2 (R project, 2015).   Details of statistical tests used 
will be given in each corresponding results chapter.
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 Introduction 
 Measurement of ETS biomarkers in companion animals 
The only biomarkers of ETS measured in published studies of companion animals 
have been nicotine and its derivatives.  These have only been measured in a 
small number of dog and cat studies.  3 studies were found which examined the 
concentration of cotinine in urine in companion animals.  Roza & Viegas (2007) 
measured urinary cotinine in 30 Yorkshire terriers, half of which were from 
homes where residents smoked at least 20 cigarettes per day, half were not 
exposed to ETS at home.  Cotinine was detected in the urine of all dogs in the 
smoking homes and was not detected in any of the non-ETS exposed dogs.  
Bertone-Johnson et al. (2008) measured cotinine concentration in urine samples 
from 30 dogs in smoking homes and 33 dogs in non-smoking homes.  Owners were 
asked if anyone in the household smoked in the previous 24 hours, number of 
cigarettes and if this smoking occurred indoors.  Cotinine concentrations were 
approximately doubled in dogs exposed to any ETS compared to unexposed dogs.  
Cotinine concentrations were increased in dogs where owners used self-applied 
lawn care, in brachycephalic dogs compared to mesaticephalic and 
dolichocephalic dogs and with every category of increasing numbers of cigarettes 
smoked.  Cotinine levels were also negatively associated with increasing dog 
age.  The third study involved the measurement of urinary biomarkers in 61 cats 
(McNiel et al., 2007).  19 of the cats were from smoking households and the 
other 42 from non-smoking households.  Nicotine, cotinine and 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) concentrations were 
measured, and all the these were found to be at a higher concentration in urine 
of exposed cats compared to unexposed cats.  While urine measures were 
successfully used in these studies as a means of determining ETS exposure, the 
use of urine for this study would not be without issues.  Urine in Roza & Viegas 
(2007) was collected by cystocentesis, which is not without risk, would have 
ethical considerations and would be likely to be unacceptable to owners.  
Bertone-Johnson et al. (2008) used free catch samples into sterile containers 
and then immediately stored at −80°C.  This would be difficult to facilitate in a 
series of 15 minute clinic appointments.  The final study, McNiel et al. (2007) 
used a combination of free catch and cystocentesis. 
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An alternative tissue to measure ETS biomarkers in is hair.  In a Glasgow study of 
38 dogs, hair samples were used to examine the relationship between ETS 
exposure and hair ETS biomarker concentration (Bawazeer, Watson and 
Knottenbelt, 2012; Knottenbelt et al., 2012).  Nicotine concentration was 
quantified in samples from all dogs, and nicotine N-oxides, cotinine, nornicotine 
and nornicotine N-oxide were measured in hair of 7 dogs with smoking owners.  
Nornicotine was only detected in 2 of the selected 7 dogs.  Nornicotine N-oxide 
was present in 5 of the 7, and in 6 of the 7 cotinine and nicotine N-oxides were 
present.  However, nicotine N-oxides were only present on the surface of the 
hair and not in a lysate of chopped up hair.  Nicotine was present in hair from all 
ETS exposed dogs.  The 38 dogs were divided into 3 groups based on zero 
exposure, occasional exposure and regular exposure to ETS based on a 
questionnaire and nicotine concentration measured in all samples.  Hair nicotine 
concentrations were highest in the regularly exposed group.  The hair was 
collected from the neck region, where hair is commonly collected in dogs when 
blood sampling and was then stored in envelopes at room temperature.  This 
method of collection and storage has advantages over the use of urine, as there 
is no need for facilities for −80°C storage, the method of collection is quick and 
simple and the procedure would be acceptable to owners. 
 
 
 Comparison of urine and hair as tissues for ETS exposure 
within individuals 
In addition to the advantages of hair in terms of collection and storage, studies 
have also compared the ability of hair biomarkers to other tissue biomarkers to 
reflect ETS exposure level within individuals.  When 297 hair samples and 158 
urine samples were collected from 322 children aged 3 to 27 months, hair 
nicotine concentrations better discriminated between exposure levels than 
urinary cotinine concentrations (Al-Delaimy, Crane and Woodward, 2002).  The 
correlation between hair nicotine concentration and number of cigarettes was 
stronger than the correlation between urinary cotinine concentration and 
number of cigarettes.   In addition, Nafstad et al. (1995) measured hair nicotine 
concentration in 94 children aged 12-36 months, and cotinine concentration in 
urine samples from 72 of these children.  Urinary cotinine could differentiate 
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between children exposed to greater than 10 cigarettes per day and zero 
exposure, but not between zero exposure and between 1 and 10 cigarettes per 
day exposure, whereas, hair nicotine concentrations could be used to 
differentiate between the three groups. 
 
 
Other tissues used to measure ETS biomarkers in humans include blood (Yang et 
al., 2013), saliva (Curvall et al., 1990), nails (Al-Delaimy et al., 2002), deciduous 
teeth (Garcia-Algar et al., 2003) and meconium (Mozaner Bordin et al., 2014).  
In the UK, blood sample collection not specifically related to the dog’s health 
would require a Home Office licence.  Studies relating to saliva describe 
collection methods such as spitting into a tube (Kim et al., 2014), holding a 
dental roll in the mouth for several minutes (Boyd et al., 1998) and chewing on a 
cotton roll for one minute (Etter, Vu Duc and Perneger, 2000), all of which 
would be impractical in a dog.  In addition, blood and saliva would reflect short 
term exposure to ETS.  Like hair, toe nails have been used to represent long 
term exposure to ETS, but the collection of hair would be likely to be less 
stressful for dogs than nail clipping.  Part of the reason for opting for nails over 
hair in humans is that chemical hair treatments have been shown to have an 
impact on ETS biomarker levels in hair and the use of nails would avoid this.  It 
is unlikely that the dogs in this study would have had their hair coloured or 
permed, so this would not be such an issue here. 
 
 
 Measurement of hair ETS biomarkers in humans 
Several studies have employed the use of hair samples in humans to assess ETS 
exposure, some examples of these are presented here.  Pichini et al. (1997) 
collected hair samples from 24 infants, aged 3 to 36 months, who were either 
non-exposed to ETS, occasionally exposed to ETS or regularly exposed to ETS.  
Nicotine and cotinine concentrations were measured.  Nicotine concentrations 
were significantly different between the 3 different exposure groups, but 
cotinine was only measured in the regularly exposed infants.  Furthermore, in a 
study by Al-Delaimy et al. (2000) hair cotinine was less strongly associated with 
exposure status than hair nicotine concentration.  For this study, hair samples 
from 112 children, aged 3 months to 10 years, and 76 of their mothers were 
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collected and measured for nicotine and cotinine concentration.  The hair 
nicotine in children increased with both the number of smokers in the house and 
the total number of cigarettes smoked at home, and was also strongly correlated 
to their mother’s hair nicotine concentration.  Kim et al. (2009) measured hair 
nicotine concentrations in samples from 1017 children under 11 years of age and 
852 non-smoking women living in households with smokers.  They also measured 
air nicotine content in the homes.  For every 1μg/m3 increase in air nicotine 
concentration, there was a 3% increase in hair nicotine concentration in children 
and only a 1% increase in adult women.  In addition, the children who spent over 
19 hours a day at home showed increased concentrations of hair nicotine 
compared to those who did not.  This is interesting for our study, as many of the 
dogs will spend all their time, aside from going on walks, at home. 
 
 
 Aims and hypotheses for this chapter 
The aim of this chapter was to establish a reliable biomarker for ETS exposure in 
the dogs in this thesis.  Hair was used as the tissue to measure the biomarker in 
as it can be used as a long-term representative tissue.  Nicotine and its 
derivatives are the only biomarkers previously measured in companion animals 
and they have also been widely studied in humans, and therefore nicotine and 
its metabolite cotinine were measured here.   
 
 
Owner questionnaire generated data were compared to nicotine and cotinine 
concentrations in dog hair, to explore whether exposure status reported 
correlated with nicotine and cotinine concentrations and if there were any 
further variables outside of smoking habit which were associated with the 
concentrations.  This information was also to be used to create cut-off values for 
the markers to classify exposure for future studies. 
 
 
It was hypothesised that hair nicotine concentrations would correlate strongly 
with increasing ETS exposure, and that cotinine would be increased in those with 
the highest exposure levels.  In terms of other variables, it was hypothesised 
that smaller dogs would have higher nicotine and cotinine levels, as would those 
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with shorter noses due to previous findings by Bertone-Johnson et al. (2008).  It 
was also hypothesised that those with access to a private garden would have 
decreased ETS biomarker concentrations, but where owners used lawn chemical 
products, this would increase cotinine levels.  It was also expected that, due to 
population density, dogs living in urban environments would have higher 
biomarker concentrations, and dogs living in areas with a lower index of 
deprivation (indicating lower social mobility) would have increased biomarker 
levels due to the increased rates of smoking found in these areas on average.    
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 Methods 
 Hair nicotine and cotinine 
The study dog group was as described in section 2.2.9.  Fur samples were 
clipped from dogs from the neck region prior to blood sampling.  Fur was placed 
in foil and within a sealed envelope to prevent any further smoke exposure.  In 
dogs attending both time points, where possible fur was collected from the same 
side of the neck.  Samples were transferred to the University of Glasgow Medical 
Forensics department, where nicotine and cotinine concentrations were 
measured using the method described in section 2.2.11. 
 
 
 Questionnaire and dog demographic details 
Dog weight was recorded at both time points.  Breed height was estimated for 
each dog using information from the UK Kennel Club and American Kennel Club 
websites and individual breed literature (The Patterdale Terrier, no date; 
Plummer, 1985; American Kennel Club, 2016; The Kennel Club Limited, 2016).  
For cross breeds, the mean of the parent breed heights was used.  Cephalic 
indices were obtained from Carrasco et al (2014).  Mean values were used for 
cross-breeds.  Cephalic index was not available for the Yorkshire terriers, Shar-
pei, Staffordshire bull terrier X lurchers, Border terrier X pug, Border terrier X 
Pomeranian, Patterdale terrier or Patterdale terrier X Lakeland terrier.   
 
 
Fur colour, type and length were noted at the time of sampling.  Lengths were 
divided into short, medium or long.  Shedding rates were obtained from the 
Purina™ pet food website (Purina, 2016) and divided into low, medium or high.  
Owner index of deprivation was obtained from the Scottish Neighbourhood 
Statistics website using their postcodes (The Scottish Government, 2015b). 
 
 
Questions regarding ETS exposure were as in Knottenbelt et al. (2012) with 
additional questions relating to time spent with the dog by each smoker, and are 
shown in Appendix 6, which contains the questionnaire in entirety.  ETS 
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exposure was divided into 3 levels: no exposure at home (group 1), owner or 
friends/family did smoke but not indoors at home (group 2) and owners smoke 
inside the home (group 3).    
 
 
 Data analysis 
Normality checks were performed on data using a Shapiro-Wilk test.  A p value 
of <0.10 resulted in the variable being treated as non-parametric.  The nicotine 
and cotinine concentrations had a non-parametric distribution, so pairwise 
comparisons were conducted using a Wilcoxon rank-sum test.  Kruskal-Wallis 
tests were used to compare data in more than 2 groups.  If the Kruskal-Wallis 
test resulted in a p value of less than 0.05, pairwise Wilcoxon rank-sum tests 
with Holm p value correction were undertaken.  To test the correlation between 
two continuous variables, Spearman’s rank correlation was used.  In addition, to 
test which variables were associated with nicotine or cotinine concentrations, 
generalised linear models were undertaken.  Model residuals were checked by 
using the plot(modelname) function in R. 
 
 
All statistical analyses were performed in R version 3.2.2 (R Core Team, 2014).  
Statistical significance level was taken as p<0.05. 
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 Results 
 Descriptive analysis of cohort 
Of the 42 dogs, 22 were reported to have no ETS exposure and were placed in 
group 1, 6 were exposed to ETS but no smoking occurred inside the house and so 
were placed in group 2, and 14 were exposed to ETS inside the house and were 
placed in group 3.  Between the two time points, the owners of 4 of the dogs 
gave up smoking and 3 of these started to use e-cigarettes, placing these 4 dogs 
in group 1 for the second time point.  Consequently, of the 25 dogs which 
returned for the second time point, 17 were in group 1, 2 were in group 2 and 6 
were in group 3.  One of the female dogs at time point 1 had insufficient fur 
sampled for mass spectrometry analysis of nicotine and cotinine concentration.  
Table 3-1 summarises the demographic variables of the dogs in each group at 
time point 1 and Table 3-2 summarises the demographics of the dogs attending 
for the second time point.  Table 3-3 details the breeds in each group. 
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Table 3-1 General description of the dogs attending for the first time point.   
Median and interquartile ranges are given, with the p values of Kruskal-Wallis tests between 
the 3 groups for the variables displayed in the final column under “Difference test” 
Time point 1 Overall Group 1 Group 2 Group 3 Difference 
test 
Number  42 22 6 14  
Males 37 20 4 13  
Females 5 2 2 1  
Nicotine ng/mg 0.14 
(0.56) 
0.03 
(0.03) 
0.16 
(0.80) 
0.73 
(1.99) 
<0.001 
Cotinine ng/mg 0.05 
(0.13) 
0.00 
(0.05) 
0.05 
(0.24) 
0.14 
(0.09) 
<0.001 
Age 1.39 
(2.22) 
1.76 
(2.31) 
1.01 
(2.31) 
1.56 
(2.14) 
0.62 
Weight kg 16.9 (7.2) 14.8 (9.4) 18.9 (5.1) 17.6 (9.0) 0.44 
Height cm 39 (18) 39 (16) 54 (29) 38 (19) 0.07 
Cephalic index 63.1 
(21.7) 
56.9 
(23.1) 
66.6 
(22.1) 
75.1 
(21.3) 
0.24 
Index of 
deprivation 
2749 
(3156) 
2912 
(2801) 
2187 
(3076) 
662 (2784) 0.16 
 
  
Chapter 3  123 
 
Table 3-2 General description of the dogs attending for the second time point. 
Median and interquartile ranges are given, with the p values of Kruskal-Wallis tests between 
the 3 groups for the variables displayed in the final column under “Difference test” 
Time point 2 Overall Group 1 Group 2 Group 3 Difference 
test 
Number 25 17 2 6  
Males 24 16 2 6  
Females 1 1 0 0  
Nicotine ng/mg 0.06 (0.31) 0.03 
(0.09) 
0.52 (0.91) 1.94 
(8.31) 
0.002 
Cotinine ng/mg 0.00 (0.18) 0.00 
(0.04) 
0.10 (0.20) 0.35 
(0.20) 
0.01 (with 
ties) 
Age 1.73 (1.78) 1.91 
(3.61) 
1.55 (0.03) 1.73 
(0.18) 
0.21 
Weight kg 17.8 (11.1) 17.2 
(11.1) 
26.7 (11.3) 15.5 
(10.2) 
0.37 
Height cm 41 (19) 47 (19) 61 (9) 33 (2) <0.05 
Cephalic index 54.4 (18.1) 53.9 (2.6) 62.6 (14.9) 75.7 
(23.8) 
0.24 
Index of 
deprivation 
2876 
(2844) 
2880 
(2434) 
3471 
(1698) 
770 
(3119) 
0.63 
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Table 3-3 Breeds in each exposure group 
Breeds are divided by divided by whether they attended both time points or time point 1 
only.  The 4 dogs in italics changed exposure from group 2 or 3 to group 1 between the time 
points 
Group Breeds at both time points Breeds at time point 1 only 
1 Pomeranian/Border terrier X (n=1) 
Bearded collie (n=1) 
Miniature schnauzer (n=1) 
Springer spaniel (n=1) 
Cocker spaniel (n=1) 
Patterdale terrier (n=1) 
German shepherd dog/Collie X 
(n=1) 
Border terrier/Pug X (n=1) 
Beagle (n=1) 
Jack Russell terrier (n=1) 
German shorthaired pointer (n=1) 
Shar-pei (n=1) 
Border collie (n=2) 
Staffordshire bull terrier (n=1) 
Boxer (n=1) 
Springer spaniel/German 
shepherd dog X (n=1) 
Staffordshire bull terrier (n=5) 
2 Retriever/Rottweiler & bull mastiff 
X (n=1) 
Collie/Labrador retriever X (n=1) 
Border collie (n=1) 
Rottweiler (n=1) 
Staffordshire bull terrier (n=2) 
3 Patterdale terrier/Lakeland terrier 
X (n=1) 
Basset hound (n=1) 
Staffordshire bull terrier/Lurcher X 
(n=1) 
Cavalier King Charles spaniel (n=2) 
Staffordshire bull terrier (n=1) 
Springer spaniel (n=1) 
Yorkshire terrier (n=1) 
Border collie (n=1) 
Staffordshire bull terrier/Lurcher 
X (n=1) 
Staffordshire bull terrier (n=3) 
Yorkshire terrier (n=1) 
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Nicotine values were log transformed for further analyses to improve model 
residuals.  There were no zero values, however there were 15 zero readings for 
cotinine concentration.  The cotinine values were square root transformed to 
improve model residuals. 
 
 
Nicotine measurements at the two time points were highly correlated 
(Spearman’s rho=0.89, p<0.001, Figure 3.1), as were cotinine measurements at 
the two time points (Spearman’s rho=0.85, p<0.001, Figure 3.2).  Nicotine 
concentration and cotinine concentrations were significantly correlated at time 
point 1 (Spearman’s rho=0.86, p<0.001, Figure 3.3) and time point 2 (Spearman’s 
rho=0.77, p<0.001, Figure 3.4).  The hair nicotine concentrations at time point 1 
(HNC1) were significantly different between the ETS exposure groups (Kruskal-
Wallis test, p<0.001, Figure 3.5).  Pairwise Wilcoxon rank sum tests with Holm p 
value adjustment showed there were significant differences in HNC1 between 
group 1 and 2 (p=0.02), and between groups 1 and 3 (p<0.001) but no significant 
difference between groups 2 and 3 (p=0.22).  There was a significant difference 
in hair cotinine concentration at time point 1 (HCC1) between the exposure 
groups as well (Kruskal-Wallis test, p<0.001, Figure 3.6).  Pairwise Wilcoxon rank 
sum tests with Holm p value adjustment showed there was only a significant 
difference in HCC1 between groups 1 and 3 (p<0.001), and not groups 1 and 2 
(p=0.53) or groups 2 and 3 (p=0.58).  A significant difference in hair nicotine 
concentration at time point 2 (HNC2) was also observed between the exposure 
groups (Kruskal-Wallis test, p=0.002, Figure 3.7).  Pairwise Wilcoxon rank sum 
tests with Holm p value adjustment showed a significant difference between 
group 1 and 3 (p=0.004), but not between group 2 and 3 (p=0.29) or group 1 and 
2 (p=0.29).  In addition, there was a significant difference in hair cotinine 
concentration at time point 2 (HCC2) between the exposure groups (p=0.01, 
Figure 3.8).  Likewise, as at time point 1, pairwise Wilcoxon-rank sum tests 
showed a significant difference in HCC2 between group 1 and 3 only (p=0.02), 
and not between groups 1 and 2 (p=0.48) or groups 2 and 3 (p=0.48).  While 
neither HNC or HCC at either time point could discriminate between groups 2 
and 3, it should be noted that there were a relatively small number of dogs in 
group 2 (6 at time point 1, 2 at time point 2), which will have impacted the 
analyses.   
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Figure 3.1 HNC at time points 1 and 2 within each dog 
Paired HNCs including dogs which changed exposure groups during the study.  
Measurements were highly correlated (Spearman’s rho=0.89, p<0.001).  N=25 (24 male, 1 
female).    
 
Figure 3.2 HCC at time points 1 and 2 within each dog 
Paired HCCs including dogs which changed exposure groups during the study.  11 dogs 
had HCC of 0ng/mg at both time points.  The correlation was statistically significant 
(Spearman’s rho=0.85, p<0.001).  N=25 (24 male, 1 female). 
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Figure 3.3 HNC and HCC measurements at time point 1 
The two measures were significantly correlated (Spearman’s rho=0.86, p<0.001).  N=41 (37 
male, 4 female).   
 
Figure 3.4 HNC and HCC measurements at time point 2 
The two measures were significantly correlated (Spearman’s rho=0.77, p<0.001).  N=25 (24 
male, 1 female) 
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Figure 3.5 HNC at time point 1 by exposure group 
Pairwise differences are indicated by ***p<0.001, **p<0.01, *p<0.05.  N=41 (37 male, 4 female) 
 
Figure 3.6 HCC at time point 1 by exposure group 
Pairwise differences are indicated by ***p<0.001, **p<0.01, *p<0.05.  N=41 (37 male, 4 female) 
 
 
*** 
*** 
* 
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Figure 3.7 HNC by exposure group at time point 2 
Pairwise differences are indicated by ***p<0.001, **p<0.01, *p<0.05.  N=25 (24 male, 1 female) 
 
Figure 3.8 HCC by exposure group at time point 2 
Pairwise differences are indicated by ***p<0.001, **p<0.01, *p<0.05.  N=25 (24 male, 1 female) 
  
* 
** 
Chapter 3  130 
 
 ROC analysis 
To use HNC and HCC as biomarkers of ETS exposure, without owner history, ROC 
analysis was performed to determine positive and negative cut off values which 
would result in the highest percentage of dogs being correctly classified as being 
exposed or unexposed.  For this section, groups 2 and 3 were combined in one 
“smoking home” group.  Figures 3.9-3.12 display the generated ROC curves. 
Using a cut-off value of 0.357ng/mg at HNC1 resulted in 87.80% of dog being 
correctly classified as being in smoking or non-smoking homes.  Cut off points of 
0.328ng/mg and 0.974ng/mg for HNC2 resulted in 92.0% of the dogs being 
correctly classified.  Using a cut off of 0.328ng/mg for HNC at both time points 
did not alter the percentage of dogs correctly classified at time point 1.  For 
HCC1, the optimum cut off was 0.092ng/mg, which correctly classified 85.37% of 
the dogs.  The cut off was higher for HCC2, with a cut off of 0.196ng/mg or 
0.284ng/mg correctly classifying 88.0% of dogs.  If the same cut off as HCC1 was 
used, 0.092ng/mg, 80.0% of dogs would be correctly classified.  If the 
0.196ng/mg cut-off point generated from time point 2 data was applied to the 
time point 1 data, only 68.3% of dogs would be correctly classified, and the 
sensitivity would be just 0.32.  Those in homes where the owners had either 
stopped smoking or switched to using e-cigarettes between the two time points 
were placed in the non-smoking home group for the time point 2 analyses.  If 
these dogs were placed in the smoking group at time point 2, a cut off of 
0.079ng/mg resulted in the correct classification of 88.0% of dogs for HCC2.   
 
 
Tables 3-4 to 3-7 tabulate the exposed and unexposed by if they were test 
positive or negative for HNC1, HNC2, HCC1 and HCC2.  These figures were used 
to calculate sensitivities and specificities, with 95% confidence intervals, which 
are shown in Table 3-8 and Table 3-9. 
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Figure 3.9 ROC curve of HNC1 
 
Figure 3.10 ROC curve of HNC2 
 
Chapter 3  132 
 
 
Figure 3.11 ROC curve of HCC1 
 
Figure 3.12 ROC curve of HCC2 
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Table 3-4 Nicotine concentration at time point 1: positive and negative by exposure 
Cut off 
0.328ng/mg 
Smoking home Non-smoking home Totals 
HNC1 positive 15 1 16 
HNC1 negative 4 21 25 
Totals 19 22 41 
 
 
Table 3-5 Nicotine concentration at time point 2: positive and negative by exposure 
Cut off 
0.328ng/mg 
Smoking home Non-smoking home Totals 
HNC2 positive 6 1 7 
HNC2 negative 1 17 18 
Totals 7 18 25 
 
 
Table 3-6 Cotinine concentration at time point 1: positive and negative by exposure 
Cut off 
0.092ng/mg 
Smoking home Non-smoking home Totals 
HCC1 positive 13 0 13 
HCC1 negative 6 22 28 
Totals 19 22 41 
 
 
Table 3-7 Cotinine concentration at time point 2: positive and negative by exposure 
Cut off 
0.196ng/mg 
Smoking home Non-smoking home Totals 
HCC2 positive 5 1 6 
HCC2 negative 2 17 19 
Totals 7 18 25 
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Table 3-8 HNC1 and HNC2 test properties 
HNC1 cut-off 
0.328ng/mg 
Value 95% confidence interval 
Sensitivity 0.79 0.54 – 0.93 
Specificity 0.95 0.75 – 1.00 
   
HNC2 cut-off 
0.328ng/mg 
Value 95% confidence interval 
Sensitivity 0.86 0.42 – 0.99 
Specificity 0.94 0.71 – 1.00 
 
 
Table 3-9 HCC1 and HCC2 test properties 
Described using the different cut off points generated by ROC analysis 
HCC1 cut-off 
0.092ng/mg 
Value 95% confidence interval 
Sensitivity 0.68 0.43 – 0.86 
Specificity 1.00 0.82 – 1.00 
   
HCC2 cut-off 
0.196ng/mg 
Value 95% confidence interval 
Sensitivity 0.71 0.30 – 0.95 
Specificity 0.94 0.71 – 1.00 
   
HCC2 cut-off 
0.092ng/mg 
Value 95% confidence interval 
Sensitivity 0.71 0.30 – 0.95 
Specificity 0.89 0.65 – 0.98 
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 Factors related to HNC and HCC  
No dog had a zero value for HNC at either time point, regardless of exposure.  
The previous study conducted in Glasgow on hair nicotine concentrations found 
zero values for HNC (Knottenbelt et al., 2012).  Therefore, in the dogs that were 
not exposed to ETS at home, the factors which were associated with their HNC 
and HCC measures were investigated.  In addition, analyses were conducted to 
see if there were variables which were related in HNC and HCC in ETS exposed 
dogs.  The description of these analysis is given in Appendix 7.   
 
 
 Change in exposure status 
4 of the dogs had a change in exposure between the two time points, with 3 of 
the owners switching from conventional cigarettes to e-cigarettes.  All 3 of the 
dogs where owners switched to e-cigarettes showed a decrease in HNC between 
the two time points, such that at time point 1 they were in the positive HNC 
group, and at time point 2 they were in the negative HNC group (using ROC 
generated cut-off points).  However, only one of these dogs demonstrated a 
decrease in HCC, and the other two showed an increase.  One of the dogs had a 
four-fold increase in HCC between the two time points.  E-cigarettes do still 
contain nicotine, and therefore could result in cotinine in the dogs’ hair, but 
given that the owners were using e-cigarettes as a means to stop smoking it 
seems unlikely that cotinine levels would increase from the e-cigarette exposure 
alone.  With such small numbers, it is difficult to comment on the reasons 
behind the cotinine concentrations in these dogs.  The dog where the owner 
stopped smoking during the year had an increase in HNC between the two time 
points.  This owner was unsure of ETS exposure their dog was experiencing from 
smoking habits of their partner and visitors, so the increase in HNC during this 
time may be due to exposure from people other than the owner smoking.  This 
dog had an HCC of 0ng/mg at both time points. 
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 Discussion 
 Questionnaire design 
The questionnaire covered many areas.  However, for future studies, an editing 
of the questionnaire would be helpful to reduce the time owners need to engage 
in questionnaire responding and keep their interest.  Little was gained from 
knowing smoking location habits other than to know if owners acted to protect 
their family from smoking in some way, such as only smoking outdoors.  Several 
owners did not own cars, for example, so this question was not helpful and 
embarrassed some.  In others, behaviours such as smoking in a car nor in close 
contact with their dog was in keeping with smoking indoors.  Given the size of 
the group and numbers who smoked, further division due to these types of 
behaviours did not aid analysis. 
 
 
The number of cigarettes groups for each smoker were too broad.  Most smoking 
owners smoked 20 cigarettes or less per day.  Given that there was a 
relationship between the number of cigarettes smoked in the household per day 
and nicotine and cotinine measures, it may have been useful to know in more 
detail the number of cigarettes smoked, rather than using wide groups.  
However, it was difficult to get some owners to quantify their habits, due to 
perhaps embarrassment or variability day-to-day, so using wide groups helped to 
glean information from owners without them feeling judged.  In addition, those 
who smoked roll-your-own cigarettes found it difficult to quantify their habits, 
and more than one of these smokers felt that their type of cigarettes “did not 
count” in terms of environmental tobacco smoke exposure, and that passive 
smoking was only an issue in factory-made cigarettes.  In hindsight, it would 
have been helpful to research common quantities of tobacco used by roll-your-
own cigarette smokers and to have a box for recording quantities of tobacco 
pouches used per week.  Data from the International Tobacco Control Europe 
Survey showed that between 2007 and 2010, exclusive roll-your-own cigarette 
use among smokers increased from 26.4% to 32.7% (Brown et al., 2015).  In 
addition, the Office for National Statistics Opinions and Lifestyle Survey found 
that in 2014, 39% of male smokers and 28% of female smokers used roll-your-own 
cigarettes in Great Britain (Office for National Statistics, 2016).  No data could 
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be found for the rate of roll-your-own cigarette use in Scotland alone, but these 
figures suggest that future studies should be designed with roll-your-own 
cigarette users in mind.  Tobacco used per cigarette would vary between roll-
your-own smokers (Darrall and Figgins, 1998), so asking about weight of tobacco 
used per week may be a more practical approach than cigarette numbers. 
This study is not alone in finding roll-your-own smokers believing them to be less 
harmful.  In a survey of 13,322 adults from Australia, Canada, the United 
Kingdom and the United States, participants were asked which out of factory-
made cigarettes, roll-your-own cigarettes, pipes and cigars they thought were 
the least and the most harmful.  Smokers from the UK were the most likely to 
report roll-your-own cigarette use of the four countries.  White male smokers 
under 25 from the UK or Australia who smoked roll-your-own cigarettes 
sometimes or exclusively were the most likely to see roll-your-own cigarettes as 
the least harmful (O’Connor et al., 2007). 
 
 
 Dogs of owners giving up smoking 
Three of the dogs went from heavy smoke exposure to e-cigarette exposure 
approximately half way between the two time points.  The nicotine 
concentration of these dogs reflected these changes.  However, the cotinine 
concentrations did not, with two of the three dogs having an increase in cotinine 
concentration.  This may be in part due to the longer half-life of cotinine and no 
sources of information regarding the half-life of nicotine and cotinine in hair 
following habitual exposure.  Alternatively, the cotinine could be due to 
lingering third-hand smoke in the environment.  Nicotine has been measured in 
the dust of homes both in homes where smoking occurs indoors and homes where 
adults attempted to protect their families from smoke exposure (Matt et al., 
2004) and third-hand smoke was demonstrated in homes where smokers had 
moved out 2 months prior to measurement (Matt et al., 2011).  The owners 
switched to e-cigarettes as part of their cessation.  The cotinine could be due to 
exposure to the e-cigarette, as serum cotinine levels were similar when passive 
smoking occurred from a tobacco cigarette and an e-cigarette in humans (Flouris 
et al., 2013).  However, salivary cotinine levels were found to be significantly 
lower in non-smokers exposed to e-cigarettes compared to tobacco cigarettes at 
home in another study (Ballbè et al., 2014) and e-cigarette emissions have been 
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shown to be far safer than tobacco cigarettes in terms of risk to human health 
(McAuley et al., 2012).  Regardless, the demonstration of reduction in hair 
nicotine of the dogs could be motivation for the owners to retain their cessation 
habit, and future projects which employ feeding back to owners the levels of 
their dog’s hair nicotine as a means of helping them stop smoking could be worth 
pursuing. 
 
 
The owner of one dog changed smoking habit from smoking only outside to not 
smoking.  The HNC of the dog actually increased between the two time points.  
When speaking to the owner at the second time point, they were unsure of the 
ETS exposure of the dog from their partner and visitors to the house when they 
were not present.  By using HNC as the measure of ETS exposure rather than 
owner reported exposure, uncertainties such as these will not impact analyses in 
studies evaluating relationships between ETS exposure and biological measures 
in the dog.  
 
 
 Nicotine and cotinine hair concentrations as biomarkers of 
ETS  
Nicotine and cotinine concentrations reflected the ETS exposure, increasing with 
number of cigarettes smoked in the home.  As predicted, nicotine was a better 
reflection of exposure, and cotinine concentration increased in higher 
exposures.  However, unlike Knottenbelt et al. (2012) there were no zero 
readings for hair nicotine.  This may be in part to the measurements being 
reported as a combination of wash and lysate measurements rather than 
separately.  If they had been reported separately, this may have given further 
information on why the non-ETS exposed dogs did not have zero nicotine 
readings.   
 
 
There were 3 dogs which had negative cotinine concentrations according to the 
ROC generated cut-off, but were exposed to ETS within the home.  A possible 
reason for this is these dogs having a variation in their cytochrome P450 2A6 
enzyme, which catalyses the main route of nicotine metabolism to cotinine.  
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Variations in this enzyme have been demonstrated in humans (Tricker, 2003).  
Without further experiments, it is not possible to know if this is the case. 
 
 
An interesting finding during the study was that weight was positively associated 
with nicotine concentration in non-ETS exposed dogs, whereas it was negatively 
related with nicotine in ETS-exposed dogs.  Smaller dogs in smoking homes may 
have increased exposure if they are close to the floor where there may be 
increased third-hand smoke exposure, and they may have more lap-dog type 
behaviours, making them physically closer to smokers.  Whereas, in non-smoking 
homes, larger dogs may spend more time exercising outside the home, 
potentially interacting with smokers or being exposed to sources of ETS 
exposure. 
 
 
The ratio of nicotine to cotinine was lower in female dogs, which could reflect 
an increased activity of cytochrome P450 2A6, with increased conversion of 
nicotine to cotinine.  This has been observed in human females as well 
(Benowitz et al., 2006), with the clearance of nicotine to cotinine being 
significantly higher in women than men. 
 
 
No significant differences were found due to coat colour or other coat variables.  
This is likely to have been due to the wide variety of coats seen in the study 
dogs, such that the numbers in each group were very small.  Seven genes which 
determine coat colours and patterns in dogs have been identified, so a great 
variety is possible (Schmutz and Berryere, 2007).  Significant differences in 
nicotine and cotinine in hair of nicotine exposed pigmented and albino rats were 
noted in a previous study (Gerstenberg et al., 1995) and nicotine and cotinine 
adducts have been demonstrated in a melanin intermediate (Dehn et al., 2001), 
suggesting melanin content of the coat may have an impact on nicotine and 
cotinine concentration.  Examining different colours of hair within the same dog 
may indicate whether hair colour is confounding the results.   
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 Chapter summary 
This chapter examined the use of hair nicotine and cotinine as biomarkers of ETS 
exposure in pet dogs.  Hair nicotine concentration demonstrated the best 
reflection of ETS exposure in smoke exposed dogs, but positive readings were 
found in non-ETS exposed dogs.  Cotinine was not present in the hair of many 
non-ETS exposed dogs, but also in some of the dogs with reported ETS exposure.  
Cut-off points for nicotine and cotinine hair concentration for ETS exposure 
status were generated using ROC analysis.  Over 85% of dogs were correctly 
classified using a nicotine concentration cut off.  If owners changed smoking 
habits between the two time points, nicotine better reflected the changes than 
cotinine concentration.   
 
 
By having biomarkers measured by an outside laboratory, this provided an 
objective reading of ETS exposure to be used for analysis in the subsequent 
chapters.  
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4 Chapter 4: Optimisation of telomere length 
measurement method  
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 Introduction 
 Methods of telomere length measurement 
 Terminal restriction fragment (TRF) analysis/Southern blot 
TRF analysis was the first method used to measure telomere length and was 
successfully used as a means of demonstrating the shortening of telomeres in 
human fibroblasts with serial passaging (Harley, Futcher and Greider, 1990).  As 
the first available method for telomere length analysis, it is often used as a 
reference to which to compare new methods and it is regarded as the “gold 
standard” method of telomere measurement (Aviv, 2009).  Because of this, TRF 
analysis was selected from the two methods cited in the literature for measuring 
canine telomere length and optimised for use in this project.  However, it could 
not be the sole method used as the procedure requires substantial amount of DNA 
and the quantities required were not always successfully extracted from clinical 
samples.  The minimum amount of DNA needed for the method in our laboratory 
was 1μg, at a minimum concentration of 58.82ng/μl (i.e. 1μg in 17μl).  Several of 
the DNA extractions performed on blood and buccal samples fell short of this 
target and, given the nature of clinical sample collection, it is not possible to 
simply collect more. 
 
 
 STELA 
Baird et al (2003) developed the single telomere length analysis (STELA) method.  
A telomere homologous 7 based linker is annealed to the 3’ overhang of the 
telomere, followed by a 20 nucleotide non-complementary tail.  The linker is then 
ligated to the 5’ end of the chromosome, resulting in the telomere being 
effectively tagged with a non-complementary tail.  PCR is then performed, with a 
primer of the matching sequence to the tail and a primer which is chromosome 
specific and located in the subtelomeric region.  The products are resolved by 
agarose gel electrophoresis, Southern blotted and probed with the particular 
subtelomeric sequence.  The resulting bands each represent a single telomere 
from an individual chromosome.   The subtelomeric region needs to be well 
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characterised and unique to the selected chromosome, which may cause issues 
when applying the technique in some organisms without a well characterised 
genome (Baird et al., 2003; Nussey et al., 2014). 
 
 
Very small amounts of DNA are required for STELA and the method is good at 
identifying short telomeres, unlike traditional Southern blotting which can be 
biased against short telomeres (Bendix et al., 2010).  Short telomeres are 
important in cell viability and chromosome stability (Hemann et al., 2001).  A 
method adaptation published in 2010, “Universal STELA”, demonstrates the 
presence of critically short telomeres regardless of which chromosome they are on, 
as opposed to the original method which is chromosome specific (Bendix et al., 
2010).  Telomeres longer than 20kb, however, are not readily identified using 
STELA which could impact upon analysis of telomeres in small mammals with long 
telomeres (Aubert, Hills and Lansdorp, 2012).   
 
 
STELA is technically difficult to optimise (Aubert, Hills and Lansdorp, 2012) and it 
was felt insufficient technical support would be available to implement this 
method.  In addition, there are no examples of the use of STELA on canine DNA in 
current literature and canine telomeres have been measured as longer than 20kb 
in previous studies (e.g. Cadile et al. 2007).   
 
 
 qPCR 
Cawthon (2002) developed a simple high throughput quantitative PCR (qPCR) 
method for measuring the factor by which telomere length differs between a 
sample of interest and a reference sample. Telomere and single gene copy primers 
are used and the relative copies of each compared to the reference sample are 
taken into account to create a relative telomere to single copy gene (T/S) ratio or 
“relative telomere length” (RTL).  The ratio is proportional to the average 
telomere length in the sample.  When the RTL is 1, the telomere repeat to single 
gene copy number is the same in the sample of interest and the reference sample.  
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The numerical differences in RTL between individuals corresponds to the relative 
difference in their telomere lengths.   
 
 
qPCR for telomere length is widely used in epidemiological studies due to the 
relatively low cost, requirements for small amounts of DNA, relative ease 
compared to techniques like q-FISH and short time to run (Nussey et al., 2014).  In 
addition, it has been used with samples from a variety of organisms including 
chimpanzees (Tackney et al., 2014), badgers (Beirne et al., 2014), humpback 
whales (Olsen et al., 2014), warblers (Barrett et al., 2013) and, importantly for 
this study, dogs (Fick et al., 2012).  For these reasons, the method was optimised 
for use in this study.  
  
 
One of the main drawbacks of qPCR is the variability between samples and assays 
(Aubert, Hills and Lansdorp, 2012).  In addition, using the Cawthon method the 
reported value is relative to a reference sample of the laboratory’s choosing, 
meaning ratios cannot be compared between laboratories.  In an attempt to 
overcome this, standard curves of oligo standards to measure “absolute telomere 
length” have been used (O’Callaghan et al. 2008) and this method was used by Fick 
et al (2012) to measure LTL in dogs of a variety of breeds.   
 
 
 Q-FISH and flow FISH 
Quantitative fluorescent in situ hybridisation (Q-FISH) is a method of studying 
telomere repeats at individual chromosomes, developed by Lansdorp et al (1996).  
The technique uses labelled (CCCTAA)3 peptide nucleic probes that specifically 
hybridise to denatured telomere DNA repeat arrays.  Fluorescence intensity of 
bound probe is used to measure telomere length.  Samples can be either cultured 
cells arrested in metaphase or fixed tissue sections. 
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The method was adapted to measure the average telomere length of cells, by 
combining the fluorescent in situ hybridisation procedure with flow cytometry.  
This technique is known as flow FISH (Rufer et al., 1998).  The fluorescence level is 
measured by flow cytometry and in addition different cell populations within a 
sample can be sorted.  Blood samples can be used with this adapted method and 
age-dependent LTL has been demonstrated with this procedure using human (e.g. 
Canela et al. 2007) and baboon (Baerlocher et al., 2003) samples.  
 
 
The main drawback with using flow FISH for the canine blood samples in this study 
is that samples need to be processed within 24 hours of collection (Baerlocher et 
al., 2006).  As surplus blood samples from the University of Glasgow Veterinary 
Diagnostics Service (VDS) were to be used for technique optimisation, which are 
only available a week after collection, this would not be possible to achieve.  In 
addition, Baerlocher et al (2006) state that “a few ml of blood” would be 
sufficient for the technique, but the volume of blood spare after clinical pathology 
testing in the dog is invariably a fraction of this amount. 
 
 
 Sequencing 
There are a small number of studies in the literature where whole genome 
sequencing was utilised to determine telomere length.  Castle et al (2010) counted 
and normalised the number of sequence reads containing (TTAGGG)4 in cell line 
and human DNA.  Parker et al (2012) improved the method by also including the 
complementary sequence (CCCTAA)4 in their counts.  They applied their method to 
paediatric cancer sequences and normal DNA from adults, and were able to 
demonstrate age-dependent telomere length changes.  Improvements in software 
have taken place so that pure telomere length can be better distinguished from 
interstitial telomere repeats (Nersisyan and Arakelyan, 2015).  The main reason 
that this method was not be employed in this thesis is the high financial cost 
associated with whole genome sequencing, which exceeded the study budget.     
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 Methods not widely used in literature 
The following methods are those which have been described in publications, but 
then not regularly applied in subsequent studies.  For this reason, these methods 
will not be used in this study. 
 
 
Dot blot 
 
The dot blot method was designed by Kimura and Aviv (2011) with the aim of 
developing a procedure which was easy to perform, inexpensive and requiring a 
relatively small amount of DNA.  Analysis is carried out using dot blots.  DNA 
content in each dot is measured by a DNA stain and telomere probe.  The telomere 
length is then normalised to the DNA content.  On investigation, the DNA stain 
used by the authors was not currently available from the listed supplier.  
 
 
Hybridisation protection assay 
 
In the hybridisation protection assay (HPA), an acridinium ester labelled telomere 
probe is hybridised to the sample.  Chemiluminescence is then measured.  An Alu 
probe is also used to normalise the telomere measurement to the amount of DNA 
in the sample.  Purified, sheared DNA can be used or unpurified DNA in cell or 
tissue lysate.  The process is simple and rapid, and measurements have been 
shown to correlate well with those using Southern blot TRF analysis (Nakamura et 
al., 1999). 
 
 
Enzyme hybridisation assay 
 
The enzyme hybridisation assay for telomere measurement was developed by 
Freulet-Marriere et al (2004).  A 96 well plate is coated with a captor 
phosphodiester oligonucleotide.  A telomere tracer oligonucleotide is hybridised to 
cell lysate samples and a streptavidin-acetylcholinesterase conjugate is used for 
colorimetric detection.  Optical density (OD) measure represents the number of 
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telomere units in the cell lysate sample and is normalised to the sample DNA 
concentration. 
 
 
Primed in situ 
 
Cycling-primed in situ (PRINS) involves the use of synthetic oligonucleotide 
telomere primers, which are annealed to sample chromosomes and elongated by 
the addition of fluorescence labelled nucleotides.  The fluorescence signals are 
detected by fluorescence microscopy.  The original method was developed in a 
Chinese hamster tumour-derived cell line (Musio and Rainaldi, 1997).  When human 
cells (which have much shorter telomeres than hamsters) were used, the primer 
annealed unevenly. The method was adapted to include primers with both 
telomere forward and complementary sequences which improved labelling 
efficiency of human telomeres (Yan et al., 2004). 
 
 
Detection of individual telomere lengths 
 
This method is a based on the Southern blotting protocol, with modification in the 
sample preparation.  A chemistry-based DNA cutter is used to separate the 
telomere from the rest of the chromosome producing a “real telomere fragment”.  
The reaction mixture is then treated as per the TRF analysis procedure, run out on 
a gel and detected by Southern blotting.  This method avoids the inclusion of the 
subtelomeric region as occurs in traditional Southern blotting (Ishizuka, Xu and 
Komiyama, 2013). 
 
 
Using surfaced enhanced Ramen scattering (SERS) probes 
 
Use of SERS probes for telomere measurement is a recently described method by 
Zong et al in 2014.  Telomere and centromere SERS probes are hybridised to a 
genomic DNA sample.  The sample is then dropped onto a SERS substrate and SERS 
signal is measured.  If a telomere is short, fewer probes can attach and the signal 
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is reduced, compared to a longer telomere with greater probe attachment.  The 
result is normalised to the centromere SERS signal.  The laboratory published an 
updated version of the method in 2016, called SERS based in situ hybridisation, 
which allows the measurement of single telomeres (Zong et al., 2016). 
 
 
Quantigene chemistry  
 
The quantigene chemistry method generates a relative telomere measurement 
using a hybridisation-based assay, which uses Luminex® magnetic beads with 
capture probes targeted to telomere repeats and a reference gene.  A lysed 
sample is incubated with the capture probes, capture extenders, label extenders 
and blocking probes.  Signal amplification occurs using branch DNA technology, 
with pre-amplifier molecules hybridised to the label extenders, multiple amplifier 
molecules hybridised to the pre-amplifier molecules, which provides multiple sites 
for biotinylated label probes.  The label probes bind Streptavidin R-Phycoerythrin, 
producing fluorescent signal which is read on a Luminex® instrument.  The signal is 
proportional to the amount of target DNA in the sample (Kibriya et al., 2014).  
 
 
 3’ overhang measurement methods 
A 3’ overhang exists on the telomere and the methods used to measure the 
overhang length will be described in brief for completeness.  Electron microscopy 
was successfully used to visualise the 3’ overhang and showed the presence of 
t-loops in the telomere overhang (Griffith et al., 1999).  The length of the 
overhang has been shown to be proportional to the rate of telomere length 
shortening in culture (Huffman et al., 2000).  
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Primer/extension-nick translation (PENT) 
 
(CCCTAA)4 oligonucleotides are hybridised under non-denaturing conditions and 
extended with Taq polymerase.  The products are then analysed by agarose gel 
electrophoresis (Makarov, Hirose and Langmore, 1997). 
 
 
Telomeric-oligonucleotide ligation assay (T-OLA) 
 
Undenatured DNA is hybridised with radioactive phosphorus (32P) labelled 
(CCCTAA)n oligonucleotides in the presence of a ligase enzyme.  The products are 
analysed using a denaturing sequencing gel (Cimino-Reale et al., 2001). 
 
 
 Correlation between telomere length measurement methods 
Current thinking among telomere measurement experts is that, in order to check 
whether the qPCR method is valid, it should be compared to another method and 
optimised until a high R2 coefficient is reached (Aviv, 2009; Aubert, Hills and 
Lansdorp, 2012).  This thinking has arisen out of concern about the repeatability of 
qPCR results between laboratories (Martin-Ruiz et al., 2015). 
 
 
Aviv et al (2011) measured telomere length in 50 samples by both TRF analysis and 
qPCR in separate laboratories.  There was a significant correlation between 
measurements made using the two methods.   However, the R2 value was improved 
by fitting a curvilinear model to the data compared to fitting a linear model.  The 
inter-assay coefficient of variation for the qPCR method was higher than the TRF 
analysis method (6.45% versus 1.74%).  Elbers et al (2013) compared qPCR and TRF 
analysis of LTL from 679 participants.  The correlation between data from the two 
methods was only modest (R2=0.27).  The inter-assay variation was higher in the 
qPCR measurements than the TRF measurements, 5.8% versus 1.5%, respectively.  
In another study, 10 different laboratories compared telomere length 
measurement, using qPCR and either TRF analysis or STELA in 185 samples (Martin-
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Ruiz et al., 2015).  Again, there was a significant correlation between telomere 
length measurement between qPCR and TRF analysis or STELA, despite the median 
inter-laboratory variation for qPCR measurement being 20.7%.  The inter-
laboratory variation between TRF or STELA measurements was lower, at 9.2%. 
 
 
 Chapter aims & hypotheses 
The primary aim of this chapter was to establish a reliable method of telomere 
length measurement in dog samples.  The secondary aim was to see if there was a 
non-invasively collected sample which could be used as a reliable substitute for 
blood in telomere length analysis.  The TRF analysis method was optimised and 
then used to demonstrate the reliability of a qPCR method.  Once the qPCR 
method was established, multiple variables were analysed to see which, if any, 
were associated with telomere length in the individuals.   
 
 
The hypotheses for the Southern blot TRF analyses were as follows: that in 
Labrador retrievers, buccal and leukocyte TRF would be negatively associated with 
age; that TRFs would be shorter in males than females; and TRFs would be shorter 
in entire dogs than neutered dogs.  In the qPCR analyses, it was hypothesised that: 
leukocyte and saliva RTL would also be negatively associated with age, that saliva 
RTL would be shorter in males, and leukocyte and saliva RTL would be shorter in 
entire dogs.  In addition, it was hypothesised that leukocyte RTL would: vary 
between breeds, be negatively associated with weight, height and cephalic index, 
and be positively associated with breed estimated effective population size and 
owner index of deprivation.     
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 Methods 
 Samples- Bloods 
Samples used in this chapter by section are summarised in Table 4-1.  Blood 
samples were obtained from the University of Glasgow Veterinary Diagnostics 
Service.  The service retains surplus samples for a week following receipt and then 
normally discards the remainder.  Surplus blood samples were obtained from 14 
individual Labrador retrievers for TRF analysis optimisation and 83 individual dogs 
of 16 different breeds for qPCR optimisation.  Samples were stored at 4°C between 
the service performing their tests and the samples being transferred to our 
laboratory, at which point they were stored at −20°C until use for analysis and 
following this moved to −80°C storage.  Information regarding age, weight, breed, 
clinical diagnosis, clinical pathology results and postcode were gathered from the 
clinical record for each animal.  The postcodes were entered into the Scottish 
Neighbourhood Statistics website to obtain measures of deprivation for the 
corresponding residential area (The Scottish Government, 2015b).  The estimated 
effective population size (EEPS) for each breed was obtained from the Kennel Club 
UK website (The Kennel Club Limited, 2016).  EEPS was given as “n/a” for 
greyhound and Rhodesian ridgeback as there was increasing genetic diversity in the 
breeds.  Figures for the cephalic index were obtained from Carrasco et al. (2014).  
No information on cephalic index was available for Dogue de Bordeaux or flat 
coated retriever.  Breed height was obtained from the UK Kennel Club breed 
standards (The Kennel Club Limited, 2016).  No information was given on height for 
Cavalier King Charles spaniel or Chihuahua on the UK Kennel Club website.  Heights 
for these breeds were obtained from the American Kennel Club website (American 
Kennel Club, 2016).  The figures for breed lifespan used in this chapter were 
generated using breed median age of death from three studies (Michell, 1999; 
Adams et al., 2010; O’Neill et al., 2013). 
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 Samples- Labrador retriever buccal swabs 
10 Labrador retriever Isohelix SK-1S (Cell Projects, Kent UK) buccal swab samples 
were collected by a veterinary surgeon at Abbey Veterinary Group, Paisley.  The 
samples were picked up and DNA extraction performed on the same day of sample 
collection to minimise the time for bacterial growth.  The date of birth and sex of 
the dogs were provided by the surgery. 
 
 
 Samples- Labrador retriever saliva and leukocyte DNA 
Matched saliva and blood samples from Labrador retrievers were collected at the 
Royal Dick School of Veterinary Studies Hospital for Small Animals.  Saliva samples 
were collected using Oragene animal kits (DNA Genotek, Ontario Canada) by Dr 
Dylan Clements.  The samples were DNA extracted in the laboratory of Prof Kim 
Summers and aliquots from the DNA samples were kindly provided for this study.  
In addition, leukocyte DNA samples from Labrador retrievers extracted in a 
laboratory at the University of Manchester participating in a collaborative project 
with Dr Clements were generously donated. 
 
 
  
153 
 
Table 4-1 Samples used by section in Chapter 4 
*=University of Glasgow Veterinary Diagnostics Service 
Tissue Source Number Sex Breed Experiment Section 
Blood Veterinary 
Diagnostics* 
3 1 F, 1 M, 
1 MN 
Labrador retriever Optimisation of TRF analysis protocol 
(sample data not used for further 
analyses) 
4.3.1 
Blood Veterinary 
Diagnostics* 
20 5 F, 8 FN, 
1 M, 6 MN 
Labrador retriever Optimisation of qPCR protocol (sample 
data not used for further analyses) 
4.3.2 
Blood Veterinary 
Diagnostics* 
14 3 F, 6 FN 
1 M, 4 MN  
Labrador retriever Checking TRF analysis protocol 4.3.4 
Buccal Abbey Veterinary 
Group 
10 5 F, 2 FN, 
1 M, 2 MN 
Labrador retriever TRF analysis of buccal samples 4.3.5 
Blood Veterinary 
Diagnostics* 
83 52 M, 31 MN Mix of 16 breeds Checking qPCR protocol 
14 of these samples analysed using 
both qPCR and TRF methods to check 
if results correlated 
4.3.6 
Blood & 
saliva 
University of 
Edinburgh 
24 2 F, 7 FN, 
3 M, 12 MN 
Labrador retriever qPCR analysis of paired tissue samples 4.3.7 
Blood University of 
Manchester 
50 16 F, 11 FN, 
19 M, 4 MN 
Labrador retriever Further qPCR samples 4.3.8 
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 DNA extraction 
DNA was extracted from blood a using a column method (section 2.2.2.1).  40 
blood samples were extracted using a QIAamp Blood Midi kit (Qiagen, Manchester 
UK), the remaining 43 qPCR optimisation and the 14 TRF optimisation blood 
samples using a Nucleospin Blood Mini kit (Macherey Nagel, Düren Germany).  A 
midi kit was used in a subsection of samples to attempt to obtain higher DNA yields 
for Southern blotting purposes.  To obtain sufficient DNA for TRF analysis, buccal 
swabs were extracted using a phenol-chloroform based method (section 2.2.2.2).  
DNA quantity and quality were measured using spectrophotometry (section 2.2.5). 
 
 
 Data analysis 
Normality checks were performed on data using a Shapiro-Wilk test.  A p value of 
<0.10 resulted in the variable being treated as non-parametric.  If possible, non-
parametric data were transformed to a normal distribution, using a natural log 
transformation, and a subsequent Shapiro-Wilk test performed to justify an 
assumption of normality for the transformed data.  Pairwise comparisons were 
performed using t-tests (normally distributed data) or Wilcoxon rank-sum tests 
(non-normal data).  One-way analysis of variance (normal data) or Kruskal-Wallis 
(non-normal data) tests were used to compare values when more than two groups 
were present, for example comparison of telomere length between breeds. To test 
the association between an explanatory variable and a non-parametric continuous 
response variable, Spearman’s rank correlation was used, for example when 
exploring the association between dog weight and leukocyte count.   
To analyse the association between a single continuous explanatory variable and a 
normally distributed response variable, linear models were used, except in 
comparing qPCR measures to TRF measures, for which a quadratic regression was 
also employed by using the “poly” function in R.  Linear models were also used to 
analyse associations between multiple explanatory variables and a normally 
distributed response variable.  Model residuals were checked by using the 
plot(modelname) function in R.   Where several explanatory variables were 
available, all explanatory variables were included and the “drop1” function used 
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to assess which explanatory variables, if any, to remove.  There were no instances 
in which associations between multiple explanatory variables and a non-normal 
response variable needed to be tested.  If the intercept was not statistically 
significant (p<0.05), the model constant was suppressed.  
 
 
All analyses were performed in R (R Core Team, 2014).  Statistical significance 
level was taken as p<0.05. 
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 Results 
 Southern Blot 
Figure 4.1 describes the overall steps of a telomere restriction fragment length 
measurement by Southern blot analysis.  In this section, each step will be 
described in further detail and, where appropriate, how the protocol was 
optimised will be detailed.  As described in section 2.2.6, prior to starting this 
protocol, the DNA integrity of each sample was checked by gel electrophoresis.  
The protocol was based on the manual provided with the kit used for the 
procedure: the TeloTAGGG Telomere Length Assay (Roche), with amendments 
inspired by Kimura et al (2010).  All buffer recipes are detailed in section 2.1.3. 
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Figure 4.1 Workflow of Southern blot analysis for measurement of telomere restriction 
fragment length  
 
 DNA Digestion with restriction endonucleases 
The DNA is cut using restriction enzymes which do not have cutting sites in the 
telomere, but cut frequently in non-telomeric DNA.  Adjacent to the telomere is 
the subtelomeric region which consists of non-canonical repeats (Allshire, 
Dempster and Hastie, 1989) and the choice of restriction enzymes determines 
whether this region is cut. The uncut section is referred to as the TRF. The most 
commonly used combination of enzymes is HinfI and RsaI, and these were used in 
this study.  These enzymes do not cut in the subtelomeric region.  Another 
combination used in telomere studies, HphI and MnII, results in cuts in the 
DNA digestion
Separation of DNA fragments 
by gel electrophoresis
Transfer DNA to Nylon 
membrane
Hybridisation with DIG-
labelled probe
Incubation with anti-DIG-
Alkaline Phosphatase
Chemiluminescent detection
TRF analysis
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subtelomeric region and has been shown to result in TRF lengths that are 
approximately 1-1.5 kb shorter than when HinfI/RsaI are used (Baird et al., 2006; 
Hunt et al., 2008).  One of the criticisms of Southern blots, and particularly of the 
use of HinfI/RsaI, is that the subtelomeric region is variable in length between 
individuals, resulting in different TRF lengths (Cawthon, 2002).  The combination 
of HinfI/RsaI, however, is not only the most commonly used in human studies, but 
has been used in multiple studies of dog telomeres and therefore the use of this 
enzyme combination in this thesis would enable results to be comparable to the 
limited dog telomere literature (Nasir et al., 2001; McKevitt et al., 2002; Cadile et 
al., 2007; Benetos et al., 2011). 
 
 
For each sample, in a 0.5ml microcentrifuge tube, 1μg of DNA was diluted with 
nuclease free water to a final volume of 17μl.  In addition, a tube was set up 
containing 1μg “Control-DNA” using the control provided in the TeloTAGGG® kit.  
2μl of digestion buffer, 0.5μl HinfI (20 units) and 0.5μl RsaI (20 units) were added 
to each sample and mixed.  The tubes were incubated in a 37°C heat block for 16 
hours and, after this time, the reaction was stopped by adding 5μl of 5X gel 
electrophoresis loading buffer and briefly centrifuging the tubes.  If not used 
immediately, the tubes were stored at −20°C.   
 
 
 Gel Electrophoresis 
The DNA fragments were separated by agarose gel electrophoresis.  Initially, a 
0.8% 15cm length agarose gel was used.  Later on, a 0.5% 20cm gel was used to 
improve separation and measurement of longer telomeres.  The agarose 
percentage used is indicated for each experiment run.   A DIG labelled molecular 
weight marker was run alongside the samples on the gel.  To prepare the marker 
for loading, 4μl of DIG molecular weight marker was added to 12μl nuclease-free 
water and 4μl of 5X loading buffer in a 0.5ml microcentrifuge tube, which was 
then briefly centrifuged.  10μl of molecular weight marker mix was added to the 
two outer wells in the gel.  The digested DNA samples were loaded in the 
remaining wells and the gel run.  The 0.8% was run at 75V and the 0.5% gel was run 
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at 40V.  The gels were run until the blue tracking dye was 2cm from the end of the 
gel, which took approximately 5 hours for a 0.8% gel and 20 hours for the 0.5% gel. 
 
 
 Transfer 
Prior to transferring the DNA to a nylon membrane, the gel was depurinated, 
denatured and neutralised.  The gel was placed in a sterile container and 
submerged in 0.25M hydrochloric acid and agitated on a shaker, until the 
bromophenol blue on the gel changed colour to yellow.  This took approximately 
10 minutes to occur.  The gel was rinsed twice with water, then submerged in 
denaturation solution twice, 15 minutes each time with agitation.  Once again, the 
gel was rinsed twice with water and then finally submerged in neutralisation 
solution twice for 15 minutes each time with agitation. 
 
 
A piece of nylon membrane was cut to the same size as the gel, submerged in 
water and then in 2X SSC for 10 minutes.  The membrane was handled with clean 
forceps only.   The transfer equipment was then prepared as described by Brown 
(2001). A solid support was placed in a large Pyrex dish, with wicks made of 
Whatman 3MM filter paper.  20X SSC was poured into the dish so the ends of the 
wick were submerged in buffer.  3 pieces of Whatman 3M paper were cut to the 
same size as the solid support, placed on top of the wick and wetted with 20X SSC.  
The gel was placed on the filter paper and air bubbles removed by rolling a glass 
pipette over the surface.  Plastic wrap was placed over the edges of the gel to 
ensure the buffer flowed through the gel rather than around it.  The pre-soaked 
membrane was then placed on top of the gel, again removing any air bubbles with 
a pipette.  5 sheets of Whatman 3MM paper, cut to the same size as the 
membrane, were placed on top.  Paper towels were then stacked on top of the 
filter paper, to a height of approximately 10cm, and a glass plate and weight used 
to hold everything in place.  This was then left overnight to allow time for the 
transfer to take place.  The next day, the stack was disassembled.  The membrane 
was washed briefly with 2X SSC and then placed on Whatman 3M paper.  The DNA 
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was fixed by UV-crosslinking using 120mJ of energy and then the membrane 
washed twice with 2X SSC, for 15 minutes each time with agitation. 
 
 
 Hybridisation 
The first time the experiment was run, the membrane was placed in a 
hybridisation tube, 18ml of prewarmed to 42°C DIG Easy Hyb Granules was added 
and the tube capped.  The tube was placed in a hybridisation oven and rotated for 
one hour at 42°C.  Following this, the prehybridisation solution was removed and 
the hybridisation solution was added to the membrane for three hours at 42°C.  
The hybridisation solution was made by adding 1.5μl DIG (digoxigenen) labelled 
Telomere probe to 7.5ml DIG Easy Hyb Granules.  Using these conditions, the first 
film which was generated at the end of the whole experiment had a very high 
background optical density (Figure 4.2).  As a result, the probe concentration and 
time spent pre-hybridising the blot were optimised to reduce the background in 
future experiments.  In previous studies, probes have been labelled with radio 
isotopes such as 32P rather than DIG as used here.  Use of these probes are said to 
improve the detection sensitivity, however they come with safety risks which 
outweigh the added precision obtained (Saldanha, Andrews and Tollefsbol, 2003).  
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Figure 4.2 First Southern blot conducted during experiment set up 
with a very high background optical density 
 
DNA was extracted from three Labrador retriever blood samples using a column 
extraction as described in section 2.2.2.1 for use in the optimisation experiments.  
The blood samples were surplus blood from the University of Glasgow Veterinary 
Diagnostics Service.  Sample 1 was from a 2 year old entire female, sample 2 was 
from a 7 year old neutered male and sample 3 was from a 12 year old entire male.    
4 sets of digests of the 3 samples were set up and digested overnight, the gel run 
and blot transferred as described previously.  The membrane was cut into four, 
with one set of the samples on each strip of the membrane.  Two of the strips had 
one hour of prehybridisation at 42C and the other two had the prehybridisation 
solution left on overnight again at 42°C.  Two concentrations of hybridisation 
solution were made up: one with 1μl of Telomere probe in 7.5ml of DIG Easy Hyb 
Granules and one with 1μl of Telomere probe in 10ml of DIG Easy Hyb Granules.  
Figure 4.3 shows the resulting blots.  No improvement in background reading was 
observed by having an overnight prehybridisation stage versus a one-hour stage, so 
a one hour prehybridisation was subsequently used.  There was still a high 
background optical density with both 1μl probe in 7.5ml and 1μl probe in 10ml so 
further experiments were set up with 1μl probe in 12.5ml and 1μl probe in 15ml 
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(Figure 4.4).  Rather than performing new digests, two of the blots were stripped 
by washing the blot in stripping buffer at 37°C in a hybridisation oven with rotation 
twice for 15 minutes each time.  The blot was then rinsed in 2X SSC.  A film was 
developed from the blot to check the stripping procedure had been successful, 
then the protocol started from the one hour prehybridisation stage.  1μl probe in 
15ml granules resulted in a very low band optical density reading and required a 
long film exposure time to visualise the bands, therefore 1μl probe in 12.5ml 
granules was decided upon for future experiments. 
 
 
 
Figure 4.3 Southern blots varying the prehybridisation time and probe concentration 
with the same 3 Labrador retriever blood DNA samples digested in each blot.  2 blots had a 1 
hour prehybridisation (A and C) and 2 had an overnight prehybridisation (B and D).  The 
hybridisation buffers were either made using 1μl Telomere probe in 7.5ml hybridisation 
granules (blots A and B) or 1μl Telomere probe in 10ml hybridisation granules (blots C and D). 
  
A B D C 
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Figure 4.4 Southern blots comparing telomere probe concentration 
1μl probe in 12.5ml hybridisation granules (A) and 1μl probe in 15ml hybridisation granules 
(B).  Note that the dark bands in blot A are a result of a long film exposure time, not an excess 
of probe. 
 
 
Following 3 hours of hybridisation with a Telomere probe, the solution was 
discarded and then the membrane was washed twice with stringent wash buffer I 
at room temperature on a shaker for 5 minutes each time.  Following this, the 
membrane was put back in the hybridisation oven at 50°C and washed twice with 
stringent wash buffer II with rotation, each wash for 20 minutes. 
 
 
 Anti-DIG-Alkaline Phosphatase incubation 
All the steps in this section were performed at room temperature on a rocker.  The 
membrane was washed with 100ml washing buffer for 5 minutes, then incubated in 
100ml blocking solution for 30 minutes.  Following this the membrane was placed 
in 75ml of Anti-DIG-AP solution for 30 minutes.  Two 15 minute washes were then 
performed using 100ml of washing buffer each time. 
 
 
A B 
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 Chemiluminescent detection   
The membrane was incubated in 100ml detection buffer for 5 minutes on a rocker 
at room temperature, then the detection buffer discarded and the membrane 
placed on a sheet of Whatman 3MM paper, DNA side up, to remove excess liquid.  
The membrane was placed in a hybridisation bag and 3ml of substrate solution 
applied to the DNA side of the membrane.  The substrate solution contains CDP-
Star, which is metabolised by the alkaline phosphatase in the Anti-DIG-AP solution 
and produces a visible signal.  The upper sheet of the bag was placed on the DNA 
side of the membrane and air bubbles removed by rolling a pipette over the bag.  
After a 5-minute incubation period, excess substrate solution was squeezed out of 
the bag and the edges were heat sealed.  The membrane was then exposed to X-
ray film for approximately 5 minutes and the film developed.  Timing of exposure 
was adjusted and multiple films exposed until the optimum film was produced for 
each membrane.  
 
 
 TRF analysis 
The film was scanned using a flatbed scanner and saved as a .jpg file.  TotalLab 
version 13.01 software (TotalLab Ltd UK, 2013) was used to analyse the images.  
The .jpg file was opened in TotalLab and saved as a .tiff file.  Line selections were 
composed using the draw shape tool for each sample lane.  The software then 
generated plots of optical density versus DNA migration distance.  The data were 
exported to a Microsoft Excel file.  The distance that each band of the molecular 
weight marker had migrated was plotted against the weight of that band.  Using R 
statistical software, third order log-linear regression was fitted for the molecular 
weight migration.  The resulting equation was used to convert the sample 
migration distances to molecular weight.  A background optical density reading 
using an area outside of the lanes was subtracted from all readings.  Mean TRF was 
calculated for each sample using the formula: 
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 𝑀𝑒𝑎𝑛 𝑇𝑅𝐹 𝑙𝑒𝑛𝑔𝑡ℎ =
Σ(ODi x MWi)
ΣOD
 
 
where ODi is the optical density at position i and MWi is the molecular 
weight at position i 
 
 
Using this formula, an average length of TRFs is reported for each sample.  By 
examining the film, one can also get an idea of the spread of lengths.  However, 
short telomeres are often hard to visualise as fewer probes are hybridised to them, 
so some information may be missed (Aubert, Hills and Lansdorp, 2012).  Duplicate 
analyses were carried out on each DNA sample on different gels to account for 
inter-gel variation.   
 
 
 qPCR Optimisation 
 Protocol optimisation 
The telomere length qPCR assay was developed as a means of finding a simple, fast 
method of telomere measurement.  It had previously been presumed that a PCR 
based assay would not be possible due to the generation of primer-dimer products 
with the use of primers designed to hybridise to the TTAGGG and complementary 
repeats.  Cawthon (2002) therefore developed a pair of primers to overcome this 
issue.  The key characteristic of the primers was that they were designed to 
amplify only when annealed to a telomere hexamer, and not when hybridised to 
the other primer. 
 
 
The telomere primers were not a perfect match with the target sequence, but 
could hybridise with partially complementary sequences along the length of the 
telomere in both directions.   The 5’ end of the primers could not hybridise to the 
sequence.  The complementary products to this 5’ end were generated at the 3’ 
end of products completed in each PCR cycle.  This blocked 3’ ends from initiating 
DNA synthesis in subsequent cycles from telomere amplification products.   
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The initial primer design by Cawthon was modified by Epel et al. (2004) and this 
new design was successfully applied to the measurement of dog telomeres by Fick 
et al (2012).  Therefore, this modified design was selected for use in this thesis.  
The sequences were as follows: 
 
Tel1b primer (forward): CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT 
Tel2b primer (reverse): GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTACCCT 
 
A representation of the primers binding to the target is depicted in Figure 4.5A, 
and potential primer-primer bonding in Figure 4.5B, modified from Cawthon (2002) 
to reflect the updated primer design.   
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A- Annealing of primers in telomere DNA in the first round of PCR, arrows at 3’ end of primers 
represent direction in which bases are added.  There are base mismatches between the 
primers and template DNA every sixth base.  B- Primers annealing to each other, there are two 
base mismatches after every four matches.  The last base at the 3’ ends of the primers cannot 
form a stable pair with the base opposite, preventing the addition of bases. 
 
The first step of the optimisation of the telomere protocol was to determine the 
concentration of the telomere primers.  Primer concentrations are seen as optimal 
when there is a low variability between replicates, adequate signal to noise ratio 
and no primer dimers seen (Mikeska and Dobrovic, 2009).  An “optimisation 
matrix” of primer concentrations was used (as in Nolan et al. 2006) to check 
several combinations of forward and reverse primer concentrations.  An example 
matrix is shown below: 
 
3’ AATCCCAATCCCAATCCCAATCCCAATCCCAATCCCAATCCCAATCCCAATCCCAATCCCAATCCCAAT 5’  
5’ TTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTAGGGTTA 3’  
telomeric  centromeric 
GTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT 3’ 
||| ||||| ||||| ||||| ||||| ||||| 
tel1b primer 
||||| ||||| ||||| ||||| ||||| ||| 
TCCCATTCCCATTCCCATTCCCATTCCCATTCC 3’ 
tel2b primer 
 ||||  ||||  ||||  ||||  |||| 
TCCCATTCCCATTCCCATTCCCATTCCCATTCC 3’ 
tel2b primer 
GTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT 3’ 
tel1b primer 
A 
B 
Figure 4.5 Annealing of primers in telomere DNA in the first round of PCR and primers 
annealing to each other 
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 Forward primer concentration (nM) 
Reverse 
primer 
concentration 
(nM) 
 100 200 300 400 
100 100 F/100 R 200 F/100 R 300 F/100 R 400 F/100 R 
200 100 F/200 R 200 F/200 R 300 F/200 R 400 F/200 R 
300 100 F/300 R 200 F/300 R 300 F/300 R 400 F/300 R 
400 100 F/400 R 200 F/400 R 300 F/400 R 400 F/400 R 
 
 
The primer concentration matrices were run both with 10ng DNA and a water blank 
to look at what concentration primer dimers may occur.  This level of checking for 
primer dimers is not usually performed, however it was justified here because the 
telomere primers may have been more prone to have this issue than other sets of 
primers.  Forward and reverse primers at the appropriate volume to produce the 
required concentrations were added to 10μl Absolute blue® SYBR green low ROX 
mix, 10ng DNA if required and then ddH2O added to a final volume of 20μl per 
well.   A wider range of primer concentrations were used initially, then a narrower 
range to get the primers concentrations required to the nearest 50nM.  The 
optimum primer concentrations using this method were 100nM tel1b and 100nM 
tel2b.   
 
   
This process was then repeated for the reference gene primer set.  The reference 
gene initially selected was 36B4, the gene encoding for acidic ribosomal 
phosphoprotein PO, and primer sequences used as per Fick et al (2012).  However, 
persistent contamination was seen in the no template control wells despite several 
attempts to rectify this.  Therefore, new primers were designed using CLC 
Genomics Workbench v6.0.4 (CLC Bio, Denmark).  The gene selected was 
haemoglobin delta (HBD), which is located on chromosome 21.  Haemoglobin genes 
have previously been used in telomere studies (e.g. Guzzardi et al. 2015) and HBD 
has the refseq status of “model” on the NCBI website, which is not the case for all 
dog genes.  The sequences of the HBD primers were: 
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HBD Forward: CAGTGCTGAGGAGTCCATAC 
HBD Reverse: AAGACCCAACTCATGATGTCC 
 
 
The concentrations of the HBD primers were then optimised using a matrix as 
described previously.  Using this method, the concentrations decided upon were 
100nM forward, 150nM reverse. 
 
 
For the absolute quantification of telomeric DNA in each sample, standard curves 
using oligomer standards needed to be included on each plate.  Oligo standards 
were polyacrylamide gel purified and the sequences of the telomere and HBD 
standards were: 
 
Telomere standard:  
(TTAGGG)14 
HBD standard: 
CAGTGCTGAGGAGTCCATACTTATGCAACTAGAACACTTCCTTTACACTCTGAACAA
CATCCTGATGCCCATACCCTTTACGGACATCATGAGTTGGGTCTT 
 
 
To each standard well, 10ng of pBR322 DNA was added as background DNA.  Rolling 
circle amplification (RCA) was used to amplify pBR322 plasmid DNA (Sigma Aldrich, 
Gillingham UK) in order to generate sufficient background DNA for multiple 
standard curve experiments.  1μl of pBR322 was added to 4μl PCR grade H2O in a 
0.2ml microcentrifuge tube.  By placing the tube in a thermocycler at 95°C for 3 
minutes, the DNA was denatured.  The tube was then placed on ice.  4μl of 25μM 
dNTP, 2.75μl of 50μM random hexamer, 0.5μl Phi29, 10μl reaction buffer, 2μl BSA, 
and 75.75μl ddH2O were added to the denatured DNA.  The tube was returned to 
the thermocycler, which was then run at 30°C for 18 hours, followed by 65°C for 
10 minutes.  The concentration of the resulting products was measured using 
spectrophotometry.   
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The quantities of oligomer standards in the standard curve dilutions needed to be 
optimised such that all dilutions were within the linear range of the assay, and test 
sample CTs fell approximately in the middle of the curve.   The CT is the PCR cycle 
where there is sufficiently greater fluorescent signal than the background to cross 
a threshold, as described in section 2.2.6.  The starting standard curve amounts 
were based on Fick et al (2012), with the telomere standard curve starting with 
60x10-12g per reaction, followed by five further one in ten dilutions.  The HBD 
standard was based on the DNA quantities required for the reference gene in the 
same paper, with six dilutions starting at 200x10-12g and ending in 2x10-15g.  The 
final point on the telomere standard curve was beyond the linear limit of the 
reaction, and therefore the standard curve was started at a higher amount.  The 
converse was true for the HBD curve, and the amount at which the dilution series 
was started was reduced.   
 
 
Once the amounts in the standard curves were decided upon, the qPCR was run 
using a range of annealing temperatures to check what temperature resulted in an 
efficiency closest to 100%.  Annealing temperatures tested depended on the 
melting temperature of the primers.  Between 58°C and 63°C were tested for the 
telomere reaction, and temperatures between 50°C and 55°C for the HBD 
reaction.  The annealing temperature was adjusted to 59°C for the telomere 
reaction and 52°C for HBD.  The final cycling conditions were decided upon once 
the sample DNA quantity was optimised.  A series of template amounts were run, 
between 5ng and 75ng, to see what amount would result in the CT of the samples 
falling in the middle of the curve.  When 25ng of sample was used, the vast 
majority of sample CTs fell around the middle of both curves.  As a result, 25ng 
was decided upon, and the amount of pBR322 in the standard curve wells was also 
changed to 25ng to reflect this. 
 
 
Both telomere and HBD PCR began with a 95°C 15-minute incubation to activate 
the Thermo-Start™ DNA polymerase.  The telomere thermal cycling profile then 
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consisted of 28 cycles of 95°C for 15 seconds, 59°C for 30 seconds and 72°C for 30 
seconds.   Following the 15-minute incubation, the HBD cycling profile had 32 
cycles of 95°C for 15 seconds, 52°C for 30 seconds and 72°C for 30 seconds.  After 
these cycles, melt curves were run for both PCRs (60-95°C).  All PCRs were 
performed on an Applied Biosystems 7500fast machine using machine compatible 
white 96 well plates (Starlab, Milton Keynes UK).  White plates were used instead 
of clear plates as white plates have been shown to increase qPCR sensitivity due to 
increased fluorescence reflection compared to clear plates (Reiter and Pfaffl, 
2008).  Mastermixes were made for the telomere and HBD plate for set up, 15μl of 
which was added to each well and 5μl of test sample, ddH20 (for no template 
control wells) or standard with pBR322 added to the appropriate wells.  The 
mastermixes consisted of Absolute blue® SYBR green mix (final concentration 1X) 
HBD or telomere primers depending on the plate (final concentrations 100nM 
Tel1b/100nM Tel2b or 100nM HBDF/150nM HBDR) and ddH2O.  The plates were 
sealed with Microamp optical cap strips and briefly centrifuged.  The plates were 
protected from light as much as possible, as SYBR green is light sensitive.  
DNAZap® was used prior to setting up experiments to clean surfaces and pipettes, 
to remove potentially contaminating nucleic acids.   
 
 
 Absolute telomere length calculation 
Once the final quantities were decided upon for the standard curve points, the 
standard curve calculations were performed as per O’Callaghan et al (2008) with 
adjustments.   
 
 
The number of telomere repeats in each standard was calculated using the 
following: 
• The oligomer standard had a molecular weight of 26667.2. 
• The weight of one molecule was 26667.2/6.02x1023 (Avogadro’s number) = 
0.44x10-19g 
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• The highest concentration of telomere standard had 60pg per reaction.  
Therefore, there were 60x10-12g/0.44x10-19g = 1.36x109 molecules in Tel 
standard 1. 
• The amount of telomere sequence in Tel standard 1 was 1.36 x109 
x84(oligomer length) = 1.18x1011 bases or 1.18x108 kb. 
 
 
A standard curve was performed through 1 in 10 serial dilutions of Tel standard 1 
to create 6 standards.  The standard curve was used to measure the amount of 
telomere sequence per sample in kb. In addition, a standard curve was created for 
6 HBD standards as per the telomere standard curve and was used to measure the 
number of diploid genome copies in each sample. 
 
 
Genome copy number calculations were as follows: 
• The synthesised HBD oligomer standard was 102 bases long with a molecular 
weight of 31239.3. 
• The weight of the HBD standard was 31239.3/6.02x1023=0.5189x10-19g 
• HBD standard 1 had 2x10-12g per reaction.  Therefore, there were  
2x10-12g/0.5189x10-19g =3.85x107 copies of oligomer in HBD standard 1. 
• As there are two copies of HBD per diploid genome, HBD standard 1 is 
equivalent to 1.93x107 diploid genome copies. 
 
 
The standard curves were required to have 100±10% efficiency and R2 value of the 
standard curve to be at least 0.98.  Example standard curves are shown in Figure 
4.6 and Figure 4.7.  The amount of telomere sequence and genome copies per 
sample were obtained using the standard curve equations.  To obtain the telomere 
length per diploid genome, the amount of telomere sequence was divided by the 
number of diploid genome copies.  This number can be further divided by 156 
(there are 78 chromosomes per dog diploid genome) to obtain average individual 
telomere length, however in the original method paper and others the telomere 
Chapter 4  173 
 
 
 
length per diploid genome is used for data analyses (O’Callaghan et al., 2008; Izzo 
et al., 2011; Barrett et al., 2012) and so this tradition was followed here.   
 
 
 
Figure 4.6 Example telomere standard curve 
R2=0.999.  The slope here had a gradient of -3.26, equating to an efficiency of 102.7%. 
 
 
Figure 4.7 Example HBD standard curve 
R2=0.995.  The slope here had a gradient of -3.462, equating to a 94.5% PCR efficiency.   
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20 Labrador retriever leukocyte DNA samples were used to test the absolute 
telomere length (aTL) protocol.  The resulting values for telomere length per 
diploid genome ranged between 571kb and 4469kb.  When the experiment was 
repeated, the values ranged from 337kb to 7646kb.  These values were higher and 
over a wider range than anticipated.  For example, in a study using human 
leukocyte DNA, aTL in kb per diploid genome ranged between 35 and 260 
(O’Callaghan and Fenech, 2011).  In a study of Australian sea lions using fin biopsy 
DNA, aTL per diploid genome ranged from 16.49 to 379.85kb (Izzo et al., 2011).  
Measurements made in Seychelles warbler erythrocyte DNA were closer in length 
to those measured here: kb per diploid genome ranged from 1172 to 4737 (Barrett 
et al., 2012).  Fick et al. (2012) calculated the individual telomere length, and the 
measures varied from less than 10kb to greater than 50kb (actual range not quoted 
in the paper), which would equate to a telomere length per diploid genome of less 
than 1560 to over 7800, similar to the figures found here, however these 
measurements significantly declined with age, whereas no significant relationship 
was found with age in the test samples (R2=0.001, p=0.87).  The measurements 
made here would indicate that the dogs with the longest aTL had telomere lengths 
30 times longer than that found by O’Callaghan & Fenech (2011).  This would not 
be in keeping with the difference between published canine and human TRF 
measurements, which have shown that canine LTL is approximately twice the 
length of human telomere length.  TRF lengths of approximately 16kb were 
measured in human foetal cord blood (Counter et al., 1995), a mean of 7.5kb in 
leukocytes from 635 adults aged 20 to 40 (Aviv et al., 2009) and 5kb in leukocytes 
from human centenarians (Vaziri et al., 1993), compared to 9.7 to 23kb TRF length 
in dog leukocyte samples (Nasir et al., 2001; McKevitt et al., 2002).  In addition, 
7646kb aTL per diploid genome would equate to an individual telomere length of 
49kb.  O’Callaghan et al. (2008) found that aTL measurements to be shorter than 
TRF measurements by approximately 7kb in humans, which they state reflects that 
TRF analysis measurements include the region proximal to the telomere.  
Therefore, 49kb seemed improbably long.  
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 Relative telomere length calculation 
Given the inter-assay variability, the query over the measured lengths, and the 
wide range of measurements obtained, it was decided to switch to the more 
commonly used relative telomere length method.  The telomere length using this 
method is given as a relative measure to a selected reference sample run on every 
plate, using the formula: 
 
𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑡𝑒𝑙𝑜𝑚𝑒𝑟𝑒 𝑙𝑒𝑛𝑔𝑡ℎ
= 2−[(𝐶𝑡
𝑡𝑒𝑙𝑜𝑚𝑒𝑟𝑒 𝑠𝑎𝑚𝑝𝑙𝑒−𝐶𝑡𝐻𝐵𝐷 𝑠𝑎𝑚𝑝𝑙𝑒)−(𝐶𝑡𝑡𝑒𝑙𝑜𝑚𝑒𝑟𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝐶𝑡𝐻𝐵𝐷 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)] 
 
 
The formula includes 2 to the power of the differences in CT as the product of the 
reaction doubles with each PCR cycle, as described in section 2.2.6. 
 
 
Initially, MDCK cell line DNA was used as the reference sample, as large quantities 
of DNA could be easily obtained, so there would be sufficient DNA for multiple 
experiments.  All blood samples tested had a longer relative telomere length (RTL) 
than the MDCK DNA, and the RTL values averaged at 8.80.  This equates to the 
telomere length of the samples averaging at 8.8 times the length of MDCK.  For 
this reason, the author was given advice to change the reference sample by Prof P 
Shiels (personal communication).  
 
 
To make a reference sample with sufficient DNA to be used in every experiment, 
and a similar telomere length to the leukocyte DNA samples, 20 canine blood 
samples from dogs of various breeds and ages (surplus blood from VDS) were 
combined and DNA extracted using a Qiagen maxi column (Manchester, UK).  A 
second multi sample DNA extraction was performed to create a sample to use as 
an inter-assay control.  MDCK DNA was also used as an inter-assay control sample.  
The RTL of both samples was calculated each time the assay was performed to 
check for variability between runs. 
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A standard curve was still run on each plate, as per the aTL method, to check the 
efficiency of each qPCR.  However, for the RTL method, the standard curve was 
made up of five serial dilutions of reference DNA, with amounts of DNA at each 
point such that the midpoint of the curve has the same amount of DNA as used for 
the test samples.  The standard curve points used were 100ng, 50ng, 25ng, 12.5ng 
and 6.25ng.  The 25ng point is then used as the reference sample relative to which 
all other telomere lengths are measured.    
 
 
The plate layout used for each experiment is shown in Figure 4.8.  Two plates were 
run for each experiment set: one using telomere primers, and one using HBD 
primers (used to adjust for variation in quantity of DNA in each well in the 
telomere plate).  Each sample, control, and standard curve point was run in 
triplicate.  The mean CT value of the three wells was used for data analyses.  The 
percentage coefficient of variation (% CV) was calculated for each triplicate 
repeat, by dividing the standard deviation by the mean and multiplying by 100.  If 
the % CV was 5 or above, the sample was repeated, provided sufficient DNA was 
available.  If insufficient DNA remained, the sample was excluded from data 
analyses.   
  
  
Chapter 4  177 
 
 
 
 
1 2 3 4 5 6 7 8 9 10 11 12 
A 1 1 1 9 9 9 17 17 17 S1 S1 S1 
B 2 2 2 10 10 10 18 18 18 S2 S2 S2 
C 3 3 3 11 11 11 19 19 19 S3 S3 S3 
D 4 4 4 12 12 12 20 20 20 S4 S4 S4 
E 5 5 5 13 13 13 21 21 21 S5 S5 S5 
F 6 6 6 14 14 14 22 22 22 C1 C1 C1 
G 7 7 7 15 15 15 23 23 23 C2 C2 C2 
H 8 8 8 16 16 16 24 24 24 NTC NTC NTC 
Figure 4.8 96 well plate set up for qPCR experiments 
24 samples were run in triplicate on each plate. S= Standard (made using serial dilutions of a 
sample made using 20 blood samples), C=control (C1= second sample made using 20 blood 
samples, C2= MDCK).  NTC= No template control. 
 
 
 TRF analysis optimisation samples 
Blood samples from the VDS were used to check the optimisation of the TRF 
analysis protocol.  All dogs were Labrador retrievers to remove any breed effect on 
telomere length.  Subsequently to this, a set of buccal swabs from Abbey 
Veterinary Group, Paisley were used to see if the protocol could be applied to 
buccal cell DNA.  0.8% agarose gels were used in these experiments.  Buccal swabs 
were DNA extracted using a phenol-chloroform based method, as preliminary 
experiments showed that using a column based extraction resulted in a DNA yield 
ranging from 550ng to 5590ng, with a mean of 1570ng, with a concentration 
ranging from 5.5 to 55.9ng/μl.  The minimum requirement was a concentration of 
55.8ng/μl (total of 1μg).  Therefore, many samples extracted using a column 
method did not produce sufficient DNA to perform TRF analysis.  Phenol-
chloroform based extraction method resulted in an average DNA yield of 12.6μg 
per swab, with an average concentration of 126.2ng/μl.  The 260/230 absorbance 
ratios were lower for the phenol-chloroform samples than the column extracted 
samples.   
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 Labrador retriever leukocyte TRF analysis 
14 Labrador retriever leukocyte DNA samples were used for TRF analysis.  There 
were 4 male neutered, 1 male entire, 6 female neutered and 3 female entire dogs, 
whose ages ranged between 0.6 years and 13.4 years.  The median age was 7.87 
years.  One sample failed the agarose gel quality check and was excluded from 
further analysis.  TRF measurements ranged from 8.1 to 14.9kb, with a mean of 
11.0kb.  Figure 4.9 shows the linear regression of TRF and age, which was not 
statistically significant (F=3.17(1,11), R2=0.22, p=0.10).   
 
 
 
Figure 4.9 Leukocyte TRF by dog age 
Scatter plot of leukocyte TRF by age of a group of Labrador retrievers, with regression line.  
The linear model was not statistically significant (R2=0.22, p=0.10).  N=13. 
 
Factors which may have modified the association between TRF length and age 
were then considered to explore whether there was a reason that a significant 
negative correlation was not generated, aside from the sample size.  Firstly, sex 
was considered.  In females, the mean TRF length was 11.6kb, compared to 9.5kb 
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in males (Figure 4.10A).  Using a t-test, this difference was found to be statistically 
significant (p=0.04).  The median age of females was less than that of males, 5.3 
compared to 9, but this difference was not significant (Wilcoxon rank sum test, 
p=0.31).  There was no significant difference in TRF length between neutered and 
entire dogs (t-test, p=0.89) (Figure 4.10B).  The addition of sex into the model did 
not result in the TRF to age regression statistically significant. 
 
 
 
Figure 4.10 Leukocyte TRF by sex and neuter status 
Dot plots of leukocyte TRF length by sex (A) and by if the dog was neutered (B).  The orange 
squares represent the mean value and green dashes the 95% confidence intervals.  Males had 
significantly shorter TRF lengths (p=0.04), but TRF length was not significantly different based 
on neutering status (p=0.89).  N=13 
 
 
Another factor on which information was available was the clinical diagnosis of the 
dogs, as they had all been seen at the Small Animal Hospital.   The dogs were then 
divided into two groups: those with a malignancy diagnosed and those without.   8 
A B 
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dogs had a malignancy diagnosed, 5 did not.  The dogs with a malignancy 
diagnosed had statistically shorter TRF lengths (t-test, p=0.01, Figure 4.11), with 
the malignancy-diagnosed dogs having a mean TRF of 9.75kb and those without 
12.86kb.  
  
 
Given that a diagnosis of malignancy seemed to have a significant association with 
telomere length, it was decided that samples from dogs with cancer should be 
avoided from this point forward.  However, this is difficult to rule out absolutely 
for all these samples in practice, given that surplus blood was obtained from a 
referral centre where dogs are in a severe enough condition to warrant referral, 
and symptoms may be reflecting an undiagnosed cancer.  In addition, cancer is 
common in dogs, with a median of 27% of mortality across breeds in the UK being 
due to cancer (Adams et al., 2010).  
 
 
 
Figure 4.11 Leukocyte TRF by presence or absence of malignancy diagnosis 
Leukocyte TRF by whether the dog had a diagnosed malignancy.  There was a significant 
difference between the groups (p=0.01).  N=13 
Chapter 4  181 
 
 
 
 
 Labrador retriever buccal TRF analysis 
10 Labrador retriever buccal DNA samples were used for TRF analysis.  These 10 
dogs comprised of: 1 entire male, 2 neutered males, 5 entire females and 2 
neutered females.  Their ages ranged from 0.1 to 11 years, with a median age of 
0.85 years.  The dogs were attending a first opinion practice when the samples 
were collected and none of the dogs had major health problems.  TRF length 
ranged from 3.8kb to 15.6kb.  A Shapiro-Wilk normality test demonstrated that the 
TRF length data were non-normally distributed (p=0.009).  The TRF lengths were 
therefore log transformed for analysis.   
 
 
A linear model of age to log buccal TRF was not statistically significant (Figure 
4.12, F=0.43(1,8), R2=0.05, p=0.53).  T-tests showed that there was no significant 
difference between TRF lengths in male and female dogs (p=0.33) and no 
significant difference between TRF lengths in neutered and entire dogs (p=0.80). 
However, when both age and neuter status were used as explanatory variables for 
the TRF length, the model was statistically significant (F=16.05(2,7), R2=0.82, 
p=0.002).  The relationship between age, neuter status and buccal TRF are 
illustrated in Figure 4.13. 
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Figure 4.12 Buccal TRF length by dog age 
Scatter plot of buccal TRF by age of a group of Labrador retrievers, with regression line.  
Linear regression was not statistically significant (R2=0.05, p=0.53).  N=10. 
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Figure 4.13 Buccal TRF by dog age and neuter status 
Scatter plot of buccal TRF by age of a group of Labrador retrievers with regression line, with 
entire dogs and neutered dogs regressed separately.  
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 qPCR optimisation samples 
 Leukocyte telomere length and demographic variables 
To check the optimisation of the qPCR protocol, and to explore whether age-
dependent attrition could be elicited using the RTL method, DNA was extracted 
from blood samples from 83 individual dogs and leukocyte relative telomere length 
was measured using qPCR.  Only male dogs were used due to the potential effect 
of sex on telomere length seen in the TRF analysis experiments.  31 were castrated 
and 52 were entire.  Samples were used from dogs of 16 different breeds, the 
information regarding the breeds is presented in Table 4-2. 
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Table 4-2 Dog demographics in qPCR optimisation sample group 
Breed Number of 
samples 
Median age in 
years 
Median weight 
(kg) 
Akita 3 4.42 41.8 
Bichon Frise 6 7.96 9 
Border collie 5 4.71 21.3 
Cavalier King Charles 
spaniel 
7 7.45 11 
Chihuahua 5 4.02 4.2 
Dalmatian 7 6.89 29.5 
Dobermann 3 7.58 44 
Dogue de Bordeaux 4 5.54 47.5 
English springer spaniel 9 5.43 19.7 
Flat coated retriever 3 4.93 36 
Greyhound 6 9.32 32.25 
Miniature schnauzer 3 2.53 9.6 
Rhodesian ridgeback 3 3.96 47.3 
Siberian husky 3 8.44 28.6 
Weimaraner 7 9.09 35.5 
West Highland white 
terrier 
9 6.53 8.5 
All breeds 83 6.89 23.5 
 
 
Relative telomere length (RTL) data were checked for normality using a Shapiro-
Wilk test, with a resulting p value of 0.03.   The data were therefore log 
transformed and a subsequent Shapiro-Wilk test gave a p value of 0.32.  RTL values 
which were greater or less than two standard deviations away from the mean were 
excluded.  This only had an impact upon miniature schnauzer data, and all RTLs 
from miniature schnauzers were excluded from further analysis due to the RTL 
measurements being very high. 
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Age of dogs ranged from 0.42 to 13.18 years.  As shown in Figure 4.14, there was a 
significant negative correlation between relative LTL and age; however, there was 
a low R2 value indicating wide variability in the data (F=5.56(1,79), R2=0.07, p=0.02).  
Only 7% of the variation in RTL was explained by age.  Therefore, further factors 
were investigated to explore whether more of the variation in RTL could be 
explained in the group of samples. 
 
 
 
Figure 4.14 Leukocyte telomere length by dog age 
Scatter plot displaying the negative correlation of natural log of relative telomere length in 
leukocytes by the patient’s age in years, with regression line and 95% confidence levels 
(R2=0.07, p=0.02).  N=80. 
 
 
The mean and standard deviation of RTL for each breed is shown in figure 4.15.  
There was not a significant relationship between breed and RTL (F=1.53(15, 65), 
R2=0.26, p=0.12); however, when age was included as an explanatory variable the 
regression was significant (F=2.62(16, 64), R2=0.40, p=0.003).  In addition, the 
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number of dogs per breed was very small, limiting the ability to find significant 
differences.   
 
 
Further analyses investigating potential sources of inter-individual variability in 
LTL in these samples are in Appendix 8. 
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Figure 4.15 Leukocyte telomere length by breed 
Dot plot of relative leucocyte telomere length by breed in 80 individual dogs.  Mean value of LTL for each breed is displayed in orange, mean ± 
standard deviation is displayed in green, with the individual values in grey.  There was no significant difference in LTL between breeds (p=0.12)
189 
 
 Correlation between TRF analysis and qPCR 
Fourteen of the blood samples used for qPCR RTL measurement were also used for 
TRF analysis to check the concordance of results generated using the two methods.  
As TRF analysis is considered the gold standard methodology for telomere length 
measurement, it was important to check that data generated by qPCR were 
concordant with that from TRF analysis.  An 0.8% agarose gel was used.  Figure 
4.16A shows that there was a significant linear regression in matched sample 
telomere length analyses (F=7.87(1,12), R2=0.39, p=0.02).  Both linear regression and 
quadratic regression were performed, due to Aviv et al (2011) previously finding 
that quadratic regression between the two methods resulted in a higher R2 value.  
The quadratic regression between the two methods in this study had a slightly 
lower R2 value than the linear regression (F(1,12)=7.50, R2=0.38, p=0.02), Figure 
4.16B.  The Southern blot procedure was performed with a BSc Hons Veterinary 
Bioscience student under supervision.  Data analyses of these blots shown were all 
generated by the author alone.   
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Figure 4.16 Paired analyses: qPCR and TRF measurements in the same samples 
Scatter plot of paired telomere length measures in leukocytes, by qPCR RTL and TRF analysis, 
with regression line and 95% confidence intervals.  Both linear regression (A) and quadratic 
regression (B) were statistically significant (p=0.02 for both).  N=14. 
 
 
 Inter-assay variation  
Southern blot TRF analysis 
 
Control DNA samples (provided in the TeloTAGGG® kit) were run on each TRF 
analysis gel to enable comparison between gel measurements.  The inter assay % 
CV was much higher when a 0.8% gel was used compared to a 0.5% gel (which was 
used in subsequent experiments in our laboratory), 8.9% versus 2.2%, respectively.  
Kit control TRF measurements were also shorter in the 0.8% gels, mean 
measurement 4.5kb, than the 0.5% gels, in which mean measurement was 7.2kb.   
 
 
A B 
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qPCR 
 
Intra assay %CV was calculated for the sample triplicate repeats.  Across the 
experiments in this chapter, the mean %CV intra assay for the telomere plates was 
1.75% and 0.38% for the HBD plates.  Two inter assay control samples were run on 
each plate.  The inter assay %CV for RTL measurements of the sample made up of 
20 blood samples was 3.64%.  The inter assay %CV for MDCK RTL was far higher, at 
19.64%. 
 
 
 Matched blood and saliva samples 
The next set of experiments sought to investigate whether saliva telomere length 
would correlate with age, and if the saliva telomere length would correlate with 
LTL from the same animal.  24 pairs of matched leukocyte and saliva DNA from 
Labrador retrievers attending the Royal Dick School of Veterinary Studies Hospital 
for Small Animals were kindly provided by Dr Dylan Clements.  The samples had 
already been DNA extracted in the laboratory of Professor Kim Summers, and 
150ng of DNA from each sample was provided. 
 
 
The dogs’ ages ranged from 0.6 years to 11.25 years, with a median age of 4.45 
years.  There were 2 entire females, 7 neutered females, 3 entire males and 12 
neutered males.  Relative telomere length was measured by qPCR in all samples.  
One LTL result was excluded due to the result being greater than 2 standard 
deviations from the mean and another leukocyte RTL was excluded due to high 
intra assay variation.  Saliva RTLs were significantly longer than leukocyte RTLs 
(paired t test, p<0.001).  Mean saliva RTL was 2.80, compared to 1.33 mean 
leukocyte RTL.  Following Shapiro Wilk testing of the RTL values, no 
transformations of the data were required. 
 
 
There was a strong negative correlation between age and LTL (F=21.15(1,20), 
R2=0.51, p<0.001, Figure 4.17).  There was also a significant negative correlation 
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between saliva RTL and age (F=6.03(1,22), R2=0.22, p=0.02, Figure 4.18); however, 
the relationship was not as strong as that between leukocyte RTL and age. 
 
 
 
Figure 4.17 Leukocyte telomere length by age 
Scatter plot displaying the negative correlation of relative telomere length in leukocytes by 
age, with regression line and 95% confidence intervals (R2=0.51, p=<0.001).  N=22. 
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Figure 4.18 Saliva telomere length and age 
Scatter plot displaying the correlation of relative telomere length in saliva by age, with 
regression line and 95% confidence intervals (R2=0.22, p=0.02).  N=24. 
 
The mean leukocyte RTL value in females was 1.13 and 1.46 in males.  This 
difference was not statistically significant (t-test, p=0.36).  The mean saliva RTL in 
females was longer, at 3.01, compared to 2.63 in males.  Although, the difference 
was again not statistically significant (t-test, p=0.46).  In addition, there was no 
significant difference between neutered and entire dogs in leukocyte RTL (t-test, 
p=0.73) or saliva RTL (t-test, p=0.50).  Grouping the dogs into four sex categories: 
female entire, female neutered, male entire and male neutered, there was a 
significant difference in saliva RTL between the groups (one-way ANOVA, p=0.04).  
As can be seen in Figure 4.19, entire males had shorter saliva RTLs than the other 
sex groups.  There was not a significant difference seen in leukocyte RTL between 
the four sex groups (one-way ANOVA, p=0.85, Figure 4.20).  The addition of this 
variable strengthened the association between saliva RTL and age (F=4.65(4,19), 
R2=0.49, p=0.009). 
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Figure 4.19 Saliva telomere length by sex and neuter status 
Saliva relative telomere length by sex and neutering status of the dog.  There was a significant 
difference between the groups (one-way ANOVA, p=0.04) 
 
 
Figure 4.20 Leukocyte telomere length by sex and neuter status 
Leukocyte relative telomere length by sex and neutering status of the dog.  There was no 
significant difference between the groups (p=0.85) 
Chapter 4  195 
 
 
 
There was a positive trend between leukocyte and saliva RTL paired 
measurements, however this relationship was not statistically significant 
(F=4.123(1,20), R2=0.17, p=0.06, Figure 4.21).  However, if the 4 group sex variable 
was added as an explanatory variable, the relationship was statistically significant 
(F=3.82(4,17), R2=0.47, p=0.02).  Figure 4.22 displays a Bland Altman plot for 
measurements using the two tissue types, plotting the mean relative telomere 
length and the difference between the two values.  There was a significant 
positive correlation between the mean and difference, such that the longer the 
mean relative telomere length, the larger the difference between the leukocyte 
and saliva RTL values (R2=0.24, p=0.02).  However, no measures fell outside the 
limits of agreement (shown by the 95% confidence interval of the mean of 
difference lines in Figure 4.22). 
 
 
 
Figure 4.21 Saliva and leukocyte telomere lengths within individual dogs 
Scatter plot displaying the correlation of relative telomere length in saliva by the relative 
leukocyte telomere length, with regression line and 95% confidence intervals (R2=0.17, p=0.06) 
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Figure 4.22 Bland Altman plot 
Bland Altman plot of saliva and leukocyte relative telomere length paired measurements.  The 
dashed lines represent the limits of agreement. 
 
 Leukocyte DNA samples from Manchester 
50 leukocyte DNA samples from Labrador retrievers were kindly provided by the 
University of Manchester.  The intention of these was to complement the data 
generated from the Edinburgh samples.  The samples were DNA extracted in 
Manchester.  Three samples provided had insufficient DNA quantity to be included.  
qPCR analysis was performed on the remaining 47 samples.  Two samples were 
then excluded, as one failed to amplify on both the telomere and reference gene 
plates and another had an intra-assay variation higher than the accepted level. 
 
 
Following Shapiro Wilk testing, the data were not transformed.  There was no 
significant correlation between RTL and age and, in fact, a positive trend was 
observed between the two variables (F=3.387(1,43), R2=0.07, p=0.07, Figure 4.23).  
There was no significant difference in RTL between males and females (t-test, 
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p=0.75), neutered and entire dogs (t-test, p=0.71) or in the four sex groups (one-
way ANOVA, p=0.35, Figure 4.24). 
 
 
To investigate the difference in results in these data compared to previous results, 
the remaining DNA from the samples was quality checked using 
spectrophotometry.  The mean 260/280 ratio was 1.82 and ranged from 1.66 to 
1.99, and so several samples met the required 1.8 cut off value for quality.  
However, the mean 260/230 value was 0.38 and ranged from 0.30 to 0.52, well 
below the accepted level and indicative of the presence of potentially inhibitory 
substances.  Therefore, these results were not added to the previous data, and 
served as a warning as to the importance of DNA samples meeting quality 
requirements if they are to be used in the qPCR assay.  The HBD CTs for the 
samples correlated negatively with the 260/230 ratios (p=0.02), all other 
correlations were not statistically significant.   
 
 
 
Figure 4.23 Leukocyte telomere length by age in dog samples collected in Manchester  
with regression line and 95% confidence intervals (R2=0.07, p=0.07).  N=47. 
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Figure 4.24 Leukocyte relative telomere length by sex status of the dog in samples from 
Manchester.   
There was no significant difference in leukocyte RTL between the sex groups (p=0.35).  N=47. 
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 Discussion 
 Telomere length measurement methodology critique 
Work described in this chapter aimed to establish a reliable method for measuring 
telomere length in canine clinical samples.  The absolute telomere length qPCR 
method, as first described by O’Callaghan et al. (2008), was decided against after 
results generated were found to be highly variable and approximately 30 times 
longer than that measured in humans.  Others have found issues with this method, 
for example Wong et al. (2014) decided not to use the method because of the 
effect of variability while working with picograms of oligomer standard affecting 
the end results.  This may have been part of the reason for variability between 
runs found here. 
   
 
While it may be beneficial to have an absolute, as opposed to, relative telomere 
length to enable comparability between laboratories and studies, it was unclear 
from the existing literature as to what lengths should be expected in the canine 
samples, and therefore the relative telomere length qPCR was used moving 
forward.  Other studies have converted RTL data to length in kilobases by 
measuring samples by both TRF analysis and RTL qPCR, plotting the resulting data 
and using the resulting equation of the regression line to convert the RTL data to 
TRF in kb (for example Ehrlenbach et al., 2009; Needham et al., 2013).  This would 
be a potential option to be used for canine samples in the future. 
Multiplexing the RTL qPCR assay has been employed in other studies, using the 
method as described by Cawthon (2009).  By using a multiplexing approach, both 
the telomere and reference gene PCRs are performed in the same well, so that 
only one plate is required to be run per RTL assay, saving time and money.  This 
also has the advantage of reduction in variation due to different amounts being 
pipetted on each plate.  Cawthon found that this method improved the correlation 
between RTL and TRF measurements compared to the original singleplex method.  
This method was not employed here as the aTL method requires singleplex qPCR 
and the primers, annealing temperature, and so forth were optimised with the aTL 
method in mind.  However, this could be something to consider in the future.  It 
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has been successfully employed in cattle samples (Brown et al., 2012) as well as 
human samples (e.g. Shen et al. 2011). 
 
 
One issue with telomere qPCR is the effect of well position on RTL.   One study 
found well position accounted for 10.4% of the variation in RTL values, and a 
method to improve the assay in this study could be to employ a well position 
correction as performed by Eisenberg et al (2015).  The variation may be due to 
limitation in uniformity in temperature across the thermal block in the qPCR 
machine (Javorschi-Miller and Delgado Orlic, 2011).  Machines such as Rotor-Gene 
(Qiagen) have much lower variation in temperature but were not available for use 
in this study. 
 
 
A potential alternative to qPCR for the future of telomere length measurement is 
the use of digital PCR (dPCR).  dPCR uses an “all or none” approach (Sykes et al., 
1992).  The test sample is partitioned into a large number of reaction chambers, 
which are then determined to be positive or negative based on the presence or 
absence of the target of interest after amplification (Baker, 2012).  The proportion 
of positive partitions is then used for quantification calculations (Huggett et al., 
2013).  Digital PCR has advantages over traditional PCR including being more 
sensitive and having a higher reproducibility (Baker, 2012).  Higher sensitivity may 
be useful for detecting small changes in telomere length, for example changes due 
to cigarette smoke exposure as will be examined in forthcoming chapters.  Use of 
dPCR has limitations for repeats of the same sequence (Huggett et al., 2013) such 
as occurs in telomeres.  For the application of dPCR in telomere length 
measurement, extra preparation steps may be required, potentially separating the 
telomere from the rest of the chromosome and there may be other issues 
encountered such as the long length of the telomere.  However, the author notes a 
“digital assay for telomere length” (Litterst and Ugozzoli, 2016) patent has been 
submitted, suggesting that this technology may be used for telomere length 
measurement in the not-too-distant future.  No published studies employing dPCR 
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for telomere length could be found, however a digital PCR based method for 
telomerase quantification has been published (A. T. Ludlow et al., 2014).  
  
 
There was a significant linear regression between qPCR and TRF measurements in 
this chapter.  Unlike in Aviv et al (2011), the R2 value was not improved by fitting 
a curvilinear model to the data.  However, the polynomial regression was 
significant.  This could be due to the use of a 0.8% agarose gel for TRF analysis in 
this chapter, resulting in underestimation of TRF length in some samples.  In data 
not included in this thesis, later experiments were performed using a 0.5% gel for 
TRF analysis.  The control sample was found to have a longer TRF and interassay 
variation was reduced.  The main reason for using TRF analysis, however, was to 
show the effectiveness of the qPCR method, and a significant linear regression was 
displayed.  Steps could be taken in the future to further optimise the TRF protocol, 
to see whether the regression between the two methods changes, and provide a 
means of converting RTLs to TRF length as described earlier in the discussion. 
 
 
Examining the TRF analysis method paper by Kimura et al (2010), they recommend 
a 0.3% agarose gel for when TRF lengths of 16-17kb are expected, so a further 
reduction in gel percentage could be used here.  Although, of course this would 
make the gel very delicate and it would require very gentle handling.  0.3% gels 
were used to examine TRF lengths in tissues from CAST/Ei mice, a wild derived 
strain with relatively short telomeres for mice, and the mean lengths in different 
tissues varied between 10.3 and 17.6kb (Cattan et al., 2008).  These lengths are 
similar to those in dog tissues found by Benetos et al (2011), but on the whole, 
shorter than those found in dog tissues by Cadile et al (2007) and Nasir et al 
(2001). 
 
 
A further option to improve the resolution of longer telomere fragments, is to use 
a non-conventional form of gel electrophoresis, namely pulsed field gel 
electrophoresis (PFGE).  PFGE can separate DNA fragments up to approximately 
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10mb in size, compared to roughly 50kb in conventional gel electrophoresis 
(Herschleb, Ananiev and Schwartz, 2007).  PFGE was developed by Schwartz & 
Cantor (1984) and uses “non-uniform, alternately pulsed, electrical fields”.  One 
difficulty with PFGE is the requirement of specialist equipment.  There are 
multiple types of PFGE.  One version is called field-inversion gel electrophoresis 
(FIGE), which has the advantage of requiring minimal specialist equipment (Carle, 
1992).  FIGE was used to measure pig tissue TRFs, which were shown to range from 
9 to over 50kb (Fradiani et al., 2004).   
 
 
One issue in this chapter which prevented the identification of long telomere 
fragments, aside from the gel percentage and electrophoresis technique, was the 
use of the molecular weight marker provided in the TeloTAGGG kit, with the 
largest fragment being 21.2kb.  A marker with fragments up to 48.5kb is 
commercially available and would be preferable for future experiments.   
Two method variations have been used in publications to improve the precision of 
the TRF analysis protocol.  One is to strip and reprobe the blot with a loading 
control to correct for differences in amounts of DNA loaded into each well.  
Schmitt et al (1994) used a minisatellite (CAC)5 probe for this purpose.  The other 
is to resolve a molecular weight marker in the sample lanes with the samples to 
correct for different rates of DNA migration across the different regions of the gel.  
The telomere probe is used first, the membrane is stripped and then a molecular 
weight marker is used (Vasan et al., 2008).  However, while these techniques may 
improve precision, they are not written about in many published studies using TRF 
analysis, and the key issue in this study appears to be insufficient resolution of 
large telomere fragments in the canine samples. 
 
 
The interassay variation in the qPCR assay was very different depending on the 
sample used to calculate this value: blood or MDCK.  In addition, the MDCK sample 
was shown to be an inappropriate reference sample, so it would be better to have 
two blood control samples in future studies.  Cell lines have been used as control 
samples in telomere studies previously (e.g. Fehrer et al. 2006), but here it was 
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decided against due to the high RTL value and variability.  Interassay variation in 
RTL measurement in published studies varies greatly, and is not always reported.  
Published examples of RTL interassay %CV include: 3.17% (Ferlin et al., 2013), 4.9% 
(Aydinonat et al., 2014), 5.8% (Elbers et al., 2014), 6.45% (Aviv et al., 2011), 8.1% 
(Ahola et al., 2012), 12.04% (Heidinger et al., 2012) and 28% (Shen et al., 2007).  
3.64% interassay variation is therefore at the lower end of the range found in the 
literature.  Interassay %CV is generally lower in TRF analyses than qPCR, for 
example 1.5% (Elbers et al., 2014), 1.7% (Fitzpatrick et al., 2011), 1.74% (Aviv et 
al., 2009), 3.6% (Kadi et al., 2008) and 3.7% (Strandberg et al., 2012).  The 
interassay variability of TRF analysis in this chapter, 8.9%, is clearly higher than 
those reported in current literature.      
 
 
The RTL in the qPCR optimisation samples were significantly different depending 
on the DNA extraction kit used.  Differences in RTL based on DNA extraction 
method were previously found by Cunningham et al (2013).  They compared RTL in 
samples using phenol chloroform, Puregene (salting out method) and Qiagen 
column extractions, and found Qiagen extracted samples had significantly shorter 
RTLs than when the other two methods were used.  In contrast, when Denham et 
al (2014) compared RTLs in samples DNA extracted by Qiagen columns, Purelink kit 
(salting out method) and a high salt method by Lahiri and Numberger (1991), they 
found RTLs measured in samples DNA extracted using Qiagen columns to be 
significantly longer than those extracted by the high salt method.  RTLs in samples 
extracted using Qiagen and Purelink kits were found to be not significantly 
different.  Tolios et al (2015) compared a bead based extraction, column 
extractions (using Qiagen, Macherey Nagel and 5prime columns), Stratec 
precipitation-based kit and an isopropanol precipitation protocol.  When a 
singleplex qPCR protocol was followed, and samples had not been frozen, they 
found the Macherey Nagel extracted samples had significantly shorter RTLs than 
those extracted using the Qiagen kit.  However, if the samples had been frozen, 
there was no significant difference in RTL measurements.  Other differences were 
found in RTL of samples extracted by the different methods, notably the 
isopropanol precipitated samples had shorter RTLs compared to other extraction 
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methods in multiple pair wise comparisons.  Cunningham et al state the reason for 
shorter RTL in Qiagen extracted samples could be the shearing of DNA through 
vortexing as part of the protocol, multiple wash steps and only the DNA that has 
remained on the column will be collected in the resulting elute.  In addition, they 
compared RTLs to TRF analysis measurements and found that the Qiagen extracted 
samples still had shorter telomere lengths.  They also performed a literature 
review, and suggest that from their findings, use of Qiagen columns may result in 
more false negative results in the link between short telomere length and cancer 
risk, compared to using phenol chloroform or salting out DNA extraction methods.  
260/280 ratios have been found to be lower, however, in canine blood samples 
extracted using phenol chloroform, compared to Qiagen columns (Clements et al., 
2008).  Puregene extracted DNA samples were found to have higher 260//280 
ratios than Qiagen extracted samples in the same study.  The phenol chloroform 
extracted samples showed significantly higher PCR inhibition than the other 
samples.  Denham et al (2014) found that Qiagen columns produced DNA with 
significantly higher 260/280 ratios than Purelink-extracted DNA.  In addition, they 
found significant correlations between both 260/280 and 260/230 ratios with RTL.  
In this chapter, correlations were found between 260/280 ratio and telomere CT in 
one data set, and 260/230 and HBD CT in the Manchester data set.  The Manchester 
samples had 260/230 ratios which fell well below the purity rules set for samples 
extracted by the author.  This was suspected to be the reason that no significant 
correlation was found between RTL and age in this group.  In addition, as the 
260/230 ratios were lower when the buccal swabs were phenol-chloroform 
extracted.  For future experiments, DNA was extracted from swabs using column 
extraction where telomere length was to be measured using qPCR.  
 
 
An issue which may have had an impact upon results when using surplus samples 
from the VDS, is the stability of RTL with sample storage conditions.  Zanet et al 
(2013) found that when EDTA anticoagulated blood samples were stored at 4°C for 
more than 4 days, there was an increase in RTL.  The samples used here will have 
been stored at 4°C for at least a week, then frozen.  Zanet et al also found that 
freeze-thawing samples did not affect RTL.  Without further investigation, it 
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cannot be known the variability of the impact of the storage conditions of the 
samples used here, and if there are any factors which may affect the stability of 
the RTL.  In this study, white cell count and differential were related to 260/230 
ratio, as well as telomere CT and HBD CT.   Age of dog also was associated with DNA 
quality ratios.   
 
 
Baker III and Sprott (1988) comprised a list of criteria which biomarkers of ageing 
should fulfil.  This list included that “biomarkers should change independently with 
the passage of time and reflect physiologic (functional) age”.  The linear model of 
age to leukocyte TRF was found not to be significant, but there was a significant 
association with sex and presence or absence of malignant disease and TRF.  The 
TRF analysis protocol could have been improved, which may have improved the 
relationship between age and TRF; however, differences in TRF between the other 
factors were observed.  The linear regression between buccal TRF and age was 
highly significant when neutering status was included as explanatory variables, 
with the R2 value reaching 0.82.  The dogs from which the buccal swabs were 
collected had no major health problems and were attending a first opinion 
practice, whereas all other samples were from dogs attending referral centres.  As 
was seen throughout the chapter, disease status, namely having cancer or not, had 
a significant association with telomere length, so having samples from dogs unwell 
enough to attend a hospital may have impacted the ability to identify the factors 
which would have a relationship with telomere length in a healthy dog population.  
The Edinburgh samples were from dogs attending an orthopaedic clinic, and the 
regression of RTL to age in these dogs was significant, with a R2 of 0.51, possibly 
because some of the presenting problems were “elbow dysplasia” and “cruciate 
disease”, which may have had less of an association with RTL than a malignancy.  
Without further studies, it is not possible to know the relationship of each 
presenting problem with telomere length in dogs. 
 
 
While the R2 of the regression between RTL and age in the qPCR optimisation 
samples was only 0.07, this value is in line with those stated in other studies using 
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human and dog samples.  Several studies examined did not state the R2 value, but 
the following examples were found: R2 of 0.026 and 0.075 in both sexes and male 
only, respectively, in pet dogs (Fick et al., 2012); R2 of 0.06 between leukocyte 
TRF and age in pet dogs (Benetos et al., 2011); R2 of 0.145 in samples from healthy 
humans and R2 of 0.079 in humans with COPD (Houben et al., 2009); and R2 of 0.04 
in humans with COPD and R2 of 0.09 in humans with HIV (Liu et al., 2015).  Neither 
dog study stated whether the dogs had underlying health concerns or not. 
 
 
 Associations between characteristics of dogs and telomere 
length    
Due to the number of cases used in this chapter, all cancer patients were grouped 
together.  Other studies have found varying effects of cancer on LTL, depending on 
the type of cancer diagnosed.  For example, Hou et al (2009) found patients with 
gastric cancer had significantly shorter LTL than controls, and Jang et al (2008) 
found lung cancer patients had significantly shorter LTL than a group of age, sex 
and smoking status matched controls.  In contrast, Sun et al (2015) observed that 
individuals with endometrial cancer had longer leukocyte telomere length than 
controls.  Shen et al (2007) found no significant difference in LTL between breast 
cancer patients and unaffected sister controls.  It would be interesting to 
investigate if there is variability in telomere length with different cancer types in 
dogs. 
 
 
The RTL in dogs in this chapter was found not to be statistically significantly 
associated with breed lifespan.  The lack of correlation between LTL and lifespan 
is rather different to the result found by Fick et al (2012).  They found a strong 
(p<0.0001) regression between breed life expectancy and LTL.  A possible reason 
for this difference is the study population used in this chapter; none of the dogs 
which were known to have died reached their breed life expectancy.  A healthier 
population may be required to generate similar results seen in the Fick et al study.  
Fick et al (2012) also examined the likelihood of death due to disease in different 
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body systems and cancer mortality based on breed with LTL.  Data from the UK 
Kennel Club were used here to compare percentage of deaths in each breed for 
the four most common causes of death in dogs: cancer, cardiac illnesses, old age 
and urological illnesses (no data were available for Chihuahuas or West Highland 
white terriers, and only limited data were available for Dogue de Bordeaux) to RTL 
and age adjusted RTL.  No cause of death was significantly correlated to RTL, age 
adjusted or not (data not shown).  In addition, using data from Fleming et al 
(2011), who examined cause of death in breeds in America (and was the study for 
which Fick et al (2012) obtained their mortality data), no significant correlations 
were found between RTL and the breed causes of death (data not shown).   
 
 
The dogs that were known to have died soon after sampling had shorter RTL when 
age was added in as an explanatory variable.  The number of dogs that died may 
have been underestimated if the dog’s death was not communicated to the small 
animal hospital.  Other studies have found a link between short telomere length 
and mortality.  Epel et al (2009) showed that, in human males, telomere 
shortening rate was linked to increased cardiovascular mortality.  Fitzpatrick et al 
(2011) found that persons in the shortest quintile of LTL were 60% more likely to 
die in the study follow up period than those in the longest quintile.   However, in 
two studies of LTL in elderly persons, there was no significant association between 
LTL and subsequent mortality found (Bischoff et al., 2006; Harris et al., 2006).  
 
 
The figures for breed lifespan used in this chapter were generated using breed 
median age of death from three studies (Michell, 1999; Adams et al., 2010; O’Neill 
et al., 2013).  Michell sent questionnaires to owners using addresses from a pet 
insurance company and at Crufts Dog Show and asked about their “last dog”.  
Adams et al sent questionnaires to breed clubs and asked about all dogs which had 
died in the past 10 years.  O’Neill et al used data from primary veterinary 
practices.  Each method had strengths and limitations.  For example, use of breed 
clubs only meant that the sample was not random, but Adams et al was the only 
study of UK dogs where information on all the breeds used in this chapter was 
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available.  O’Neill et al found there were issues with missing data.  Questionnaire 
data could not be corroborated with the dogs’ veterinary practices, so cause of 
death may not be entirely reliable.  Breed age at death in all studies included data 
from both euthanised dogs and dogs which died naturally, as well as deaths due to 
trauma and behavioural issues.  In fact, trauma was the most common cause of 
death in Chihuahuas, one of the breeds in this study, in an investigation of causes 
of death in American dogs (Fleming, Creevy and Promislow, 2011).  To check 
whether there was an effect of the sample group or method, the breed lifespan 
from each of the studies was tested for correlation with RTL, both age adjusted 
and not.  There was no significant correlation with the breed life expectancy and 
RTL using the Adams et al, O’Neill et al or Michell figures (data not shown).   
 
 
Some studies have suggested that telomere length in early life is predictive of 
lifespan.  For example, Fairlie et al (2015) found that female soay sheep with 
longer LTL in the first two years of life had improved survival rates, but there was 
no link in later life.  RTL at 25 days of age was seen to be predictive of lifespan in 
Zebra finches (Heidinger et al., 2012).  Examining the youngest 10 dogs in the 
qPCR optimisation samples, there was, in fact, a significant negative correlation 
between RTL and breed life expectancy (Spearman’s rho=−0.64, p=0.047). 
 
 
Variables related to breed, other than lifespan, were associated with RTL when 
age was included as an explanatory variable.  The estimated effective population 
size, a measure of inbreeding, was inversely related to age adjusted RTL, such that 
dog breeds with a higher rate of inbreeding had longer telomere lengths.  One 
weakness of using the estimated effective population size to assess the level of 
inbreeding was that figures were not available for greyhound or Rhodesian 
ridgeback breeds due to there being increasing genetic diversity in these breeds.  
Although, interestingly, the average RTL for the Rhodesian ridgebacks was the 
shortest average RTL out of the breeds, both unadjusted and age-adjusted.  
Greyhounds had on average the eighth shortest RTL but, as will be discussed later, 
dogs with lower cephalic indices had longer RTLs.  The finding that inbreeding was 
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associated with longer telomere lengths is in line with Manning et al (2002), who 
found that mice from inbred lines had longer LTL than outbred strains of mice.  
However, Leroy et al (2014) found inbreeding was associated with reduced survival 
to two years of age in 7 breeds of dog.  Shorter RTL was associated with mortality 
in this chapter, yet inbreeding was associated with longer LTL. 
 
 
The cephalic index was significantly related to RTL in a model with age included.  
Cephalic index (CI) is not routinely measured and recorded, so breed averages 
were used for CI values.  The variability of the skull conformations within each 
breed was not known.  Dogs with lower CIs had longer RTLs when age was included 
in the model.  Higher CI has been associated with health problems and reduced 
lifespan, as discussed in section 1.8.3.  However, thus far the RTL measurements 
have not reflected breed lifespan, so possibly the association between RTL and CI 
reflect the health of the individuals.  There were no studies of RTL and cephalic 
index found to compare the results to. 
 
 
Breed averages were also used for height, due to this information not routinely 
being measured and recorded.  While this may have led to some inaccuracy, Sutter 
et al (2008) demonstrated low phenotypic variation within breeds, with at least 70 
percent of dogs conforming to their breed’s height standards.  Therefore, they 
stated that Kennel Club (in their case American Kennel Club) measurements are a 
good proxy for actual height measurements.  Weight was not significantly related 
to RTL, yet weight was significantly correlated with lifespan.  Initially, there was 
no significant regression found between height and RTL, yet height was included in 
one of the final models, with an estimated coefficient of −0.12 indicating a 
negative relationship, such that shorter dogs had longer RTLs.  The link between 
weight and lifespan was expected, given that this relationship has been found in 
multiple previous studies (e.g. O’Neill et al. 2013; Galis et al. 2007).  Kraus et al 
(2013) examined breed mortality data, including age at death and the average 
weight for the breeds.  They concluded that large dogs die at a younger age 
because they “age quickly”.  They found a positive link between body size and the 
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absolute speed at which mortality hazard increased.  However, they found no 
significant relationship between size and age at which a mathematically calculated 
onset of senescence occurred Benetos et al (2011) speculated that the variation in 
the difference between leukocyte and skeletal muscle telomere length was due to 
the longer growth period of larger dogs.  Examining the RTL of dogs under two 
years of age in this chapter, there was still no relationship with weight.  While Fick 
et al (2012) did not comment on correlation between LTL and weight, it can be 
seen in their study that Labrador retrievers, a large breed, had the longest average 
age-adjusted LTL.  Cocker spaniels, a medium sized breed, had a mean age 
adjusted LTL of more than 10kb less than the Labrador retrievers. 
There was a significant difference in age adjusted RTL between breeds, although 
the above findings suggest that this was due to differences in factors such as 
cephalic index and inbreeding rate, rather than size or lifespan, as might have 
been originally anticipated.   
 
 
It is unclear why RTL was so long in miniature schnauzers.  The values for this 
breed were excluded from the analyses as the RTLs were greater than two 
standard deviations above the mean.  Two miniature schnauzer samples were 
measured by TRF analysis and were within the range of the other samples.  The 
HBD CTs were not significantly different to the other breeds, but the CTs for the 
telomere plate were lower.  It may be possible that the telomere primers are 
annealing elsewhere in the genome as well as to the telomere in this breed.  The 
efficiency of a standard curve generated using miniature schnauzer DNA could be 
checked using the same primer conditions as normal to see if the telomere 
reaction has very high efficiency.  
 
 
Linear models showed that haematological and biochemical measures seemed to 
have little association with RTL.  This may be in part due to acute changes of 
parameters while the dog is in hospital, such that the measures do not reflect long 
term organ function.  One parameter which had highly significant relationship to 
RTL was neutrophil to lymphocyte ratio.  This ratio has recently been reported as 
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being increased in dogs with soft tissue sarcoma compared to dogs with benign soft 
tissue tumours (L. Macfarlane et al., 2016).  The relationship between neutrophil 
to lymphocyte ratio and RTL may reflect the poor health of the dogs sampled; 
when higher ratios were considered, regression to RTL was significant.  Previously, 
it has been demonstrated that different types of leukocyte have different 
telomere lengths (e.g. Robertson et al. 2000).  The proportion of each present and 
therefore extracted from may have therefore had an impact upon the RTL.  One 
option to overcome this is to separate out the different white cell types, using 
flow cytometry or a product such as Lymphoprep, and measure the telomere 
lengths separately.  A problem would be potential poor recovery of granulocytes 24 
hours after sample collection (Baerlocher et al., 2006) and the blood samples 
obtained from the clinical pathology service were available 8 days after sample 
collection.  However, neither neutrophil to lymphocyte ratio or lymphocyte to 
monocyte ratio were included in the final models.  All four platelet variables were 
included (platelet count, mean platelet volume, plateletcrit and platelet 
distribution width) in model1, as well as calcium and monocyte count and PDW in 
model2.  Only two studies could be found where platelet count was positively 
correlated with LTL (Hao et al., 2005; Kozlitina and Garcia, 2012).  No studies 
could be found regarding LTL and other platelet variables. 
 
 
Several of the variables included in the final models for the qPCR optimisation 
samples are involved in inflammatory pathways, including cholesterol, calcium, 
monocytes and platelets.  As discussed in section 1.7, telomere length is affected 
by oxidative stress.  The pathways will not be discussed in detail as they are out of 
the remit for this thesis.  Briefly, increased cholesterol concentrations lead to an 
inflammatory response through cholesterol accumulation in macrophages and other 
immune cells (Tall and Yvan-Charvet, 2015).  Leukocyte-platelet interactions have 
been well-documented, and have shown to be relevant for inflammation and 
thrombosis.  Activation of leukocytes through inflammation can lead to a 
procoagulant state (Afshar-Kharghan and Thiagarajan, 2006; Rumbaut and 
Thiagarajan, 2010).  Moritz et al (2005) found that MPV and PDW, but not platelet 
count, were increased in dogs with both septic and non-septic inflammation 
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compared to healthy dogs.  In addition, dogs with untreated multicentric 
lymphoma were found to have significantly greater platelet aggregation than 
control dogs (Thomas and Rogers, 1999).  There is also platelet variability between 
breeds, which may explain why more platelet variables were included in model1, 
where breed was included.  Greyhounds have been shown to have lower platelet 
count than non-greyhounds (Sullivan, Evans and McDonald, 1994) and Cavalier King 
Charles Spaniels had higher platelet aggregation response than Cairn Terriers, 
Boxers and Labrador retrievers (Nielsen et al., 2007).  Cavalier King Charles 
spaniels are prone to an inherited giant platelet disorder.  In blood from 69 
clinically normal Cavalier King Charles Spaniels, thrombocytopenia was found in 
51.43% and macrothrombocytes were present in 33.33% (Cowan et al., 2004).  A 
reduction in albumin to globulin ratio is likely to represent a fall in albumin levels, 
which is often seen in chronic disease states (Moshage et al., 1987) and serum 
albumin acts as a major antioxidant (Cha and Kim, 1996).  The inclusion of sodium 
to potassium ratio in both models may represent a disease element due to the 
study population used.  Reduced sodium to potassium ratio in dogs may be found in 
multiple disease states such as renal failure, pancreatitis, hypoadrenocorticism 
and heart failure (Roth and Tyler, 1999). 
 
 
An issue of relating RTL to haematological and biochemical measures is the length 
of time between pathology testing and DNA extraction.  Stability of complete 
blood count over time has been investigated.  However, nearly all studies looked 
at stability of measures up to 72 hours, and the samples used here were stored for 
far longer.  Hedberg and Lehto (2009) found that when samples were stored at 
4°C, as they are in the diagnostics laboratory, all complete blood count 
parameters remained stable for 72 hours, except a slight increase in mean platelet 
volume.  Interestingly, as previously mentioned, RTL has been demonstrated to be 
stable in EDTA-anticoagulated whole blood samples for up to 4 days (Zanet et al., 
2013).  Whether this means the white cell differential becomes unstable at this 
point cannot be known without further study. 
 
 
Chapter 4  213 
 
 
 
As the neutrophil to lymphocyte ratio to RTL regression was significant, numbers 
for the neutrophil and lymphocyte counts for the dogs used in the leukocyte TRF 
analysis were obtained.  There was not a significant correlation between TRF and 
neutrophil to lymphocyte ratio (R2=0.09, p=0.33).  However, inclusion of neutrophil 
to lymphocyte ratio as an explanatory variable along with diagnosis of malignant 
disease and sex improved the linear model to TRF (F=22.87(4,8), R2=0.92, p<0.001).  
Age was still not statistically significant as an explanatory variable for TRF. 
 
 
There was no difference seen in LTL between entire and neutered dogs.  It may be 
that neutering does not make a difference in LTL, but there was also no 
information on how long the dogs had been neutered for so it is not known if there 
was a time-dependent effect.  There was also no relationship between LTL and 
index of deprivation.  A reason that there was not an effect found may be that the 
sample was not representative of all backgrounds, given that the dogs from which 
the blood samples were taken were being treated at a referral centre.   
 
 
 Telomere length in oral samples 
Another key aspect of this chapter was to consider whether a non-invasive sample 
could be used to measure representative telomere length in dogs.  Buccal and 
saliva samples from Labrador retrievers were used.  Buccal RTL regression to age 
was not initially significant, but the model was highly significant when neutering 
status were added to the model.  This set of samples tested had the advantage of 
being from healthy dogs so the results were not affected by the presence of 
serious illness in the dogs.  There was a significant regression between saliva RTL 
and age, which was also strengthened by the addition of sex into the model.  
Entire males had shorter saliva RTL, yet leukocyte RTL in these animals was not 
shorter.  There was a significant regression between leukocyte and saliva RTL in 
matched samples, but only when sex was corrected for.  The results show that 
saliva or buccal samples could be used in future dog studies, but there is a strong 
sex effect which needs to be corrected for.  It would be helpful to perform 
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matched buccal and leukocyte RTL measurements to see if saliva or buccal 
telomere length correlated better with LTL. 
 
 
It is not obvious why there was a sex effect on the oral telomere length 
measurements which was not present in the Edinburgh leukocyte samples.  No sex 
difference was found in buccal telomere length in 109 children (Drury et al., 2012) 
or in saliva telomere length in 89 adults aged 19-69 years (Chen et al., 2015).  One 
possibility for sex effecting oral telomere length is difference in dental disease 
prevalence between sexes.  However, in beagles there was no sex difference in 
tooth clinical attachment due to dental disease (Kortegaard, Eriksen and Baelum, 
2008).  In addition, Gad (1968) found no sex difference in tooth cleanliness in 62 
mongrels.  No studies could be found regarding sex difference in dental disease in 
Labrador retrievers.  Bender et al (2006) found oral neutrophil count was 
significantly higher in human patients with periodontal disease compared to 
controls.  In the qPCR optimisation samples, neutrophil to lymphocyte ratio was 
seen to have a significant relationship with RTL; therefore, differences in white 
cell content could be present in each sex.   
 
 
Limited information was available on the dogs from whom the saliva and buccal 
samples were taken, so it is not known if factors such as weight affected oral 
telomere length.  In addition, only one breed was used so it is not known if the 
factors that affected leukocyte RTL, such as cephalic index and inbreeding, affect 
oral telomere length.     
 
 
 Chapter summary 
The main focus of this chapter was to optimise the qPCR methodology for telomere 
length measurement in dog samples.  The method was used to demonstrate age 
related decline in LTL successfully.  However, factors such as presence of 
malignancy in the individual, breed, cephalic index and inbreeding affected the 
regression, so the picture was not straight forward.  In addition, DNA sample 
Chapter 4  215 
 
 
 
quality and extraction method were shown to have an impact upon LTL and these 
factors need to be considered in future experiments. 
 
 
There was a significant association observed between samples measured by qPCR 
and the “gold standard” telomere measurement technique, TRF analysis.  
However, the relationship was not strong and this may have been due to the TRF 
technique not being fully optimised for dog sample measurement.  An absolute 
telomere length qPCR technique was attempted, but decided against after highly 
variable results were generated.  Thus, subsequent telomere length measurements 
were made using the relative qPCR method.  The relative qPCR method was 
optimised and was used to demonstrate age related changes in groups of samples, 
and thus was deemed suitable to measure telomere length in Chapter 5. 
 
 
Buccal and saliva samples were tested for their possibility of use for telomere 
length measurement and showed promise in this area, with the caveat that sex, 
including neutering status, had a large association with results.  Further 
investigation is warranted into this area.  
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5 Chapter 5: Evaluating the relationship between 
environmental tobacco smoke and telomere 
length  
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 Introduction 
 Smoking and telomere length 
No documented evidence of the effect of ETS on canine telomere length could be 
found in the literature.  Therefore, evidence from human studies, and murine 
studies, will be presented here.  Studies on the relationship between smoking and 
telomere length in humans were found via PubMed and Ovid Medline using the 
search terms “cigarette”, “smok*” or “tobacco” and “telomere”.  A total of 216 
studies were found.  However, in only a small number of these is smoking a main 
focus of the study.  Examples of studies where investigating the association 
between smoking and telomere length is one of the key aims of the study are given 
below. 
 
 
 Smoking and cross-sectional leukocyte telomere length 
Valdes et al. (2005) examined leukocyte TRF length in 1122 white females aged 18 
to 76.  They found current smokers had the shortest TRF lengths and a dose-
dependent relationship existed between smoking and leukocyte TRF length, with 
an additional 18% of LTL lost over and above the average attrition rate per pack-
year smoked.  Latifovic et al. (2016) measured LTL using qPCR in 477 healthy 
volunteers aged 20 to 50.  Again, current daily smoking was associated with 
significantly shorter LTL than never smokers.  However, while those with >0 to 
6.25 and >6.35 to 16 tertiles of pack-years smoking had shorter LTL than never 
smokers, the group with greater than 16 pack-year smoking history did not have 
significantly different LTL to never smokers.  In a third study, leukocyte TRF length 
was measured in 305 adults, with mean age 42.5, randomly recruited from a 
Flemish community.  After adjustment for age, TRF length was significantly shorter 
in smokers than non-smokers in this study too, and TRF decreased with increasing 
number of pack years (Nawrot et al., 2010).   Strandberg et al. (2011) measured 
leukocyte TRF length in 622 men, of mean age 75.7, partaking in a follow-up of the 
Helsinki Businessmen Study.  They also calculated the proportion of telomeres less 
than 5kb in length in each sample.  Age-adjusted TRF was again significantly longer 
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in never smokers than past or current smokers.  There also tended to be a higher 
proportion of short telomeres in former or current smokers than non-smokers.  
Morlá et al. (2006) measured lymphocyte telomere length in 26 never-smokers of 
mean age 57, 24 smokers with normal lung function with mean age 58 and 26 
smokers with COPD of mean age 61 using FISH.  There was a negative association 
between pack year and telomere length, which was not affected by the degree of 
airflow obstruction present.  Verde et al. (2015) measured LTL in 147 healthy 
smokers with mean age 43.2.  Pack years of smoking were associated with an 
increased odds ratio of having short LTL.  However, no significant correlation was 
observed between LTL and urinary nicotine concentration or between LTL and 
urinary cotinine concentration.  They also calculated the nicotine metabolism ratio 
(the ratio of trans-3’-hydroxycotinine to cotinine), which reflects P450 2A6 
activity.  The nicotine metabolism ratio was also unrelated to LTL.  
   
 
Two of the studies examining smoking and telomere length were case-control 
studies.  Mirabello et al. (2009) examined risks for prostate cancer in men aged 55 
to 74.  The study included 612 cases and 1049 matched controls.  LTL was 
measured by qPCR.  They examined the association between smoking and LTL in 
the cases and controls combined, and found a significant inverse correlation 
between LTL and pack-years smoked.  However, when they separated the cases 
and controls, there was only a significant relationship between pack-years and LTL 
in controls, not cases.  McGrath et al. (2007) examined LTL, cigarette smoking and 
bladder cancer risk, using 184 cases and 192 controls from the Nurses’ Health 
Study and Health Professional Follow-up Study (HPFS).  They observed a significant 
difference in LTL across pack-years of smoking, adjusted for age and gender, but 
only an association between LTL and pack-years of smoking in HPFS control 
subjects when the subjects were divided into studies and cases and controls.   
 
 
 Smoking and longitudinal leukocyte telomere length 
Huzen et al. (2014) measured LTL using qPCR in 8074 participants aged 28 to 75 in 
an ongoing community based prospective cohort study.  LTL was measured 1 to 3 
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times over an average period of 6.6 years.  Active smoking tripled the average LTL 
attrition rate per year.  In another study, 4576 individuals from the Copenhagen 
City Heart Study, aged 40 to 47 at baseline, gave blood samples at two time points 
10 years apart.  LTL was measured by qPCR.  Current smoking was associated with 
shorter LTL at time point 1 only, and daily tobacco consumption was not 
associated with LTL at either time point.  Increased baseline tobacco consumption 
was actually associated with an increase in LTL base pairs between the two time 
points in a univariate analysis, but there was no significant association between 
tobacco consumption and LTL change in multivariable analyses when variables such 
as age were included (Weischer, Bojesen and Nordestgaard, 2014).  Müezzinler et 
al. (2015) measured LTL in a subset of an ongoing cohort study using qPCR.  LTL 
was measured at baseline in 3600 participants aged 50-75 and repeated in 1000 
participants after 8 years.  At baseline, current smokers statistically had the 
shortest LTL, and a trend was seen in LTL shortening with increasing cigarettes per 
day.  Conversely, there was a non-significant trend for never smokers to 
experience greater attrition in LTL per year compared to smokers between the two 
time points, except in those who smoked 20 or more cigarettes per day. 
 
 
 Smoking and telomere length in other tissues 
The majority of telomere length studies published measure telomere length in 
blood, but in this thesis other tissues were examined as well as blood.  Chen et al. 
(2015) measured telomere length in saliva using qPCR in a group of 89 caregivers 
aged 19 to 69.  They found that current smokers had significantly shorter saliva 
telomere length compared to former or never smokers.  Broberg et al. (2005) 
studied the risk of bladder cancer based on buccal cell telomere length, and 
investigated the impact of smoking on this risk in 63 bladder cancer cases aged 35 
to 85 and 93 controls aged 21 to 90.  No significant difference in buccal cell 
telomere length was found between current and non-smokers (including former 
smokers).  However, the people at the greatest risk of bladder cancer were 
current smokers with short buccal cell telomere length.  In another study, small 
airway epithelium was collected in 29 healthy lifelong non-smokers (mean age 38) 
and 29 healthy smokers (mean age 38.8).  Smoking status was verified by urinary 
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nicotine and cotinine concentrations.  Small airway epithelium telomere length 
was measured by TRF analysis.  Initially, no association between TRF length and 
pack-year history was found, but when the data was subsetted by race, TRF 
shortening with increasing pack-years was observed, with the relationship being 
statistically significant in the white population.  Leukocyte TRF length was also 
measured in a subset of the study population.  No difference was observed in 
leukocyte TRF length between smokers and non-smokers, yet in this subpopulation 
there was a significant difference in small airway epithelium TRF length between 
smokers and non-smokers (Walters et al., 2014).    
   
 
A recent study examined the impact of polycyclic aromatic hydrocarbons (PAHs), a 
component of cigarette smoke, on sperm telomere length.  666 human male 
volunteers provided semen for telomere length analysis and urine for measurement 
of eight PAH metabolites.  Two of the metabolites were significantly related to a 
decrease in sperm telomere length, but the other six metabolites were not 
associated with telomere length (Ling et al., 2016).  
 
 
 Study related factors and relationship between smoking and 
telomere length 
The 216 studies found where smoking was investigated as a potential explanatory 
variable for telomere length are listed in a table in Appendix 9.  It was noted if 
telomere length measurements in each study were cross sectional or longitudinal, 
the method of telomere length measurement and coefficient of variation for the 
method, the tissue used for telomere measurement and DNA extraction method.  
In terms of study participants, the number of individuals with both telomere length 
measurement and smoking history, percentage of participants who were current 
smokers, average participant age, sex, notable chronic health problems and if the 
smoking status was recorded in categories or numerically were tabulated.  It was 
also recorded if there was a significant relationship between telomere length and 
age.  Finally, it was recorded if smoking was found to have a significant 
relationship with telomere length, taking significance as p<0.05.  Where 
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components were not explicitly stated, if possible an estimate was made using the 
information in the publication, if not, “n/a” was entered in the cell.  Some studies 
involved a subset of a larger cohort study, which was used in several publications.  
Where studies used the same cohort, these were grouped in the table. 
 
 
99 studies found a significant relationship between smoking and telomere length.  
Six of these studies found a positive association between pack year history and LTL 
or reduced loss over time in smokers; all others demonstrated a negative 
relationship between pack year history and telomere length and/or a reduction in 
telomere length based on smoking status.   
 
 
 Environmental tobacco smoke exposure and telomere length 
The majority of studies found on the association of ETS exposure with telomere 
length focussed on prenatal exposure.  For example, Salihu et al. (2015) assessed 
foetal telomere length by qPCR, using cord blood leukocytes from 86 individuals.  
Statistically significant differences were found between smoke exposure groups.  
Telomere length was shortest when the mother actively smoked during pregnancy, 
followed by the group of non-smoking mothers exposed to ETS, and was longest in 
non-smoking mothers not exposed to ETS.  Imam et al. (2012) collected various 
perinatal tissues from 103 mothers with infants including: maternal venous blood, 
maternal blood spot, infant heel prick blood, placental tissue from both maternal 
and foetal sides, and cord blood.  Telomere length was measured in all tissues by 
qPCR.  Telomere lengths were then compared based on maternal smoking status.  
Cord blood telomere length was significantly shorter in infants exposed to 
maternal smoking.  Maternal side placenta telomere length was also significantly 
shorter in smoking mothers, but only when other factors were adjusted for.  No 
significant differences were found in the other tissues based on maternal smoking 
behaviours.  In a third study, 169 cord blood samples were collected and T cell 
telomere length was measured using qPCR.  Smoking status of the mother was 
obtained by questionnaire and confirmed by maternal venous and cord blood 
cotinine concentrations.  In contrast to the findings by Imam et al. 2012 and Salihu 
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et al. 2015, cord blood T lymphocyte telomere length was significantly longer in 
new-borns of smoking mothers. 
 
 
Further studies investigated the impact of retrospective prenatal ETS exposure on 
telomere length in children.  For example, Pawlas et al. (2015) examined LTL in 99 
Polish 8-year-old children, using qPCR.  They found that LTL was significantly 
shorter in children whose mothers smoked during pregnancy.  Furthermore, when 
saliva telomere length was measured in 104 children aged 4 to 14 years, saliva 
telomere length was significantly shorter in children with a prenatal tobacco 
smoke exposure history (Theall et al., 2013).  In contrast, when LTL was measured 
in 331 Australian children (with mean age 3.6 years) by qPCR, there was no 
significant difference in telomere length based on maternal smoking during 
pregnancy (Skilton et al., 2016).  Ip et al. (2016) measured buccal cell telomere 
length using qPCR in 196 children of mean age 6.33.  Like Pawlas et al. 2015 and 
Theall et al. 2013, telomere length was shorter in children whose mothers smoked 
throughout pregnancy.  However, they found no association between maternal ETS 
exposure during pregnancy and child telomere length, or between post-natal ETS 
exposure and telomere length. 
 
 
 Murine telomere length and tobacco smoke 
Murine experiments regarding ETS exposure and telomere length are limited, 
perhaps due to the difference in human and mouse telomeres, or the availability 
of clinically obtained human samples demonstrating the association between ETS 
and telomeres.  It should be noted that all the following studies were written by 
the same author.  In experiments investigating the effect of cigarette smoke on 
embryo development in vivo, female CD1 mice were exposed to cigarette smoke, 
given doses of cigarette smoke condensate or untreated.  They were mated and 
their embryos harvested after 4 days.  While telomere length was significantly 
shortened in the embryos of mice exposed to cigarette smoke or cigarette smoke 
concentrate compared to no exposure, as measured by Q-FISH, there was no 
change in the rate of chromosomal abnormalities or fusions (Huang et al., 2009).  
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In further experiments, CD1, B6C3F1 or telomerase RNA component (Terc-/-) 
knockout C57B1/6 female mice were superovulated using PMSG (pregnant mare 
serum gonadotrophin), followed by hCG (human chorionic gonadotrophin) and then 
mated.  Zygotes were collected, cumulus cells removed and embryos cultured.  
The embryos were exposed to cigarette smoke condensate or cadmium (an 
abundant compound in tobacco).  Both exposures resulted in an increase in 
oxidative stress and shorter telomere length, measured by Q-FISH.  Significantly 
more telomere loss occurred in the Terc knockout mice than in the wild-type mice.  
In addition, cigarette smoke condensate resulted in loss of telomere free ends and 
chromosome fusion (Huang et al., 2010).  Similar experiments were conducted on 
mouse embryonic stem cells.  Mouse embryonic stem cells were isolated from C57 
mice and cultured.  The cells were treated with cigarette smoke condensate or 
cadmium, or were controls.  Telomere lengths of cells treated with cigarette 
smoke concentrate were consistently shorter than those of control cells.  Cells 
treated with cadmium had the shortest telomere lengths.  Cells treated with low 
dose cadmium or cigarette smoke concentrate demonstrated the loss of telomere 
free ends and chromosome fusion (Huang et al., 2013). 
 
 
 Chapter aims and hypotheses 
The key aim of this chapter was to explore whether there was an association 
between ETS exposure and telomere length.  However, to achieve this, the 
correlation between telomere lengths in individuals was tested, to establish if one 
measure of telomere length would reflect telomere lengths elsewhere in the body.  
In addition, as telomere length was being viewed as a biomarker of ageing, tissues 
and the differences between pairs of tissues were tested to see which would be 
the best representation of dog age.  Using hair nicotine and cotinine as objective 
measures of ETS, it was then aimed to explore whether either of these markers 
were associated with telomere lengths both cross-sectionally at both time points, 
and longitudinally between the two time points.  In addition, further analyses were 
undertaken to explore whether other variables impacted upon telomere length. 
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It was hypothesised that tissue telomere lengths would be highly correlated within 
individuals.  As cremaster muscle is generally considered to be a post-mitotic 
tissue, cremaster muscle telomere length was expected to be the longest telomere 
length measure and to not be associated with age.  In addition, vas deferens 
telomere lengths were not expected to significantly change with age, unless a 
trauma was reported to the area, as smooth muscle cells are capable of repair.  
Epididymis telomere length was hypothesised to increase with age, as a proxy for 
sperm telomere length.  Leukocyte and buccal telomere lengths were expected to 
shorten between the time points, and to be negatively associated with age.  In 
addition, those with longer leukocyte and buccal telomere lengths at time point 1 
were expected to have larger decreases in telomere length over the study period.   
 
 
It was also expected that dogs exposed to ETS would have shorter leukocyte and 
buccal telomere lengths cross-sectionally, and that these dogs would experience 
greater rates of telomere attrition. The difference between leukocyte and 
cremaster muscle telomere lengths was expected to increase with age, and to 
increase with exposure to ETS, and the rate of change between these tissues was 
expected to decrease with age but increase with ETS.  These age-related changes 
were also expected for the difference between leukocyte and vas deferens 
telomere lengths.  However, as it is not a post mitotic tissue, damage from ETS 
may be evident in vas deferens telomere shortening.  It was predicted that the 
difference between LTL and epididymis telomere length would increase with age 
at a faster rate than the differences between the other tissue pairs, with 
epididymis telomere length increasing with age and LTL decreasing with age.  
However, it was also expected that ETS would cause damage to epididymis 
telomeres and these would shorten with increasing exposure to ETS. 
 
 
In the additional analyses, it was hypothesised that weight and height would be 
negatively associated with telomere length in all tissues.  Males were expected to 
have shorter leukocyte and buccal telomere lengths than females.  Breed life 
expectancy was expected to be positively associated with telomere lengths, and 
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those with a shorter life expectancy to show an increased rate of loss in telomere 
length between the two time points.  
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 Methods 
 Study participants 
To decide upon the number of dogs required to investigate the association 
between ETS and telomere length, a power analysis was conducted using the 
limited published data.  Calculations were based on the mean leukocyte – muscle 
telomere length in dogs being −1.25±0.65 kb (using data from Benetos et al. 2011) 
and exposure to environmental tobacco smoke (ETS) causing the same level of 
damage to dog telomeres as smoking in humans (using data from Valdes et al. 
2005).  An age matched design was assumed and it was calculated that a study 
with 16 dogs in both ETS exposed and non-ETS exposed groups would have 80% 
power to detect a statistically significant difference (at p<0.05) in leukocyte – 
muscle telomere length.  Given the uncertainties in the calculations, 20 per group 
seemed prudent.  As described in section 2.2.9.2, 2 further dogs were added after 
discovering that 2 dogs had been rehomed soon after the first study time point, 
resulting in the 42 dogs described in section 2.2.9.5.   
 
 
 Samples 
Samples were collected as described in section 2.2.9.1.  Blood haematology and 
biochemistry results were collated for both time points.  One of the cavalier King 
Charles spaniels was found to have giant platelet disorder, so the platelet data for 
this dog were excluded from analyses.  4 samples had biochemical results 
indicating EDTA contamination, and therefore the potassium and calcium 
concentrations for these were excluded as well.   
 
 
Dog weight was recorded at both time points and the percentage weight change 
calculated.  To account for expected weight gain due to growth, growth curves 
were used to calculate expected final adult weight in the dogs which appeared to 
have not finished growing.  The percentage difference between the expected adult 
weight and weight at time point 2 was also then calculated.  Breed height and 
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cephalic index were as in Chapter 3.  The estimated effective population size for 
breeds were obtained from the Kennel Club UK website (The Kennel Club Limited, 
2016).  Due to the nature of this measure, there were no values for cross breeds.  
In addition, no values for Patterdale terrier or Shar-pei were present on the 
website.  The value for Parson Russell terrier was assigned to the Jack Russell 
terrier.  Breed life expectancy was obtained using figures from Adams et al. 2010, 
Michell 1999 and O’Neill et al. 2013.  Life expectancy figures were not available 
for specific cross breeds, or for the Patterdale terrier.   
 
 
Questionnaire and hair analysis data were as in Chapter 3.  Using their postcodes, 
owner indices of deprivation were obtained from the Scottish Neighbourhood 
Statistics website (The Scottish Government, 2015b). 
 
 
 Telomere length measurement 
DNA was extracted from blood and buccal swabs using a column extraction method 
as detailed in section 2.2.2.  DNA was extracted from cremaster muscle, 
epididymis, vas deferens and uterus samples using a phenol-chloroform method as 
described in section 2.2.1.  DNA quantity and quality were measured using 
spectrophotometry as per section 2.2.5, ensuring that the minimum quality control 
standards were reached for each DNA sample.  If the quality was deemed 
unacceptable, either the extraction process was repeated or the DNA sample 
cleaned until an acceptable standard was reached.  Relative telomere length was 
measured by qPCR, using the optimised protocol from chapter 4.  DNA samples 
from dogs from both smoking and non-smoking homes were analysed on each plate 
to reduce the chance of finding a difference in RTL between the exposure groups 
because of inter-assay variation. 
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 Data analysis 
 Smoking and telomere length studies 
Binomial generalised linear regression was used to compare the outcomes of 
existing telomere studies assessing the impact of smoking based on study design 
features.  If a significant association was found, the study was assigned a “1”.  If 
no significant association between smoking and telomere length, the study was 
assigned a “0”.  Different elements of study design such as method used to 
measure telomere length were then input into the model as explanatory variables. 
 
 
 Longitudinal RTL measurements 
The differences between RTLs at time points 1 and 2 were taken for each dog.  As 
some participants did not attend the clinic at appointments exactly a year apart, 
the change in RTL was adjusted by dividing the number of days between 
appointments by 365.25 and multiplying this number by the change in RTL.  This 
calculation assumed a constant daily rate of change.  When comparing the change 
in leukocyte and buccal RTLs to the time point 1 values, the change was corrected 
for regression to the mean using the formula given in Verhulst et al. (2013): 
 
 𝐷 = 𝑝(𝑋1 − ?̅?1) − (𝑋2 − ?̅?2) 
where  
𝑝 =
2𝑟𝑆1𝑆2
𝑆1
2 + 𝑆2
2 
𝑆2 = 𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 
 
 
 Comparison between postmitotic and proliferative tissue RTL 
Comparisons between tissue telomere lengths were as per the model proposed by 
Benetos et al. (2011) (see Chapter 1).  The basis of using a comparative tissue is 
that a post-mitotic tissue would reflect telomere length at birth, so by subtracting 
leukocyte or buccal telomere length the loss since birth would be reflected.  By 
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then dividing by age in months, this would give the rate of loss per month since 
birth (based on a constant rate of loss).  For the tissue telomere length comparison 
analyses, the difference was calculated simply by subtracting either cremaster 
muscle RTL, epididymis RTL or vas deferens RTL from leukocyte RTL or buccal RTL.  
To calculate the rate of change between the tissues, leukocyte or buccal RTL was 
subtracted from cremaster muscle, vas deferens or epididymis RTL and then 
divided by the dog age in months.  As there is only one point at which the dogs 
were castrated, for obvious reasons, time point 2 leukocyte and buccal telomere 
lengths were compared to the telomere lengths of tissues obtained at time point 1.   
 
 
 Statistical testing 
Linear modelling analysis was as described in chapter 4 methods.  Paired Wilcoxon 
rank sum tests were used to compare RTL measurements between tissues.  Pearson 
product moment correlation was used to test the relationship in RTL in different 
tissues. 
 
 
As not all breeds had the same life expectancy, life expectancy (LE) adjusted age 
was calculated by dividing age by life expectancy. 
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 Results 
 Study design in publications 
Binomial generalized linear regression was employed to see if there were any 
factors in study design which impacted upon finding a significant relationship 
between telomere length and smoking, in the 216 studies in Appendix 9. 
As may be expected, having an increased number of individuals in the study 
resulted in an increased likelihood of finding a relationship between telomere 
length and smoking.  In addition, having a higher proportion of smokers had a 
similar effect.  If fewer than 25% of participants were current smokers, an effect 
was less likely to be found and if more than 50% of the group were current 
smokers, a relationship was more likely to be found.   There was a tendency for a 
relationship being less likely when the average age of the participants increased, 
perhaps due to other factors such as ill health confounding.   This was compounded 
by the increased tendency to find an effect in studies where the participants were 
“healthy”.  No sex effect was found on the likelihood of finding an association.  
Aside from the salting-out DNA extraction method tending to have a negative 
impact on the likelihood of finding an association between smoking and telomere 
length, there was no effect of DNA extraction and measurement method or 
coefficient of variation seen.  However, quite a few studies did not state DNA 
extraction method or coefficient of variation.  If a significant relationship was seen 
between age and telomere length in a study, a relationship between smoking and 
telomere length was significantly more likely to be found.  Longitudinal telomere 
measurements did not make finding an association more likely.  Finally, an effect 
was more likely to be found if a numerical measure of smoking was included, 
rather than just smoking status.     
 
 
An interesting observation on these publications is that some use subsets of 
participants from the same larger studies, but the result can be different.  For 
example, 4 studies used participants from the Prevention of Renal and Vascular 
End-Stage Disease Study.  2 found a significant relationship between smoking and 
telomere length, 2 did not (Kingma et al., 2012; Huzen et al., 2014; van 
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Ockenburg et al., 2014, 2015).  The sub-cohorts were similar in age and smoking 
rate and telomere lengths were measured by qPCR in all, yet the findings were not 
the same.  Studies using the same larger study are grouped together in Appendix 7 
for comparison. 
 
 
 Study dogs 
Table 5-1 gives the ages, weights and smoking variables associated with each 
breed at time point 1, and Table 5-2 provides this information for time point 2.  
Given the wide range of breeds in the study, breeds were sorted into 4 groups to 
ease analysis: terrier/terrier cross, collie/collie cross, spaniel/spaniel cross and 
other (Table 5-3 and Table 5-4).  As can be seen in Table 5-1, there were no dogs 
which could fall into two groups.  The Staffordshire bull terrier breed was the only 
breed with any females.   
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Table 5-1 Dog breeds in the study at time point 1 with associated variables 
with age, weight, HNC in ng/mg and HCC in ng/mg.  Where more than two dogs of a breed are 
present, the range of values and median are given. 
Breed Number Age Weight Nicotine Cotinine 
Basset hound 1 0.76 16.6 2.44 0.14 
Beagle 1 0.74 14.5 0.03 0.05 
Bearded collie 1 2.33 18.4 0.27 0.05 
Border collie 
4 
0.65  
(0.61-1.1) 
16.7  
(13.1-
19.5) 
0.08  
(0.01-1.08) 
0.01  
(0-0.01) 
Border terrier X Pug 1 0.62 9.3 0.08 0.06 
Boxer 1 2.1 33.1 0.20 0.08 
Cavalier King Charles 
spaniel 2 0.62, 0.70 6.3, 9.2 4.05, 5.93 0.22, 0.62 
Cocker spaniel 1 0.53 10.5 0.03 0.02 
Collie X Labrador 
retriever 1 0.47 13.6 1.79 0.24 
German shepherd 
dog X collie 1 1.42 24 0.01 0 
German shorthaired 
pointer 1 6.58 31.2 0.09 0 
Jack Russell terrier 1 0.72 5.9 0.02 0 
Miniature schnauzer 1 6.16 9.1 0.01 0 
Patterdale terrier 1 5.33 12.8 0.01 0 
Patterdale terrier X 
Lakeland terrier 1 0.51 12.3 0.44 0.04 
Pomeranian X Border 
terrier 1 0.51 5.1 0.02 0 
Retriever X 
Rottweiler/Bull 
mastiff 1 0.46 18.8 0.08 0 
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Rottweiler 1 1.36 44.2 0.16 0.05 
Shar-pei 1 2.83 11 0.06 0 
Springer spaniel 2 0.53, 2.19 17.2, 19.8 0.02, 0.36 0, 0.05 
Springer spaniel X 
German shepherd 
dog 1 0.51 20.4 0.06 0 
Staffordshire bull 
terrier 
12  
(5F, 7M) 
2.33  
(0.57-
5.09) 
18  
(13.5-
20.8) 
0.14 
(0.01-1.73) 
0.08  
(0-0.678) 
Staffordshire bull 
terrier X Lurcher 2 2.84, 2.84 19.9, 27.5 0.45, 1.73 0.13, 0.15 
Yorkshire terrier 2 4.40, 7.04 6.6, 7.3 0.81, 13.80 0.19, 0.87 
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Table 5-2 Dog breeds in the study at time point 2 with associated variables 
Where more than two dogs of a breed are present, the range of values and median are given. 
Breed Number Age Weight Nicotine Cotinine 
Basset hound 1 1.68 21.7 1.94 0.28 
Bearded collie 1 3.42 25.7 0.10 0 
Border collie 4 
1.72  
(1.67-2.10) 
18.4  
(15.6-22.9) 
0.13  
(0.01-0.36) 
0.10 
(0-0.42) 
Border terrier X 
Pug 1 1.66 12.2 0.15 0.05 
Cavalier King 
Charles spaniel 2 1.73, 1.86 9.5, 11.6 9.62,12.59 0.35, 0.48 
Cocker spaniel 1 1.59 12.3 0.02 0 
Collie X Labrador 
retriever 1 1.56 21 0.97 0.20 
German shepherd 
dog X collie 1 2.46 24.9 0.01 0 
German 
shorthaired 
pointer 1 7.59 31.8 0.02 0 
Jack Russell 
terrier 1 1.71 
 
0.03 0 
Miniature 
schnauzer 1 7.25 11 0.01 0 
Patterdale terrier 1 6.24 15.4 0.01 0 
Patterdale terrier 
X Lakeland terrier 1 1.52 15.5 0.33 0 
Pomeranian X 
Border terrier 1 1.64 6.5 0.04 0 
Retriever X 
Rottweiler/Bull 
mastiff 1 1.54 32.3 0.06 0 
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Springer spaniel 2 1.40, 3.24 23.3, 26.9 0.01, 0.20 0, 0.21 
Staffordshire bull 
terrier 2 (1M, 1F) 1.40, 5.73 16.5, 17.8 0.02, 0.04 0, 0 
Staffordshire bull 
terrier X Lurcher 1 3.83 36.2 1.31 0.71 
Yorkshire terrier 1 5.27 7.2 0.09 0.08 
 
 
Table 5-3 Dogs in the study at time point 1 arranged into four breed groups 
With median and ranges of variables 
Breed group Number Age Weight Nicotine Cotinine 
Collie/CollieX 7 
0.65  
(0.47-2.33) 
18.4  
(13.1-24) 
0.14  
(0.01-1.79) 
0.01  
(0-0.24) 
Spaniel/SpanielX 6 
0.58  
(0.51-2.19) 
13.9  
(6.3-20.4) 
0.21  
(0.02-5.93) 
0.04  
(0-0.62) 
Terrier/TerrierX 21 
2.57  
(0.51-7.04) 
15  
(5.1-27.5) 
0.29  
(0.01-13.79) 
0.07  
(0-0.87) 
Other 8 
1.73  
(0.46-6.58) 
17.7  
(9.1-44.2) 
0.09  
(0.01-2.44) 
0.02  
(0-0.14) 
 
 
Table 5-4 Dogs in the study at time point 2 arranged into four breed groups 
with median and ranges of variables 
Breed group Number Age Weight Nicotine Cotinine 
Collie/CollieX 7 
1.72  
(1.56-3.42) 
21.0  
(15.6-25.7) 
0.01 
(0.01-0.97) 0 (0-0.20) 
Spaniel/SpanielX 5 
1.73  
(1.40-3.24) 
12.3  
(9.5-26.9) 
0.20  
(0.01-12.59) 
0.21  
(0-0.48) 
Terrier/TerrierX 9 
1.71  
(1.40-6.24) 
15.4  
(6.4-36.2) 
0.04  
(0.01-1.31) 0 (0-0.71) 
Other 4 
4.46  
(1.54-7.59) 
26.8  
(11-32.3) 
0.04  
(0.01-1.94) 0 (0-0.28) 
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 Tissue synchrony 
Relative telomere length (RTL) was measured using qPCR in leukocytes and buccal 
samples from time points 1 and 2, as well as cremaster muscle, epididymis, vas 
deferens and uterus samples.  As there were only five females, uterus RTLs were 
not used in further analyses.   
 
 
RTL measurements greater or less than two standard deviations away from the 
mean for each tissue across the population were deemed outliers and were 
excluded.  Of note of these exclusions were all measurements for the miniature 
schnauzer and a Border collie, aged 7 months at time point 1.  The CT values for 
the HBD PCRs for the Border collie were approximately four cycles higher than the 
average value for all dogs, resulting in very high RTL values for this dog.  In 
addition, DNA yielded from 5 of the buccal swabs was of insufficient quantity and 
quality to use for qPCR analysis.  After applying the exclusions, 40 leukocyte RTLs 
from time point 1 (LRTL1), ranging in value from 0.40 to 2.72, 23 leukocyte RTLs 
from time point 2 (LRTL2), ranging from 0.35 to 3.62, 39 buccal RTLs at time point 
1 (BRTL1), ranging from 0.23 to 4.89, and 19 from time point 2 (BRTL2), with 
values from 0.48 to 6.10, remained for analysis.  Due to the samples with 
insufficient DNA and RTL values outside of the accepted range, there were only 18 
individuals with longitudinal buccal RTL measurements (measurements at both 
time points).  35 cremaster muscle RTLs (CMRTL) (ranging 0.38 to 4.75), 33 
epididymis RTLs (ERTL) (0.47 to 5.24) and 34 vas deferens RTLs (VDRTL) (0.31 to 
4.29) were available for analysis.  7 dogs had LRTL1 values which were longer than 
their CMRTL.  In addition, 6 dogs had a longer LRTL2 than CMRTL, with 4 of these 
dogs also having longer LRTL1 than CMRTL too.  8 dogs had longer LRTL2 than 
LRTL1.  One dog had a smaller percentage change than the inter-assay variation 
(i.e. less than 3.64%), and thus was labelled as a “maintainer”.  BRTL2 was longer 
than BRTL1 in 11 out of the 18 dogs who had valid measures at both time points.   
 
 
Figures 5.1 and 5.2 show the RTL measurements in tissues used for analyses.  
Wilcoxon rank sum tests were performed to look for pairwise differences between 
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RTLs in tissues.  CMRTLs were significantly longer than LRTL1s (p<0.001), LRTL2s 
(p<0.001) and BRTL1s (p=0.03), but not BRTL2s (p=0.23).  Likewise, ERTLs were 
significantly longer than LRTL1s (p=0.006) and LRTL2s (p=0.003) but not BRTL1s 
(p=0.17) or BRTL2s (p=0.87).  VDRTLS were not significantly different from LRTL1s 
(p=0.20), LRTL2s (p=0.11), BRTL1s (p=0.66) or BRTL2s (p=0.68).  There were no 
significant differences between LRTL1s and LRTL2s (p=0.32), BRTL1s and BRTL2s 
(p=0.35) or LRTL1s and BRTL1s (p=0.49), but BRTL2s were significantly longer than 
LRTL2s (p=0.02).  There were no significant differences between VDRTLs, CMRTLs 
and ERTLs (p>0.05 for all pairwise tests). 
 
 
Following Shapiro-Wilk tests, LRTL1, LRTL2, BRTL1, BRTL2, ERTL and VDRTL values 
were log transformed to normalise their distributions.  However, this resulted in 
negative values and so non-transformed values were used when examining the 
difference in RTL between tissues.   
 
 
To investigate if telomere lengths were well synchronised within individuals, 
pairwise correlation tests using Pearson’s product moment correlation coefficient 
were performed between tissues (Table 5-5).  Significant positive correlations only 
existed between ln(LRTL1) and ln(BRTL1) (p<0.001), and ln(VDRTL) and ln(ERTL) 
(p=0.047).  The correlations between LRTL1 and LRTL2 (p=0.36) and BRTL1 and 
BRTL2 (p=0.67) were not statistically significant (Figure 5.3 and Figure 5.4). 
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Table 5-5 Correlation coefficients between different tissue types 
* indicates p<0.05, ** p<0.01, ***p<0.001 
ln(LRTL2) 0.20      
ln(BRTL1) 0.53*** 0.32     
ln(BRTL2) 0.43 0.04 0.11    
CMRTL 0.14 0.09 0.19 0.30   
ln(VDRTL) 0.04 0.14 0.16 -0.21 0.19  
ln(ERTL) 0.08 0.04 0.30 0.15 0.23 0.35* 
 ln(LRTL1) ln(LRTL2) ln(BRTL1) ln 
(BRTL2) 
CMRTL ln 
(VDRTL) 
 
 
Figure 5.5 shows ladder plots of paired measures in individuals of CMRTL and LRTL1 
(A), LRTL1 and LRTL2 (B) and BRTL1 and BRTL2 (C).  The plots demonstrate that 
individuals with the longest RTLs at time point 1 or longest CMRTLs do not 
necessarily maintain their rank at time point 2 or between tissues.   
 
 
It was next considered whether the difference in RTL measurements at time points 
1 and 2 were dependent on the baseline measure at time point 1.  The linear 
model of the difference between LRTL1 and LRTL2 to LRTL1 was statistically 
significant (F=9.20, R2=0.29, p=0.006), indicating that the individuals with longer 
LRTL1 had increased attrition between the two time points.  However, it has been 
hypothesised that this observation may be due to regression to the mean.  
Therefore, the difference in RTL between the time points was corrected for this 
effect.  The linear model was still statistically significant, although the 
relationship was weaker (Figure 5.6A, F=7.28, R2=0.25, p=0.01).  The process was 
repeated with the BRTL measurements from the two time points.  Without 
correction for regression to the mean, the linear model of BRTL1-BRTL2 to BRTL1 
was statistically significant (F=9.32, R2=0.37, p=0.008), with again those with 
longer BRTL1 having a greater degree of telomere length loss by time point 2.  
After incorporating the regression to the mean correction, the linear model was 
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still statistically significant, although again the relationship was weaker (F=5.38, 
R2=0.24, p=0.03, Figure 5.6B). 
 
 
 
Figure 5.1 Relative telomere length in tissues at time point 1 
Relative telomere lengths in leukocytes at baseline (LRTL1), buccal cells at baseline (BRTL1), 
vas deferens (VDRTL), epididymis (ERTL) and cremaster muscle (CMRTL).  Significant 
pairwise differences identified using Wilcoxon rank sum tests are indicated by *=p<0.05, 
**=p<0.01 or ***=p<0.001  
Chapter 5  240 
 
 
 
 
Figure 5.2 Relative telomere lengths in leukocyte and buccal samples 
Relative telomere lengths in leukocytes at time point 1 (LRTL1) and 2 (LRTL2), and in buccal 
cells at time point 1 (BRTL1) and 2 (BRTL2).  Significant pairwise differences identified using 
Wilcoxon rank sum tests are indicated by *=p<0.05, **=p<0.01 or ***=p<0.001  
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Figure 5.3 Scatterplots of relative telomere lengths in pairs of tissues 
Scatterplots with regression lines of natural log of leukocyte RTL and natural log of buccal 
RTL in individuals at time point 1 (A) (p<0.001); natural log of leukocyte RTL and natural log of 
buccal RTL in individuals at time point 2 (B) (p=0.87); natural log of leukocyte RTL in 
individuals at time point 1 and cremaster muscle RTL (C) (p=0.41) 
 
  
A 
B 
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Figure 5.4 Relative telomere lengths within dogs at both time points 
Scatterplots with regression line of natural log of leukocyte RTL in individuals at both time 
points (A) (p=0.36) and natural log of buccal RTL at both time points (B) (p=0.67). 
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Figure 5.5 Ladder plots of pairs of samples within individuals 
Ladder plots displaying pairwise values within individuals of cremaster muscle RTL and 
leukocyte RTL at time point 1 (A); leukocyte RTL at time points 1 and 2 (B); buccal RTL at time 
points 1 and 2 (C) 
A 
B 
C 
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Figure 5.6 Scatterplots of the change in telomere length by the baseline telomere length 
Scatterplots of the change in LRTL and BRTL between the two times point and baseline LRTL 
(A) and baseline BRTL (B). The red points with blue regression lines correspond to the original 
data, and the green points with the gold lines show the data corrected for the regression to the 
mean effect 
         𝑦 = 0.76𝑥 
         𝑦 = 0.24𝑥 
         𝑦 = 1.78𝑥 − 0.96 
         𝑦 = 0.13𝑥 
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 Age 
An aim of this chapter was to investigate which tissue or tissue combination out of 
those available was the most reflective of the age of the dogs.  After log 
transforming age to improve model residuals, age was linearly regressed to each 
tissue or tissue combination.  Combinations with CMRTL, ERTL or VDRTL using 
either leukocyte or buccal telomere lengths were used to check which of these 
pairs of telomere lengths could potentially be a biomarker for age.  Neither of the 
leukocyte telomere measurement sets on their own were significantly related to 
age (LRTL1, F=0.73(1,38), R2=0.02, p=0.40; LRTL2, F=2.02(1,22), R2=0.08, p=0.17, 
Figures 5.7A&B).  Buccal RTLs at time point 1 were not significantly regressed to 
age (F=0.05(1,37), R2=0.001, p=0.82, Figure 5.7C) however, at time point 2, buccal 
RTLs significantly increased with age (F=9.37(1,18), R2=0.34, p=0.007, Figure 5.7D).  
Although, when any of a number of variables including, for example, weight, or 
height, were included in the model the relationship between age and BRTL2 was 
no longer significant.  There was no significant relationship between the change in 
leukocyte RTL or buccal RTL between the two time points and age (LRTL1-LRTL2, 
p=0.15; BRTL1-BRTL2, p=0.71) (Figure 5.8).  Cremaster muscle RTLs, vas deferens 
RTLs and epididymis RTLs did not significantly change with age (p=0.36, p=0.15 
and p=0.32, respectively; Figure 5.9).   
 
 
Next, differences between pairs of tissue types were considered as potential age 
markers.  The differences between LRTL1 and CMRTL, LRTL1 and ERTL, and LRTL1 
and VDRTL were not significantly related to dog age (p=0.36, p=0.19 and p=0.23, 
respectively; Figure 5.10).  Likewise, the difference between LRTL2 and VDRTL 
was not significantly associated with dog age (p=0.28).  However, the linear 
models of dog age to the differences between LRTL2 and CMRTL (F=16.94(1,21), 
R2=0.45, p=0.0005) and LRTL2 and ERTL (F=5.37(1,20), R2=0.21, p=0.03) were 
statistically significant (Figure 5.11).    The differences between BRTL1 and 
CMRTL, BRTL1 and ERTL, BRTL1 and VDRTL, BRTL2 and ERTL, and BRTL2 and 
VDRTL were not significantly associated with dog age (p>0.1 for all).  As models 
with better fit were being found using LRTL with other tissues than buccal 
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telomere length with other tissues, buccal telomere length was only used as a 
single tissue moving forward. 
 
 
The rate of change between tissues and LRTL1 by age were also examined.  The 
linear model of age to the change between CMRTL and LRTL1 per month was 
statistically significant (AIC=−35.48, p=0.02), with older dogs having a slower rate 
of change (Figure 5.12A).  In addition, the change between ERTL and LRTL1 per 
month of life also had a significant relationship with dog age (AIC=−51.93, p=0.01) 
(Figure 5.12B).  This was not the case, however, when vas deferens was used as 
the comparative tissue (AIC=−35.04, p=0.10).  None of the age to rates of change 
linear models for time point 2 were statistically significant: CMRTL minus LRTL2 
per month (p=0.13), VDRTL minus LRTL2 per month (p=0.22) and ERTL minus LRTL2 
per month (p=0.28).   
 
 
To see if dog age as a proportion of their life expectancy (LE) was related to 
telomere length, age was divided by breed life expectancy and tested for 
association with telomere length.  Age divided by LE was log transformed to 
improve model residuals.  There was a positive trend between LRTL1 and life 
expectancy corrected age (F=3.54(1,28), R2=0.11, p=0.07, Figure 5.13A).  The linear 
model of LE adjusted age to BRTL1 was statistically significant, with a negative 
relationship observed (F=6.13(1,28), R2=0.18, p=0.02, Figure 5.13B).  The linear 
models of age to LRTL2 and BRTL2 were not statistically significant (p=0.35, p=0.09 
respectively).  Likewise, there was no significant relationship between CMRTL and 
LE adjusted age (p=0.82).  The linear models of LE adjusted age to RTL 
(F=27.37(1,24), R2=0.53, p<0.001, Figure 5.13C) and age to VDRTL (F=20.08(1,24), 
R2=0.46, p<0.001, Figure 5.13D) were both statistically significant.  The linear 
model of LE adjusted age to the change in LRTL between time points 1 and 2 was 
not statistically significant (F<0.001(1,14), R2<0.001, p=0.99).  The change in buccal 
RTL was also not related to LE adjusted age (F=0.11(1,9), R2=0.01, p=0.75). 
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Interestingly, the differences between LRTL1 and CMRTL, and LRTL2 and CMRTL 
significantly decreased with LE adjusted age (AIC=80.03, p=0.003 and F=5.95(1,13), 
R2=0.31, p=0.03; Figure 5.14A/B).  The regression lines in these plots have a 
positive beta coefficient as the difference between the tissues approaches zero 
with increasing age.  In addition, the rate of change per month between CMRTL 
and LRTL1, and CMRTL and LRTL2 decreased with increasing LE adjusted age 
(AIC=−32.0, p=0.002 and F=9.98(1,13), R2=0.43, p=0.008; Figure 5.14C/D).  Likewise, 
the differences between LRTL1 and VDRTL, and LRTL2 and VDRTL decreased with 
LE adjusted age (F=12.52(1,24), R2=0.34, p=0.002 and F=7.80(1,13), R2=0.38, p=0.02, 
respectively. Figure 5.17A/B).  In addition, as with CMRTL, the rate of change 
between VDRTL and both LRTL1 and LRTL2 decreased with LE adjusted age 
(AIC=−27.03, p=0.001 and AIC=−31.81, p=0.02, respectively.  Figure 5.17C/D).  
These findings were replicated in the differences between LRTL and ERTL, 
however at time point 2 there were non-statistically significant trends (LRTL1 
minus ERTL: F=11.4(1,24), R2=0.32, p=0.002; LRTL2 minus ERTL: F=3.80(1,13), R2=0.23, 
p=0.07; ERTL minus LRTL1 per month AIC=−51.31, p<0.001; ERTL minus LRTL2 per 
month F=4.44(1,13), R2=0.25, p=0.06.  Figure 5.16). 
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Figure 5.7 Scatterplots of tissue telomere lengths by age 
Scatterplots with regression line of natural log of leukocyte RTL and natural log of age at time 
point 1(A) (R2=0.02, p=0.40); natural log of leukocyte RTL and natural log of age at time point 2 
(B) (R2=0.08, p=0.17); natural log of buccal RTL and natural log of age at time point 1 (C) 
(R2=0.001, p=0.82); natural log of buccal RTL and natural log of age at time point 2(D) (R2=0.34, 
p=0.007). 
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Figure 5.8 Scatterplots of change in telomere length between the time points by age 
Scatterplots with regression line of leukocyte RTL 1 minus leukocyte RTL 2 and natural log of 
age at time point 2 (A) (R2=0.09, p=0.15); change in buccal RTL between time points 1 and 2 
and natural log of age at time point 2 (B) (R2=0.008, p=0.71) 
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Figure 5.9 Scatterplots of CMRTL, VDRTL and ERTL by age 
Scatterplots with regression line of cremaster muscle RTL and natural log of age at time point 
1 (A) (R2=0.03, p=0.36); natural log of epididymis RTL and natural log of age at time point 1 (B) 
(R2=0.02, p=0.49) and natural log of vas deferens RTL and natural log of age at time point 1 (C) 
(R2=0.03, p=0.32). 
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Figure 5.10 Difference between tissue telomere lengths and age 1 
Scatterplots with regression line of difference in leukocyte RTL and cremaster muscle RTL and 
natural log of age at time point 1 (A) (AIC=116.59, p=0.36); difference between leukocyte RTL 
and epididymis RTL and natural log of age at time point 1 (B) (R2=0.06, p=0.19); difference 
between leukocyte RTL and vas deferens RTL and natural log of age at time point 1 (C) 
(R2=0.04, p=0.23) 
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Figure 5.11 Differences between tissue telomere lengths and age 2 
Scatterplots with regression line of difference in leukocyte RTL and cremaster muscle RTL and 
natural log of age at time point 2 (A) (R2=0.45, p<0.001); difference between leukocyte RTL and 
epididymis RTL and natural log of age at time point 2 (B) (R2=0.21, p=0.03); difference between 
leukocyte RTL and vas deferens RTL and natural log of age at time point 2 (C) (R2=0.06, 
p=0.28) 
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Figure 5.12 Change between telomere lengths over life by age 1 
Scatterplots with regression line of rate of change between leukocyte RTL and cremaster 
muscle RTL per month and natural log of age at time point 1 (A) (AIC=−35.48, p=0.02); and rate 
of change between leukocyte RTL and epididymis RTL and natural log of age at time point 1 
(B) (AIC=−51.93, p=0.01) 
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Figure 5.13 Telomere lengths by life expectancy adjusted age 
Scatterplots with regression line of natural log of leukocyte RTL and natural log of age divided 
by breed life expectancy at time point 1(A) (R2=0.11, p=0.07); natural log of buccal RTL and 
natural log of age divided by breed life expectancy at time point 1 (B) (R2=0.18, p=0.02); natural 
log of epididymis RTL and natural log of age divided by breed life expectancy (C) (R2=0.53, 
p<0.001); natural log of vas deferens RTL and natural log of age divided by breed life 
expectancy (D) (R2=0.46, p<0.001). 
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Figure 5.14 Differences between tissue telomere lengths by life expectancy adjusted age 1 
Scatterplots with regression line of difference in leukocyte RTL and cremaster muscle RTL and 
natural log of age divided by breed life expectancy at time point 1 (A) (AIC=80.03, p=0.003); 
difference between leukocyte RTL and cremaster muscle RTL and natural log of age divided by 
breed life expectancy at time point 2 (B) (R2=0.31, p=0.03); rate of change between leukocyte 
RTL and cremaster muscle RTL per month and natural log of age divided by breed life 
expectancy at time point 1 (C) (AIC=−32.0, p=0.002); and rate of change between leukocyte RTL 
and cremaster muscle RTL and natural log of age divided by breed life expectancy at time 
point 2 (B) (R2=0.43, p=0.008) 
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Figure 5.15 Differences between tissue telomere lengths by life expectancy adjusted age 2 
Scatterplots with regression line of difference in leukocyte RTL and epididymis RTL and 
natural log of age divided by breed life expectancy at time point 1 (A) (R2=0.32, p=0.002); 
difference between leukocyte RTL and epididymis RTL and natural log of age divided by breed 
life expectancy at time point 2 (B) (R2=0.23, p=0.07); rate of change between leukocyte RTL and 
epididymis RTL per month and natural log of age divided by breed life expectancy at time 
point 1 (C) (AIC=−51.31, p<0.001); and rate of change between leukocyte RTL and epididymis 
RTL and natural log of age divided by breed life expectancy at time point 2 (B) (R2=0.25, 
p=0.06) 
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Figure 5.16 Differences between tissue telomere lengths by life expectancy adjusted age 3 
Scatterplots with regression line of difference in leukocyte RTL and vas deferens RTL and 
natural log of age divided by breed life expectancy at time point 1 (A) (R2=0.34, p=0.002); 
difference between leukocyte RTL and vas deferens RTL and natural log of age divided by 
breed life expectancy at time point 2 (B) (R2=0.38, p=0.02); rate of change between leukocyte 
RTL and vas deferens RTL per month and natural log of age divided by breed life expectancy 
at time point 1 (C) (AIC=−27.03, p=0.001); and rate of change between leukocyte RTL and vas 
deferens RTL and natural log of age divided by breed life expectancy at time point 2 (B) 
(AIC=−31.81, p=0.02) 
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 Nicotine 
Hair nicotine and cotinine concentrations (HNC and HCC) were used as objective 
measures of ETS exposure.  These markers were examined against telomere length 
in each tissue to see if there was an association present.  HNC was log transformed 
and the square root of HCC taken as per Chapter 3 to improve model residuals.   
 
 
A significant linear model was found between LRTL1 and HNC1 (F=6.25(1.38), 
R2=0.14, p=0.02), with higher nicotine exposure being associated with shorter 
LRTL.  There was also a negative relationship between leukocyte RTL and HNC at 
time point 2, however the linear model was not statistically significant 
(F=4.21(1,22), R2=0.16, p=0.05).   There was a negative, significant relationship 
between buccal RTL and HNC at time point 1 (F=8.16(1,37) R2=0.18, p=0.007) and 
also at time point 2 (F=9.62(1,18), R2=0.35, p=0.006) (Figure 5.17).  The change in 
leukocyte RTL and buccal RTL between the two time points did not depend on 
HNC2 (LRTL1-LRTL2, p=0.38; BRTL1-BRTL2, p=0.98; Figure 5.18).   
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Figure 5.17 Telomere lengths by ETS biomarker concentrations 1 
Scatterplots with regression line of natural log of leukocyte RTL and natural log of hair 
nicotine at time point 1(A) (R2=0.14, p=0.02); natural log of leukocyte RTL and natural log of 
hair nicotine at time point 2 (B) (R2=0.16, p=0.05); natural log of buccal RTL and natural log of 
hair nicotine at time point 1 (C) (R2=0.18, p=0.007); and natural log of buccal RTL and natural 
log of hair nicotine at time point 2(D) (R2=0.35, p=0.006) 
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Figure 5.18 Changes in telomere lengths between study time points and HNC 
Scatterplots with regression line of leukocyte RTL 1 minus leukocyte RTL 2 and natural log of 
hair nicotine at time point 2 (A) (R2=0.03, p=0.38); change in buccal RTL between time points 1 
and 2 and natural log of hair nicotine at time point 2 (B) (R2<0.001, p=0.98) 
 
Cremaster muscle RTL and epididymis RTL were not significantly related to HNC1 
(p=0.94 and p=0.66, respectively).  However, vas deferens RTL significantly 
increased with HNC1 (F=9.92(1,32), R2=0.24, p=0.004) (Figure 5.19). Interestingly, 
when LE adjusted age was added into the linear model of HNC1 to VDRTL, both 
explanatory variables remained significant, with the beta coefficient for HNC1 
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remaining positive and the beta coefficient for LE adjusted age remaining negative 
(F=16.86(2,23), R2=0.59, p<0.001). 
 
 
 
Figure 5.19 Telomere lengths by ETS biomarker concentrations 2 
Scatterplots with regression line of cremaster muscle RTL and natural log of hair nicotine at 
time point 1 (A) (R2=0.0002, p=0.94); natural log of epididymis RTL and natural log of hair 
nicotine at time point 1 (B) (R2=0.006, p=0.66); and natural log of vas deferens RTL and natural 
log of hair nicotine at time point 1 (C) (R2=0.24, p=0.004). 
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As well as CMRTL and ERTL as a lone variable not being significantly related to 
HNC1, the linear models of HNC1 to the differences between LRTL1 and CMRTL or 
LRTL1 and ERTL were not significant (p=0.82, p=0.80, respectively, Figure 5.20).  
The linear model of HNC1 to the difference between LRTL1 and VDRTL was 
significant (F=10.3(1,32), R2=0.24, p=0.003).  There were also no significant linear 
models between HNC2 and the differences between LRTL2 and CMRTL (p=0.51), 
and LRTL2 and ERTL (p=0.77).  A downward, non-significant, trend existed 
between the difference between LRTL2 and VDRTL with HNC2 (p=0.05, Figure 
5.20D).   
 
 
The rate of change between tissues per month was also examined to see if it 
changed with HNC.  CMRTL minus LRTL1 per month, CMRTL minus LRTL2 per 
month, VDRTL minus LRTL1 per month, VDRTL minus LRTL2 per month, ERTL minus 
LRTL1 per month and ERTL minus were LRTL2 all did not have statistically 
significant linear models with HNC (p=0.96, p=0.94, p=0.07, p=0.08, p=0.73 and 
p=0.48, respectively).   
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Figure 5.20 Differences in tissue telomere lengths and hair nicotine concentration 
Scatterplots with regression line of difference in leukocyte RTL and cremaster muscle RTL and 
natural log of hair nicotine at time point 1 (A) (AIC=116.83, p=0.82); difference in leukocyte RTL 
and epididymis RTL and natural log of hair nicotine at time point 1 (B) (R2=0.002, p=0.80); 
difference in leukocyte RTL and vas deferens RTL and natural log of hair nicotine at time point 
1 (C) (R2=0.24, p=0.003); and difference between leukocyte RTL at time point 2 and vas 
deferens RTL and natural log of hair nicotine at time point 2 (D) (R2=0.18, p=0.05) 
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 Cotinine 
LRTL1, LRTL2, BRTL1 and BRTL2 were not significantly related to HCC (p=0.33, 
p=0.08, p=0.42 and p=0.66, respectively, figure 5.21).  As with the HNC2, linear 
models of HCC2 and the changes in leukocyte and buccal RTL between the two 
time points were not significant (LRTL1-LRTL2, p=0.20; BRTL1-BRTL2, p=0.35).   
 
 
 
Figure 5.21 Telomere lengths by hair cotinine concentration 1 
Scatterplots with regression line of natural log of leukocyte RTL and square root of hair 
cotinine at time point 1 (A) (R2=0.03, p=0.33); natural log of leukocyte RTL and square root of 
hair cotinine at time point 2 (B) (R2=0.14, p=0.08); natural log of buccal RTL and square root of 
hair cotinine at time point 1 (C) (R2=0.02, p=0.42); and natural log of buccal RTL and square 
root of hair cotinine at time point 2 (D) (R2=0.01, p=0.66) 
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Figure 5.22 Telomere lengths by hair cotinine concentration 2 
Scatterplots with regression line of cremaster muscle RTL and square root of hair cotinine at 
time point 1 (A) (R2=0.02, p=0.47); natural log of epididymis RTL and square root of hair 
cotinine at time point 1 (B) (R2=0.03, p=0.31); and natural log of vas deferens RTL and square 
root of hair cotinine at time point 1 (C) (R2=0.37, p<0.001) 
 
Linear models of HCC1 to CMRTL (p=0.47) or ERTL (p=0.31) were not significant.  
However, the linear model was statistically significant between VDRTL and HCC1 
(F=19.18(1,33), R2=0.37, p<0.001) (Figure 5.22).  Similarly, the linear models of 
HCC1 to the differences between LRTL1 and CMRTL (p=0.77) and LRTL1 and ERTL 
(p=0.98) were not significant, but HCC1 was significantly related to LRTL1 minus 
VDRTL (F=15.92(1,33), R2=0.33, p<0.001) (Figure 5.23).  As with at time point 1, the 
linear models of HCC2 to the differences between LRTL2 and CMRTL (p=0.48) and 
LRTL2 and ERTL (p=0.77) were not significant, but there was a significant linear 
model between LRTL2 and VDRTL (F=20.03(1,20), R2=0.50, p<0.001, Figure 5.23D).   
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Figure 5.23 Differences in telomere lengths and hair cotinine concentration 
Scatter plots with regression line of the difference in leukocyte RTL and cremaster muscle RTL 
and square root of hair cotinine at time point 1 (A) (AIC=116.8, p=0.77); difference in leukocyte 
RTL and epididymis RTL and square root of hair cotinine at time point 1 (B) (R2<0.001, p=0.98); 
difference in leukocyte RTL and vas deferens RTL and square root of hair cotinine at time 
point 1 (C) (R2=0.33, p=0.0003); difference in leukocyte RTL and vas deferens RTL and square 
root of hair cotinine at time point 2 (D) (R2=0.50, p=0.0002) 
 
HCC was not significantly modelled to the rates of change between CMRTL and 
LRTL1 (AIC=−30.4, p=0.54), ERTL and LRTL1 (p=0.94) or ERTL and LRTL2 per month 
(p=0.06).  The rates of change between CMRTL and LRTL2 (F=6.44(1,21), R2=0.23, 
p=0.02), VDRTL and LRTL1 (AIC=−37.24, p=0.006) and VDRTL and LRTL2 
(AIC=−59.98, p<0.001) per month were significantly modelled with HCC.   
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 Additional analyses 
While the main focus of this chapter was on telomere dynamics with age and ETS 
exposure, additional analyses were carried out to investigate factors in the dogs 
associated with telomere length, both to inform future studies and to see if there 
may be interactions occurring which could impact the relationship between 
telomere length and ETS.  These analyses are in Appendix 10. 
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 Discussion 
 Tissue synchronicity within individuals 
The first area of interest in this chapter was the degree of synchronicity in 
telomere length between tissues within individuals.  There were few significant 
correlations between tissues.  Interestingly, there was a positive correlation 
between LRTL1 and BRTL1, but no significant relationship between LRTL2 and 
BRTL2.  This may be explained by there being fewer dogs at time point 2, or due to 
the factors influencing buccal telomere length which will be discussed later.  
  
 
Several studies have found that telomere length in various tissues are highly 
correlated within individuals.  TRFs of fat, muscle and leukocytes were shown to 
be highly correlated within individual dogs (Benetos et al., 2011).  Significant 
intra-individual correlations in telomere length in different tissues were also found 
in zebra finches (Reichert et al., 2013), rhesus monkeys (Smith Jr et al., 2011) and 
macaques (Gardner et al., 2007).  Intra-individual telomere length correlations 
have also been observed in newborn (Okuda et al., 2002; Kimura, Gazitt, et al., 
2010) and adult humans (Granick et al., 2011; Daniali et al., 2013).  One study was 
found with few correlations between telomere length in tissues obtained from 
human cadavers (Dlouha et al., 2014), but this study was certainly in the minority 
in terms of intra-individual observations.  It is unclear why there were few 
correlations between tissues found in this study.  This may have been due to some 
of the dogs growing and undergoing rapid telomere length changes.  By adding in 
an interaction with biochemical or haematological measures to account for some 
of the physiological changes which may have been occurring, there were improved 
relationships seen between the tissues.  For example, a linear model of LRTL1 and 
albumin:globulin ratio to CMRTL was highly significant (F=54.38(3,32), R2=0.84, 
p<0.001).  When LRTL2 and the change in monocyte count between the two time 
points was regressed to LRTL1, the relationship was significant (F=5.44(2,21), 
R2=0.34, p=0.01).  Growth may have also accounted for, in part, the lack of 
consistency in individuals rank position of LRTL between the two time points.  
Benetos et al. (2013) found that in 1156 adult individuals with multiple LTL 
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measurements, 94.1% kept their decile rank or only changed one place.  Unlike 
here, only fully developed adults were included in their study.  Their observations 
were also on a much higher number of individuals. 
 
 
 Longitudinal telomere length measurements 
Neither LRTL1 and LRTL2 or BRTL1 and BRTL2 were significantly correlated, with 
individuals not retaining their rank position within the group for either tissue, i.e. 
those with the longest LRTL1 or BRTL1 did not necessarily have the longest LRTL2 
or BRTL2.  8 (32%) individuals had longer LRTL2 than LRTL1.  Telomere lengthening 
would not have been expected based on telomere physiology.  However, this study 
is not alone in having this occur in longitudinal telomere length studies.  The rate 
of lengthening was similar to that in Nordfjäll et al. 2009, who found that in 
measures 10 years apart, one third of LTLs were either stable or increased.  
Steenstrup et al. (2013) suggested that leukocyte telomere lengthening is an 
artefact and due to factors such as short follow up periods or not using high 
precision methods of measurement.  It was found that there was a difference in 
haematological measures between shorteners and lengtheners which may have 
reflected some underlying physiology.  It was difficult to schedule time points 
exactly one year apart for logistical reasons.  5 dogs attended their time point 2 
appointments a month early; 4 of these dogs were in the lengthener group.  While 
this is not a huge difference from a year, Rehkopf et al. (2014) noted seasonal 
variation in LTL in humans.  There was not enough of a spread over the year to 
estimate if having samples taken in different months would have had such an 
impact.  Only one study could be found which examined the link between clinical 
pathology results and telomere length elongators (Kato et al., 2016).  They found 
that in 59 dialysis patients, telomere length elongators had a higher baseline white 
cell count.  This finding was not replicated here, but change in monocyte count 
was.  Interestingly, there were a few health problems reported in some of the 
elongators.  One of the dogs had received steroid treatment.  Another dog had 
received behavioural treatment for an aggression problem.  Given the differences 
in haematology measures between the two groups, the slide reports were 
reviewed.  Polychromasia was present in 3 of the dogs in the L group.  The 
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combination of the L group having higher MCV and MCHC, as well as polychromasia 
on some of the dogs’ blood films, implies that these dogs may have had a greater 
proportion of reticulocytes, although not at pathological levels.  It could be 
related to their diet, for example vitamin B12 intake.  Without nutrient analysis of 
the blood, this cannot be confirmed.  Telomerase levels have been linked to diet 
in previous studies.  Higher fat intake has been linked to higher telomerase activity 
in human leukocytes (Daubenmier et al., 2012).  Therefore, a contributing factor 
could be diet.  It may have been worth asking about the diet the dogs were fed in 
the questionnaire, although there would have been a wide variety of brands, 
quantities fed and supplementation with treats. In addition, the dogs were likely 
fed a commercial diet, which is more standard than a human diet.  It is only 
possible to postulate reasons, with the small numbers involved and lack of 
longitudinal canine telomere studies published. 
 
 
The change in LRTL depended on baseline LRTL, with individuals with longer LRTL1 
losing more bases than those with shorter LRTL1, as found in other studies, for 
example Farzaneh-Far et al. 2010 and Weischer et al. 2014.  This remained the 
case after correction for regression to the mean, which Verhulst et al. 2013 also 
found.  Therefore, the dependence of the rate of change on the baseline was only 
in part due to a statistical phenomenon.  This was also the case for buccal cell 
telomere lengths.  In addition, as part of this relationship, the individuals with the 
shortest telomere lengths at the first time point tended to experience lengthening 
between the two time points.  
 
 
 Telomere length relation to age 
The second key area of this chapter was to assess which tissue or combination of 
tissues would best represent age.  Contrary to expectations, the buccal and 
leukocyte telomere length measures did not reduce with age, and in fact the 
buccal telomere measures at time point 2 increased with age.  In addition, after 
correcting for breed life expectancy, there was a trend for leukocyte RTL1 to 
increase with age.  However, the negative relationship expected was found 
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between buccal RTL1 and life expectancy adjusted age.  Part of the reason for the 
lack of age-related changes expected may be partly due to the wide range of 
breeds and crosses, with a corresponding range of life expectancies.  With the 
presence of crossbreeds and less common breeds in the study, such as the 
Patterdale terrier, not all dogs age could be corrected for life expectancy, further 
limiting the number available for statistical analysis.  Issues with life expectancy 
as a measure in dogs were discussed in Chapter 4 discussion.  As well as there only 
being a small number of participants, there was a skew to the younger ages.  
Multiple studies have found that the rate of leukocyte telomere loss is greatest at 
the younger ages of humans, and in one study dogs (Frenck Jr, Blackburn and 
Shannon, 1998; Zeichner et al., 1999; Benetos et al., 2011).  In addition, different 
breeds have different rates of growth (Hawthorne et al., 2004).  Therefore, with 
many the dogs being younger and some still growing, this may be why a linear 
model of age related telomere attrition in leukocytes was not able to be captured.  
In addition, a wide inter-individual variation in LTL has been displayed in several 
previous studies (e.g. Slagboom, Droog and Boomsma, 1994; Factor-Litvak et al., 
2016) and the variation between individuals may have been too great to capture 
underlying age related changes. 
 
 
As a means of attempting to overcome the issue of inter-individual variability in 
LTL, telomere length was also measured in a post mitotic tissue, the cremaster 
muscle.  The cremaster muscle telomere length was meant to represent the 
telomere length at birth, and the difference between the two the loss since birth 
(assuming all tissue telomere lengths correlated well within individuals at birth).  
Vas deferens was also trialled as a comparative tissue, as while smooth muscle is 
capable of undergoing mitosis if damaged, the use of skeletal muscle as an internal 
control has been critiqued and only one study had previously used cremaster 
muscle for this purpose in dogs (Benetos et al., 2011).  Therefore, to test another 
tissue from those available from castration seemed prudent.  For this model of 
telomere length dynamics to work as hypothesised, the telomere length in the 
muscle should not change with time.  The linear models of cremaster muscle 
telomere length to age and life expectancy adjusted age were not significant.  
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However, the linear model of life expectancy adjusted age to vas deferens 
telomere length was highly significant. 
 
 
The pattern of telomere dynamics with age in the epididymis was similar to that of 
the vas deferens, with a significant decrease with life expectancy adjusted age.  It 
was hoped to use the epididymis samples as a proxy for spermatozoa samples due 
to practical issues faced collecting spermatozoa alongside the other samples at the 
point of castration.  Fradiani et al. (2004) demonstrated that, in pigs, spermatozoa 
isolated from the corpus, cauda I, cauda II and ejaculated spermatozoa TRFs were 
similar in size, with testis and caput TRFs slightly longer.  Their sample 
preparation method differed from that here: they released sperm cells from small 
pieces of the tissues with cold PBS and used the solution.  The method used here 
resulted in the inclusion of epidydimal tissue along with any spermatozoa present 
and did not give the result anticipated (that telomere length would increase with 
age due to the nature of telomere length dynamics in sperm), so adopting a 
method such as that used by Fradiani et al may be beneficial in future studies.   
 
 
Cremaster muscle telomere lengths were significantly longer than leukocyte 
telomere lengths at both time points and buccal telomere lengths at time point 1, 
and non-significantly longer than the remaining tissues.  Skeletal muscle having the 
longest telomere length was expected and has been shown in other studies.  
Epidydimal telomere lengths were longer on average than leukocyte telomere 
lengths at both time points, and vas deferens telomere lengths were non-
significantly longer than leukocyte telomere lengths.  High turnover tissues, like 
leukocytes and skin, have been shown to have the shortest telomere lengths (Smith 
Jr et al., 2011; Daniali et al., 2013).  What was unusual here is with increasing life 
expectancy adjusted age, the difference between telomere length in vas deferens 
and epididymis and leukocyte telomere length was approaching zero.  In addition, 
this reduction in difference with increasing adjusted age was also seen between 
cremaster muscle and leukocyte telomere lengths. 
 
Chapter 5  273 
 
 
 
No studies could be found examining age related changes of vas deferens telomere 
length, or epididymis telomere length (except the spermatozoa telomere length 
contained within).  The largest component of both epididymis and vas deferens is 
layers of smooth muscle.  Many smooth muscle telomere length studies examine 
smooth muscle in the context of vascular tissue in the context of atherosclerosis, 
which would not be relevant here.  Various organ telomere lengths have been 
measured in the context of age-related change.  For example, changes in thyroid 
and lung, but not kidney cortex, kidney medulla or testis with age were 
demonstrated in macaques (Gardner et al., 2007); reduction with age was shown in 
liver, renal cortex and spleen, but not cerebral cortex or myocardium in human 
cadavers (Takubo et al., 2002); and percentage of short telomeres was shown to 
increase with age in kidney, liver, pancreas and lung of male and female rats 
(Cherif et al., 2003).  Gastrointestinal telomere length may behave similarly to 
that of vas deferens and epididymis, having also a tube-like structure for the most 
part and the presence of smooth muscle.  A significant reduction in telomere 
length with age was found in duodenum samples, but not stomach, blood or colon 
in a group of human patients undergoing upper or lower GI endoscopy (Craig, 
McKinlay and Vickers, 2003); which is particularly interesting as duodenum would 
be the most comparable to vas deferens out of the four and the relationship with 
age was stronger in duodenal telomere length than blood telomere length.  
Another factor which could be involved in epididymis and vas deferens telomere 
length changes is puberty and hormonal changes.  Interestingly, when 42 pairs of 
epididymes from healthy cats aged 6 months to “7+” years undergoing castration 
were examined, 70% of cats 6 months to 1 year-old displayed epidydimal 
intraepithelial cysts and epithelial hyperplasia.  Other age related changes were 
uncommon, bar increasing thickness of tunica adventitia with age (Elcock and 
Schoning, 1984).  Peri-pubertal changes in dogs in the current study could have 
occurred and potentially cause telomere shortening in the epididymis and vas 
deferens.    
 
 
Cremaster muscle telomere length was found not to significantly change with dogs 
in a previous study (Benetos et al., 2011), which was repeated here.  Telomere 
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length in the various tissues did not shorten at equivalent rate to different tissues 
as found in Daniali et al. (2013), who found that skeletal muscle shortened at a 
similar rate as leukocytes, skin and fat.  Part of the criticism of the thinking that 
telomere length in skeletal muscle does not change with age is that in vivo it is 
part of a dynamic system.  Satellite cells are the proliferative cell type within 
skeletal muscle, and can be activated and proliferate due to a variety of factors, 
including hormone changes and environmental factors.  Satellite cell activation can 
be associated with changes in telomere length (Kadi and Ponsot, 2010).  The fact 
that many of the dogs were peri-pubertal therefore is very interesting given the 
potential hormonal impact on satellite cells.  There are published examples of 
satellite cell induction through testosterone treatment.  Satellite cells in rat 
levator ani muscle were induced by testosterone injection (Joubert and Tobin, 
1995).  In addition, testosterone treatment in elderly men induced satellite cell 
proliferation (Sinha-Hikim et al., 2006).  In addition, skeletal muscle satellite cells 
have also been shown to be reduced in cigarette smoke exposed mice (Jackson et 
al., 2013).  Satellite cell activation is part of the notch pathway, which has been 
shown to be impacted by smoking (e.g. Tilley et al. 2009).  So, while there was not 
a significant relationship between cremaster muscle telomere length and age, 
cremaster muscle telomeres are certainly under the influence of environmental 
and hormonal changes. 
 
 
While the findings regarding single tissue telomere length changes and age were 
not encouraging to use telomere length as a biomarker of age, it was still tested to 
see whether the combination of two tissues better represented age, and if findings 
from previous studies could be replicated.  The differences between leukocyte and 
vas deferens telomere lengths were not significantly modelled to age and the 
difference between leukocyte and epididymis telomere lengths was only modelled 
to age at the second time point.  As previously mentioned, however, for all the life 
expectancy adjusted age to leukocyte minus cremaster muscle, epididymis or vas 
deferens telomere lengths, the regression line approached zero, indicating a 
reduction in difference over time.   
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There was no perfect age reflecting tissue found.  The change between leukocyte 
and cremaster muscle telomere length seemed to reflect age best out of the tissue 
combinations.  Adjusting age for life expectancy improved fit of models but limited 
the dogs which could be included for analysis, given the limited information on 
data on lifespan for some breeds and cross-breeds, and would limit the potential 
for dogs being recruited in future studies if that form of analysis was opted for. 
 
 
 Telomere length association with ETS exposure 
Having not found a change in age with leukocyte telomere length at time points 1 
or 2, there was a significant decline with HNC at time point 1 and a near 
significant decline at time point 2.  Buccal telomere length at time points 1 and 2 
also shortened with increasing HNC.  Correcting for HNC did not improve 
relationships with age.  Contrary to previous studies examining the impact of 
smoking on human telomeres, ETS exposure, as determined by HNC, had a larger 
effect on leukocyte telomere length than age did in these dogs.  HCC was not 
significantly related to the leukocyte or buccal telomere lengths, unlike with HNC.  
Part of the issue was that, unlike with HNC, there were several zero HCC values, 
which limited the linear modelling analysis.  If higher numbers of participants were 
involved, HCC may have been significantly related to the leukocyte and buccal 
telomere lengths. 
 
 
Interestingly, vas deferens telomere length increased with ETS exposure.  There 
have been studies previously where telomere length has increased due to smoking 
(Appendix 7), but the increase here occurred on a background of other tissues 
within the same dogs decreasing with ETS exposure.  A reason may be that 
telomerase in being activated in this tissue as a result of the exposure.  No studies 
could be found regarding telomerase levels in the vas deferens, ETS exposure or 
not.  However, telomerase reverse transcriptase expression was found to decrease 
in the skin of smokers (Lotfi et al., 2014) and the lymphocytes of smokers with 
Crohn’s disease (Getliffe et al., 2005).  It may be that the effect is tissue 
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dependent, the information is too limited to know what is happening throughout 
the body.  This lengthening of telomeres may initially appear attractive, with 
reduced cellular senescence and the opposite of the proposal that smoking 
shortens telomere length.  However, this increase of cell proliferative potential is 
a potential cancer risk.  Telomerase activity has previously been detected in 
canine mammary tumour samples (Yazawa et al., 2001).  It would be interesting to 
see if telomerase activity levels in different tissues throughout the body are 
affected by ETS exposure, and if malignancy development is affected by this. 
 
 
The differences in leukocyte and vas deferens telomere lengths were significantly 
related to markers of ETS exposure, however this was likely due to the large effect 
on vas deferens telomere length rather than the tissue combination being a useful 
model.  The other tissue comparisons were either not related to ETS exposure, or 
required the inclusion of further explanatory variables to be significant.  While 
inclusion of a second tissue telomere length, namely cremaster muscle telomere 
length with leukocyte telomere length may have helped establish an age marker, 
leukocyte and buccal telomere lengths relationships with HNC alone adequately 
displayed the effects of ETS exposure. 
 
 
Buccal telomere length decreased with increasing age at time point 1, yet 
increased with age at time point 2.  Previous findings in chapter 4 indicated that 
entire males had significantly different oral telomere length.  The change in buccal 
telomere length in this chapter also points to the same finding, with more dogs 
experiencing telomere lengthening than shortening between the two time points.  
It appears there may be an effect of testosterone on buccal cell telomere length.  
Perhaps the increase with age after castration is that the remaining testosterone, 
produced by the adrenal gland, decreases with age.  In addition, as shown in 
Chapter 7, the dogs with less testosterone at time point 2 gained more weight.  
This may explain the increasing buccal telomere length with additional weight gain 
model.   
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A highly interesting finding on further analysis was the positive link between 
weight and cremaster muscle telomere length.  In addition, weight was positively 
associated with leukocyte telomere length at time point 1, buccal telomere length 
at time point 1, epididymis telomere length and vas deferens telomere length.  
The differences between leukocyte and cremaster muscle or epididymis telomere 
length were negatively associated with increasing weight.  It appears from the 
information gathered that larger dogs start life with longer telomeres and have a 
faster rate of telomere loss.  Obviously, some dogs were not their ideal weight, 
and where dogs gained weight above that expected as part of normal growth 
between the two time points, the difference between leukocyte and cremaster 
muscle telomere lengths increased.  Height was also positively linked to telomere 
length, but measures of height for breeds were obtained from other sources.  An 
idea for future studies would be to take measurements of height and leg length for 
each dog.  However, with imperfect explanatory variables, a strong relationship 
with cremaster muscle telomere length both weight and height was demonstrated.  
A possible reason for longer CMRTL in larger dogs is a positive relationship between 
telomere length and IGF-1 levels, which has been demonstrated in previous studies 
(e.g. Barbieri et al. 2009; Movérare-Skrtic et al. 2009), with IGF-1 being a key 
determinant of dog size (e.g. Greer et al. 2011; Sutter et al. 2007).  If the general, 
although imperfect, rule of large dogs have shorter life expectancies is applied 
here, the greater rate of loss in larger dogs would be in keeping with other studies 
which have found that telomeres shorten more slowly in long-lived mammals 
(reviewed in Haussmann et al. (2003)).  Previous studies in dog telomeres have not 
commented on the relationship with weight.  The idea of larger dogs having longer 
telomeres initially goes against the idea of smaller animals having longer telomeres 
(Gomes et al., 2011), however mostly this rule is talked about at a species level 
rather than at a breed level.  At time point 2, leukocyte telomere length could be 
significantly modelled to breed life expectancy and vice versa (generalised model 
of LRTL2 to life expectancy, p=0.02).  At time point 1, life expectancy can be 
significantly modelled to leukocyte telomere length, but leukocyte telomere 
length cannot be used to significantly explain life expectancy.  The findings at 
time point 2 are in keeping with those of Fick et al. (2012), who found a highly 
significant linear regression of telomere length to life span. 
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Multiple statistical tests have been performed in this chapter without p value 
correction.  This could have led to many Type-1 errors.  However, given that this 
study is to be used for pilot data to inform future studies, it seemed prudent fully 
explore the implication of physiological changes with growth and changes in the 
body due to smoking, and how this was associated to linear models of telomere 
length.  By correcting the p value, this increases the Type 2 errors and interesting 
biological relationships could be overlooked.  The strong relationship between 
cremaster telomere length and dog weight, for example was not expected.   
 
 
 Chapter summary 
This chapter aimed to find the best tissue combination of telomere lengths to 
provide a biomarker of ageing, to assess change in biological age caused by ETS.  
While the best marker of ageing was provided by using the difference between 
cremaster muscle and leukocyte telomere length, this was then not actually the 
best means of evaluating ETS exposure impact.  
 
 
Nicotine exposure impacted leukocyte and buccal telomere length at both time 
points (time point 2 leukocyte close to significance).  Age related changes were 
not observed in leukocyte telomere lengths, yet a clear relationship with nicotine 
could be seen in the plots.  Little extra information was obtained by having the 
change between these measures, and like most studies, fewer individuals attended 
at the second time point.  A review of previous work did not find that longitudinal 
telomere length studies were any more likely to find an impact of ETS, and 
therefore future studies could be simplified using a single time point.  The use of 
nicotine as a biomarker of ETS exposure was a useful measure, as it provided an 
objective way of measuring exposure that enabled linear modelling analysis.  
Without having a larger study population, it is not clear that having cotinine as a 
second measure added anything to the study. 
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Using a method similar to that used by Benetos et al (see Chapter 1) did not 
improve illustration of age-related change in telomere length until the second time 
point, when numbers were smaller.  The cohort may have been too young at time 
point 1 for the model to be utilised, or the TRF analysis method of measurement 
may have been required to generate the necessary data.  It was not expected for 
there to be such a strong relationship between cremaster telomere length and 
weight, which also may have affected the usefulness of this measure. 
 
 
Overall, it has been demonstrated in this chapter that there appears to be a 
relationship between ETS exposure and telomere length.  Further work on a larger 
scale using this information would be worthwhile, to both provide owners with 
evidence as to the potential impact their health behaviours may have on their 
pet’s welfare, and to inform potential human studies based on the parallels 
between canine and human telomere dynamics.  However, given the overall aim of 
this thesis was to demonstrate whether an increase in biological age occurs as a 
result of ETS exposure, further potential biomarkers were investigated and are 
described in Chapter 6.  
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6 Chapter 6: Testicular gene expression and 
leukocyte DNA methylation as biomarkers of 
ageing  
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 Introduction 
Aside from telomere length, several other potential ageing biomarkers have been 
investigated.  This chapter examined markers which have either been examined in 
previous studies or could be biologically plausibly expected to change with age.  
Summarised below is the previous evidence regarding tobacco smoke exposure in 
the markers which were investigated. 
 
 
 CDKN2A/p16INK4a 
CDKN2A is a marker of cell senescence and mRNA expression levels have been 
shown to increase with age (e.g. Krishnamurthy et al. 2004).  CDKN2A was selected 
to study here as, along with telomere length, it is one of the two proposed 
biomarkers of ageing which have met the majority of the Baker III & Sprott (1988) 
criteria for a biomarker of ageing.  As well as increasing with age, CDKN2A mRNA 
levels were shown to increase with pack years of smoking in peripheral T 
lymphocytes of 128 human volunteers (Liu et al., 2009).  Nyunoya et al. (2006) 
demonstrated that cigarette smoke upregulated the p16-retinoblastoma protein 
pathway in a human lung fibroblast cell line.  They also observed that when the 
cells were exposed to cigarette smoke concentrate over a time course, cell growth 
was inhibited at multiple cell cycle phases, but the cells did not die.  However, in 
a study examining bronchioles and parenchyma of C57BL/6 female mice exposed to 
cigarette smoke for 6 months, there was no difference observed in CDKN2A 
expression due to exposure compared to a control group exposed to air in young or 
old animals (Zhou et al., 2013).   
 
 
 Sirtuin 1 
Sirtuins are a group of proteins, several of which have been shown to change with 
age.  Of these proteins, sirtuin 1 was chosen.  This was decided because sirtuin 1 
has previously been measured in dogs and cats (Ishikawa et al. 2015; Marfe et al. 
2012), it has been shown to be expressed in all tissues (including testes) 
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(Michishita et al., 2005), and it is the most widely studied in mammals.  In 
addition, an interaction has been observed between sirtuin 1 and telomerase 
(Narala et al., 2008) and it would be interesting to explore whether a relationship 
was seen in the dogs in this study.  Sirtuin 1 has been shown to both reduce with 
age (e.g Donato et al. 2011) and as a result of cigarette smoke exposure.  Lung 
tissue from 37 subjects undergoing lung surgery demonstrated decreased sirtuin 1 
protein concentrations in lungs of smokers and COPD patients compared to non-
smokers (Rajendrasozhan et al., 2008).  In the same study, a decrease in sirtuin 1 
concentration was seen in macrophages, alveolar epithelial cells and airway 
epithelial cells in smokers and COPD patients compared to non-smokers.  In 
addition, Yang et al. (2007) demonstrated a decrease in sirtuin 1 due to cigarette 
smoke exposure in monocyte-macrophage cells (Mono Mac 6 cells) and 
bronchoalveolar cells of Sprague-Dawley rats exposed in chambers to cigarette 
smoke.  In contrast, Csiszar et al. (2008) measured sirtuin 1 in twenty 14-16 week 
old Wistar rats exposed to cigarette smoke for one week and found no difference 
to controls, unless smoke exposed rats were treated with resveratrol, an inducer of 
sirtuin 1.  
 
 
 AHR 
AHR is activated by xenobiotic ligands, which include chemicals found in 
cigarettes, such as polycyclic aromatic hydrocarbons (PAHs).  The downstream 
pathway components not only include p450 enzymes for metabolism of the ligand, 
but also genes involved in the cell cycle.  This gene was selected for this study 
because not only is its activity directly affected by smoking, but it is also involved 
in processes related to biological ageing.  In addition, the metabolism of PAHs by 
p450 enzymes has also been shown to sometimes result in the production of 
reactive oxygen species (Puntarulo and Cederbaum, 1998), and therefore negative 
downstream effects.  Hepatic AHR in beagles was shown to have similar binding for 
[3H]-2,3,7,8-tetrachlorodibenzo-p-dioxin to that shown by cynomolgus monkeys, 
and the binding seemed to be comparable to that of humans for both species.  
Therefore, the dog could work well as a model organism for humans for AHR 
Chapter 6  283 
 
 
 
biology when exposed to ETS in the home.  In addition, AHR is expressed in germ 
cells (Coutts, Fulton and Anderson, 2007) so can be measured in testicular tissue.   
 
 
When mouse spermatocyte cell line GC-2spd cell line was cultured, cigarette 
smoke concentrate (CSC) produced a dose dependent increase in AHR mRNA 
expression.  CSC mediated changes in other genes and proteins were examined.  
When an antagonist to the AHR was included, several of the CSC-mediated changes 
were rescinded (Esakky et al., 2012).  In addition, when blood samples from 20 
healthy adult humans were examined, the concentrations of AHR and AHR nuclear 
translocator (Arnt) increased with smoking in a dose-dependent manner (Hayashi 
et al., 1994).  They combined AHR and Arnt in this analysis, so it is not clear 
whether individually AHR was related to smoking intensity, however, it was shown 
in this study that AHR and Arnt expression was significantly positively correlated.  
In contrast, a reduction in AHR mRNA level was observed in human uterine 
endometrium samples taken from smokers, compared to non-smokers in a group of 
30 women undergoing surgery for benign disorders (Igarashi et al., 1999). 
Fowler et al. (2014) examined the effect of maternal cigarette smoking on mRNA 
expression levels in human female foetal ovaries.  Foetuses were collected from 
elective termination of pregnancy and were of 11 to 21 weeks’ gestation.  In 22 
foetuses studied, there was no significant difference in the level of AHR expression 
with maternal smoking status.  However, they also measured the expression of AHR 
associated and response genes and found that for COUP (chicken ovalbumin 
upstream promoter) transcription factor 1, a gene with multiple AHR binding sites, 
mRNA levels were significantly higher in smoke exposed foetuses.  As with these 
foetal ovaries, when 22 human male foetal testes were examined, there was no 
significant difference in AHR mRNA levels with maternal smoking (Fowler et al., 
2008).  Similarly, in 14 full term human placentae, there was no significant 
difference in AHR mRNA expression level between smoking and non-smoking 
mothers (Huuskonen et al., 2016).  Also, Lin et al. (2003) measured AHR expression 
in cultured lymphocytes collected from healthy adult humans, and found no 
difference in expression level based on smoking status.   
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 Clusterin 
Clusterin is increased in the presence of stress-inducing agents and senescence, 
and helps prevent apoptosis.  Mixed evidence exists as to its changes with ageing, 
but study numbers are limited.  This gene was chosen because it has been 
previously measured in dogs (as a renal marker) (García-Martínez et al., 2012), it is 
present in testes (Fritz et al., 1983) and while its mechanisms are said not to be 
fully understood, it has been studied in the context of diseases for which smoking 
and/or ETS exposure are risk factors, for example, coronary heart disease 
(Poulakou et al., 2008) and childhood asthma (Sol et al., 2016).   
 
 
Carnevali et al. (2006) exposed human lung fibroblasts to cigarette smoke extract 
(CSE).  Clusterin mRNA and protein levels were significantly upregulated after 
exposure to 2.5% and 5.0% CSE after 72 hours.  Clusterin appeared to protect 
against cigarette smoke-induced oxidative stress in these cells.  In another study, 
peripheral blood mononuclear cells were isolated from blood samples collected 
from 16 healthy adult human male donors and the cells were differentiated into 
monocyte-derived macrophages.  Clusterin mRNA expression was measured in 
these monocyte-derived macrophages, and expression level was found to be 2.1 
times higher in smokers than non-smokers (Doyle et al., 2010).   Furthermore, 
when Yanni et al. (2014) obtained carotid artery samples from 42 human patients 
undergoing surgery for carotid artery stenosis, density of clusterin expression on 
carotid tissue was significantly higher in smokers than non-smokers.  When serum 
clusterin protein concentration was measured in 183 human patients undergoing 
coronary angiography, there was a non-significant trend for the clusterin levels to 
be higher in smokers.  Additionally, when plasma clusterin protein concentration 
was measured in 204 human adults attending a health screen, there was no 
significant difference in percentage of smokers between quartiles of clusterin 
concentration, however the highest percentage of smokers were in the highest 
quartile of clusterin concentration (Won et al., 2014).  In contrast, when relative 
clusterin content in red blood cell membrane was measured in blood samples from 
45 healthy adult humans, smokers had significantly lower clusterin levels 
(Antonelou et al., 2011).    
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 TERT 
TERT, an element of the telomerase enzyme, was selected for this study as 
telomerase activity has previously been measured in dog testis (Nasir et al., 2001), 
human and canine TERT promoters behave in an equivalent manner (Arendt, Nasir 
and Morgan, 2010) and it was interesting to examine the relationship between 
TERT and telomere length.  Due to the small number of studies found, examples of 
the relationship between smoking and both TERT and telomerase level and activity 
will be presented here. 
 
 
When telomerase activity was determined in bronchial epithelial cells obtained 
from 26 humans, telomerase activity increased with increasing pack years smoked 
(Yim et al., 2007).  In addition, when leukocyte telomerase activity was measured 
in 440 adult men, smoking was associated with higher telomerase activity (Kroenke 
et al., 2012).  Whereas, when TERT relative expression was measured in blood 
samples from 334 male lead smelters, there was no association between smoking 
and TERT expression (Pawlas et al., 2016).  In addition, when telomerase activity 
was measured in leukocytes from 217 humans of mean age 77.9, there was no 
relationship between smoking habit and telomerase activity when analysed as part 
of a multivariate model.  In contrast, when TERT was measured in skin punch 
biopsies from 20 current smokers and 20 non-smokers, pack years of smoking was 
inversely correlated to TERT expression in the epidermis (Lotfi et al., 2014).  
Getliffe et al. (2005) measured TERT mRNA expression levels in activated 
lymphocyte samples from 15 human adults with ulcerative colitis, 14 adults with 
Crohn’s disease and 15 controls.  In those with Crohn’s disease, smoking was 
associated with significantly lower TERT expression.  In the other two groups, 
smoking non-significantly lowered TERT expression. 
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 Steroidogenic pathway 
mRNA levels of 3βHSD, 17βHSD, p450 SCC and StAR were measured.  As well as age 
related change being demonstrated elsewhere (e.g. Luo, Chen and Zirkin, 1996; 
Leers-Sucheta, Stocco and Azhar, 1999), it was decided to measure these genes as 
the tissue being used was testes, so high levels of these genes were expected to be 
present.  In addition, the ability to measure these genes in testes would be an 
interesting model for human fertility, as it would be problematic (and no doubt 
objectionable to men) to obtain testis tissue from humans in a home environment 
to investigated relationships with ETS exposure.   
 
 
Jana et al. (2010) subjected 4 month-old inbred male Wistar rats to 12 weeks of 
daily nicotine injections.  The rats were then euthanised and testicles harvested.  
Nicotine treatment resulted in a significant decrease in 3βHSD and 17βHSD activity 
compared to control rats.  In addition, there was a significant decrease in StAR 
expression in nicotine exposed rats.  In another study, female mice were exposed 
to cigarette smoke from 8-9 weeks of age for 4 hours a day, 5 days a week, for 14 
weeks.  The mice were then euthanised and the adrenal tissues collected.  
Mitochondria were isolated from the adrenal tissues and StAR import measured.  
StAR is required for the movement of cholesterol to the inner mitochondrial 
membrane for steroidogenesis.  Mice exposed to cigarette smoke demonstrated a 
reduction of StAR import compared to control unexposed mice.  As a result, 
cigarette smoke showed a reduction in pregnenolone synthesis (Bose et al., 2008).  
Yan et al. (2014) subcutaneously administered nicotine to pregnant Wistar rats 
from gestational days 11 to 20.  The feto-placental units were removed and RNA 
isolated from foetal adrenal glands.  The expression of StAR and 3βHSD mRNA were 
inhibited by maternal nicotine administration compared to controls.  p450 SCC 
mRNA expression was also inhibited, but not significantly.  In further experiments, 
they also treated human adrenal carcinoma cells with nicotine.  Total RNA was 
isolated.  StAR and p450 SCC mRNA were reduced with increasing concentrations of 
nicotine, but there was no difference in 3βHSD mRNA with nicotine concentration. 
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In 3 further studies, human foetal mRNA expression levels in relation to maternal 
smoking were examined.  Foetal material was collected in all studies from elective 
termination of pregnancies, between 11 and 21 weeks’ gestation.  When RNA was 
extracted from 22 foetal ovaries, p450 SCC was significantly reduced as a result of 
maternal smoking, whereas StAR, 17βHSD type 3 (the major type in males) and 
3βHSD type 2 (the type found in testes) were non-significantly reduced with 
maternal smoking (Fowler et al., 2014).  In RNA from 22 foetal testes, there were 
non-significant decreases in StAR and p450 SCC expression levels with maternal 
smoking, and little change in 17βHSD type 3 expression (Fowler et al., 2008).  In 
mRNA from 55 foetal livers, there was no significant change in p450 SCC or 17βHSD 
type 3 with maternal smoking status (O’Shaughnessy et al., 2013).  Huuskonen et 
al. (2016) examined RNA expression levels in 14 full-term human placentae, and 
found that there was no significant difference in 3βHSD type 2 or p450 SCC 
expression level with maternal smoking. 
 
 
Changes in testosterone concentration itself relating to ETS exposure will be 
discussed in Chapter 7. 
 
 
 Global DNA methylation 
Global DNA methylation, the percentage of cytosine residues modified to 5-
methylcytosine, has been shown to decrease with age (e.g. Wilson and Jones, 
1983).  It was measured in this study as it can be examined longitudinally in a 
variety of tissues.  LINE-1 constitutes approximately 17% of the human genome 
(Cordaux and Batzer, 2009), so methylation of LINE-1 is regarded as a surrogate 
measure of global DNA methylation.  Therefore, examples of studies examining the 
relationship between smoking and both global DNA methylation and LINE-1 
methylation will be discussed here. 
 
 
Ivorra et al. (2015) measured global DNA methylation in cord blood samples from 
20 new born human babies.  They found that infants exposed to maternal smoking 
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during pregnancy had significantly reduced global DNA methylation.  Similarly, 
when Guerrero-Preston et al. (2010) measured global DNA methylation in 30 cord 
blood samples, there was a reduction in global DNA methylation with maternal 
smoking, but there was also a reduction in global DNA methylation when the 
mother was exposed to passive smoking.  In addition, cord blood cotinine 
concentration was inversely related to global DNA methylation.  Whereas, when 
LINE-1 methylation in buccal scrapes from children was measured, there was no 
difference in level based on prenatal tobacco smoke exposure, but there was a 
significant difference in AluYb8 methylation based on prenatal tobacco smoke 
exposure (Breton et al., 2009).  Like LINE-1, AluYb8 is also a repetitive element in 
the human genome (Cordaux and Batzer, 2009). 
 
 
In DNA from non-cancerous oesophageal mucosa samples from 109 patients, a 
reduction in LINE-1 methylation was found with both years of smoking and 
increased number of cigarettes per day (Shigaki et al., 2012).  Whereas, in 
leukocyte DNA from newly diagnosed breast cancer patients plus controls, there 
was no significant difference in global DNA methylation with smoking status or 
number of pack years (Choi et al., 2009).  In addition, when global DNA 
methylation and hydroxymethylation were measured in blood samples from 48 
healthy adults of mean age 54.9, there was no significant difference with smoking 
status in either measure (Tellez-Plaza et al., 2014).  When global DNA methylation 
was measured in 298 DNA samples from a group of parents and offspring, there was 
no significant difference in global DNA methylation between smokers and non-
smokers.  In addition, within smokers there was no significant relationship 
between pack years of smoking and global DNA methylation (Hillemacher et al., 
2008).  Flom et al. (2011) measured LINE-1 methylation in 90 blood samples from 
the New York Women’s Birth cohort.  They found no significant difference in LINE-
1 methylation between those exposed prenatally to cigarette smoke or not, or in 
adult smoking status. 
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 Chapter aims and hypotheses 
Multiple gene expressions were measured in the testes of study dogs to establish if 
any changed with age and/or ETS exposure.  In addition, global DNA methylation 
was measured in leukocyte DNA to see if this could be a viable biomarker of ageing 
in dogs.   
 
 
Firstly, protocols for measurement of relative gene expressions were established 
and mRNA expression levels of genes measured in cDNA samples from testes.  
Global DNA methylation in leukocyte DNA samples was measured using an ELISA 
kit.  Gene expression of steroidogenic enzymes: 3βHSD, 17βHSD, StAR and p450 
SCC were expected to decrease with both age and ETS exposure as part of leydig 
cell ageing.  CDKN2A and clusterin expression were hypothesised to increase with 
age and ETS exposure, due to their link with senescence.  Whereas, sirtuin 1 and 
global DNA methylation were hypothesised to decrease with age and ETS exposure.  
Both AHR and TERT mRNA levels were expected to decrease with age, but to 
increase with ETS exposure as an attempt to protect from the damage being 
caused. 
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 Methods 
 Samples 
Details regarding owner and dog demographics and ETS exposure were as in 
chapters 3 and 5.  Leukocyte DNA used was from the same DNA extracted for 
assays in chapter 5.  Testes were obtained from the dogs detailed in chapter 5.  In 
addition, testes were obtained from a 1 year old and a 3 year old dog (both cross 
breeds) courtesy of the SSPCA, which were used for a comparative sample and for 
inter-assay comparisons.  These were placed on dry ice and transported to our 
laboratory, where the testes were dissected from the surrounding tissues, snap 
frozen in liquid nitrogen and stored at −80°C.   
 
 
 RNA extraction and cDNA synthesis 
RNA extraction on ~50mg of testis from the 37 male dogs was performed as in 
section 2.2.3.  The quality and quantity of RNA was measured using 
spectrophotometry as described in section 2.2.5.  Initially, the smaller sections 
from each testis were placed in RNAlater®-ICE (Life Technologies, Paisley UK).  
This was to ease processing by maintaining RNA integrity if the tissue thawed.  
However, using this treatment resulted in unacceptably low 260/280 and 260/230 
ratios.  Therefore, RNA was extracted straight from the frozen tissue.  This solved 
the quality issues, and all samples had 260/280 and 260/230 ratios over 2.0, but 
meant that the tissue had to be handled with great care to avoid RNA degradation.   
 
 
cDNA synthesis was performed as per section 2.2.4.  The quantity and quality of 
cDNA produced was measured using spectrophotometry, as detailed in section 
2.2.5.   
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 Global DNA methylation measurement 
Percentage 5-methylcytosine (5-mc) was measured using an ELISA kit (Zymo 
Research, Tustin California USA).  The kit was used to measure percentage 5-mc in 
leukocyte DNA from the study dogs with sufficient DNA remaining after telomere 
length analysis.  This resulted in 41 dogs (36 male, 5 female) at time point 1 and 
24 dogs (23 male, 1 female) at time point 2 being used for 5-mc analysis.  Standard 
curves were run on each plate to quantify the percentage 5-mc in the test 
samples.  All samples and standards were tested in duplicate and the mean 
absorbance readings of the two repeats taken. 
 
 
The standard curve point samples were made by mixing the negative and positive 
controls provided in the kit.  By combining different amounts of the positive and 
negative controls, the points on the standard curve were: 0%, 5%, 10%, 25%, 50%, 
75% and 100% 5-mc.  The volumes of the positive and negative controls were added 
to a 0.2ml microcentrifuge tube and brought to a final volume of 100μl with 5-mc 
coating buffer (kit provided).  In addition, 100ng of each DNA sample was added to 
a 0.2ml microcentrifuge tube, then the volume made up to 100μl with 5-mc 
coating buffer.  The tubes were placed in a thermal cycler and the DNA denatured 
at 98°C for 5 minutes.  Immediately after, the tubes were put on ice for 10 
minutes.  The entire volume from the tubes was then added to the wells of a 96 
well plate (kit provided).  The plate was then covered in foil and placed in a 37°C 
incubator for one hour.  Following the hour, the buffer was discarded from the 
wells, tapping out any remaining buffer.  200μl of 5-mc ELISA buffer (kit provided) 
was added to each well.  The plate was recovered with foil and incubated at 37°C 
for a further 30 minutes.  The buffer was then discarded from the wells.  100μl of 
an antibody mix, containing 1:2000 anti-5-mc and 1:1000 secondary antibody in 5-
mc ELISA buffer, was then added to each well.  The plate was again covered with 
foil, then incubated at 37°C for one hour.  The antibody mix was then discarded, 
and the wells washed 3 times with 5-mc ELISA buffer.  100μl of horseradish 
peroxidase developer (kit provided) was added to each well.  The colour was 
allowed to develop for 15 minutes, then absorbance was measured at 405nm using 
a plate reader (MTX Lab Systems, Virginia USA). 
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In order to calculate the percentage 5-mc in the test samples, the percentage 5-
mc in the standards were plotted against their absorbance at 405nm.  A curve was 
fitted to the points, and the line equation used to calculate the percentage 5-mc 
in the test samples from their absorbance at 405nm.   
 
 
 Data analysis 
Linear modelling analyses were performed as per chapter 4.  Pearson product 
correlation testing was used to assess relationships between mRNA expression 
levels.  Spearman’s rank correlation assessed the relationship between 5-mc at 
time points 1 and 2.  Regression to the mean correction for the change in 5mc in 
relation to the baseline as per Chapter 5.  Life expectancy corrected age was 
calculated as per Chapter 5. 
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 Results 
 qRT-PCR optimisation 
Primer sequences for CDKN2A and two reference genes, RPL13A and GAPDH, were 
kindly provided by Dr Dagmara McGuinness (Institute of Cancer Sciences, University 
of Glasgow).  The remaining primers were designed using Primer Express 2.0 
software (Applied Biosystems, Paisley UK).  The design parameters were set as: 
optimum temperature 65°C (minimum 64°C, maximum 66°C), primer length 
optimum 20 bases (minimum 18, maximum 22) and amplicon length of between 
160 and 200 base pairs.  The primer sequences are shown in Table 6-1.  
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Table 6-1 Primer sequences for mRNA expression qRT-PCR assays 
Gene Gene name Genbank 
number 
Forward primer/ 
reverse primer 
RPL13A Ribosomal 
protein L13A 
AJ388525 GCCGGAAGGTTGTAGTCGT/ 
GGAGGAAGGCCAGGTAATTC 
GAPDH Glyceraldehyde
-3-phosphate 
dehydrogenase 
AB038240 TCACCAGGGCTGCTTTTAAC/ 
AGGAGGCATTGCTGACAATC 
CDKN2A Cyclin-
dependent 
kinase inhibitor 
2A 
AB675384 GGTCGGAGCCCGATTCA/ 
ACGGGGTCGGCACAGTT 
3βHSD 3β-
hydroxysteroid 
dehydrogenase  
NM1010954 CCCAACTCCTACAGGGACATCATCC/ 
GCACAAGTATGCAAAGTGCCACCA 
17βHSD 17β-
hydroxysteroid 
dehydrogenase  
XM3638870 CCAAACCTCCTCCCGAGCCA/ 
AGGGCCACCCCGGAAGAAAT 
AHR Aryl 
hydrocarbon 
receptor 
XM532485 TGTCTGCTGGATAATTCGTCCGG/ 
TCAAGGATGGATGGTGGTTGAAGTG 
CLU Clusterin NM1003370 GGCTAGTTGGCCACCAGCTCG/ 
CATGATGCTGGATGCCCGGTT 
P450SCC Cytochrome 
P450 side-
chain-cleaving 
XM535539 AGACCCGTCGGCGTCCTGTT/ 
TGCTTGATGCGCCTGTGCAG 
SIRT1 Sirtuin 1 XP546130 CAATTGAAGATGCTGTGAAATTACTGCAA
/ 
TGCTTGAGGATCTGGAAGGTCTGG 
StAR Steroidogenic 
acute 
regulatory 
protein 
EF522840 AGGTGAGCATGGTCCCACGTG/ 
CGCAGGTGGTTGGCAAAATCC 
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TERT Telomerase 
reverse 
transcriptase 
NM1031630 GGCTGGTAGAGGTGATTGCCAATG/ 
AAACTGTCTCATGTAAGGCTGCAGGTCT 
 
 
 
CDKN2A mRNA expression levels were measured first and separately to the other 
genes.  The primer concentrations were optimised for the target gene and two 
reference genes.  As in chapter 4, an optimisation matrix of primer concentrations 
was used to check several combinations of forward and reverse primers.  25ng of 
cDNA made from the testes obtained from the SSPCA were added to the positive 
control wells and ddH2O to the blank wells.  10μl of Absolute blue® SYBR green low 
ROX mix was added to each primer combination, cDNA if appropriate and ddH2O 
added to a final volume of 20μl per well.  The resultant forward/reverse primer 
concentrations were RPL13A 100/150nM, GAPDH 100/100nM and CDKN2A 
100/100nM.  However, it was noticed that the CTs of the CDKN2A PCRs were very 
high with 25ng of cDNA, likely due to the low expression of the gene in the testis.  
A range of cDNA amounts were tested to see what amount would result in 
acceptable CT values in the target and reference genes.  As a result, 250ng was 
added to each well in subsequent experiments.   
 
 
All three PCRs began with a 95°C 15 minute incubation to activate the Thermo-
Start™ DNA polymerase.  The thermal cycling profile then consisted of 95°C for 15 
seconds, 53°C for 30 seconds and 72°C for 30 seconds.  The thermal cycling was 
run for 45 cycles in the CDKN2A PCR, and 40 cycles in the RPL13A and GAPDH PCRs, 
as the average CT value was higher in the CDKN2A PCR than in the other PCRs.  
Following the cycles, melt curves were run for all PCRs (60-95°C).  All the PCRs 
were performed on an Applied Biosystems 7500fast machine (Applied Biosystems, 
Paisley UK) using machine compatible white 96 well plates (Starlab, Milton Keynes 
UK).  Mastermixes were made for the PCR set ups, 15μl of which were added to 
each well, followed by 5μl of test sample, ddH2O for no template control wells, or, 
on the initial run, 5μl of control with no reverse transcriptase added.  This control 
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was generated from a mix of RNA samples, and put through the cDNA synthesis 
procedure, but instead of reverse transcriptase, ddH2O was added instead.  By 
including this control, it can be seen if contaminating genomic DNA is present, 
which was not removed during the on-column DNase treatment.  It is highly 
unlikely that all DNA would have been removed, but by running this control, it can 
be seen to what extent contaminating genomic DNA contributes to amplification in 
the test wells.  For example, if the no reverse transcriptase wells amplify 10 cycles 
later than the test wells, the control wells contain roughly one thousandth of 
target sequence compared to test wells (based on 100% PCR efficiency), and 0.1% 
of amplification in the test wells is due to genomic DNA presence.  The plates were 
sealed with Microamp optical cap strips (Applied Biosystems, Paisley UK) and 
briefly centrifuged.  The plates were protected from light where possible, as SYBR 
green is light sensitive.  DNAZap® was used prior to setting up experiments to 
clean surfaces and pipettes, and filter pipette tips were used. 
 
 
The relative expression of CDKN2A was calculated using the 2−∆∆𝐶T method (Livak 
and Schmittgen, 2001).  This method measures the expression of the gene relative 
to the expression in a control sample.  The sample from the testis of the 1 year-old 
obtained from the SSPCA was used as this control.  The gene of interest expression 
is also corrected for the expression of a housekeeping gene, which corrects for 
different amounts of cDNA being loaded into the wells.  In this case, the relative 
expression was calculated twice, using each housekeeping gene in turn.  The 
formula for calculation is as follows: 
 
𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛
= 2−[(𝐶𝑡
𝐶𝐷𝐾𝑁2𝐴 𝑠𝑎𝑚𝑝𝑙𝑒−𝐶𝑡𝐻𝑜𝑢𝑠𝑒𝑘𝑒𝑒𝑝𝑖𝑛𝑔 𝑠𝑎𝑚𝑝𝑙𝑒)−(𝐶𝑡𝐶𝐷𝐾𝑁2𝐴 𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝐶𝑡𝐻𝑜𝑢𝑠𝑒𝑘𝑒𝑒𝑝𝑖𝑛𝑔 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)] 
 
Two housekeeping genes were used as previously housekeeping genes have been 
shown to vary in expression so using more than one gene may help with errors 
related to this (Vandesompele et al., 2002).  The mean of relative expressions 
using each housekeeping gene was taken.   
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Each sample and control was run in triplicate.  The mean CT value from the three 
wells was used for analysis.  As with the telomere assay, if the percentage 
coefficient of variation for the three wells was 5 or above, the sample was 
repeated.  The sample from the 3 year-old from the SSPCA was run on each plate 
to calculate the inter-assay coefficient of variation, which was 4.6%.   
 
 
Subsequently, the assays for the remaining genes were optimised and performed.  
The conditions for the housekeeping genes were kept the same.  On advice, to 
save time and money, the primers were all checked to see if they would operate at 
100nM/100nM concentrations.  Each pair was run with 100ng cDNA, ddH2O and no 
reverse transcriptase control samples.  100nM concentrations for all primers was 
found to be acceptable.  In addition, as 100ng cDNA produced acceptable CT 
values, this amount of cDNA was used for all reactions.  Due to machine 
availability, these PCRs were performed on a MxPro 3000P qPCR machine (San 
Diego, California USA) using machine compatible 96 well plates (Thermo Scientific, 
Paisley UK).  The gene of interest PCRs began with a 15-minute incubation, 
followed by 45 cycles of 95°C for 25 seconds, 63°C for 25 seconds and 72°C for 25 
seconds, and finally a melt curve (63-95°C).  As with previous experiments, the 
plates were set up using 15μl of mastermix and 5μl of sample or ddH2O.  Plate 
seals were adhered to the plate and then the plate briefly centrifuged.  The 
relative expressions were calculated as per CDKN2A expression. 
 
 
The median and interquartile range of relative mRNA expression for each gene are 
presented in Table 6-2. 
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Table 6-2 Relative mRNA expression levels 
Median and interquartile range of mRNA expression levels of tested genes relative to a control 
sample 
Gene Median expression Interquartile range 
3 beta HSD 0.70 0.61 
17 beta HSD 0.58 0.22 
AHR 0.74 0.37 
CDKN2A 0.36 0.36 
Clusterin 1.28 1.45 
P450 SCC 0.41 0.37 
Sirtuin 1 0.59 0.47 
StAR 0.91 0.62 
TERT 0.60 0.47 
 
 
Following Shapiro-Wilk tests, 3βHSD, 17βHSD, AHR, p450 SCC and CDKN2A 
expression levels were natural log transformed and the square root of sirtuin 1, 
StAR and TERT expression levels were taken to normalise the distributions of the 
data.  Values greater than two standard deviations greater or less than the mean 
were treated as outliers and excluded.   
 
 
The interindividual Pearson correlation coefficients between pairs of mRNA 
expression levels are presented in Table 6-3.  CDKN2A and 17βHSD expression 
levels were significantly negatively correlated (p=0.01).  17βHSD and sirtuin 1 were 
significantly positively correlated (p=0.02).  Clusterin expression was significantly 
positively correlated with sirtuin 1 (p=0.01) expression levels.  P450 SCC expression 
levels were significantly positively correlated to StAR (p=0.02) and TERT (p=0.02) 
expression levels. 
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Table 6-3 Correlations between mRNA gene expression levels 
Correlation coefficients of pairwise comparisons between mRNA gene expression levels.  
Significance levels are donated by *p<0.05, **p<0.01, ***p<0.001 
ln 3 beta -0.001 
ln 17 beta -0.40* 0.13 
ln AHR -0.27 0.14 0.20 
Clusterin 0.17 -0.09 -0.09 -0.17 
ln p450 
SCC 0.15 0.27 -0.05 -0.002 -0.007 
sqrt Sirt1 0.07 0.07 0.39* 0.29 0.40* 0.10 
sqrt StAR -0.07 -0.23 0.13 -0.15 0.30 0.38* 0.13 
sqrt TERT 0.18 -0.30 -0.14 -0.006 0.33* 0.37* 0.32 0.14 
 
ln 
CDKN2A 
ln 
3βHSD 
ln 
17βHSD ln AHR Clusterin 
ln p450 
SCC 
sqrt 
Sirt1 
sqrt 
StAR 
    
 
 Age 
3βHSD mRNA expression significantly increased with age in a linear model 
(F=30.81(1,35), R2=0.47, p<0.001).  When the “poly” function was employed, the fit 
of age to 3βHSD model was improved (F=20.65(2,34), R2=0.55, p<0.001, Figure 6.1A).  
3βHSD mRNA expression also increased with increasing life expectancy (LE) 
adjusted age (F=36.02(1,26), R2=0.58, p<0.001, Figure 6.1B).  The fit of this model, 
however, was better not using a polynomial variable.  Linear models of age and LE 
adjusted age to 17βHSD were not statistically significant (Age: F=2.28(1,34), R2=0.06, 
p=0.14; LE adjusted age: F=3.96(1,25), R2=0.14, p=0.06, Figure 6.1C&D).  The linear 
models of age and LE adjusted age to p450 SCC were not statistically significant 
(age: F=1.00(1,33), R2=0.03, p=0.33; LE adjusted age: F=0.02(1,24), R2<0.001, p=0.90, 
Figure 6.2A&B).  Similarly, the linear models of age and LE adjusted age to StAR 
were not statistically significant (age: F=1.77(1,33), R2=0.05, p=0.19; LE adjusted 
age: F=3.44(1,23), R2=0.13, p=0.08, Figure 6.2C&D).   
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Clusterin mRNA expression decreased non-significantly with age (AIC=87.52, 
p=0.07, Figure 6.3A).  Life expectancy adjusted age significantly decreased with 
increasing clusterin mRNA expression (AIC=63.41, p<0.001, Figure 6.3B).  Age and 
LE adjusted age non-significantly decreased with increasing CDKN2A mRNA 
expression level (age: F=1.57(1,35), R2=0.04, p=0.22; LE adjusted age: F=1.24(1,25), 
R2=0.05, p=0.28, Figure 6.3C&D).  The linear models of age and LE adjusted age to 
sirtuin 1 mRNA expression level were not statistically significant (age: F=0.73(1,34), 
R2=0.02, p=0.40; LE adjusted age: F=2.53(1,24), R2=0.10, p=0.12).  In addition, it 
appeared that a polynomial regression may be a better model.  The model of age2 
to sirtuin 1 mRNA expression level neared significance (F=3.83(1,34), R2=0.10, 
p=0.06, Figure 6.4A).  In addition, using polynomial regression, the model of LE 
adjusted age to sirtuin 1 was highly significant (F(2,24)=138.47, R2=0.92, p<0.001, 
Figure 6.4B). 
 
 
Age was not significantly related to TERT mRNA expression level (F=0.45(1,33), 
R2=0.01, p=0.51, Figure 6.4C).  The linear model of LE adjusted age to TERT mRNA 
expression was not statistically significant (F=0.006(1,23), R2<0.001, p=0.94, Figure 
6.4D).  The linear model of age to AHR mRNA expression was not statistically 
significant (F=0.04(1,33), R2=0.001, p=0.84, Figure 6.5A).  Although, the LE adjusted 
age significantly increased with AHR mRNA expression level (F=20.14(1,25), R2=0.45, 
p<0.001, Figure 6.5B).   
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Figure 6.1 3βHSD & 17βHSD gene expression levels by dog age 
Relative mRNA expression of 3βHSD with dog age (A, N=37, R2=0.55, p<0.001) and life-
expectancy adjusted age (B, N=27, R2=0.58, p<0.001); and 17βHSD relative expression with dog 
age (C, N=36, R2=0.06, p=0.14) and life-expectancy adjusted age (D, N=27, R2=0.14, p=0.06) 
A 
C D 
B 
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Figure 6.2 p450SCC & StAR gene expression levels by dog age 
Relative mRNA expression of p450 SCC with dog age (A, N=35, R2=0.03, p=0.33) and life-
expectancy adjusted age (B, N=26, R2<0.001, p=0.90); and StAR relative expression with dog 
age (C, N=35, R2=0.05, p=0.19) and life-expectancy adjusted age (D, N=25, R2=0.13, p=0.08) 
 
 
A 
C D 
B 
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Figure 6.3 Clusterin & CDKN2A gene expression levels by dog age 
Relative mRNA expression of clusterin with dog age (A, N=37, AIC=87.52, p=0.07) and life-
expectancy adjusted age (B, N=27, AIC=63.41, p<0.001); and CDKN2A relative expression with 
dog age (C, N=37, R2=0.04, p=0.22) and life-expectancy adjusted age (D, N=27, R2=0.05, p=0.28) 
 
 
A 
C D 
B 
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Figure 6.4 Sirt1 & TERT gene expression levels by dog age 
Relative mRNA expression of sirtuin 1 with dog age (A, N=36, R2=0.10, p=0.06) and life-
expectancy adjusted age (B, N=27, R2=0.92, p<0.001); and TERT relative expression with dog 
age (C, N=35, R2=0.01, p=0.51) and life-expectancy adjusted age (D, N=25, R2<0.001, p=0.94) 
 
A 
C D 
B 
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Figure 6.5 AHR gene expression levels by dog age 
Relative mRNA expression of AHR with dog age (A, N=35, R2=0.001, p=0.84) and life-
expectancy adjusted age (B, N=27, R2=0.45, p<0.001)  
A 
B 
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 Nicotine 
3βHSD mRNA expression non-significantly increased with increasing HNC1 
(F=2.31(1,35), R2=0.06, p=0.14, Figure 6.6A).  There was a non-significant decrease 
in 17βHSD mRNA expression with increasing HNC1 (F=1.18(1,34), R2=0.03, p=0.29, 
Figure 6.6C).  The linear model of HNC1 to p450 SCC mRNA expression level was 
not statistically significant (F<0.001(1,33), R2<0.001, p=0.94, Figure 6.7A).  Similarly, 
the linear model of HNC1 to StAR mRNA expression was not significant (F=0.85(1,33), 
R2=0.03, p=0.36, Figure 6.7C). 
 
 
There was a non-significant decrease in clusterin mRNA expression with increasing 
HNC (AIC=89.75, p=0.29, Figure 6.8A).  CDKN2A mRNA expression significantly 
increased with HNC1 (F=9.87(1,35), R2=0.22, p=0.003, Figure 6.8C).  The linear 
model of HNC to sirtuin1 mRNA expression was not statistically significant 
(F=0.21(1,34), R2=0.006, p=0.65, Figure 6.9A).  The linear model of HNC1 to TERT 
mRNA expression was not statistically significant (F=0.66(1,33), R2=0.02, p=0.42, 
Figure 6.9C).  The linear model of HNC1 to AHR mRNA expression level was not 
significant (F=0.06(1,33), R2=0.002, p=0.81, Figure 6.10A).   
 
 
 Cotinine 
There was a non-significant increase in 3βHSD mRNA expression level with HCC1 
(F=3.27(1,35), R2=0.09, p=0.08, Figure 6.6B).  Whereas, 17βHSD mRNA expression 
level non-significantly decreased with HCC (F=1.55(1,34), R2=0.04, p=0.22, Figure 
6.6D).  The linear model of HCC1 to p450 SCC mRNA expression level was not 
statistically significant (F=0.003(1,33), R2<0.001, p=0.95, Figure 6.7B).  There was a 
non-significant decrease in StAR mRNA expression with increasing HCC1 
(F=1.23(1,33), R2=0.04, p=0.27, Figure 6.7D).   
 
 
Clusterin mRNA expression significantly decreased with increasing HCC1 
(AIC=86.16, p=0.03, Figure 6.8B).  CDKN2A mRNA significantly increased with 
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increasing HCC1 (F=7.39(1,35), R2=0.17, p=0.01, Figure 6.8D).  The linear model of 
HCC1 to sirtuin 1 mRNA expression level was not statistically significant 
(F=0.92(1,34), R2=0.03, p=0.34, Figure 6.9B).  TERT mRNA expression level was not 
related to HCC1 (Figure 6.9D, F=0.51(1,33), R2=0.02, p=0.48).  There was no 
statistically significant relationship between HCC1 and AHR mRNA expression level 
(F=0.01(1,33), R2<0.001, p=0.91, Figure 6.10B).   
 
 
 
Figure 6.6 3βHSD & 17βHSD gene expression levels and ETS biomarker concentrations 
Relative mRNA expression of 3βHSD with hair nicotine concentration (A, N=37, R2=0.06, 
p=0.14) and hair cotinine concentration (B, N=37, R2=0.09, p=0.08); and 17βHSD relative 
expression with hair nicotine concentration (C, N=36, R2=0.03, p=0.29) and hair cotinine 
concentration (D, N=36, R2=0.04, p=0.22) 
 
A 
C D 
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Figure 6.7 p450SCC & StAR gene expression levels and ETS biomarker concentrations 
Relative mRNA expression of p450 SCC with hair nicotine concentration (A, N=35, R2<0.001, 
p=0.94) and hair cotinine concentration (B, N=35, R2<0.001, p=0.95); and StAR relative 
expression with hair nicotine concentration (C, N=35, R2=0.03, p=0.36) and hair cotinine 
concentration (D, N=35, R2=0.04, p=0.27) 
 
 
A 
C D 
B 
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Figure 6.8 Clusterin & CDKN2A gene expression levels and ETS biomarker concentrations  
Relative mRNA expression of clusterin with hair nicotine concentration (A, N=37, AIC=89.75, 
p=0.29) and hair cotinine concentration (B, N=37, AIC=86.16, p=0.03); and CDKN2A relative 
expression with hair nicotine concentration (C, N=37, R2=0.22, p=0.03) and hair cotinine 
concentration (D, N=37, R2=0.17, p=0.01) 
 
 
A 
C D 
B 
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Figure 6.9 Sirt1 & TERT gene expression levels and ETS biomarker concentrations 
Relative mRNA expression of sirtuin 1 with hair nicotine concentration (A, N=36, R2=0.006, 
p=0.65) and hair cotinine concentration (B, N=36, R2=0.03, p=0.34); and TERT relative 
expression with hair nicotine concentration (C, N=35, R2=0.02, p=0.42) and hair cotinine 
concentration (D, N=35, R2=0.02, p=0.48) 
 
 
A 
C D 
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Figure 6.10 AHR gene expression levels and ETS biomarker concentrations 5 
Relative mRNA expression of AHR with hair nicotine concentration (A, N=35, R2=0.002, p=0.81) 
and hair cotinine concentration (B, N=35, R2<0.001, p=0.91) 
  
A 
B 
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 Further analyses 
Dog weight was statistically significantly modelled to all gene mRNA expression 
levels except p450 SCC and TERT (Figures 6.11-6.13), with weight being negatively 
related to CDKN2A mRNA (F=80.81(1,36), R2=0.69, p<0.001), 3βHSD mRNA 
(F=14.67(1,36), R2=0.29, p<0.001), 17βHSD mRNA (F=67.04(1,35), R2=0.66, p<0.001) 
and AHR mRNA (F=22.08(1,34), R2=0.39, p<0.001) expression levels, and weight being 
positively associated to clusterin mRNA (AIC=83.30, p<0.001), sirtuin 1 mRNA 
(F=339.5(1,35), R2=0.91, p<0.001) and StAR mRNA (F=4.46(1,33), R2=0.12, p=0.04) 
expression levels.  Weight was also non-significantly positively related to p450 SCC 
mRNA (F=2.92(1,33), R2=0.08, p=0.10) and TERT mRNA (F=1.31(1,33), R2=0.04, p=0.26) 
expression levels. 
 
 
Breed life expectancy was also significantly related to 8 of the 9 gene mRNA 
expression levels.  Life expectancy was significantly negatively related to CDKN2A 
mRNA (F=57.81(1,26), R2=0.69, p<0.001), 3βHSD mRNA (F=16.97(1,26), R2=0.40, 
p<0.001), 17βHSD mRNA (F=59.17(1,26), R2=0.69, p<0.001), AHR mRNA (F=20.52(1,25), 
R2=0.45, p<0.001) and p450 SCC mRNA expression (F=39.47(1,25), R2=0.61, p<0.001) 
levels.  Whereas, life expectancy was positively associated with clusterin mRNA 
(AIC=63.04, p<0.001), sirtuin 1 mRNA (F=167.90(1,25), R2=0.87, p<0.001) and StAR 
mRNA (F=344.10(1,24), R2=0.93, p<0.001) levels.  The linear model of life 
expectancy to TERT mRNA levels was not statistically significant (F=0.77(1,23), 
R2=0.03, p=0.39). 
 
 
Rudimentary analyses were carried out to see if any breed differences were 
evident in the mRNA expression levels of any of the genes.  A paired t-test showed 
that 17βHSD mRNA expression levels (p=0.001) and AHR mRNA expression levels 
(p=0.008) were significantly higher in Staffordshire bull terriers than all other 
dogs.  Whereas, Staffordshire bull terriers had significantly lower CDKN2A 
expression levels (p=0.03) than all other dogs.  When Staffordshire bull terrier or 
not was included in a linear model with HNC to CDKN2A expression, the model was 
significant, with Staffordshire bull terriers having a decrease in CDKN2A with HNC 
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unlike other dogs (F=15.64(3,32), R2=0.59, p<0.001).  Clusterin mRNA and TERT 
mRNA expression levels were significantly lower in pure bred dogs than cross 
breeds (p=0.02 and p<0.001, respectively).  No significant differences between 
breeds were found in the remaining genes. 
 
 
 Protein level of CDKN2A 
A subset of samples had protein levels of CDKN2A to examine if the mRNA 
expression level correlated with protein level.  The methods, optimisation process 
and results are detailed in Appendix 11. 
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Figure 6.11 3βHSD, 17βHSD & p450SCC gene expression levels and dog weight 
Dog weight with relative mRNA expression of 3βHSD (A, N=37, R2=0.29, p<0.001), 17βHSD (B, 
N=36, R2=0.66, p<0.001) and p450 SCC (C, N=35, R2=0.08, p=0.10)  
 
A 
C 
B 
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Figure 6.12 StAR, sirt1 & TERT gene expression levels and dog weight 
Dog weight with relative mRNA expression of StAR (A, N=35, R2=0.12, p=0.04), sirtuin 1 (B, 
N=36, R2=0.91, p<0.001) and TERT (C, N=35, R2=0.04, p=0.26) 
A 
C 
B 
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Figure 6.13 AHR, clusterin & CDKN2A gene expression levels and dog weight 
Dog weight with relative mRNA expression of AHR (A, N=35, R2=0.39, p<0.001), clusterin (B, 
N=37, AIC=83.30, p<0.001) and CDKN2A (C, N=37, R2=0.69, p<0.001)  
A 
C 
B 
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 Global DNA methylation 
The median percentage 5-mc in leukocyte samples from study time point 1 was 
3.34, and 2.00 at time point 2.  The natural logarithms of the values were taken to 
improve model residuals, and outliers greater than 2 standard deviations from the 
mean were excluded, resulting in data from 38 dogs (34 male, 4 female) at time 
point 1 and from 24 dogs (23 male, 1 female) at time point 2 remaining for 
analyses. 
 
 
Percentage 5-mc at time point 1 (5mc1) was significantly correlated with 
percentage 5-mc at time point 2 (5mc2) (Spearman’s rho=0.52, p=0.01, Figure 
6.14).  In addition, the change between 5mc1 and 5mc2 was significantly 
correlated with 5mc1 (Spearman’s rho=0.50, p=0.02), such that those with higher 
5mc1 had the greatest percentage loss between the two time points.  Correction 
for regression to the mean was performed on the change, using the same equation 
as in chapter 5.  The relationship between 5mc1 and the change in 5mc between 
the two time points remained significant (Spearman’s rho=0.51, p=0.01). 
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Figure 6.14 % 5mc at time points 1 and 2 
There was a significant correlation observed (Spearman’s rho=0.52, p=0.01.  N=24, 23 male, 1 
female) 
 
 
Age significantly increased with leukocyte percentage DNA methylation at time 
point 1 (5mc1) (AIC=72.35, p=0.03, Figure 6.15).  LE adjusted age also increased 
with 5mc1, but the linear model was not significant (AIC=56.86, p=0.21, Figure 
6.16).  In addition, at time point 2, the linear model of age to 5mc2 was 
statistically significant (AIC=53.31, p<0.001), but the model including LE adjusted 
age was not significant (AIC=38.95, p=0.50).  The change in 5mc between the two 
time points was not related to age (F<0.001(1,20), R2<0.001, p=0.98) or LE adjusted 
age (F=0.71(1,13), R2=0.05, p=0.41). 
 
 
5mc1 significantly increased with both HNC1 (AIC=65.74, p=0.002, Figure 6.17) and 
HCC1 (AIC=62.58, p<0.001, Figure 6.18).  Both models were improved by including 
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age (HNC1: AIC=63.47, p<0.001; HCC1: AIC=61.64, p<0.001).  However, at time 
point 2 neither HNC2 or HCC2 were significantly modelled to 5mc2 (HNC2: 
AIC=54.64, p=0.63; HCC2: AIC=54.50, p=0.55).  The change between 5mc1 and 
5mc2 was unrelated to HNC2 (F=0.20(1,20), R2=0.01, p=0.66) or HCC2 (F=0.06(1,20), 
R2=0.003, p=0.81). 
 
 
Briefly, analyses of potential further explanatory variables were undertaken.  
Weight was unrelated to 5mc1 (AIC=76.55, p=0.41, Figure 6.19), or the change 
between 5mc1 and 5mc2 (F=0.08(1,20), R2=0.004, p=0.78), but was significantly 
positively related to 5mc2 (AIC=54.29, p<0.001).  Percentage weight change 
between the two time points was not significantly related to 5mc2 (AIC=54.82, 
p=0.79) or the change between 5mc1 and 5mc2 (F=0.01(1,20), R2<0.001, p=0.92).  
Cephalic index was significantly positively related to 5mc1 (AIC=46.45, p<0.001, 
Figure 6.20), and 5mc2 (AIC=37.90, p<0.001).  In addition, cephalic index was 
significantly negatively related to 5mc1 minus 5mc2 (F=5.99(1,13), R2=0.32, p=0.03, 
Figure 6.21), with dogs with lower cephalic indices reducing in 5mc percentage 
between the two time points, but those with higher cephalic indices tending to 
have an increase in 5mc percentage.  Age was no longer significantly related to 
5mc1 when cephalic index was included as an explanatory variable.  Also, HNC2 
and HCC2 were not significantly modelled to 5mc2 when cephalic index was 
included.   HNC1 was no longer significantly related to 5mc1 when cephalic index 
was included, however HCC1 was still significantly associated with 5mc1 
(AIC=42.70, p<0.001).  Pure breed dogs had significantly higher 5mc1 than cross 
bred dogs (Wilcoxon rank sum test, p<0.001).  However, pure breed dogs tended to 
have a higher cephalic index. 
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Figure 6.15 %5mc1 by dog age 
%5mc at time point 1 was positively related to age of dog (AIC=72.35, p=0.03).  N=38 (34M, 4F) 
 
Figure 6.16 %5mc1 by dog life expectancy adjusted age 
%5mc at time point 1 was not significantly associated with life expectancy adjusted age 
(AIC=56.86, p=0.21).  N=28 (24M, 4F). 
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Figure 6.17 %5mc1 by hair nicotine concentration 
%5mc at time point 1 was significantly positively associated with hair nicotine concentration 
(AIC=65.74, p=0.002).  N=37 (34M, 3F) 
 
Figure 6.18 %5mc1 by hair cotinine concentration 
%5mc at time point 1 was significantly positively associated with hair cotinine concentration 
(AIC=62.58, p<0.001).  N=37 (34M, 3F) 
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Figure 6.19 %5mc1 by dog weight 
%5mc at time point 1 was not significantly related to dog weight (AIC, p=0.34).  N=38 (34M, 4F) 
 
 
Figure 6.20 %5mc1 by breed cephalic index 
%5mc at time point 1 was positively associated with cephalic index (AIC=46.45, p<0.001).  
N=29 (25M, 4F) 
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Figure 6.21 The difference between %5mc1 and %5mc2 by breed cephalic index  
Cephalic index was significantly associated with the change in %5mc (N=15, R2=0.32, p=0.03) 
 
 
 Relationships between mRNA expression levels, global DNA 
methylation and telomere length 
Telomere lengths measured in chapter 5 were compared to gene expressions and 
5-mc measurements in this chapter.  Table 6-4 shows the correlation coefficients 
from correlation testing between mRNA expression of each gene and either 
telomere length or 5mc1.  5mc1 was significantly correlated with 3βHSD mRNA 
expression (Spearman’s rho=0.48, p=0.004) and significantly negatively related to 
TERT mRNA expression (Spearman’s rho=−0.50, p=0.004).  In addition, a linear 
model of 5mc1 to TERT expression was highly significant when cephalic index was 
included as an explanatory factor (F=184.5(3,20), R2=0.97, p<0.001).  CDKN2A, 
3βHSD, 17βHSD, sirtuin 1 and StAR mRNA expression were not significantly 
correlated to any of the telomere length measurements.  Cremaster muscle RTL 
was significantly negatively correlated with AHR mRNA expression (Pearson’s 
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correlation coefficient=−0.42, p=0.01).  AHR expression was negatively related to 
dog weight and cremaster muscle was positively related to weight, which was 
considered as a possible explanation.  However, in a linear model of AHR to 
cremaster muscle, when weight was included as an explanatory variable the 
negative relationship between AHR and cremaster muscle remained significant.  
Similarly, AHR expression was negatively related to breed life expectancy and 
cremaster muscle telomere length was positively related to breed life expectancy.  
When life expectancy was included as an explanatory variable, the relationship 
between AHR and cremaster muscle telomere length was no longer significant.  
Clusterin was significantly correlated with buccal telomere length at time point 1 
(Spearman’s rho=0.38, p=0.03).  This relationship remained significant when 
several other explanatory factors were included.  P450 SCC mRNA expression was 
significantly correlated with cremaster muscle telomere length (Pearson’s 
correlation coefficient=0.42, p=0.01).  This relationship also remained significant 
on further testing.  TERT mRNA expression was significantly negatively correlated 
to vas deferens telomere length (Pearson’s correlation coefficient=−0.49, 
p=0.004).  This relationship remained significant when further explanatory 
variables were included in linear models between the two, and, in addition, both 
HNC and TERT were significant explanatory variables in a linear model to vas 
deferens telomere length (F=9.39(2,29), R2=0.39, p<0.001). 
 
 
5mc1 was not significantly correlated to LRTL1 (p=0.49), BRTL1 (p=0.53) or CMRTL 
(p=0.67).  Correlation between 5mc1 and ERTL was close to being statistically 
significant (Spearman’s rho=−0.34, p=0.06).  5mc1 and VDRTL were significantly 
positively correlated (Spearman’s rho=0.39, p=0.03).  In addition, a linear model of 
5mc1 to VDRTL was significantly improved by including HNC as an explanatory 
variable (F=9.89(2,29), R2=0.41, p<0.001).  5mc2 was not significantly correlated to 
LRTL2 (Spearman’s rho=0.38, p=0.09) or BRTL2 (Spearman’s rho=0.13, p=0.61).  
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Table 6-4 Correlations between gene expressions and telomere length and %5mc1 
Correlation coefficients are displayed, with significance level *=p<0.05, **=p<0.01 
 
CDKN2A 3βHSD 17βHSD AHR Clusterin 
p450 
SCC 
Sirtuin 
1 StAR TERT 
Leukocyte RTL1 -0.15 0.005 -0.15 -0.02 0.3 0.08 -0.05 -0.1 -0.01 
Cremaster muscle 
RTL -0.09 0.16 0.04 -0.42* 0.29 0.42* 0.1 0.24 0.13 
Buccal RTL1 -0.05 -0.12 -0.11 -0.18 0.38* 0.008 -0.17 -0.01 -0.08 
Epididymis RTL -0.14 -0.24 -0.11 -0.18 0.25 0.004 0.03 0.26 0.08 
Vas deferens RTL 0.22 0.03 0.07 -0.32 -0.03 -0.19 -0.21 0.04 -0.49* 
% 5-mc 1 0.14 0.48** 0.05 -0.03 -0.28 -0.25 -0.27 -0.11 -0.50** 
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 Discussion 
 CDKN2A and ETS exposure 
An increase in CDKN2A expression with ETS exposure was observed, in keeping with 
results previously seen in humans with pack years of smoking (Liu et al., 2009).  
Smoking has been linked to cellular senescence (Tsuji, Aoshiba and Nagai, 2004; 
Nyunoya et al., 2006), so it logically follows that CDKN2A levels would increase in 
exposed dogs.  No significant change in CDKN2A expression was seen with ageing in 
testis, which was also seen when CDKN2A levels in mouse testes in 2.5 month old 
and 26 month old C57BL/6 mice (Krishnamurthy et al., 2004).  In that study, they 
did observe significant age related changes in other organs such as kidney and 
ovary.  It may be that this marker would be a viable ageing biomarker in dogs if 
RNA from another tissue was used or if female reproductive tissues were studied.  
CDKN2A expression levels decreased with life expectancy and weight on initial 
analysis, but these variables were no longer significant when if the dog was a 
Staffordshire bull terrier or not was corrected for.  ETS exposure still impacted 
expression regardless of breed, though.  Index of deprivation was significantly 
related to CDKN2A, but not when HCC was included.  However, in the absence of 
ETS data in future studies, having a postcode to generate an index of deprivation 
may be a helpful guide of exposure. 
 
 
 Clusterin expression and ETS exposure 
Clusterin mRNA decreased with HCC, which was unexpected given that only one 
previous study demonstrated a decrease in clusterin with smoking (Antonelou et 
al., 2011).  In other studies, either there was no association demonstrated, or an 
increase in clusterin was observed with smoking (Carnevali et al., 2006; Doyle et 
al., 2010).  It was unexpected that the expression of clusterin decreased with ETS 
exposure, as this marker has been observed to increase with senescence or in the 
presence of stress-inducing agents (Viard et al., 1999; Petropoulou et al., 2001).  
In addition, clusterin expression decreased with life expectancy adjusted age.  It 
was anticipated that clusterin would increase with age, due to its link with 
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senescence, however, many of the dogs were pubescent so this may explain the 
decrease.  An increase may have been observed if the dogs were older.  In 
addition, a model of clusterin to 3βHSD was highly significant, which may be in 
keeping with this idea, that the levels are being impacted on by puberty.  Clusterin 
mRNA levels also increased with dog weight.  When clusterin protein levels were 
measured in plasma of 37 obese dogs, unlike in this study there was no association 
with body weight, but levels were seen to decrease with weight loss (García-
Martínez et al., 2012).  Another aspect which may have caused a disconnect 
between the hypothesis and results, was that clusterin studies related to age in 
the literature that could be found are rodent studies so findings in other studies 
may not extend to dogs. 
   
 
 AHR expression and ETS exposure 
AHR mRNA expression was hypothesised to increase with ETS exposure and 
decrease with age.  While there was no significant relationship with unadjusted 
age, there was actually a significant positive relationship between AHR mRNA 
expression and life expectancy adjusted age.  However, there was no significant 
relationship between AHR expression and ETS variables.  It may have been worth 
measuring mRNA expression levels of genes downstream of AHR.  For example, 
Fowler et al. (2014) did not find a significant difference in AHR mRNA expression 
level in foetuses exposed to maternal smoking, but did find a significant difference 
in COUP transcription factor 1, which has multiple AHR receptor sites.  
Staffordshire bull terriers had significantly higher AHR mRNA expression levels.  
Variables such as weight were no longer significantly related to AHR expression 
when Staffordshire bull terrier or not as a variable was included, so the difference 
seen in Staffordshire bull terriers is unlikely due to confounding factors.  By having 
increased AHR expression, it is not known whether this breed would be at higher 
risk of developing malignancies through exposure to ETS.  Shimizu et al. (2000) 
found that when AHR-deficient transgenic mice and AHR-positive mice were 
injected with benzo[a]pyrene (a tobacco smoke constituent), or had 
benzo[a]pyrene applied topically, AHR-deficient mice did not develop tumours, 
whereas those with AHR present developed subcutaneous tumours from the 
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injection and skin tumours from the topical application.  In addition, when 
transgenic mice with constituently active AHR and wild type mice were treated 
with an injection of 2,3,7,8-tetrachlorodibenzo-p-dioxin, an AHR ligand and 
hepatotoxin, there was only one small liver tumour found in 15 wild type mice and 
19 tumours found in 18 transgenic mice (Moennikes et al., 2004).  However, Fan et 
al. (2010) found that, in the absence of xenobiotic ligands, AHR served as a tumour 
suppressor.  This is in keeping with its link with cell cycle arrest and inhibition of 
cell proliferation.  Transgenic AHR deficient mice were seen to significantly 
develop more liver tumours than wild type mice, when treated with a liver 
carcinogen which is not an AHR ligand.  So, while having increased AHR expression 
may lead to a greater risk of tumours on exposure to AHR ligands, there may be a 
protective effect against tumours due to other causes. 
 
 
 Sirtuin 1 expression and ETS exposure 
Sirtuin 1 mRNA expression was hypothesised to decrease with age and ETS 
exposure.  The study dogs demonstrated an initial increase in expression with age 
up to around 1 year-old, then a decrease.  This may have been linked with an 
increase with puberty, followed by a gradual decrease post-puberty.  Once age was 
corrected for, there was a slight decrease in sirtuin 1 with ETS exposure.  A 
gradual decrease could be observed with HNC1 and HCC1 when dogs a year old and 
over were included only, but this relationship did not reach significance, perhaps 
due to the small numbers above age 1.  In terms of future studies using testes, the 
pattern with age would be an issue given that many owners opt to castrate their 
dogs when unwanted sexual behaviours start to occur.  Sirtuin 1 expression was 
also seen to be positively associated with weight.  No studies could be found on 
dog size and sirtuin 1 expression, however in cats, which share 95.3% similarity in 
sirtuin 1 sequence, an increase in body weight was positively associated with 
leukocyte sirtuin 1 mRNA expression (Ishikawa et al., 2013).  In addition, sirtuin 1 
is linked to metabolism and sirtuin 1 knockout mice were demonstrated to be 
smaller than their wild type counterparts (Boily et al., 2008).  Basal metabolic rate 
differs between dog breeds (Speakman, van Acker and Harper, 2003), and sirtuin 1 
levels may increase with dog breed size to meet the dog’s metabolic needs.  Life 
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expectancy was no longer related with sirtuin 1 when weight was included in the 
analysis. 
 
 
 TERT expression and ETS exposure 
The linear models between unadjusted age or life expectancy adjusted age and 
TERT expression were not statistically significant.  HNC1 was also unrelated to 
TERT.  Sirtuin 1 and TERT expressions were not significantly correlated as may 
have been expected, but a linear model of TERT and dog weight to sirtuin 1 was 
significant (p<0.001).  Sirtuin 1 maintenance effects on telomeres have been 
shown to be mainly due to telomerase activity (Palacios et al., 2010) and it may be 
interesting to measure telomere length in the testis itself and to see if sirtuin 1 
and TERT expressions interact with telomere length in this tissue. 
 
 
 Steroidogenic enzymes expressions and ETS exposure  
StAR and 17βHSD expression levels decreased with age, although not significantly.  
This may be in part due to the small numbers in the study, and in terms of life 
expectancy adjusted age, the smaller numbers for which breed life expectancy 
was known.  Life expectancy adjusted age came close to being significantly 
modelled to StAR expression, with a p value of 0.08, and a pattern of descent 
could be observed when plotted.  StAR and 17βHSD also decreased non-
significantly with HNC and HCC.  It would be interesting in future studies to see 
these relationships with increased study numbers, to see if the pattern of decrease 
in expression with age and ETS exposure would be replicated.  3βHSD was 
expected to decrease with both age and ETS exposure, however both these factors 
caused an increase in expression (HNC and HCC non-significantly).  This could be 
due to expression increasing with puberty.  Possibly, the expression levels may 
start to decrease at an older age, however the plot of expression against life 
expectancy adjusted age does not seem to plateau towards the older ages. 
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17βHSD expression was significantly higher in Staffordshire bull terriers.  The other 
enzymes were not significantly different in Staffordshire bull terriers, so without 
further experiments it is not known if this would correspond to increased 
testosterone production in this breed.  Therefore, this relationship was explored in 
Chapter 7.  In addition, the levels of CDKN2A mRNA were lower in this breed, 
indicating lower levels of cellular senescence.  Correlation testing between 
17βHSD and CDKN2A mRNA expression was not statistically significant, but a linear 
model of 17βHSD to CDKN2A expression including whether the dog was a 
Staffordshire bull terrier or not as an explanatory variable was statistically 
significant (F=6.14(3,32), R2=0.37, p=0.002).   
 
 
The other breed relationship which was seen was that pure breed dogs had 
reduced TERT and clusterin mRNA expression levels, compared to cross breeds.  It 
is difficult to reason why this would be, given that this comparison existed 
between a range of breeds and crosses.  One possibility is that it is immune 
related; cross breeds generally have a greater mixture of canine major 
histocompatibility complex alleles than pure breed dogs (Kennedy et al., 2002).  
MHC defects have been shown to have a link with spermatogenesis in human 
studies (van der Ven et al., 2000), so may be related to different gene expression 
levels in the dogs. 
 
 
 mRNA expression level measurement methodology 
The qRT-PCR measurement calculations are based on the reference gene having a 
stable expression level.  However, studies have shown that expression of some 
commonly used reference genes are not constant throughout different tissues.  For 
example, GAPDH, which was used here, was found to vary up to 15 times in 
expression between a panel of 72 human tissues (Barber et al., 2005).  Therefore, 
expression levels of various reference genes in different species and tissues have 
been measured in an effort to find which genes are optimum to use for the 
samples in question.  Unfortunately, no studies could be found on stability of 
reference genes in canine testis.  It may have been wise to establish which 
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reference genes had the most stable expression prior to measuring the relative 
expressions of genes in the study samples, to improve precision and avoid error 
due to variation of the reference gene expression.  Software such as geNorm and 
Normfinder have been used for this purpose in previous canine studies (e.g. 
Schlotter et al. 2009; Wood et al. 2008).  In addition, when levels of reference 
genes were studied in murine testes, β-actin mRNA levels varied significantly 
during development (O’Shaughnessy, Willerton and Baker, 2002).  If there had 
been any effect of puberty and growth on the reference genes in the study dogs, 
this may have masked age related changes in the target genes.  On a practical 
level, to establish the best reference gene combination, testis RNA would have 
needed to be collected from an age range of dogs and from different breeds which 
would be time consuming to collect.  A range of breeds would be best to check due 
to the breed effect found on the telomere assay in chapter 4 and 5, with miniature 
schnauzers having unusual results.  An age range would need to be examined to 
check for growth and puberty related changes.  One positive aspect of the assay 
design was that the target genes were measured relative to two reference genes.  
It has been said that the use of multiple reference genes are required for accurate 
expression levels to be measured (Vandesompele et al., 2002). 
 
 
 Global DNA methylation 
Percentage 5-mc initially appeared to increase with age, although age was no 
longer significantly related when cephalic index, which happened to generally 
increase with age, was included in the analysis.  In the existing study which could 
be found examining DNA methylation in dogs, 5-mc increased with age (Gryzinska 
et al., 2016).  In humans, there is a general loss of methylation with age, but it has 
been demonstrated that this is not the whole story.  Loci in CpG islands gain 
methylation with age, whereas loci not in CpG islands lose methylation with age 
(Christensen et al., 2009).  The CpG content in dogs is increased relative to 
humans (Han and Zhao, 2009), which may explain why 5-mc did not decrease with 
age in this study and in Gryinska et al (2016).  There was a relationship observed 
between cephalic index and 5-mc.  The information for cephalic index in the dogs 
was incomplete, with previously published data used to obtain the index figures.  
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In addition, no dogs with very high cephalic index, such as a French bulldog, or a 
very low cephalic index, such as a greyhound, were included in the study.  A 
potential future study could involve measurement of 5-mc level in dogs of a wide 
range of cephalic indices, measuring the index clinically to obtain a more accurate 
measure.  There is also no obvious reason why cephalic index would be more linked 
to 5-mc than age, or any published material which may suggest a cause.  No 
relationship with weight was found, which was also the case in Gryinska et al. 
(2016).  Percentage 5-mc increased with ETS markers, with HCC remaining 
significant when cephalic index was included in the analysis.  Global 5-mc 
percentage was hypothesised to decrease with ETS exposure, however this may be 
due to the CpG island content in dogs again.  A way to investigate this further, 
without using an expensive whole genome sequencing technique, would be to 
measure the methylation status of one gene of interest.  Methylation of aryl 
hydrocarbon receptor repressor has been shown to be strongly associated with 
smoking (Monick et al., 2012; Gao et al., 2016).  Changes in this gene would be 
interesting to compare with markers of ETS exposure. 
 
 
An ELISA method to measure global DNA methylation was employed in this study.  
The reasons for this were that this method is cheap, does not require specialist 
knowledge or equipment, it can be used in dogs and requires relatively small 
amounts of DNA compared to some other methods.  Other whole genome 
methylation methods include mass spectrometry, high performance liquid 
chromatography-ultraviolet and pyrosequencing.  These methods were not used 
due to cost and need for specialist equipment.  The most popular method for 
methylation profiling uses array or bead hybridisation, and many commercial kits 
are available.  However, these kits are not suitable for use with canine DNA.  A 
possible future method to use in canine samples would be a methylation-specific 
PCR, which uses qPCR to calculate relative methylation.   This method only 
provides information on a small amount of the genome, but is one that could be 
used in dogs and is not high in cost. 
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 Chapter summary 
This chapter has examined multiple potential biomarker of ageing candidates in 
dogs.  Few published data in dogs in this area are currently available.  By 
examining multiple markers, pilot data is now available to inform future studies, 
and to base power calculations on to calculate sample sizes needed. 
Testis RNA was used for gene expression studies of 9 genes.  This tissue would 
normally be discarded at a castration procedure and large quantities of RNA could 
be extracted, enabling multiple genes to be tested.  However, issues in some of 
the genes were found in the changes around growth and puberty of the younger 
dogs. 
 
 
Global DNA methylation was measured using leukocyte DNA.  This marker was 
found to change with ETS exposure, and was easy and cost effective to measure.  
Further data would need to be gathered regarding the effects of breed cephalic 
index and gene specific changes to use this marker in the future, but it can be 
measured longitudinally so could be a potential marker to monitor dogs over time, 
given further investigation.   
 
 
 
 
334 
 
 
 
 
7 Chapter 7: Steroid hormone concentrations and 
weight change post neutering  
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 Introduction 
 Testosterone and age 
A decrease in blood testosterone concentration with age has been observed in 
multiple human studies.  For example, Pirke and Doerr (1973) observed a steady 
decrease in plasma testosterone concentration with age in 84 human males aged 
22 to 90 and the decline in sex steroid hormones with age was recently proposed as 
a biomarker of ageing in men (Walther et al., 2016).  Thus far, in studies of dog 
testosterone concentration, evidence of a decline with age seems to be lacking.  A 
study of 15 beagle dogs, aged 3 to 14 years, found no significant relationship 
between age and serum testosterone concentration (Lowseth et al., 1990).  A 
further study using 96 dogs of various breeds aged 6 months to 11 years found no 
relationship between plasma testosterone concentration and dog age (Taha and 
Noakes, 1982). 
 
 
 Testosterone and smoking 
In addition to age-related changes, in humans, relationships have been observed 
between testosterone concentrations and smoking habits, and in addition, in one 
dog study.  Sofikitis et al. (1995) measured testosterone concentrations in blood 
samples obtained from the left testicular vein of 49 smokers, mean age 30.3, and 
28 never smokers, mean age 33.1.  They found a significantly lower testosterone 
concentration in the smoking group.  In a study using blood samples from 3486 
Danish men with a median age of 19, both exposure to tobacco smoke prenatally 
and their own smoking habits were found to be significantly associated with 
testosterone concentrations.  If the men were exposed to ETS prenatally, but did 
not smoke themselves, there was an increase in free testosterone concentration 
observed compared to non-exposed prenatally.  In blood, 98 to 99.5% of 
testosterone is protein bound, to sex hormone-binding globulin or albumin 
(Luetjens and Weinbauer, 2012).  Free testosterone is calculated using a 
combination of testosterone and SHBG concentrations.  If the men were exposed 
prenatally and they also smoked themselves, there was a decrease in free 
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testosterone seen, due to an increase in SHBG.  If they were not exposed 
prenatally, but did smoke themselves, total testosterone concentration was higher 
than in non-smokers unexposed prenatally, but the free testosterone concentration 
was unchanged (Ravnborg et al., 2011).  Similarly, Field et al. (1994) found when 
they measured serum testosterone concentration of 1241 men aged 38 to 70, 
higher total testosterone concentration, but no change in free testosterone 
concentration, was found in smokers.  In another study of 126 non-smoking and 178 
smoking males with primary infertility, testosterone concentration was 
significantly lower with increased smoking habit (Mitra et al., 2012).   In the study 
of dog testosterone and the relationship to smoking, Mittler et al. (1983) fitted 
permanently tracheostomised male beagles with machines which held cigarettes 
and emulated a “standard puff profile” of smoking.  Serum testosterone 
concentrations were seen to decrease with increasing degrees of tar and nicotine 
quantities in the cigarettes administered.  6β-hydroxylase liver activity was 
stimulated by smoking, resulting in an increase in hepatic metabolism of 
testosterone. 
 
   
 Other factors related to testosterone concentration in dogs 
Limited information is available on breed differences in testosterone 
concentration. Urhausen et al. (2009) measured testosterone concentration in a 
total of 27 dogs of 4 different breeds: beagle, fox terrier, Labrador retriever and 
Great Dane.  Median ages for each breed ranged between 1.5 and 3.5.  
Testosterone concentration was higher in beagles than in fox terriers.   
 
 
Seasonal variations in testosterone concentrations have been demonstrated 
previously.  When the serum and seminal concentrations of 12 adult mixed-breed 
dogs aged 3 to 6 years were measured on a monthly basis for one year, seminal 
testosterone peaked in October and was at its lowest in April.  In contrast, serum 
testosterone concentrations did not significantly change throughout the year 
(Albrizio et al., 2013).   In a similar study, plasma concentration of testosterone 
was measured in 4 mixed-breed dogs every 15 days for one year.  The dogs were 
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housed individually in a vivarium under an artificial lighting schedule.  A peak in 
testosterone concentration was observed in late August and early September, and 
concentrations were significantly higher at this point than other times of the year.  
The authors suggest this is related to the normal reproductive behaviour of the dog 
and other canids, due to the timings at which females go into heat (Falvo et al., 
1980).  In contrast, when serum testosterone concentrations were measured in 7 
dogs every 15 days over a 14-month time period in a study by Martins et al. (2006), 
a reduction in testosterone concentration was observed in the summer period.  
The study in question was conducted in a tropical zone, and the authors suggest 
that the summer weather of high temperature and high rainfall led to the reduced 
concentration in the summer.  High temperatures would not have affected 
testosterone concentrations in our study, being based in Glasgow, but the author 
notes there is certainly high rainfall all year round.  In addition to season, variation 
throughout the day has been observed.  In 3 mature mixed-breed dogs housed 
individually in a vivarium with an artificial lighting schedule, blood samples were 
taken at 20 minute intervals, and were shown to vary from 0.4 to 6ng/ml over a 
24-hour period.  There was, however, no significant difference observed between 
samples taken in the light and dark periods (DePalatis, Moore and Falvo, 1978). 
 
 
Another self-evident factor relating to testosterone concentrations in dogs is if 
they have been castrated or not.  When DePalatis et al. (1978) measured plasma 
testosterone concentration in 2 castrated dogs, they found the concentrations to 
be below the lower limit of detection for their assay.  Frank et al. (2003) 
measured testosterone concentrations in 20 intact and 30 castrated male dogs of 
various breeds.  The median testosterone concentration was 2.8ng/ml in intact 
dogs, versus 0.04ng/ml in castrated dogs. 
 
 
 Cortisol and age 
There are limited data on any association between cortisol concentration and age, 
and no studies examining the relationship between dog age and cortisol could be 
found.  Salivary cortisol concentration was measured in 1671 adult humans aged 
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between 30 and 74 years.  Cortisol was measured in samples taken in the morning 
and evening.  Evening cortisol concentration was significantly higher in older 
subjects than younger subjects, and in older men than younger men in the morning 
(Larsson et al., 2009).  In addition, when hair cortisol concentration was measured 
in 654 adults aged 47 to 82, cortisol concentration significantly increased with age 
(Feller et al., 2014).  In two studies relating to cortisol concentrations in saliva of 
young children at home versus in childcare, there was no significant relationship 
between baseline cortisol concentration and age, only the change from baseline 
cortisol in response to stress, which will not be measured in this study (Dettling, 
Gunnar and Donzella, 1999; Watamura et al., 2003).   
 
 
 Cortisol and smoking 
In the study of hair cortisol concentrations of 654 adults by Feller et al. (2014) 
mentioned in the previous subsection, current smoking was associated with 
significantly higher cortisol concentration, even after age was included in the 
analysis.  Badrick et al. (2007) examined salivary cortisol concentration in 3103 
men and 1128 women.  Current smokers had a higher release of total cortisol 
compared to never smokers.  No significant relationship was observed between 
number of cigarettes smoked and cortisol concentration, but increased 
concentration of cortisol on awakening was seen in those with higher cigarette 
consumption.  Granger et al. (2007) measured salivary cortisol concentrations in 
mothers and their infants.  Cortisol concentrations were significantly higher in that 
of the mothers who smoked, but there was no significant difference in infant 
cortisol concentration based on the mothers’ smoking habit.  Varvarigou et al. 
(2009) measured cortisol concentration in cord blood of neonates of 100 smoking 
and 100 non-smoking mothers.  Not only were the cortisol concentrations in cord 
blood in neonates with smoking mothers significantly higher, but there was also a 
positive linear association between cortisol and the number of cigarettes smoked 
by the mother per day. 
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 Measuring cortisol in dogs 
Cortisol concentration has been measured in a variety of dog tissues, including 
saliva, blood, faeces, and hair (Accorsi et al., 2008; Bennett and Hayssen, 2010; 
Ouschan, Kuchar and Möstl, 2013).  Due to the nature of the sample, dog hair 
cortisol concentration has been demonstrated to be representative of baseline 
cortisol concentrations over a period of time (Bryan et al., 2013).  Bennett & 
Hayssen (2010) measured cortisol concentrations in both hair and saliva of dogs.  
The concentrations in both tissues were significantly positively correlated.  
However, they also demonstrated differences in cortisol concentration in different 
colours of hair, with black dogs having lower cortisol concentrations in their hair 
than non-black dogs.  This difference was not evident in the saliva of these dogs.  
Saliva cortisol concentrations were reported to be lower in neutered males and 
females than their intact counterparts in a study of 19 dogs.  In addition, salivary 
cortisol concentrations were higher in small dogs than large or giant dogs (Sandri 
et al., 2015).  
 
 
 Testosterone, cortisol and telomeres 
Limited information could be found regarding the relationship between the 
hormones and telomere length.  Bekaert et al. (2005) measured TRF length in 110 
samples from an elderly healthy male human population (aged 71-86 years), and 
found no significant relationship between TRF length and free testosterone 
concentration.  Needham et al. (2014) measured telomere length in 851 individuals 
and compared relationships with sex hormones to try to understand the observed 
gender difference in telomere length.  No significant relationship could be found 
between testosterone and LTL in a multivariate model. 
 
 
Choi et al. (2008) cultured peripheral blood mononuclear cells from 8 donors aged 
25 to 55.  They exposed the cells to increasing concentrations of hydrocortisone 
and found a significant negative relationship with telomerase activity levels.  Zalli 
et al. (2014) measured LTL in 333 individuals aged 54-76, and divided the results 
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into two groups: long telomeres and short telomeres.  There was no significant 
difference in saliva cortisol concentration between the groups.  Saliva telomere 
length was measured in a group of 97 girls aged 10-14.  There was no significant 
difference in salivary cortisol concentration between individuals with long and 
individuals with short telomeres, however individuals with short telomeres 
displayed a larger increase in cortisol concentration following a stressful stimulus 
(“cortisol reactivity”) (Gotlib et al., 2015). 
 
 
 Dog weight gain after neutering 
Neutered dogs are known to be at increased risk of obesity (Colliard et al., 2006; 
Lund et al., 2006).  Studies have demonstrated a decrease in metabolic rate in 
neutered animals compared to intact animals (e.g. Root et al. 1996).  Testosterone 
concentrations are associated with lean mass (Griggs et al., 1989) and the 
reduction in concentration in males post-castration can lead to loss of lean mass.  
Various other factors have been suggested as risk factors for obesity, such as 
breed, household income, steps taken per day by the dog and owner age (Colliard 
et al. 2006; Kienzle et al. 1998; Lund et al. 2006; Warren et al. 2011).  A factor 
which has not been discussed is owner smoking.  Interestingly, recent studies have 
demonstrated a potential link between child obesity and parental smoking habits 
(e.g. Han et al. 2015; Robinson et al. 2016).   
 
 
Given the link between obesity and oxidative stress (Vassalle et al., 2009), a link 
between telomere length and obesity has been observed in multiple studies.  When 
LTL was measured in 793 children aged 2 to 17 years of age, the mean LTL in obese 
children was 23.9% shorter than that of children classed as non-obese (Buxton et 
al., 2011).  Cui et al. (2013) measured LTL in 2912 Chinese women aged 40-70.  
Telomere length was found to be significantly inversely associated with weight, 
waist circumference, hip circumference, body mass index and waist to height 
ratio.  In addition, telomere length was demonstrated to be shorter in adipose 
tissue cells with increasing body mass index (Moreno-Navarrete et al., 2010).  
However, not all studies have found associations between obesity and telomere 
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length.  For example, when LTL was measured in 1459 individuals with a mean age 
of 21.7 years, no association between telomere length and waist circumference or 
body mass index was found (Bethancourt et al., 2017). 
 
 
 Chapter aims and hypotheses 
Given the decrease in testosterone with age in humans, plasma testosterone 
concentrations were measured in male dogs at both time points to investigate the 
pattern with age in dogs.  It was hypothesised that concentrations would be 
inversely related to ETS biomarkers and age.  Aside from age, concentrations were 
anticipated to be lower at the second time point as this would be more or less a 
year after castration.   
 
 
Psychological stress has been associated with early mortality in dogs (see Chapter 
1).  As a measure of chronic stress, cortisol hair concentration was measured at 
the second time point.   A positive relationship was expected with ETS biomarkers, 
but variables such as hair colour also needed to be accounted for.   
 
 
Potential links have been established between telomere length and obesity.  The 
weight at both time points was also recorded, and the body condition score.  Body 
condition scores were hypothesised to be increased in dogs living in smoking homes 
and to be negatively associated with telomere length.  
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 Methods 
 Study dogs 
Study dogs and demographic variables were as those described in chapter 5.  
Nicotine and cotinine concentrations were described in chapter 3.  Male dogs were 
sorted into prepubescent, pubescent and postpubescent groups based on their age, 
size and physical examination by a veterinary surgeon. 
 
 
 Plasma testosterone concentration 
Testosterone concentration was measured in spare plasma from blood samples 
taken as part of the health check at both time points, in the male dogs only.  
Concentrations were measured by a veterinary laboratory technician in the 
University of Glasgow Veterinary Diagnostic Service using a chemiluminescence 
method on an Immulite 2000 (Siemens, Erlangen Germany). 
 
 
 Measurement of cortisol concentration in hair 
Hair clipped for blood sampling purposes at time point 2 was divided between that 
to be used for measurement for nicotine and cotinine concentrations, and to be 
used for cortisol concentration measurement.  Hair for cortisol measurement was 
kept in sample envelopes at room temperature.  Cortisol concentration was 
measured in hair samples from all dogs attending time point 2 appointments (24 
males, 1 female), using an ELISA kit (R&D Systems, Minneapolis USA).  Prior to 
performing the ELISA, the fur samples were prepared as following.  A 20ml 
scintillation vial was half filled with dog hair sample.  The hair was washed 5 times 
with water and twice with ethanol, for 30 seconds each wash and removing all 
liquid possible after each wash.  The hair was then allowed to dry in a fume hood 
for 2 days.  35mg of hair was placed in a 2.5ml microcentrifuge tube.  The hair was 
homogenised by adding two cone ball bearings, immersing the tube into liquid 
nitrogen for a minute then placing in a MM400 Ball Mill (Retsch, Düsseldorf 
Germany), milling the sample for 3 minutes at a frequency of 25Hz.  This process 
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was repeated until the hair was powdered.  35-40mg of powdered hair was placed 
into a 2ml screw cap borosilicate glass vial, recording the weight of hair used.  1ml 
of HPLC-grade methanol was added to the powder and the vial sealed.  The vial 
was placed in a shaking incubator at 52°C, 125rpm for 16 hours.  Following this, 
the powder was allowed to settle for 20 minutes and then 750μl of supernatant 
was transferred to a 15ml borosilicate test tube.  The solution was then 
evaporated using a sample concentrator.  250μl of Calibrator Diluent (provided in 
ELISA kit) was added and the tube vortexed for 10 minutes.  The ELISA was then 
performed as per the kit instructions.  Reconstituted cortisol standard (kit 
provided) was used to make 7 concentrations of standard ranging from 10ng/ml to 
0.156ng/ml for the standard curve.  100μl of the standards or sample was added to 
each well of a microplate (kit provided).  Samples and standards were assayed in 
duplicate.  In addition, non-specific binding wells were set up by adding 150μl of 
Calibrator Diluent to 2 wells and 100μl of Calibrator Diluent was added to a further 
2 wells assigned as zero standard wells.  50μl of Cortisol Conjugate (kit provided) 
was then added to all wells, followed by 50μl of Primary Antibody Solution (kit 
provided) to all wells except for the non-specific binding wells.  The plate was 
covered with an adhesive strip and incubated for 2 hours at room temperature on 
an orbital microplate shaker at 500rpm.  The contents of the wells were removed 
and the wells washed 4 times using 400μl of 1X Wash Buffer (diluted to working 
concentration from kit provided buffer) each time.  Substrate Solution was 
prepared by combining equal volumes of Color Reagents A and B (kit provided), 
protecting the solution from light.  200μl of Substrate Solution was added to each 
well and the plate incubated at room temperature for 30 minutes on the bench 
top, with the plate protected from light.  50μl of Stop Solution (kit provided) was 
added to each well.  After 10 minutes, optical density was measured at 540nm 
using a microplate reader.  The standard curve was generated using the optical 
density readings from the cortisol standards and used to find the corresponding 
cortisol concentrations for the test samples.  The resulting concentration was 
corrected for dilution factors and adjusted for the input sample weight to obtain a 
final concentration of pg of cortisol per mg of hair. 
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 Dog weight assessment 
Dogs were weighed on an electronic scale at both time points.  Percentage weight 
change was calculated, adjusting for expected weight gain due to growth.  Body 
condition score (BCS) was assessed by a veterinary surgeon, and dogs with a BCS of 
3.5/5 or greater were placed in the “overweight” group. 
 
 
 Data analyses 
Linear models were analysed as previously described in chapter 4, using R (R Core 
Team, 2014).  As testosterone at time point 1, cortisol concentration and weight 
gain data were non-parametric as determined by a Shapiro-Wilk test, group 
comparisons were tested with either Wilcoxon rank sum or Kruskal Wallis tests.  
Correlations involving these variables were examined using Spearman’s rank 
correlation coefficient testing.     
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 Results 
 Plasma testosterone concentrations 
As expected, pre-castration plasma testosterone concentrations (T1TC) were 
significantly higher than post-castration plasma testosterone concentrations a year 
later at time point 2 (T2TC) (p<0.001, Wilcoxon rank-sum test).  The median T1TC 
was 43nmol/L, compared to 1.68nmol/L for T2TC.  The upper limit of detection of 
the assay was 56nmol/L, and 13 of the dogs had T1TC above this limit.  Given the 
distribution of the data for T1TC, and it not being known how far above 56nmol/L 
the concentrations of T1TC in the 13 above upper limit dogs were, the T1TC was 
divided into 3 groups, summarised in Table 7-1. 
 
 
Dogs with plasma testosterone concentration of above 56noml/L were assigned a 
concentration of 56noml/L for analyses and figures.  There was a non-significant 
difference in age between the 3 groups (Kruskal-Wallis test, p=0.15).  As can be 
seen in Figure 7.1, there was a trend in increase of age across the groups.  The 
dogs were sorted into pre-pubescent, pubescent and post-pubescent according to 
their size and age.  Pre-pubescent dogs had the lowest median T1TC (13.4nmol/L), 
followed by pubescent dogs (30.2nmol/L) and post-pubescent dogs having the 
highest median T1TC (53.5nmol/L) (Figure 7.2).   There was not a significant 
difference in T1TC between puberty statuses (Kruskal Wallis test, p=0.07), but 
there was a significant difference in T1TC in pre-pubescent dogs compared to the 
other two puberty statuses combined (Wilcoxon rank-sum test, p=0.04).  
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Table 7-1 Demographics of dogs grouped according to plasma testosterone concentration at 
time point 1 
Median values are given, with inter-quartile range in brackets.  Numbers of each breed and 
puberty status are listed.  SS=Springer spaniel, GSD=German shepherd dog, BT=Border 
terrier, Ret/RW & BM X= Retriever/Rottweiler & bull mastiff X, SBT=Staffordshire bull terrier, 
PT=Patterdale terrier, LT=Lakeland terrier, CKCS=Cavalier King Charles spaniel, JRT=Jack 
Russell terrier, German SP=German shorthaired pointer, M.Schnauzer=miniature Schnauzer 
 Group 1 Group 2 Group 3 
T1 (nmol/L) <20 20-56 >56 
Age 0.45 (0.65) 1.36 (2.31) 2.02 (1.94) 
Weight (kg) 14.4 (7.00) 17.2 (18.4) 18 (6.40) 
HNC1 0.08 (0.78) 0.20 (0.41) 0.08 (0.56) 
HCC1 0.01 (0.14) 0.05 (0.06) 0.00 (0.09) 
Breeds Basset hound (n=1) 
Beagle (n=1) 
Border collie (n=3) 
Collie/Labrador X 
(n=1) 
Pomeranian/BT X 
(n=1) 
Ret/RW & BM X 
(n=1) 
Shar-pei (n=1) 
SS/GSD X (n=1) 
SBT (n=1) 
Yorkshire terrier 
(n=2) 
Bearded collie (n=1) 
Boxer (n=1) 
CKCS (n=1) 
Cocker spaniel 
(n=1) 
JRT (n=1) 
M. Schnauzer (n=1) 
PT/LT X (n=1) 
Rottweiler (n=1) 
Springer spaniel 
(n=1) 
SBT X Lurcher (n=1) 
SBT (n=1) 
Border collie (n=1) 
BT/Pug X (n=1) 
CKCS (n=1) 
GSD/Collie X (n=1) 
German SP (n=1) 
PT (n=1) 
Springer spaniel 
(n=1) 
SBT X Lurcher 
(n=1) 
SBT (n=5) 
 
Pre-
pubescent 
Pubescent 
Post-
pubescent 
n=7 
 
n=3 
 
n=3 
n=3 
 
n=3 
 
n=5 
n=2 
 
n=4 
 
n=7 
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There was no significant difference between the T1TC groups in weight (p=0.32), 
hair nicotine concentration (p=0.90) or hair cotinine concentration (p=0.70).  It 
was noted that there were 5 Staffordshire bull terrier dogs in group 3 (T1 of 
>56nmol/L).  T1TCs were significantly higher in the Staffordshire bull terriers than 
the other dogs (Wilcoxon rank-sum test, p=0.02).  If the Staffordshire bull terrier 
crosses were included with the pure Staffordshire bull terriers, there was again a 
significant difference with the other breeds of dog (p=0.009, Figure 7.3). 
 
 
 
Figure 7.1 Box plot of dog ages in groups of plasma testosterone concentration (nmol/L) at 
time point 1.   
The difference in age between groups of testosterone concentrations was not statistically 
significant (p=0.15).  N=37. 
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Figure 7.2 Box plot of plasma testosterone concentrations (nmol/L) at time point 1 in dogs by 
their puberty status.   
There was no significant difference in testosterone concentration by puberty status (p=0.07).  
N=37. 
 
Figure 7.3 Box plot of plasma testosterone concentrations (nmol/L) at time point 1 by whether 
the dog was a Staffordshire bull terrier or cross 
(“SBT or SBT cross”) or not (“Other breeds”).  There was a significant difference in 
testosterone concentration between the two groups (p=0.02).  N=37. 
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The correlation between T1TC and T2TC was not statistically significant 
(Spearman’s rho=−0.17, p=0.42).  Age was negatively related to T2TC (F=4.77(1,22), 
R2=0.18, p=0.04, Figure 7.4).  While dog weight was negatively related to T2TC, 
the relationship was not significant (F=2.57(1,22), R2=0.10, p=0.12).  However, 
weight gain in kilogrammes was negatively related to T2TC (F=5.67(1,22), R2=0.20, 
p=0.03), as was percentage weight gain (F=4.48(1,22), R2=0.17, p=0.046).  The linear 
model of percentage weight gain to T2TC was significantly improved by including 
age (F=4.60(2,21), R2=0.30, p=0.02).  Too few Staffordshire bull terriers returned at 
time point 2 to test whether there was a significant relationship between the 
breed and T2TC.  There was a significant positive relationship between T2TC and 
breed life expectancy (F=235.3(1,15), R2=0.94, p<0.001).  The linear models of hair 
nicotine concentration at time point 2 to T2TC (F=0.12(1,22), R2=0.005, p=0.74), and 
cotinine concentration at time point 2 to T2TC (F=1.16(1,22), R2=0.05, p=0.29) were 
not statistically significant. 
 
 
Figure 7.4 Plasma testosterone 2 by dog age 
Scatter plot with regression line of plasma testosterone concentration (nmol/L) by natural log 
of dog age at time point 2.  The linear model was statistically significant (R2=0.18, p=0.04).  
N=24 
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Table 7-2 shows the beta coefficients of models of mRNA expression of genes 
measured in testis of the dogs to T1TC.  Dogs with T1TC of over 56nmol/L were 
assigned T1TC of 56nmol/L for this analysis as there was no way of knowing how 
far above 56nmol/L their concentration of plasma testosterone was.  3βHSD and 
StAR, enzymes in the testosterone synthesis pathway, were significantly modelled 
to T1TC (3βHSD: AIC=327.01, p<0.001; StAR: AIC=323.98; p<0.001).  In addition, 
mRNA expression levels of TERT and sirtuin 1 were significantly modelled to T1TC 
(TERT: AIC=321.27, p<0.001; sirtuin 1: AIC=324.74, p<0.001).  Initially, p450 SCC 
mRNA expression was not related to T1TC (AIC=322.37, p=0.72).  As p450 SCC 
catalyses conversion of cholesterol for the synthesis of hormones, cholesterol 
concentration was included as an explanatory variable in the model of p450 SCC 
mRNA expression to T1TC.  This resulted in a significant model to T1TC 
(AIC=311.55, p<0.001).  As AHR is known to be activated by chemicals in cigarette 
smoke, cotinine concentration was included as an explanatory variable in the 
model of AHR mRNA expression to T1TC.  This model was statistically significant 
(AIC=316.45, p=0.02).  In addition, as the genes were potential biomarkers of 
ageing, age was included in models of the gene expressions to T1TC to see if this 
impacted the relationships.  When age was included, 17βHSD was significantly 
modelled to T1TC (AIC=324.57, p=0.01).  This was also the case for the models of 
CDKN2A mRNA expression (AIC=324.07, p=0.008) and clusterin mRNA expression 
(AIC=323.73, p=0.007) to T1TC. 
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Table 7-2 Beta coefficients of linear models of the gene mRNA expressions to testosterone 
concentration at T1. 
*** indicates significance level of p<0.001. 
Gene β coefficient 
3βHSD 18.61*** 
17βHSD 10.76 
TERT 39.67*** 
StAR 33.89*** 
Sirtuin 1 44.88*** 
P450 SCC 1.79 
Clusterin -2.95 
AHR 9.25 
CDKN2A -5.46 
 
 
Table 7-3 Testosterone concentrations to telomere length and %5mc linear models 
Beta coefficients are listed.  Significance level is denoted by *=p<0.05, **=p<0.01, 
***=p<0.001 
Linear model β coefficient 
LRTL1 ~ T1TC -0.003 
LRTL2 ~ T2TC 0.07 
BRTL1 ~ T1TC -0.01* 
BRTL2 ~ T2TC -0.50 
CMRTL ~ T1TC 0.007 
ERTL ~ T1TC -0.002 
VDRTL ~ T1TC -0.006 
LRTL1 – CMRTL ~ T1TC -0.02*** 
LRTL2 – CMRTL ~ T2TC 0.86 
LRTL1 – LRTL2 ~ T2TC 0.08 
BRTL1 – BRTL2 ~ T2TC 1.82* 
%5mc1 ~ T1TC <0.001 
%5mc2 ~ T2TC -0.30 
%5mc1 − %5mc2 ~ T2TC 0.31 
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Table 7-3 lists the beta coefficients of models using T1TC or T2TC as explanatory 
variable for telomere lengths or global DNA methylation percentage.  BRTL1 was 
significantly negatively related to T1TC (F=5.08(1,32), R2=0.14, p=0.03), as was the 
difference between LRTL1 and CMRTL (AIC=115.78, P<0.001).  In addition, T2TC 
was significantly modelled to the difference between BRTL1 and BRTL2 
(F=4.91(1,16), R2=0.23, p=0.04).  Age was added in as an explanatory factor and the 
significance of the models rechecked.  When age was included, T2TC was 
significantly modelled to BRTL2 (F=6.31(3,16), R2=0.54, p=0.005).  In addition, with 
age included T1TC and T2TC were significantly modelled to %5mc1 (AIC=55.29, 
p<0.001) and %5mc2 (AIC=49.31, p<0.001), respectively.  HNC and HCC were also 
added as explanatory variables to explore whether this would alter the significance 
of the models.  By adding HNC1 as an explanatory variable, T1 was significantly 
modelled to VDRTL (F=6.59(3,30), R2=0.40, p=0.001).    
 
 
 Cortisol 
Median hair cortisol concentration was 3.46pg/mg (IQR 4.70pg/mg).  Cortisol 
concentrations were log transformed for analyses to improve model residuals.  As 
fur colour has previously been shown to have an impact upon hair cortisol 
concentration in dogs, fur variables were first checked for differences in cortisol 
concentration to potentially avoid confounding in further analyses.  Due to the 
range of coat colours, colours were grouped into black, white and other.  There 
was a significant difference in hair cortisol concentration (HCOR) between the 
three colour groups (Kruskal Wallis test, p=0.04, Figure 7.5).  Pairwise Wilcoxon 
rank-sum tests showed there was a significant difference between HCOR in black 
and white fur (p=0.03).  Median HCOR in black fur was 5.87pg/mg and 1.58pg/mg 
in white fur.  No significance difference in HCOR was found between short, 
medium and long hair (p=0.84), between coat types (p=0.78), or between dogs 
with single or double coats (p=0.62).  Median HCOR was higher in low shedding 
dogs (16.90pg/mg) than high shedding (4.23pg/mg) or moderate shedding 
(1.65pg/mg) dogs, but the Kruskal Wallis test was not statistically significant 
(p=0.15).  There were only 4 dogs in the low shedding group, so small numbers are 
likely to be the cause of the lack of a significant relationship. 
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When coat colour was included, age (p=0.67), weight (p=0.61), HNC2 (p=0.58) and 
HCC2 (p=0.76) were not significantly related to HCOR.  Breed life expectancy was 
significantly negatively related to HCOR (AIC=43.81, p=0.004), and it remained 
significant after correction for hair colour.  HCOR and T2TC were non-significantly 
negatively correlated (Spearman’s rho=−0.27, p=0.22).  In terms of psychological 
stress, there was no significant difference in HCOR between dogs purchased 
directly from a breeder or adopted at an older age (p=0.67).  Linear models of 
HCOR to LRTL2, BRTL2 and %5mc2 were not statistically significant (p=0.17, 
p=0.67, p=0.41, respectively).  These models remained non-significant when age 
was included as an explanatory variable. 
 
 
 
Figure 7.5 Natural log of hair cortisol concentration (pg/mg) by whether cortisol was measured 
in black, white or another colour of hair.   
Cortisol concentration in black hair was significantly greater than in white hair (p=0.03).  N=25 
(24 male, 1 female). 
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 Possible factors relating to weight change over the study 
period 
All except 2 of the dogs gained weight above and beyond that expected due to 
normal growth between the two time points.  The percentage weight gains relative 
to weight at time point 1 (or that expected when fully grown) were calculated.  
The median percentage weight gain was 15.1% (IQR 16.8%).  Factors relating to 
weight gain were considered.  Age of dog was not significantly related to weight 
gain (Spearman’s rho=0.15, p=0.48).  No significant breed effect could be found.  
Height did not relate to weight gain (Spearman’s rho=−0.07, p=0.74), nor did breed 
cephalic index (Spearman’s rho=0.05, p=0.84).  
 
 
Having access to a private garden was not related to weight gain (Wilcoxon rank-
sum test, p=0.98), nor was the hours of walking per day (Spearman’s rho=−0.03, 
p=0.90).  Dogs living in urban environments tended to gain more weight than dogs 
living in rural environments (median percentages: 15.6, 3.32, respectfully), but the 
difference was not significant (Wilcoxon rank-sum test, p=0.17).  Hair cotinine 
concentration at time point 2 was significantly positively correlated with 
percentage weight gain (Spearman’s rho=0.50, p=0.01, Figure 7.6).  Hair nicotine 
concentration at time point 2 was positively related, however non-significantly, to 
percentage weight gain (Spearman’s rho=0.36, p=0.08).  The odds ratio of having 
greater than 20% weight gain between the two time points, if cotinine at time 
point 2 was positive (based on the ROC generated cut off point from Chapter 3), 
was 7.5 (95% confidence interval 1.09-51.68) compared to having negative cotinine 
at time point 2.  In addition, weight gain was negatively correlated to T2TC 
(Spearman’s rho=−0.41, p=0.046, Figure 7.7).   A linear model of T2TC and age to 
percentage weight gain was statistically significant (AIC=182.88, p<0.001).  
   
Chapter 7  355 
 
 
 
 
Figure 7.6 Percentage weight change between the two time points and hair cotinine 
concentration at time point 2 
Correlation was statistically significant (Spearman’s rho=0.50, p=0.01). 
 
Figure 7.7 Plasma testosterone concentration (nmol/L) and percentage weight change between 
the two time points 
The correlation was statistically significant (Spearman’s rho=−0.41, p=0.046).  
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 Discussion 
 Testosterone 
Plasma testosterone concentrations were measured before and after castration.  
Pre-castration, the concentrations were seen to increase from pre-puberty to 
puberty.  This is in keeping with Mialot et al. (1988) who measured testosterone 
concentrations in blood samples in fox terriers every week from birth until one 
year of age.  They found concentrations remained relatively low for the first 27 
weeks of life, then drastically increased.  What was unexpected was how high 
some of the testosterone concentrations were compared to values published in the 
literature, resulting in concentrations which were above the upper limit of the 
assay.  Multiple studies reviewed showed testosterone concentrations consistently 
of less than 10ng/ml (e.g. DePalatis, Moore and Falvo, 1978; Urhausen et al., 2009; 
Albrizio et al., 2013).  The majority of published studies involved dogs either kept 
in kennels or in vivariums.  The dogs in this study were in their own homes and 
would have interacted with other dogs outside.  No studies regarding testosterone 
concentrations in Staffordshire bull terriers could be found.  Staffordshire bull 
terriers had significantly higher plasma testosterone concentrations at time point 1 
than the other breeds in this study, so breed selection could play a part in 
explaining the higher testosterone concentrations found here than in other studies.  
Having several dogs above the upper limit of the assay limited the analyses and it 
would be interesting to know how far above the upper limit the concentrations 
were.  It is interesting in particular that Staffordshire bull terriers were the dogs 
with comparatively high testosterone concentrations, given the numbers of this 
breed in rescue centres in the UK.  Battersea Dogs & Cats Home 2015 annual report 
stated that Staffordshire bull terriers were the most common breed of dog they 
rescued, with 1,288 dogs of this breed being taken in by the charity, more than 
twice the second and third most common breeds: 497 mongrels and 443 Jack 
Russell terriers (Battersea Dogs and Cats Home, 2016).  There is only a limited 
selection of breeds included in this study, and a more comprehensive examination 
of breed related differences in concentration of testosterone levels would be of 
value for both animal welfare purposes and to be instructive for future studies. 
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As the testosterone concentrations were so high at time point 1, the method of 
analysis for future studies would need to be improved.  In addition, the 
concentrations of SHBG would be worthwhile measuring, to calculate the 
concentrations of free testosterone.  Mass spectrometry could be employed to 
measure several proteins at the same time from one sample and could offer a 
solution to the methodological problems of using a chemiluminescence-based 
assay.  A non-invasive method could be used to obtain the sample required, to 
avoid the necessity for a Home Office licence.  For example, testosterone 
concentration has been previously measured in dog faeces and was positively 
correlated with serum testosterone concentration in a study of 22 female beagles 
(Gudermuth et al., 1998). 
 
 
A decline in testosterone concentration at older age was not seen in testosterone 
at time point 1, but this relationship was affected by the presence of prepubescent 
and pubescent dogs.  An inverse weak relationship was seen between age and 
testosterone concentration at time point 2, when all dogs were post-pubescent.  
The relationship may have been weak due to the small sample size and lack of 
spread across the age range, but testosterone concentration could be a potential 
biomarker of ageing in castrated dogs. 
 
 
 Cortisol 
Hair cortisol concentration seemed to be strongly associated with hair colour.  
Bennett & Hayssen (2010) also observed a difference in cortisol concentration in 
dogs with hair colour, and demonstrated differences in cortisol concentration 
within the same animal based on the colour of hair sampled.  However, they noted 
a converse relationship to that found here.  They observed lower cortisol 
concentration in black hair and higher concentration in white hair.  Hair cortisol 
concentrations were also higher in white hair than black hair in cattle (González-
de-la-Vara et al., 2011).   However, similar to this study, when cortisol 
concentrations were measured in 2484 human children, the lowest levels were 
found in blond hair and the highest found in black hair (Rippe et al., 2016).  The 
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observation of higher hair cortisol seen in obese children (Veldhorst et al., 2014) 
was not replicated in dogs here, possibly due to so many of the dogs gaining more 
weight than expected between time point 1 and 2, because the relationship was 
masked by the effects of hair colour on cortisol concentration or differences in 
physiology between the species.  If cortisol concentration had been measured by 
blood or saliva, an acute stress response may have affected the result.  Cortisol 
response has been shown to be related to telomere length and smoking, as 
discussed in the chapter introduction, but in order to capture this phenomenon a 
baseline cortisol reading would still be required.  As with testosterone, using a 
faecal sample may be a way round the issue.  The problem would be it would 
require owner compliance and some may feel that collecting a faecal sample is too 
unpleasant.  Hair and faecal cortisol concentrations were shown to be significantly 
correlated in study of 29 dogs (Accorsi et al., 2008). 
 
 
The ELISA used for the measurement of the cortisol concentration may not have 
produced reliable data.  Low concentrations in the samples were measured 
relative to the standard curve.  Ideally, the optical density of the sample wells 
would fall around the middle of the standard curve, but this was not the case.  A 
more sensitive method may be required to detect the concentrations of cortisol in 
the fur.  However, given the dominant association between hair colour on cortisol 
concentration, a more sensitive method would be more expensive and time 
consuming, and yet not necessarily yield any further associations beyond that with 
colour.   
 
 
 Weight gain 
Nearly all dogs in the study gained weight.  A large drop in testosterone 
concentration was observed between the two time points.  The drop was large 
relative to other studies which recorded much lower testosterone concentrations 
in intact males, as already discussed.  If the dogs were fed as prior to their 
neutering procedure, Root et al. (1996) suggested this would lead to weight gain, 
as the dogs’ metabolic rates would have dropped.  Diet questions were not 
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included in the questionnaire, so it is not known to what extent feeding regime 
contributed compared to ETS exposure or other factors.  Body mass index has 
previously been shown to be related to steps taken by the dog measured using a 
pedometer (Warren et al., 2011).  Daily walking activity was asked about in the 
questionnaire, but many owners were not forthcoming with this information and 
the time spent on walks may have been under or over estimated.  Daily steps taken 
could have been measured experimentally using a pedometer, but this would have 
beyond the remit of this study.  Dogs with positive hair cotinine at time point 2, 
based on the cut-off point generated in Chapter 3, gained more weight between 
the two time points.  Cotinine represents longer term exposure than nicotine, 
which is why cotinine may have had a stronger relationship with weight gain than 
nicotine.  Similar findings have been observed in child obesity with parental 
smoking, as described in the chapter introduction.  However, it is not clear why 
this is.  Leptin has a role in regulating body fat mass and has been observed to be 
at significantly higher concentration in obese dogs than normal dogs (Park et al., 
2014).  However, in human studies, maternal smoking resulted in decreased leptin 
concentration in infant cord blood, and in 82 men of mean age 22, smoking was 
negatively related to leptin concentration (Mantzoros et al., 1997, 1998).  Another 
possibility is IGF-1 level in the dogs exposed to smoking.  Pack-year history was 
positively associated with IGF-1 in a study of 130 adult human subjects aged 30 to 
84 years old (Kaklamani et al., 1999).   In addition, when 7 adult beagles were 
experimentally overfed, IGF1 positively correlated with weight gain (Gayet et al., 
2004).   
 
 
 Chapter summary 
Testosterone and cortisol concentrations were measured in study dogs.  
Testosterone concentration pre-castration was breed associated and the 
distribution of the data was affected by limitations of the assay.  Testosterone 
concentration at time point 2 was negatively associated with age, and combined 
with hair cotinine concentration, was strongly associated with weight gain after 
castration.  Hair cortisol concentrations were related to hair colour but no other 
factors.  Many of the dogs in the study gained weight above that which was 
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expected for growth.  Given the growing prevalence of obesity in dogs, the factors 
linking increased weight gain with ETS exposure warrant further analyses.  
Consultation at the time of neutering surgery may be an ideal point at which to 
speak to owners about the risks of exposure to ETS for their pet, and owners who 
do smoke may require extra nutrition advice to manage weight in their pet. 
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 Study design and recruitment 
 Breeds recruited 
The initial plan for the study was to only use Staffordshire bull terriers.  By 
keeping to one breed, it was hoped to limit some of the inter-individual variation 
not explained by age or ETS exposure in both telomeres and further potential 
biomarkers of ageing.  However, to recruit sufficient dogs for the study, the breed 
pool needed to be widened.  Some of the relationships with telomere length 
observed in this study had not previously been reported.  As seen in chapter 4, 
variables such as cephalic index were shown to be associated with telomere 
length.  This was not anticipated prior to the recruitment of cases and may 
instruct future studies such that only recruiting one breed might be better, as the 
sources of inter-individual variation in telomere length in dogs are not currently 
well described and warrant further investigation.  There were issues with 
recruitment and retention of Staffordshire bull terriers related to factors such as 
location of the Small Animal Hospital in relation to the place of residence of 
owners of these dogs.  Without private transport, the hospital can be difficult to 
access and potentially expensive.  Owners living some distance away could justify 
attending for free-of-charge neutering of their animal, but not to return for the 
follow-up.  Owners were offered a free booster vaccination as a ‘thank you’ for 
attending the 12-month follow up appointment, but the when designing the study, 
it was not anticipated that several of the Staffordshire bull terriers were not 
vaccinated, so a preliminary course may have been required rather than a one-off 
booster.  These issues are important for future work, as there is a higher 
proportion of smokers living in areas with a lower index of deprivation.  In 
addition, these owners benefitted from the offer of free neutering, as cost had 
previously been a barrier for them, which meant that a wider range of ages of 
intact dogs were recruited. 
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 Recruitment methods 
Local charities and veterinary surgeries were contacted regarding the study, but 
for various unknown reasons they generally did not assist with recruitment.  Some 
felt that by offering free-of-charge neutering they were being denied business, or 
they may have been too busy, or felt that they had no incentive to help.  Further 
discussion with such agencies would be beneficial.  If sample collection could be 
moved to a location within easier access for owners without their own transport, 
potentially this could ease recruitment and retention of owners.  The SSPCA were 
helpful in the provision of testes; however, no history could be gleaned on ETS 
exposure of these dogs.  In addition, age of these dogs was estimated through 
examination by a veterinary surgeon rather than being a matter of historical 
record.  However, by developing cut-off points in the biomarkers of ETS exposure 
in hair, the dogs could be sorted into likely exposed and unexposed groups from a 
sample of their hair.  In which case, further exploratory data could be generated 
prior to recruiting owners and dogs for future studies. 
 
 
While retention was an issue, it would be interesting to follow dogs long-term to 
see whether changes in ageing biomarkers resulted in earlier onset of diseases of 
ageing.  However, such a study would take a long time and potentially be 
expensive.  If asking about ETS exposure became part of routine veterinary history 
taking, potentially a study on veterinary databases could examine prevalence of 
diseases in ETS exposed and non-ETS exposed and at what age they occurred.  If 
diseases of ageing were demonstrated to occur at a younger age in ETS-exposed 
dogs, this could be the platform to justify a large long-term biomarker of ageing 
study in pet dogs. 
 
 
 Limitations 
As one person conducted the owner questionnaires, arranged sample collection, 
performed experimental procedures and data analyses, there was a lack of 
blinding in this study.  One of the few experiments not conducted by the author 
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was the measurement of hair nicotine and cotinine concentrations.  These 
measurements were then used as objective measures of exposure in subsequent 
chapters.  However, ideally, the person performing the laboratory work would be 
completely blind to the exposure status of the dog.  Unfortunately, there was not 
a sufficient budget available for such a person to be available. 
 
 
 Biomarkers of ETS exposure 
 Use of nicotine and cotinine 
As seen in Chapter 3, hair nicotine concentration reflected the ETS exposure of the 
dogs well.  In addition, a decrease in hair nicotine concentration was seen when in 
3 of 4 owners who gave up smoking between the two time points.  A drawback of 
using nicotine and cotinine as biomarkers of exposure, is that these compounds are 
not carcinogenic.  As discussed in Chapter 1, the carcinogenic compounds in 
tobacco smoke are present at a lower concentration than nicotine, so there may 
be issues with their measurement.  A recent study evaluated the measurement of 
tobacco specific nitrosamines in hair of non-smokers, and found that NNK showed 
promise as a biomarker of exposure (Pérez-Ortuño et al., 2016).  Pilot data could 
be generated to see if it would be possible to quantify NNK in hair of ETS exposed 
dogs, and if this relates to future cancer diagnosis.      
 
 
 Aid to smoking cessation 
As discussed in chapter 3, if smoking owners could be shown their dog’s hair 
nicotine concentration before and after giving up smoking, this could be an 
incentive to help them maintain a quit attempt.  Figures from surveys of Scottish 
smokers discussed in Chapter 1 imply that while around two-thirds of smokers wish 
to stop smoking, long term cessation can be an issue.  However, an exception to 
this plan would be the roll-your-own smokers, many of whom felt their habit did 
not cause harm to those around them.  Educating these owners regarding the 
harmful effects of ETS with their habits would certainly be a challenge and may 
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need to come from elsewhere, though awareness of adverse effects on pets could 
be a contributory incentive for some. 
 
 
 Experimental procedures 
A qPCR protocol was developed for the measurement of telomeres.  While the 
inter-assay variability of the protocol was relatively low compared to those 
published elsewhere, Southern blot is regarded as the gold standard for telomere 
measurement.  In addition, qPCR only provides an average length of telomeres, 
whereas Southern blotting procedures can be used to look at the proportion of 
short telomeres, which could be related to cellular senescence.  However, the 
inter-assay variation of the Southern blot procedures in this thesis was high.  
Further work would need to be undertaken to reduce this variability.   
Furthermore, some of the procedures could be streamlined to avoid resource 
waste.  For example, columns could be used such as AllPrep by Qiagen (Dusseldorf, 
Germany) to simultaneously extract DNA, RNA and protein from the same sample.  
This would enable telomere measurement and mRNA expression levels of CDKN2A, 
for example, from the same sample.  In addition, different brands and methods of 
DNA extraction were used in this thesis.  As was discussed in chapter 4, variation in 
telomere length has been related to the use of different extraction methods, so 
one method or brand alone should be used throughout a study. 
 
 
Further limitations of assays used has been discussed in the relevant chapters. 
 
 
 Tissues used for analyses 
Where possible, tissues which were either minimally invasive to collect or would 
otherwise be discarded, were used.  By using such tissues, samples can be 
collected from companion animals and the use of laboratory animals can be 
avoided.  As described in chapter one, biological ageing in dogs is more similar to 
humans than that of mice, so results could be more applicable to humans.  In 
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addition, for a subsection of the population, the use of experimental animals is not 
acceptable morally and samples such as these could have greater ethical 
acceptance.  However, there were some issues which arose when using these 
samples, which will be further discussed here.    
 
 
 mRNA expression in testes 
mRNA expression levels of various potential biomarkers of ageing were measured in 
testes in chapter 6.  While the testes were used because they were snap-frozen 
immediately after castration enabling extraction of good quality RNA, and they 
provide a large amount of tissue which would otherwise be discarded, several of 
the gene expressions appeared to be associated with puberty status.  Whether the 
same patterns of expression would occur in other tissues is unknown.  In addition, 
a dog can only be castrated once, so using this tissue does not offer the potential 
for longitudinal measures of gene expression levels.  In addition, many owners opt 
to castrate their dogs at around 6 months of age.  There appeared to be an 
association between mRNA expression levels of some of the genes and changes 
related to growth or puberty.  It would be interesting to measure gene expression 
levels of these markers in blood; however, collection of blood has practical, 
ethical and legal issues in the UK, for which a Home Office licence is required 
(unless the blood is surplus to requirements from clinically directed sampling).  
Spare blood samples obtained from the Veterinary Diagnostic Service were only 
available after several days’ post sampling.  Experiments would need to be 
conducted as to how long RNA in a blood sample would be stable for to assess 
whether spare blood could be used for such experiments.  
 
 
 Oral telomere length 
Buccal and saliva telomere length appeared to be associated with neutered status 
in males.  An explanation for this could not be found.  Data from chapter 4 and 5 
show that entire males often have shorter oral telomere length than castrated 
males.  In addition, chapter 7 data showed an association between buccal 
  367 
 
 
 
telomere length and testosterone concentration, reinforcing the potential link 
between buccal telomere length and neuter status.  Possibly, there is something in 
the intact male saliva which causes DNA degradation.  As telomeres are at the ends 
of chromosomes, they are at greater risk of degradation than the rest of the 
chromosome.  Without examination of the saliva of intact and castrated males it is 
difficult to speculate.  Even with such samples, it would be difficult to know what 
to look for, possibly digestive enzymes, but this would be entirely speculative.  
Another problem with the use of oral DNA in some of the dogs was aggression.  If 
the dog did not like the person collecting the sample going near its mouth, this left 
the person collecting the sample at risk of a bite injury.  Some dogs were swabbed 
through a muzzle, but if they were particularly stressed this was a rather difficult 
task, which was also questionable ethically. 
 
 
One further use for buccal DNA could be assessment of methylation.  Buccal DNA 
has been used for this purpose in human studies (e.g. Kaminsky et al., 2009).  
Given that changes in 5-mc could be demonstrated at time point 1 with both age 
and ETS exposure, it would be interesting to see if these findings could be 
replicated in a non-invasive sample. 
 
 
 Hair sampling 
While hair was successfully employed for the measurement of ETS biomarkers, 
cortisol concentration varied with colour of hair.  In addition, some of the dogs 
were nervous of clippers used to collect the hair sample.  As mentioned in chapter 
7, in future work steroid hormones could be measured in faecal samples.  A mass 
spectrometry protocol could be developed which measured hormones and ETS 
biomarkers from one sample.  However, hair nicotine was shown to be a good 
representative measure of the dog’s exposure and faecal ETS biomarkers may not 
be as good of a reflection. 
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 Issues related to neutering  
Nearly all the dogs in the study gained weight as discussed in chapter 7.  Dogs with 
a positive cotinine measure at time point 2 tended to have a higher percentage 
weight gain.  Potentially, this warrants further discussions with the owners of dogs 
at the time of neutering.  While the dogs are at lower risk of diseases such as 
pyometra in females and testicular tumours in males, there could be a risk of 
harming the dogs due to excessive weight gain causing diseases related to obesity.  
In addition, many of the dogs in non-smoking homes gained weight as well, so all 
owners may benefit from education regarding energy intake requirements after 
neutering, not just those in smoking homes.   
 
 
Staffordshire bull terriers were found to have increased testosterone 
concentrations at time point 1 compared to other breeds.  This was found in 
conjunction with increase 17βHSD mRNA expression and decreased CDKN2A mRNA 
expression in this breed in chapter 6.  Testosterone can be related to unwanted 
behaviours in dogs such as aggression, sexual behaviours and roaming.  This breed 
often has a negative reputation and it would be interesting to evaluate more fully 
whether testosterone concentration is a key part of this story.  Two of the 
Staffordshire bull terriers were relinquished by their owners during the study due 
to aggression.  However, this was, of course, after they were castrated, so there 
may well be a learnt behavioural component to this potentially complex issue.  
One Staffordshire bull terrier had a lower testosterone concentration than the 
others.  He had recently been adopted and had previously been maltreated.  As 
this was an isolated example, it is not known whether he is an exception in terms 
of his breed or if owner treatment influenced testosterone concentration in this 
dog.  Further studies are certainly warranted around this for the welfare of this 
breed.  In addition, a wider range of breed testosterone levels would be useful to 
assess whether any other breeds have particularly high testosterone 
concentrations.  This could also influence the selection of dogs for use in future 
studies examining gene expression in testes, to avoid breed confounding issues. 
 
  369 
 
 
 
 Further potential areas of investigation 
 Biomarkers of ETS exposure 
As already mentioned, the measurement of NNK concentration in dog hair could be 
trialled as a biomarker of ETS exposure.  As NNK is a carcinogen, if it is possible to 
quantify it in dog hair, it could be measured in oncology cases and a control group 
to see if concentration of NNK in dog hair is a risk factor for cancer diagnosis.  In 
the additional analyses section for Chapter 3, it was observed that there was a 
potential sex effect on nicotine metabolism.  Another possible source of variation 
is genetic variation of P450 2A6.  Genetic variations exist in humans (Malaiyandi, 
Sellers and Tyndale, 2005) and polymorphisms of other cytochrome P450 enzymes 
exist in dogs (e.g. Aretz and Geyer, 2011).  Therefore, it would be useful to 
investigate if polymorphisms exist in P450 2A6 which could impact on metabolism 
in different breeds. 
 
 Telomere length measurement 
A potential way to measure telomere length in dogs in future studies could be DNA 
sequencing.  This would avoid problems encountered such as the miniature 
schnauzers having very low telomere CT values when using qPCR, and DNA quality 
ratios being related to CT values.  While the price of this technique was too high 
for use in this study, prices are decreasing and in the future sequencing may be a 
viable option for this type of study. 
 
While there were many possible sources of inter-individual differences in telomere 
length observed, a significant relationship was demonstrated between leukocyte 
telomere length and ETS exposure.  However, unlike in the samples used in 
Chapter 4, there was no significant relationship observed between leukocyte 
telomere length and age in the ETS study dogs.  A study utilising one breed of a 
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wider range of ages could be used to see if there is a difference in age-related 
changes in telomere length with ETS exposure. 
 
 CDKN2A expression 
CDKN2A expression was significantly related to ETS exposure, but not age.  This 
could be due to the use of testes and the age distribution of the cohort.  A study of 
CDKN2A in a cohort using a different tissue could be trialled.  In addition, a 
different marker of senescence, such as beta-galactosidase, could be used to 
provide further evidence for the presence of senescent cells. 
 
 DNA methylation 
Global DNA methylation was related to ETS exposure.  As discussed in Chapter 1, a 
study earlier this year used the methylation status of selected CpGs to  generate 
an “epigenetic age” in dogs (Thompson et al., 2017).  A method such as used by 
Thompson et al could be utilised to see if dogs exposed to ETS have an older DNA 
methylation age than those not exposed. 
 
 Overall conclusions 
This study has provided a large amount of pilot data.  The numbers involved were 
small, but many avenues for further work have been generated.  This study has 
also demonstrated the use of a One Health approach to science, with the results of 
such an approach potentially benefitting both humans and animals. 
 
The study has shown: 
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• In relation to published literature at the time of the study’s inception, 
greater insight into the methods available for studying markers of ageing in 
dogs; 
• Clear evidence of an effect of ETS on some markers of ageing in verifiably 
exposed dogs; 
• Evidence of interesting and potentially important relationships between 
markers of ageing and testosterone concentration in male dogs that appears 
to be variable among breeds; 
• Some evidence that changes that occur in male dogs as they reach sexual 
maturity may be more complex and far reaching than the physiological and 
behavioural changes already known 
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ASSESSING THE EFFECTS OF ENVIRONMENTAL TOBACCO SMOKE ON CANINE 
TELOMERE LENGTH & REPRODUCTIVE FUNCTION 
 
STUDY INFORMATION FOR OWNERS 
 
 
Thank you very much for taking an interest in participating in this study which is aiming to 
look at the effects of passive smoking on pet dogs.  We will be particularly looking at the 
effect on a certain part of your pet’s DNA (the telomere), hormone levels and the cells in 
their testicles.  We will do this by neutering your pet and studying tissues collected at this 
point, and performing follow up health checks and tests over the course of a year. 
 
We are looking for male pet dogs to take part who have not been neutered previously- they 
will be neutered free of charge as part of the study.  The dogs can be of any age.  The only 
breeds excluded are those which are toy and giant sizes, due to the way the telomere 
behaves in these breeds, and non-shedding breeds such as poodles.  We would prefer the 
dogs not to have any major illnesses, but we can discuss suitability of your dog to take part 
depending on what the illness is. 
 
The study will be comparing dogs from smoking and non-smoking households, so you are 
welcome to take part whether or not you and/or another member of your household smoke.  
The levels of nicotine the dog has been exposed to will be measured by taking a small 
sample of fur at intervals.  We will ask you specific questions on the days that fur samples 
are taken so we can gather information regarding the dog’s exposure and other factors that 
may affect DNA length.  We will make use of the information about your dog and that of 
others enrolled in our study to learn more about factors that may be related to DNA length in 
dogs.  Reports of our findings will be based on trends in groups of dogs and will not identify 
individuals. 
 
You will be asked to participate in the study for one year.  At the initial assessment, your dog 
will have a check by a vet, blood tests, cheek DNA samples and a fur sample taken, and you 
will be asked various questions about your pet’s health and exposure to tobacco smoke.  If 
the dog is confirmed to be suitable for the study, a date will then be arranged for them to be 
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neutered.  We will examine the dog’s testicles and the surrounding tissues removed routinely 
at surgery.  All post-operative care required will be provided by the Small Animal Hospital 
and we will provide pain relief for you to administer to your dog at home.  You will be 
requested to return at 12 months after your dog is neutered for follow up health checks, 
cheek DNA tests and fur sampling.  During the year, I will contact you at 3 monthly intervals 
to check whether the smoking status of your household has changed and to see if your pet 
has had any health problems.   
 
As a thank you for participating, your dog will be given a free vaccination when you have 
completed the study (the exact date the vaccine is provided will depend on at what point 
your dog is in its vaccination programme).  You will be given two lots of wormers free of 
charge for allowing me to contact you 3-monthly.  Unfortunately, we will not be able to cover 
transport costs for your attendance at our clinic. 
 
If you would like to enquire further regarding the study or would like to sign up, please 
contact:  
Natalie Hutchinson  n.hutchinson.1@research.gla.ac.uk 
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EFFECTS OF ENVIRONMENTAL TOBACCO SMOKE ON CANINE 
TELOMERE LENGTH & REPRODUCTIVE FUNCTION 
 
 
Study Number…………. Name of Dog……………………………………… 
 
This sheet provides a place to record your appointment dates and gives you an idea 
of what will happen at each session. 
 
NB- You are not charged money for any of these appointments or services.  If you 
are asked to pay at any point, please do not do so and contact Natalie Hutchinson or 
Clare Knottenbelt who will remedy this situation. 
 
 
Initial assessment: 
Date:     Time:  
 
What will happen at this appointment:  
This is a meet-and-greet where you can find out more about the project and we can 
check whether your dog is definitely a suitable candidate.  You will be asked to 
complete a questionnaire about your dog and the environment they are kept in- this 
will take around 15 minutes to fill in.  You will be asked to sign a study consent form 
so we will be able to use the information you provide us for the project.   
 
Your dog will be examined by a vet and a blood sample taken for routine tests to 
ensure he is fit and well for surgery.  You will be notified immediately by telephone if 
there is any abnormality found in the blood tests when we have the results.  In order 
to take the blood sample, we will need to clip some fur from your dog’s neck. This fur 
clipping will be tested for nicotine levels. 
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Neutering: 
Date:     Admission Time: 
 
What will happen at this appointment:  
If you are happy to proceed with the study after the initial assessment, you will be 
given a date for your dog to be admitted to the Small Animal Hospital and undergo a 
neutering procedure.  This is a surgical procedure and therefore a member of 
hospital staff will go through the necessary information and provide aftercare advice 
for you to follow.  You will be asked to sign a separate consent form for surgery.  You 
will be given medication to give to your dog at home for pain relief.  You will be kept 
informed over the course of the day with how your dog is getting on and all being 
well he will be ready for collection later on the same day. 
 
During the surgery, we will take a cheek swab and retain the tissues removed during 
the operation for our study. 
 
You will need to come back for your dog’s stitches to be removed at 7-10 days after 
this day. 
 
Removal of stitches: 
Date:     Time:        
 
 
 
3/6/9 month checks (by phone or email): 
     
What will happen: 
You will be asked a complete a short questionnaire detailing any significant events 
that have occurred to your dog since we last saw you and any changes in the 
environment your dog lives in.  This can be done easily via phone or email. 
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As a thank you for completing the questionnaire, you will be provided with two lots of 
worming medication for your dog free of charge when you return for the 12 month 
appointment.  
 
 
  
 
12 month check (at Small Animal Hospital): 
Date:     Time: 
 
Your dog will have a vet check and a blood sample taken.  This will again involve 
clipping fur from the neck region.  Routine blood tests will be performed on the 
sample and you and your local vet will be notified of the results. We will take a cheek 
swab as well.  You will be asked to complete a final short questionnaire. 
 
As a thank you for attending, arrangements will be made for your dog to be 
vaccinated free of charge. 
 
 
 
 
If you have any problems with attending one of your appointments, please contact 
Natalie Hutchinson on 0141 330 8578 or by email on 
n.hutchinson.1@research.gla.ac.uk 
 
Or the Small Animal Hospital directly on 0141 330 5848 (please mention you are part 
of Clare Knottenbelt’s passive smoking dog study when speaking to reception so 
appropriate appointments can be arranged) 
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School of Veterinary Medicine 
College of Medical, Veterinary and Life Sciences 
University of Glasgow 
464 Bearsden Road 
Glasgow 
G61 1QH 
 
ASSESSING THE EFFECTS OF ENVIRONMENTAL TOBACCO SMOKE ON CANINE 
TELOMERE LENGTH & REPRODUCTIVE FUNCTION 
 
STUDY CONSENT FORM 
 
Project Number: Owner: 
Dog Name: Address: 
Age:  
Sex:  
Date:  
 
I, the owner, or agent of the above animal, hereby give my consent for the above animal to 
be included in this study. 
 
I understand that as part of the study the dog will be neutered and, as such, will be 
administered anaesthetic drugs, have surgery and require post-operative medication and 
care.  I understand that there is a small risk of anaesthetic complications, bleeding and 
infection with such a procedure.  I understand that to ensure my dog is fit to undergo such a 
procedure, pre-operative routine blood tests will be performed.  I give my permission for the 
retention of the dog’s reproductive organs which will be removed at neutering.  At the end of 
one year following the neutering procedure I agree for my dog to have further blood testing 
as part of a routine health check.  I also give my permission for a mouth swab to be taken at 
both these points. 
 
All samples, including swab from the mouth, semen, fur, testicles with surrounding tissues, 
and bloods taken will be retained for this study and other future research projects.   
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I understand that I will be asked to complete questionnaires detailing the exposure to 
tobacco smoke that this dog has experienced on a regular basis.  Fur clippings will be taken 
from the animal’s neck and tested for nicotine levels to confirm tobacco smoke exposure 
level. 
 
I understand that my dog will be allocated a project number and that all documents relating 
to this study will therefore remain anonymous, however the information may be accessed by 
staff at the Small Animal Hospital in order to provide appropriate care for the dog. 
 
I understand that it is my right to withdraw from the study at any time and that the 
participation of the dog in the study may be terminated early in the case of issues such as 
the dog developing a major illness during the study period. 
 
 
 
Signed…………………………………………………Date……………………… 
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School of Veterinary Medicine 
College of Medical, Veterinary and Life Sciences 
University of Glasgow 
464 Bearsden Road 
Glasgow 
G61 1QH 
 
 
 
 
 
 
27/08/2017 
 
ASSESSING THE EFFECTS OF ENVIRONMENTAL TOBACCO SMOKE ON 
CANINE TELOMERE LENGTH & REPRODUCTIVE FUNCTION 
 
 
Dear  
 
Re:  
The above named dog has been enrolled in our studies, “Assessing the Effects of 
Environmental Tobacco Smoke on Canine Telomere Length” and “Assessing the 
Effects of Environmental Tobacco Smoke on Canine Reproductive Function”.  The 
owner has granted me permission to contact you in inform you of their 
involvement in the study, and to communicate to you clinical information gathered 
during the study period regarding their animal. 
 
We are recruiting male pet dogs from the Glasgow area, collecting various samples 
from them to perform DNA extractions on and thus measure telomere length.  We 
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will be working with 40 dogs in all, dividing them into exposure groups based on 
both information obtained from the owner and by performing mass spectrometry 
analysis on fur samples.  All of the appointments for the study will take place at 
the University of Glasgow Small Animal Hospital and the clinical care will be 
overall supervised by Clare Knottenbelt, the Clinical Director of the hospital.   
 
In order to collect the initial samples, the dog will be neutered following a pre-
operative assessment.    At the pre-operative assessment, the dog will be 
examined by one of the vets at the Small Animal Hospital and blood samples for 
routine haematology and biochemistry tests taken as a means of health screening, 
the results of which will be made available to you.  If the dog is deemed suitable 
for the study, they will be admitted to the Small Animal Hospital soon after initial 
assessment for the neutering procedure.  We will retain the tissues removed at 
surgery for our study, and testicles and ovaries will then also be used for the 
collaborative study on reproductive function.  Post-operative care and medication 
will be provided by the hospital. 
 
The dog will then be followed up for a period of 12 months.  At 3, 6 and 9 months 
the owner will be contacted by telephone to check if there has been any change in 
their smoking or in the health of the dog.  At 12 months, the owner will be asked 
to bring their dog back to the Small Animal Hospital, when the dog will be 
examined by one of the vets and also have a further routine blood test.  In order to 
encourage owners to stay on the study, free wormers will be provided for 
completing questionnaires and a free vaccination will be given for attending the 12 
month appointment. 
 
The owner will not be charged for any of the services provided related to the 
study, including the neutering procedure.  We hope you do not feel that we are 
encroaching on services you would wish to provide for this animal.  Several of the 
dogs we are enrolling will be through charitable agencies who would normally 
partly or wholly financially contribute to the neutering of these animals, so we 
hope to ease their burden in a small way. 
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If you know of any intact male dogs you would like to be considered for the study, 
or have any other questions, please do feel free to contact myself or Clare 
Knottenbelt using the details below.  The surest contact to use is my email address 
(n.hutchinson.1@research.gla.ac.uk).  Please note, you may have heard previously 
we are recruiting only Staffordshire Bull Terriers, but we have now widened the 
study to all breeds, bar toy and giant size and non-shedding breeds. 
 
 
 
Yours sincerely 
 
 
 
 
 
Natalie Hutchinson, PhD Student 
 
 
353 Jarrett Building 
464 Bearsden Road 
University of Glasgow 
G61 1QH 
Office:  0141 3308578 
Email: n.hutchinson.1@research.gla.ac.uk 
 
 
Clare Knottenbelt 
c/o Small Animal Hospital 
Office:  0141 3307459 
Email: clare.knottenbelt@glasgow.ac.uk 
  386 
 
 
 
 
 
 
Appendix 5: Consent form to contact local 
veterinary surgeon 
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ASSESSING THE EFFECTS OF ENVIRONMENTAL TOBACCO SMOKE ON 
CANINE TELOMERE LENGTH & REPRODUCTIVE FUNCTION 
 
PARTICIPANT LOCAL VET 
 
 
 
 
 
Participant Number:   
 
Dog Name:    
 
Local Vet Name/Practice:  
     
 
 
 
I, the undersigned, hereby do/do not give permission for my local vet to be informed 
of my dog’s participation in this study.  I do/do not given permission for details 
regarding procedures undertaken and test results obtained to be communicated to 
this vet. 
 
 
 
 
 
Signed ……………………………………………… Date…………….……. 
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Appendix 6: Questionnaire 
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Assessing the Effects of Environmental Tobacco 
Smoke on Canine Telomere Length: 
Dog Fact Sheet: 1 
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Section 1: General information about your dog  
1. How old is your dog?            Years               Months 
Is this age approximate 
 Approximate  Accurate 
2. How long have you 
owned your dog? 
           Years                 Months 
3. How did you come to 
own your dog? 
 Born into my home- go to section 2 
 Purchased as puppy- go to section 2 
 Rehomed e.g. from a charity, from an 
acquaintance-                  continue to question 4 
4. If you rehomed your 
dog, where was this 
from? 
  
5. Do you know anything 
about the dog’s life 
history prior to 
rehoming? 
 Yes  No- go to section 2 
6. If you know about your 
dog’s life history prior 
to rehoming, could you 
please elaborate? 
Paying particular 
attention to any major 
events, illness or injury, 
ill treatment and, for the 
relevance of our study, 
whether the dog was 
previously in a smoking 
household 
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Section 2: your dog’s health 
7. Has your dog ever been 
treated for any of the 
following medical 
problems? Please give 
further details on the 
nature of the problem, 
treatments given and the 
date the problem was 
diagnosed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Please give details of 
illnesses and list any other 
conditions your dog has 
experienced that are not 
named here 
 
 
 
 
 Condition 
 Cancer 
Epilepsy/seizures/fits 
 Anaemia/other blood disorder 
 Heart disease 
 Lung disease 
 Kidney disease 
 Chronic diarrhoea/ other gut problem 
 Liver disease 
 Diabetes 
 Allergies 
 Skin complaints 
 Arthritis/ other joint problem 
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8. Has your dog had any 
surgical procedures in 
the past? 
 If Yes, please list 
 Yes 
 
 
 
 
 
  No  Don’t know 
 
9. If your dog is female, 
has she had any puppies 
previously? 
 
 
 
 
If yes, how many litters 
has she had? 
 N/A (dog is male) 
 Yes 
 No 
 Don’t know 
            
 
10. Does your dog receive 
any regular medications 
(including creams, 
drops, etc.)? 
 If yes, please specify 
 Yes 
 
 
 
 
 No 
11. When was your dog last 
vaccinated? 
   
12. How many times have 
you wormed your dog in 
the past 6 months? 
 None (skip to question 14) 
 Once 
 Twice 
 More than twice 
13. If you have used 
wormers, what was the 
method of 
administration? (tick all 
that apply) 
 Oral (tablet/mixed in with food) 
 Topical (Spot On) 
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14. How many times have 
you used products 
against fleas and/or 
ticks on your dog in the 
past 6 months?  
 None (skip to question 16) 
 Once 
 Twice 
 More than twice 
15. If you have used flea or 
tick treatments, what 
was the method of 
administration? 
(tick all that apply) 
 
 
 
 
 
 
 
 
 
 
 
If other, please specify 
 Oral 
 Spot On formulation  
 Spray 
 Shampoo 
 Collar 
 Other 
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Section 3: your dog’s grooming regime  
16. Are there any other dogs in 
your household? 
If yes, does this dog groom 
(lick) any of these other dogs? 
 
 Yes 
 Yes 
 No 
 No 
17. How often do you bathe your 
dog (i.e. clean with soap & 
water) or use a grooming 
service for this? 
 At least once per week 
 At least once per month 
 Every 2-3 months 
 Less often than 2-3 monthly 
 Never 
18. How often do you brush your 
dog’s fur? 
 More than once per week 
 Once per week 
 At least once per month 
 Less than once per month 
 Never 
19. How often do you brush your 
dog’s teeth? 
 More than once per week 
 Once per week 
 At least once per month 
 Less than once per month 
 Never 
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Section 4: your dog’s environment  
20. Thinking of an average day, 
what routine would your dog 
have?   
How many hours inside?  Of 
these hours inside, how many 
are spent in a room where 
smoking takes place?   
How many hours outside?  Of 
these hours outside, how many 
are spent in the company of 
someone who may be 
smoking? 
How many walks does the 
dog go on & what duration are 
these?  
 
 
 
 
               Hours inside 
               Hours inside with smoker 
               Hours outside 
               Hours outside with smoker 
Time being walked 
21. Does your dog have access to a 
private garden? 
 Yes 
 No- go to question 23 
 
22. If your dog has access to a 
garden, are any of the following 
used there (tick all that apply) 
 
 
 
 
 
 If Other, please specify 
 Weed killer 
 Slug/snail killer 
 Ant killer or other insect killer 
 Fertiliser e.g. on lawn, on plants 
 Other chemical product in garden 
 
  
Further detail: 
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23. Are any pest control products 
used in the indoor environment 
to which your dog has access? 
 
If yes, please specify 
 
 Yes 
 No 
 
 
24.  Has your dog ever lived in the 
same household as a smoker? 
 Yes  No/not that I’m 
aware of 
25. Has your dog been in regular 
contact with a smoker in the 
past 3 months? 
(NB- regular contacts includes 
household members and 
people interacted with on a 
DAILY basis outside the home) 
 Yes  No 
 
IF YOU HAVE ANSWERED “NO” TO QUESTION 26 YOU MAY FINISH THE 
QUESTIONNAIRE HERE.  THANK YOU.  IF YOU ANSWERED “YES” TO 
QUESTION 25, PLEASE COMPLETE THE REMAINING QUESTIONS. 
26. For how long has your dog 
been in regular contact with a 
smoker? 
 
 
 
 
 
 
Space for added details provided 
by owner.  For example, 
intermittent exposure with periods 
of giving up smoking, changes in 
who is at home. 
 
 For entire length of ownership 
 0-3 months 
 Longer than 3 months but less than 
one year 
 1-2 years 
 3-4 years 
 5+ years 
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27. When your dog is in contact with 
tobacco smoke where does this 
take place? Please indicate by 
circling for each of the following 
places if this contact is regularly 
(daily), occasionally (weekly or 
less) or never. 
 
During close contact with a smoker 
In pet’s home 
During car travel 
In friend’s or family’s home 
Outdoors 
 
 
 
 
 
 
 
 
 
Regularly/ Occasionally/ Never 
Regularly/ Occasionally/ Never 
Regularly/ Occasionally/ Never 
Regularly/ Occasionally/ Never 
Regularly/ Occasionally/ Never 
28. How many smokers does your 
dog regularly come into contact 
with: 
a) Within their house of 
residence 
 
b) Outside their house of 
residence 
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29. For all smokers included in the answer to question 29, please list how many 
cigarettes and other tobacco products they smoke per day on average.   
Smoker 1: Hours per day with dog 
Cigarettes (including roll up): 
 1-20 
 21-40 
 41+ 
 
 
 
 
 
 
 
 
Other tobacco products: 
 Pipe 
If yes, length of time pipe smoked per day 
  
 
 Cigars 
if yes, number of cigars  
 
Smoker 2: Hours per day with dog 
Cigarettes (including roll up): 
 1-20 
 21-40 
 41+ 
 
 
Other tobacco products: 
 Pipe 
If yes, length of time pipe smoked per day 
 
  
 Cigars 
if yes, number of cigars  
Smoker 3: Hours per day with dog 
Cigarettes (including roll up): 
 1-20 
 21-40 
 41+ 
 
 
Other tobacco products: 
 Pipe 
If yes, length of time pipe smoked per day 
 
  
 Cigars 
if yes, number of cigars  
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Smoker 4: Hours per day with dog  
Cigarettes (including roll up): 
 1-20 
 21-40 
 41+ 
 
 
Other tobacco products: 
 Pipe 
If yes, length of time pipe smoked per day 
 
  
 Cigars 
if yes, number of cigars  
 
Smoker 5: Hours per day with dog 
Cigarettes (including roll up): 
 1-20 
 21-40 
 41+ 
 
 
 
 
Other tobacco products: 
 Pipe 
If yes, length of time pipe smoked per day  
 
 
 Cigars 
if yes, number of cigars  
Smoker 6: Hours per day with dog 
Cigarettes (including roll up): 
 1-20 
 21-40 
 41+ 
 
 
 
Other tobacco products: 
 Pipe 
If yes, length of time pipe smoked per day 
 
  
 Cigars 
if yes, number of cigars  
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. 
 
 
 
 
 
 
 
 
 
Thank you very much for completing the fact sheet.  Your help with our study is 
greatly appreciated.  If you wish to give feedback on the questionnaire, please do so 
to a study representative 
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Appendix 7: Chapter 3 additional analysis 
Variables associated with hair nicotine and cotinine 
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Factors related to HNC and HCC in non-ETS exposed dogs 
In the dogs that were not exposed to ETS at home, the factors which were 
associated with their HNC and HCC measures were investigated, to see if there 
were any factors which could explain why there were no dogs with a HNC of 
0ng/mg.  Given the small numbers involved, it was likely that statistically 
significant relationships would not be found, but informative trends may have been 
seen.  In addition, as previously stated, HNC1 was not statistically significantly 
increased in group 3 dogs compared to group 2 dogs (Wilcoxon rank-sum test, 
p=0.22), nor was HCC1 increased in group 3 compared to group 2 (p=0.58).  The 
non-significant difference in HNC1 may be due to the sample size as the groups 
visually appear different on the box and whisker plots.  Therefore, analyses were 
conducted to explore whether any other variables could be associated with HNC1 
and HCC1 other than smoking not occurring indoors which could be corrected for in 
analyses.    
 
 
Time point 1 measures were focussed on, due to the higher number of dogs 
included compared to the number at time point 2.  Firstly, dog characteristics 
were considered.  No meaningful analyses could be conducted into breed or sex 
effects due to the wide variety of breeds and small number of females.  HNC1 non-
significantly increased with dog age (AIC=71.67, p=0.23).  The relationship was less 
strong between HCC1 and age (AIC=−26.97, p=0.53).  The linear model of dog 
weight to HNC1 was statistically significant (AIC=68.67, p=0.04), with weight being 
positively related to HNC1.  However, the linear model of breed height to HNC1 
was not statistically significant (AIC=71.77, p=0.24).  In addition, when HCC1 was 
examined, the linear model of dog weight to HCC1 was highly significant 
(AIC=−30.08, p<0.001), with weight being positively associated with HCC1.  Unlike 
HNC1, breed height was significantly related to HCC1 (AIC=−27.14, p=0.001), with 
taller dogs having an increased HCC1.  Breed cephalic index was non-significantly 
related to HNC1 (AIC=60.40, p=0.23), but significantly positively associated with 
HCC1 (AIC=−24.61, p<0.001).  Coat-related factors were also considered.  A 
Kruskal-Wallis test of fur length (short, medium, long) by HNC1 was statistically 
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significant (p=0.04); however, no pairwise Wilcoxon-rank sum tests were 
statistically significant after Holm p value correction, with the difference between 
medium and short hair being close to significance (p=0.06).  These findings 
regarding coat length were replicated with HCC1.  Single coat dogs had non-
significantly increased HNC1 (Wilcoxon-rank sum test, p=0.08) and had borderline 
statistically significant increased HCC1 compared to double coat dogs (p=0.045).  
Rate of shedding (low, moderate, high) and coat type (silky, smooth, wirey) did 
not impact HNC1 (p=0.57, p=0.76 respectively).  HNC1 was not significantly 
different based on hair colour (p=0.34).  In addition, rate of shedding, coat colour 
and coat type were not related to HCC1 (p=0.57, p=0.41, p=0.69, respectively).  
Regarding owner treatment of the dog’s coat, no significant differences in HNC1 or 
HCC1 were found based on regularity of brushing (HNC1: p=0.45; HCC1: p=0.43) or 
bathing (HNC1: p=0.76; HCC1: p=0.95).  
 
 
Factors relating to the dogs’ environments were also considered.  The linear model 
of index of deprivation to HNC1 was not statistically significant (AIC=71.75, 
p=0.24).  However, a significant relationship existed between index of deprivation 
and HCC1, with the linear model of index of deprivation to HCC1 indicating a 
significant positive relationship (AIC=−24.76, p=0.005).  Season of the year during 
which the hair sample was obtained, which may have impacted upon the amount 
of time spent indoors or outdoors, had no significant impact on HNC1 or HCC1 
(Kruskal-Wallis tests, HNC1 p=0.32, HCC1 p=0.13).  There was a non-significant 
tendency for HCC1 to be higher in March-May compared to the other seasons, 
however this was confounded by the dogs seen at this time tending to be heavier.  
As several people lived in flats, only a subsection of owners had private gardens.  
However, whether the dogs in the non-smoking homes had access to such a space 
or not was not significantly associated with HNC1 (Wilcoxon rank-sum test, 
p=0.61).  However, for HCC1 there was a non-significant decrease in those dogs 
with a private garden (Wilcoxon rank-sum test, p=0.06).  In those who had private 
gardens, no significant difference was found in HNC1 or HCC1 if the owners used 
garden chemicals or not (Wilcoxon rank sum tests, HNC1 p=0.52, HCC1 p=0.22).  
The times per day the dog was walked or spent outdoors were not significantly 
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modelled to HNC1 (AIC=71.27, p=0.18; AIC=72.39, p=0.37, respectively).  However, 
both the time being walked and the time spent outdoors were both significantly 
modelled to HCC1 (AIC=−28.53, p<0.001; AIC=−33.47, p=0.01).  The longer the dog 
was taken on walks per day had a positive relationship with HCC1.  This was time 
the dog spent away from the non-smoking home environment.  Time spent 
outdoors was negatively related to HCC1.  This included time spent in a private 
garden, and time spent outdoors was increased when access to a garden was 
available.  Location was divided into inner city or large town, suburban and rural 
areas.  There was no significant difference in HNC1 or HCC1 of dogs based on 
which on these types of locations they lived in (Kruskal-Wallis tests, HNC1 p=0.08, 
HCC1 p=0.42).  However, it was noted that rural based dogs tended to have lower 
HNC1 on a plot of the data.  If urban and suburban groups were combined, these 
dogs had higher HNC1 than rural based dogs (Wilcoxon rank-sum test, p=0.03).  
This comparison was not significant for HCC1 (p=0.26).  While all the dogs 
examined in these analyses currently lived in non-smoking homes, some had been 
rehomed from owners who smoked and, in the case of 2 of the dogs, their owner 
stopped smoking cigarettes 3 years ago.  Combining the dogs in the homes of 
former smokers and those adopted from smoking homes, and comparing these dogs 
with those who had been in non-smoking homes since leaving their breeder, there 
was a non-significant increase in HNC1 in those who had ever lived in smoking 
homes (Wilcoxon rank-sum test, p=0.18).  The difference was less notable in HCC1 
(p=0.32). 
 
 
Following these analyses, it was considered why one dog in group 1 had a positive 
HNC1 based on ROC generated cut-off, and if there were reasons other than assay 
related error.  This dog was a male and weighed 20.6kg.  As previously mentioned 
the median weight in this group was 14.8kg so this dog was above this.  It was a 
Staffordshire bull terrier, which have one of the highest cephalic indices of the 
breeds examined.  It was 5 years old, one of the oldest dogs to take part.  In 
addition, it lived in an inner city location.  These factors combined, particularly its 
weight and location may have been contributed to the positive HNC1.   
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Variables related to HNC and HCC in ETS exposed dogs 
As previously stated, HNC1 was not statistically significantly increased in group 3 
dogs compared to group 2 dogs (Wilcoxon rank-sum test, p=0.22), nor was HCC1 
increased in group 3 compared to group 2 (p=0.58).  The non-significant difference 
in HNC1 may be due to the sample size as the groups visually appear different on 
the box and whisker plots.  Therefore, analyses were conducted to explore 
whether any other variables could be associated with HNC1 and HCC1 other than 
smoking not occurring indoors which could be corrected for in analyses.  Again, 
time point 1 measures were focussed on due to the higher number of measures 
available for analyses.   Table A7-1 summarises the locations in which the dogs 
were exposed to ETS and results of tests to see if location where ETS exposure 
occurred was linked to HNC1 or HCC1.  Regularity of exposure of any of the noted 
locations was not significantly related with HNC1 or HCC1.   
 
 
Table0A7-1 Locations where dogs are exposed to ETS 
If exposure happens regularly (at least once a week), occasionally (less than weekly) or never.  
Kruskal-Wallis tests were conducted to explore whether the HNC1 or HCC1 were different in 
regularity of location exposure.  KW p= Kruskal-Wallis test p value 
 Regularly Occasionally Never HNC1 KW 
p 
HCC1 
KW p 
Close contact with 
owner 
14 1 5 0.27 0.15 
In pet’s home 13 1 6 0.08 0.25 
During car travel 2 5 13 0.50 0.61 
In family or friends’ 
home 
2 7 11 0.85 0.91 
Outdoors 19 1 0 0.43 0.31 
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The upper limit of the group of number of cigarettes smoked per day were totalled 
for the smokers within each dog’s home.  The total number of cigarettes were 
borderline significantly modelled to HNC1 (AIC=69.40, p=0.048), and highly 
significantly modelled to HCC1 (AIC=−0.20, p<0.001) (Figure A7.1A&B).  Adjusting 
the number of cigarettes by the proportion of the day each person spent time with 
the dog generated similar results (HNC1: AIC=69.43; p=0.049; HCC1: AIC=0.16, 
p<0.001).   
 
 
The linear model of dog age to HNC1 was not statistically significant (AIC=72.80, 
p=0.76).  HCC1 non-significantly increased with dog age (AIC=3.74, p=0.06), but 
when number of cigarettes was included in the analysis, the relationship between 
HCC1 and dog age reduced in significance (p=0.67), as owners of older dogs tended 
to smoke more cigarettes per day.  The linear model of dog weight to HNC1 was 
statistically significant (AIC=65.47, p=0.007), with dog weight being negatively 
related to HNC1.  This relationship remained significant when number of cigarettes 
smoked per day was included (AIC=66.48, p=0.009).  The negative relationship 
between dog weight and HNC1 was in contrast to that of the dogs in the non-
smoking group, which displayed a positive relationship between HNC1 and dog 
weight (Figure A7.2).  The linear model of dog weight to HCC1 was borderline 
significant (AIC=3.22, p=0.049).  This relationship was no longer significant when 
number of cigarettes per day in the home was included (p=0.42 for the weight 
variable).  Similarly to dog weight, breed height was negatively related to HNC1 
(AIC=67.63, p=0.02).  This relationship remained significant when number of 
cigarettes smoked per day was included in the analysis (AIC=67.04, p=0.01).  HCC1 
also decreased with breed height (AIC=0.28, p=0.01), but the relationship when no 
longer significant when number of cigarettes smoked per day was included.  The 
linear model of breed cephalic index to HNC1 was not statistically significant 
(AIC=53.96, p=0.19).  HCC1 was positively related to breed cephalic index 
(AIC=3.18, p<0.001), but the relationship was no longer significant when number of 
cigarettes smoked per day was included in the analysis (p=0.38).  Regarding coat-
related factors, Kruskal-Wallis tests indicated that there were significant 
differences in HNC1 and HCC1 between fur lengths (p=0.04, p=0.02, respectively).  
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Pairwise Wilcoxon rank sum tests with Holm p value correction did not reveal any 
pairwise differences in HNC1 between lengths, but a significant difference in HCC1 
was found between dogs with short and dogs with long fur (p=0.04).  However, this 
difference was no longer significant when number of cigarettes per day was 
included in a linear model of fur length to HCC1.  Fur type, single or double coat, 
fur colour and shedding rate were not significantly related to HNC1 or HCC1 (p>0.1 
for all).  In addition, no significant differences in HNC1 or HCC1 were found with 
brushing or bathing frequency (p>0.1 for all).  
 
 
Of the 6 dogs in smoking homes with negative cotinine values based on the cut-offs 
generated from the ROC analysis, 3 were in group 2 so were protected from some 
exposure within the home.  There were no obvious reasons why the other dogs had 
negative HCC1 values (aside from assay error), and did not have any shared 
characteristics of note. 
 
 
Gender 
Studies in humans have shown an increased rate of nicotine metabolism in women 
(e.g. Benowitz et al. 2006).  Therefore, dog gender was investigated for 
associations with HNC1 and HCC1.  Given the small number of females, and that 
they were spread across the exposure groups, gender was examined as a variable 
with all exposures combined.   There was no significant difference in HNC1 with 
gender (Wilcoxon rank-sum test, p=0.97).  HCC1 was increased in female dogs, but 
not significantly (p=0.23).  The ratio of HNC1:HCC1 was lower in female dogs than 
male dogs.  The test did not reach significance (p=0.06), but a trend can be seen in 
Figure A7.3.  Gender was a significant explanatory variable when included in a 
linear model of number of cigarettes per day to HNC1:HCC1 ratio, and the model 
was highly significant (AIC=156.41, p<0.001).    
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Figure0A7.1 Upper limit of number of cigarettes smoked in dog’s home by HNC1 (A) and HCC1 
(B)  
Number of cigarettes smoked in the home was significantly related to HNC1 (AIC=69.40, 
p=0.048) and HCC1 (AIC=−0.20, p<0.001) (n=19, 17 male 2 female) 
A 
B 
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Figure0A7.2 HNC1 and dog weight  
By whether the dog was in a non-smoking or a smoking home (n=41, 22 no ETS exposure, 19 
ETS exposure) 
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Figure0A7.3 The ratio of nicotine to cotinine at time point 1 by sex  
 (n=41, 37 male, 4 female)  
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Appendix 8: Chapter 4 additional analyses 
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The following analyses were conducted to determine if the causes of inter-
individual variability in LTL in the qPCR optimisation samples.  Neither weight nor 
height were significantly associated with RTL (F=0.34(1,79), R2=0.004, p=0.56, and 
F=0.81(1,79), R2=0.01, p=0.37, respectively) (Figures A8.1, A8.2).  If age was added 
as an explanatory variable, both weight and height were significantly associated 
with RTL (F=5.22(2,78), R2=0.12, p=0.007 and F=5.73(2, 78), R2=0.12, p=0.007, 
respectively).  Breed average cephalic index (CI) was also not significantly 
associated with RTL (F=3.15(1,72), R2=0.04, p=0.08, Figure A8.3), but was when age 
was added as an explanatory factor (F=4.79(2, 70), R2=0.12, p=0.01).  The breed 
estimated effective population size (EEPS), a measure of inbreeding, was not 
significantly associated with RTL (F=2.35(1,70), R2=0.03, p=0.13, Figure A8.4), but 
again when age was added as an explanatory factor the linear model was 
statistically significant (F=6.41(2,68), R2=0.16, p=0.003).  When age, cephalic index 
and estimated effective population size were used as explanatory variables, the 
linear regression to RTL was significant (F=6.36(3,60), R2=0.24, p<0.001).   
 
 
A student’s t-test showed there was no significant difference in RTL between 
neutered and entire dogs (Figure A8.5, p=0.32), despite a Wilcoxon-rank sum test 
demonstrating that dogs in the neutered group were significantly older (p=0.01).  
The difference in RTL between neutered and entire dogs was still not statistically 
significant when age was corrected for.   
 
 
While the aim was to avoid individuals with a cancer diagnosis, 7 dogs were 
subsequently discovered to have a diagnosed malignancy.  There was a statistically 
significant difference in RTL between dogs diagnosed and not diagnosed with a 
malignancy (t-test, p=0.04, Figure A8.6).  When age and diagnosis were used as 
explanatory variables, the model to RTL was statistically significant (F=5.95(3,77), 
R2=0.19, p=0.001).  When EEPS and CI were also included as explanatory variables, 
the model was improved (F=7.77(4,59), R2=0.35, p<0.001). 
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Figure A8.1 Leukocyte telomere length by dog weight  
Scatter plot of natural log of relative telomere length in leukocytes in dogs by weight of the 
dog in kilograms, with regression line.  Linear regression was not statistically significant 
(R2=0.004, p=0.56) 
 
Figure A8.2 Leukocyte telomere length by breed height  
Scatter plot of mean natural log of relative telomere length in leukocytes in dogs by the 
average height for the breed, with 95% confidence intervals (dashed lines).  The linear model 
was not statistically significant (R2=0.01, p=0.37) 
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Figure A8.3 Leukocyte telomere length by breed cephalic index 
Scatter plot of mean natural log of relative telomere length in leukocytes by breed cephalic 
index, with 95% confidence intervals (dashed lines).  The linear model was not statistically 
significant (R2=0.04, p=0.08). 
 
Figure A8.4 Leukocyte telomere length by breed EEPS 
Scatterplot of mean natural log of relative telomere length in leukocytes in dogs the estimated 
effective population size of the breed, with 95% confidence intervals (dashed lines).   The 
linear model was not statistically significant (R2=0.03, p=0.13). 
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Figure A8.5 Leukocyte telomere length by neuter status 
Dot plot of relative LTL by whether the dog was entire or neutered.  Mean value of LTL for each 
is displayed in orange, mean ± standard deviation in green, with the individual LTL values in 
grey.  There was no significant difference in RTL between the groups (p=0.32)  
 
Figure A8.6 Leukocyte telomere length by whether the dog had a malignancy diagnosed  
Dot plot of relative LTL by whether the dog was diagnosed with a malignancy.  Mean value of 
LTL for each is displayed in orange, mean ± standard deviation in green, with the individual 
RTL values in grey.  There was a significant difference between the groups (p=0.04).  
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Biochemical and haematological measures 
Biochemistry data were available for all except three dogs and haematological 
data for all bar two dogs.  However, glucose concentration was measured in only 
71 dogs and phosphate concentration in 62 dogs.  In order to look for confounding 
factors prior to exploring associations between RTL and biochemical and 
haematological measures, each measure was assessed against age, weight and 
breed life expectancy using Spearman’s rank correlation.  The Spearman’s rho 
value is displayed for each correlation test and the values in bold indicate that the 
correlation was statistically significant (Table A8-1).  The neutrophil to lymphocyte 
ratio and lymphocyte to monocyte ratio were examined in addition to the standard 
haematology measures.  
  
 
While 8 measures were significantly correlated with age, only alkaline phosphatase 
concentration (ALKP) (F=4.23(1,76), R2=0.05, p=0.04), glucose concentration 
(F=6.08(1,67), R2=0.08, p=0.02) and neutrophil to lymphocyte ratio (F=13.04(1,77), 
R2=0.14, p<0.001) were significantly associated with RTL.  None of the renal 
parameters or electrolytes, the other liver and protein parameters, red cell 
parameters, or platelet parameters were significantly associated with RTL.  
Concentrations of cholesterol and triglyceride were not significantly associated 
with RTL.  White cell parameters, except neutrophil to lymphocyte ratio, were 
also not significantly associated with RTL.  However, when factors such as age and 
EEPS were added as explanatory variables, several of the biochemical and 
haematological parameters were significantly associated with RTL.  After inclusion 
of age alone, potassium concentration was significantly associated with RTL 
(F=4.99(2,75), R2=0.12, p=0.009) as was chloride concentration (F=4.97(2, 75), R2=0.12, 
p=0.009), creatinine concentration (F=5.10(2, 75), R2=0.12, p=0.008) and mean 
platelet volume (MPV) (F=5.08(2, 76), R2=0.12, p=0.008).  Inclusion of EEPS as an 
explanatory variable resulted in lymphocyte to monocyte ratio being significantly 
associated with RTL (F=4.17(2, 67), R2=0.11, p=0.02).  When age and EEPS were 
added as explanatory factors, sodium concentration was significantly associated 
with RTL (F=4.45(3,65), R2=0.17, p=0.007), as was calcium concentration (F=4.87(3, 
65), R2=0.18, p=0.004) as well as globulin concentration (F=4.44(3, 65), R2=0.17, 
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p=0.007), red cell count (RBC) (F=5.03(3, 66), R2=0.19, p=0.003), haemoglobin 
concentration (F=4.46(3, 66), R2=0.17, p=0.006), haematocrit percentage (HCT) 
(F=4.25(3, 66), R2=0.16, p=0.008), mean corpuscular haemoglobin concentration 
(MCHC) (F=4.40(3, 66), R2=0.17, p=0.007) and red cell distribution width percentage 
(RDW) (F=4.19(3, 66), R2=0.16, p=0.009).     
 
 
Figure A8.7 illustrates the correlation between age, weight, life expectancy and 
RTL with serum phosphate concentration.  Phosphate concentration was 
significantly negatively correlated with age, but unrelated to RTL.  Median serum 
phosphate concentration was not significantly correlated with breed life 
expectancy, but there was a downward trend and the breed with the shortest life 
expectancy, the Dogue de Bordeaux, had the highest median serum phosphate 
(2.2mmol/L).  In addition, breed life expectancy was not correlated with breed 
mean RTL (Spearman’s rho=−0.30, p=0.28), but was significantly negatively 
correlated with median breed weight (Spearman’s rho=−0.64, p=0.01), Figure A8.8. 
Dogs that were known to have died during the episode of treatment in which the 
blood sample used for analysis was taken were grouped and compared to the other 
dogs who were not recorded to have died during the episode.  It was not known 
how much longer the dogs in the alive group lived, some may have died soon after.  
Those in the “died” group included those euthanised, as there were only 7 dogs 
known to have died in total.  Illnesses related to deaths, or reasons for euthanasia, 
were hepatopathy, granulomatous meningoencephalitis, degenerative cerebral 
disease, spinal cord embolism, renal disease and two cases of osteosarcoma.  A 
t-test showed there was not a significant difference in RTL between those who 
died and did not (p=0.12), but when age and death were used as explanatory 
variables in linear regression to RTL, the model was significant (F=4.07(3,77), 
R2=0.14, p=0.01).  
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Table A8-1 Correlations between biochemical and haematological blood measures and age, 
weight and breed life expectancy 
Spearman’s rho correlation values are shown in the cells.  Rho values in bold indicate the 
correlation was statistically significant, with *=p<0.05, **=p<0.01, ***=p<0.001. 
  Age Weight Breed life expectancy 
Sodium -0.04 0.08 -0.05 
Potassium -0.13 0.03 -0.22* 
Chloride -0.04 0.21 0.04 
Calcium -0.06 -0.08 0.09 
Phosphate -0.29* -0.23 0.02 
Urea 0.23* 0.31** -0.13 
Creatinine 0.23* 0.56*** -0.16 
Glucose 0.04 -0.19 0.14 
Cholesterol 0.18 0.02 -0.13 
Triglyceride 0.26* -0.06 -0.003 
Alkaline phosphatase 0.29** -0.22* 0.23* 
AST 0.14 0.11 -0.05 
ALT 0.06 0.03 -0.06 
GGT 0.06 0.21 0.17 
Total protein 0.06 -0.05 0.02 
Albumin -0.08 -0.17 0.10 
Globulin 0.11 0.05 -0.07 
Albumin:globulin ratio  -0.18 -0.10 0.05 
RBC 0.04 0.27* -0.07 
Haemoglobin 0.01 0.29** -0.07 
HCT -0.01 0.26* -0.04 
MCV -0.20 -0.20 0.13 
MCH -0.19 -0.05 -0.06 
MCHC 0.12 0.27* -0.20 
RDW 0.05 -0.19 0.05 
Leukocytes 0.01 -0.10 -0.006 
Neutrophils 0.08 -0.11 0.02 
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Lymphocytes -0.37*** -0.04 -0.04 
Neutrophil:lymphocyte 
ratio 0.27* -0.07 0.08 
Monocytes 0.09 -0.15 0.04 
Lymphocyte:monocyte ratio -0.28* 0.11 -0.09 
Eosinophils -0.15 0.11 -0.09 
Basophils -0.14 -0.12 0.26* 
Platelets 0.12 -0.29** 0.10 
MPV -0.12 0.22* -0.28* 
PCT 0.11 -0.27* 0.02 
PDW -0.11 0.25* -0.29** 
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Figure A8.7 Serum phosphate concentration 
Scatterplots of log phosphate by dog age (A), log phosphate by dog weight (B), median serum 
phosphate by breed life expectancy (C) and log telomere length by serum phosphate (D), with 
regression line.  The red dashed lines in plot D represent the reference range values given by 
the diagnostics laboratory.  There was a significant linear regression between log phosphate 
and age (R2=0.07, p=0.04), but no significant regression between log phosphate and weight 
(R2=0.04, p=0.11), log telomere length and phosphate (R2=0.01, p=0.53) or breed life expectancy 
and median serum phosphate (Spearman’s rho=-0.04, p=0.90). 
 
 
  
A B 
C D 
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Figure A8.8 Breed life expectancy by leukocyte telomere length and by dog weight 
Scatterplots of breed life expectancy by breed mean relative telomere length (A) and breed 
median weight (B), with regression line.  There was no significant correlation between life 
expectancy and telomere length (Spearman’s rho=−0.30, p=0.28), but there was between life 
expectancy and weight (Spearman’s rho= −0.64, p=0.01). 
A 
B 
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Other factors 
Index of deprivation 
The index of deprivation was obtained for each owner using their postcode.  Five 
owners lived in England and therefore were not included, as the measure was 
obtained from the Scottish government website.  The linear model of the index of 
deprivation to RTL was not significant (Figure 4.24, F=3.22(1,74), R2=0.04, p=0.08).  
Index of deprivation was still not a statistically significant explanatory variable 
when other factors such as age, cephalic index and estimated effective population 
size were included. 
 
 
 
Figure A8.9 Leukocyte telomere length in dogs by owner index of deprivation  
Scatter plot of natural log of relative telomere length in leukocytes by owner index of 
deprivation, with regression line.  The linear model was not significant (R2=0.04, p=0.08). 
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Extraction kit 
A portion of the bloods were DNA extracted using a Qiagen kit and the remaining 
using a Macherey Nagel kit, as described in the methods section.  A t-test showed 
that the log RTLs were significantly longer when the samples were extracted using 
a Qiagen kit (Figure A8.9, p=0.01).  However, when age in the two groups was 
compared using Wilcoxon rank sum tests, the Macherey Nagel extracted group 
were significantly older (p=0.01) and had higher neutrophil to lymphocyte ratios 
(p=0.03). 
 
 
The 260/280 ratios of samples extracted using the Qiagen kit were significantly 
higher than those extracted using the Macherey Nagel kit (Wilcoxon rank sum test, 
p=0.003).  The converse was true for the 260/230 ratio; those extracted with the 
Macherey Nagel kit had significantly higher ratios (Wilcoxon rank sum test, 
p<0.001).  Linear models revealed no significant relationship between RTL and 
260/280 (p=0.35) or 260/230 (p=0.84) ratio.  There was, however, a statistically 
significant negative correlation between 260/280 ratio and telomere CT 
(Spearman’s rho=−0.27, p=0.01), but no significant correlation between telomere 
CT and 260/230 ratio (Spearman’s rho=0.06, p=0.64).  There were no statistically 
significant correlations between HBD CT and 260/280 ratio (Spearman’s rho=-0.008, 
p=0.94), or HBD CT and 260/230 ratio (Spearman’s rho=−0.06, p=0.63).  In addition, 
there was a significant negative correlation between 260/280 and age (Spearman’s 
rho=−0.27, p=0.02) and a statistically significant positive correlation between 
260/230 ratio and age (Spearman’s rho=0.25, p=0.04).  Table A8-2 shows the 
correlation values for white cell counts and ratios against DNA quality measures 
and CT values from the telomere and HBD PCRs.  The white cell count of the 
sample was significantly positively correlated with 260/230 ratio, as well as being 
negatively correlated with CT values in both PCRs.    
  
424 
 
 
 
Table A8-2 Correlations between white cell differentials, DNA quality and qPCR crossing 
points 
Correlations between white cell differential values, DNA sample absorbance ratios and 
crossing points in qPCR assays.  The values displayed are the correlation coefficients.  *= 
p<0.05, **=p<0.01, ***=p<0.001 
 
260/280 260/230 Ct Tel Ct HBD 
White cell count 0.20 0.39*** -0.29** -0.26* 
Neutrophil count 0.18 0.43*** -0.14 -0.25* 
Lymphocyte count 0.10 -0.14 0.07 -0.09 
Neutrophil:lymphocyte 
ratio 0.05 0.29* -0.18 -0.18 
Monocyte count 0.26* 0.30* -0.08 -0.19 
Lymphocyte:monocyte 
ratio -0.18 -0.33** 0.24* 0.14 
Eosinophil count 0.09 -0.01 0.13 -0.04 
Basophil count -0.07 -0.03 0.05 -0.09 
 
 
 
  
425 
 
 
 
 
Figure A8.10 Leukocyte telomere length by the kit used to extract DNA 
Dot plot of natural log of relative telomere length by whether the DNA had been extracted 
using a kit by Macherey Nagel or Qiagen.  The mean value is shown in orange and 95% 
confidence intervals in green.  A student’s t-test was performed which showed a significant 
difference in log of LTL between the groups (p=0.01) 
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Overall linear regression model 
To work out the combination of explanatory variables from all those examined for 
the qPCR optimisation samples that would best explain inter-individual variation in 
RTL, the “drop1” function was used.  As there were so many variables, there were 
not enough degrees of freedom in the model to permit all explanatory variables to 
be tested in one attempt.  Therefore, one model, “model1”, was developed with 
breed and without phosphate and glucose concentrations, as not all dogs had these 
variables tested in biochemical analyses and breed took up many degrees of 
freedom.  In addition, this model did not include CI, EEPS, breed lifespan or breed 
height as these were the same for members of each breed (Table A8-3).  A second 
model, “model2” was developed without breed as a variable, but with CI, EEPS, 
lifespan and height included as starting variables (Table A8-4).  The drop1 
combined with an “F” test provides p values for each variable.  The highest p value 
variable is removed and then the model re-tested, until all variables have a p 
value of less than 0.05.  As the intercept was not significant for model1, the model 
was fitted without an intercept.  Interestingly, age was not retained as an 
explanatory variable in model1. 
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Table A8-3 model1, generated using drop1 to decide upon explanatory variables to model RTL 
Parameter Estimate Standard 
error 
t value Pr 
(>|t|) 
Breed- Akita -1.35 0.77 -1.74 0.09 
Breed- Bichon frise -0.90 0.78 -1.15 0.26 
Breed- Border collie -1.38 0.77 -1.78 0.08 
Breed- Cavalier King Charles 
spaniel 
-1.88 0.80 -2.34 0.02 
Breed- Chihuahua -1.42 0.76 -1.88 0.07 
Breed- Dalmatian -1.40 0.74 -1.89 0.07 
Breed- Dobermann -1.27 0.77 -1.65 0.11 
Breed- Dogue de Bordeaux -1.04 0.76 -1.37 0.18 
Breed- English springer spaniel -1.18 0.75 -1.57 0.12 
Breed- Flat coated retriever -1.13 0.77 -1.47 0.15 
Breed- Greyhound -0.99 0.77 -1.29 0.20 
Breed- Rhodesian ridgeback -1.87 0.79 -2.37 0.02 
Breed- Siberian husky -1.29 0.68 -1.88 0.07 
Breed- Weimaraner -0.96 0.74 -1.29 0.20 
Breed- West Highland white 
terrier 
-1.28 0.76 -1.70 0.10 
Diagnosis- Cancer -0.53 0.13 -4.22 0.0001 
Sodium:potassium ratio -0.02 0.009 -2.34 0.02 
Cholesterol -0.03 0.01 -2.68 0.01 
Albumin 0.04 0.01 2.65 0.01 
Albumin:globulin ratio -0.79 0.31 -2.54 0.01 
Red blood cell count -0.09 0.04 -2.34 0.02 
Lymphocyte count 0.14 0.06 2.55 0.01 
Monocyte count -0.22 0.08 -2.60 0.01 
Platelet count 0.003 0.001 2.06 0.04 
Mean platelet volume 0.06 0.02 2.86 0.006 
Plateletcrit -2.37 1.11 -2.14 0.04 
Platelet distribution width 0.03 0.008 3.28 0.002 
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Multiple R2 0.69    
Adjusted R2 0.51    
F (27,48) 3.92    
p-value 1.819x10-5    
 
 
 
 
Table A8-4 model2, generated using drop1 but excluding breed as an explanatory variable 
Parameter Estimate Standard 
error 
t value Pr 
(>|t|) 
Intercept -5.22 1.72 -3.03 0.004 
Age -0.03 0.01 -2.53 0.02 
Diagnosis- Cancer -0.39 0.14 -2.75 0.008 
Extraction kit- Qiagen 0.20 0.07 2.81 0.007 
Estimated effective population size -0.004 0.001 -3.83 0.0004 
Cephalic index -0.01 0.004 -3.49 0.001 
Potassium 0.78 0.18 4.36 0.00007 
Sodium:potassium ratio 0.10 0.02 4.15 0.0001 
Mean cell volume -0.02 0.007 -2.20 0.03 
White cell count -0.08 0.04 -2.10 0.04 
Neutrophil count 0.11 0.04 2.40 0.02 
Neutrophil:lymphocyte ratio -0.01 0.004 -3.03 0.004 
Platelet distribution width 0.01 0.005 2.15 0.04 
     
Multiple R2 0.66    
Adjusted R2 0.58    
F (12,47) 7.70    
p-value 1.23x10-7    
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9  
Appendix 9: Studies examining telomere length and 
smoking 
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Studies examining relationship between smoking and telomere length in humans 
Community and occupational based recruitment studies 
Abbreviations 
CS/Lo  Cross sectional/longitudinal telomere length measurement 
M  Male 
F  Female 
#  Number of study participants 
%Smoker Percentage of study participants classed as active smokers 
PC  Phenol/chloroform 
IP  Isopropanol precipitation 
CL  Cell lysis 
SO  Salting-out 
SI  Sodium iodide 
MB  Magnetic bead 
TRF  TRF analysis 
%COV  Percentage inter-assay coefficient of variation 
Cat  Categorical 
Cont  Continuous 
-ve  Negative (active smoking status or increasing pack years decreased telomere length) 
+ve  Positive (active smoking status or increasing pack years increased telomere length) 
DM  Diabetes mellitus 
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MDD  Major depressive disorder 
BPD  Bipolar disorder  
SLE  Systemic lupus erythematosus  
TAA  Thoracic aortic aneurysms 
AAA  Abdominal aortic aneurysm 
COPD  Chronic obstructive pulmonary disease 
CCU  Coronary care unit 
GI  Gastrointestinal 
HIV   Human immunodeficiency virus 
CABG  Coronary artery bypass graft  
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 Study group CS/Lo 
# 
Sex %Smoker Age Healthy? Tissue 
DNA 
Extraction 
Measure 
COV% 
Relation 
with age 
Smoking 
measure Effect 
Barbieri et 
al. 2009 
Residents in 
the Campania 
region  CS 
476 
MF <25 45-59 Yes Blood NS 
TRF 
NS Yes Cat No 
Boccardi 
et al. 2013 
Residents in 
the Campania 
region  CS 
217 
MF <25 60+ Yes Blood Column 
qPCR 
1.98 Yes Cat Yes -ve 
Borghini 
et al. 2015 
Endurance 
athletes plus 
controls CS 
62 
MF <25 45-59 Yes Saliva Column 
qPCR 
4.6-7 No Cat No 
Carty et 
al. 2015 
Enrolled by 
the Women's 
Health 
Initiative CS 
1525 
F <25 60+ Yes Blood Unclear 
TRF  
2 Yes Cat Yes, -ve 
Chan et al. 
2010 
Invited to 
health check CS 
2006 
MF <25 60+ Yes Blood PC 
qPCR 
11.2/14.2 No Cat No 
Cui et al. 
2014 
Community 
based cohort 
populations CS 
4351 
MF 25-49 45-59 
CHD, 
controls Blood Auto 
qPCR 
1.28 Yes Cat No 
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Hoxha et 
al. 2009 
Traffic officers 
and office 
workers CS 
134 
MF 50+ NS Yes Blood PC 
qPCR 
NS Yes Both Yes -ve 
Kahl et al. 
2016 
Community 
sample CS 
124 
MF <25 <45 Yes Blood Column 
qPCR 
NS No Cat Yes -ve 
Kasielski 
et al. 2015 
Routine 
physical 
examination 
attendees CS 
28 
MF 50+ <45 Yes Blood Column 
qPCR 
NS NS Cat No 
Kiefer et 
al. 2008 
Pre- and post- 
menopausal 
women CS 36 F <25 <45 Yes Blood NS 
qPCR 
NS No Cat No 
Laine et 
al. 2015 
Elite athletes 
& controls CS 
586 
M <25 60+ Yes Blood NS 
qPCR 
7.14 Yes Cat No 
Latifovic 
et al. 2016 
Healthy 
volunteers CS 
477 
MF <25 NS Yes Blood IP 
qPCR 
6.39 Yes Both Yes -ve 
Li et al. 
2011 
Rubber 
industry 
workers CS 
157 
MF 25-49 <45 Yes Blood Column 
qPCR 
6.4 Yes Cat No 
Li et al. Healthy CS 364 50+ <45 Yes Blood CL qPCR Yes Cat Yes -ve 
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2013 volunteers M 7.2 
Lynch et 
al. 2016 
Recruits from 
Centers for 
Population 
Health and 
Health 
Disparities CS 
1510 
MF 50+ 45-59 
15.7% 
cancer Blood Mix 
TRF  
1.25 No Cat No 
Pawlas et 
al. 2015 
Lead smelters 
& controls CS 
394 
M 25-49 <45 Yes Blood Column 
qPCR 
NS Yes Cat No 
Raymond 
et al. 2014 
Families 
recruited CS 
580 
MF <25 <45 Yes Blood SO 
qPCR 
NS Yes Cat No 
Satoh et 
al. 1996 
Company 
employees & 
former poison 
gas factory 
workers CS 
352 
MF NS NS Yes Blood SI 
TRF 
NS Yes Cat No 
Shin et al. 
2010 
Community 
based health 
survey CS 
84 
MF 25-49 45-59 Yes Blood SO 
qPCR 
7.5 No Cat No 
Song et al. Healthy CS 103 NS NS Yes Blood SO qPCR Yes Cont Yes -ve 
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2010 volunteers NS NS 
Tyrka et 
al. 2015 
Community 
sample CS 
335 
MF <25 <45 
Mental 
health 
issues Blood NS 
qPCR 
NS No Cat Yes -ve 
Walters et 
al. 2014 
General 
population 
recruits CS 
58 
MF 50+ <45 Yes 
Blood & 
Small airway 
epithelium SO 
TRF 
NS 
Only in 
non-
smokers Both Yes -ve 
Woo et al. 
2009 
Community 
health check CS 
1936 
MF NS NS 
Diseases 
of old age Blood PC 
qPCR 
6.1, 7.5 
Only in 
men Cat Yes -ve 
 
Clinical recruitment studies 
 
Study group CS/Lo 
# 
Sex %Smoker Age  Tissue  Extraction 
Method 
COV % 
Relation 
with age 
Smoking 
measure Effect  
Aida et al. 
2013 
Upper GI endoscopy 
patients with alcohol 
dependency CS 
52 
M 50+ 60+ 
Oesophageal 
biopsies n/a 
qFISH 
NS NS Cat No 
Aida et al. 
2015 
Lung cancer cases 
and non-lung cancer 
autopsy cases CS 
89 
MF 50+ 60+ Lung n/a 
qFISH 
NS No Cat Yes +ve 
Atturu et AAA cases and CS 373 50+ 60+ Blood SO TRF No Cat No 
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al. 2010 controls MF NS 
Aulinas et 
al. 2015 
Cushing's syndrome 
cases & controls CS 
154 
MF <25 45-59 Blood PC 
TRF 
NS Yes Cat No 
Balistreri et 
al. 2014 
Sporadic TAA cases 
and controls CS 
160 
MF 25-49 60+ Blood Column 
TRF 
NS Yes Cat Yes -ve 
Boyer et al. 
2015 
COPD cases plus 
controls CS 
273 
MF 25-49 45-59 Blood NS 
qPCR 
NS NS Cat No 
Broberg et 
al. 2005 
Bladder cancer cases 
plus controls CS 
156 
MF <25 60+ Buccal Column 
qPCR 
NS 
Only in 
cases Cat No 
Brouilette 
et al. 2003 
Recruited from CCU 
registries plus 
controls CS 
383 
MF <25 45-59 Blood SO 
TRF 
3.3 Yes Both No 
Brouilette 
et al. 2008 
Recruits with family 
history of coronary 
artery disease & 
controls CS 
104 
MF 25-49 <45 Blood NS 
TRF 
NS 
Only in 
cases Both No 
Cronkhite 
et al. 2008 
Idiopathic interstitial 
pneumonia cases & 
controls CS 
353 
MF 50+ 45-59 Blood NS 
qPCR & 
TRF 
<9, 13.6 Yes Both No 
de Vusser Donors of kidney CS 217 25-49 45-59 Blood SO qPCR Yes Cat No 
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et al. 2015 transplants & 
recipients  
MF NS 
Dlouha et 
al. 2016 
Acute coronary 
syndrome cases plus 
controls CS 
1147 
F 25-49 45-59 Blood SO 
qPCR 
3.4-14.8 Yes Cat No 
Du et al. 
2015 
Gastric cancer cases 
& controls CS 
2148 
MF 50+ NS Blood NS 
qPCR 
10.16 Yes Cat 
Yes +ve 
in 
cases 
Farhat et 
al. 2008 
Patients undergoing 
CABG CS 
67 
MF 25-49 60+ 
Endothelial 
cells PC 
TRF 
NS NS Cat Yes +ve 
Garland et 
al. 2014 Breast cancer cases CS 
392 
F <25 60+ Blood NS 
TRF 
NS Yes Cat No 
Getliffe et 
al. 2005 
Ulcerative colitis & 
Crohn’s disease cases CS 
34 
MF 25-49 45-59 Blood SO 
qPCR 
NS Yes Cat No 
Haque et 
al. 2013 SLE cases & controls CS 63 F NS 45-59 Blood Auto 
qPCR 
NS No Cat Yes +ve 
Hartmann 
et al. 2010 
Depression cases & 
controls CS 
74 
MF 25-49 45-59 Blood Column 
TRF 
NS Yes Cat No 
Hou et al. 
2009 
Gastric 
adenocarcinoma CS 
716 
MF 25-49 NS Blood NS 
qPCR 
8.1 Yes Both Yes -ve 
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cases & controls 
Houben et 
al. 2009 
COPD patients plus 
controls CS 
122 
MF NS 60+ Blood SO 
qPCR 
NS Yes  Cont No 
Humphreys 
et al. 2012 
Women reporting 
interpersonal 
violence & controls CS 
102 
F 25-49 <45 Blood NS 
qPCR 
3.5 Yes Both Yes +ve 
Imam et al. 
2012 
HIV infected women 
and women enrolled 
in a mother/child HIV 
cohort study CS 
120 
F 25-49 <45 Blood Auto 
qPCR 
NS NS Cat No 
Immonen 
et al. 2013 
Age related macular 
degeneration cases & 
controls CS 
186 
MF 25-49 60+ Blood SO 
TRF 
NS No Cat No 
Jang et al. 
2008 
Lung cancer cases & 
controls CS 
486 
MF 25-49 45-59 Blood Column 
qPCR 
7.5 Yes Both No 
Jergović et 
al. 2014 
Post-traumatic stress 
disorder cases & 
controls CS 
47 
M 50+ 45-59 Blood PC 
qPCR 
11.21 No Cat 
Yes -ve 
in 
cases 
Jiang et al. 
2013 
Stroke patients & 
siblings, & controls CS 
450 
MF 25-49 45-59 Blood Column 
qPCR 
6.7 Yes Cat No 
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Kato et al. 
2016 Dialysis patients Lo 
59 
MF <25 60+ Blood NS 
qPCR 
NS No Cat No 
Leung et al. 
2016 
Mindfulness program 
for overweight 
pregnant women Lo 
65 
F 25-49 <45 Blood Column 
qPCR 
2.5 Yes Cat No 
Lin et al. 
2013 
Part of a cancer 
screening study CS 
231 
MF 25-49 45-59 
Oesophageal 
cells SO 
qPCR 
8.5 No Cat No 
Liu et al. 
2009 
Gastric 
adenocarcinoma 
patients & controls CS 
774 
MF 25-49 45-59 Blood Column 
qPCR 
NS Yes Cat No 
Liu et al. 
2011 
Hepatocellular 
carcinoma cases, 
hepatitis B virus 
related chronic liver 
disease cases & 
controls CS 
480 
MF 25-49 45-59 Blood Column 
qPCR 
NS 
Only in 
chronic 
liver 
disease 
cases Cat No 
Liu et al. 
2015 
HIV positive cases & 
controls CS 
922 
MF 50+ 45-59 Blood Column 
qPCR 
NS Yes Both Yes -ve 
Magd et al. 
2015 
COPD cases & 
controls CS 
31 
M 25-49 45-59 Blood NS 
qPCR 
NS No Both Yes -ve 
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Matsumoto 
et al. 2015 Acromegaly cases CS 
46 
MF <25 45-59 Blood SO 
qPCR 
NS No Cat No 
Morlá et al. 
2006 
Smokers with & 
without COPD, plus 
controls CS 76M 50+ 45-59 Blood n/a 
FISH 
NS 
Only in 
smokers Cont Yes -ve 
Neuner et 
al. 2015 Blood donors CS 
343 
MF 50+ <45 Blood NS 
qPCR 
3.9 Yes Both No 
Pathai et 
al. 2013 
HIV positive cases & 
controls CS 
486 
MF NS <45 Blood Auto 
qPCR 
NS No Cont No 
Pavanello 
et al. 2011 
Alcohol dependents 
plus controls CS 
457 
M 25-49 <45 Blood IP 
qPCR 
3 Yes Both Yes +ve 
Raymond 
et al. 2013 
Idiopathic dilated 
cardiomyopathy & 
controls CS 
450 
MF <25 45-59 Blood SO 
qPCR 
NS Yes Cat Yes -ve 
Sadr et al. 
2015 
COPD cases & 
controls CS 
169 
MF 50+ 60+ Blood Column 
qPCR 
NS NS Cat No 
Sanchez-
Espiridion 
et al. 2014 
Lung cancer cases & 
controls CS 
2052 
MF 50+ 60+ Blood Column 
qPCR 
NS Yes Both Yes -ve 
Savale et COPD cases & CS 291 50+ 60+ Blood NS qPCR Yes Both No 
441 
 
 
 
al. 2009 controls MF NS 
Shen et al. 
2012 
Type 2 DM cases & 
controls CS 
4016 
MF <25 60+ Blood NS 
qPCR 
NS Yes Cat No 
Simon et 
al. 2006 
MDD, BPD, & 
controls CS 
88 
MF 25-49 45-59 Blood NS 
TRF 
NS No Cat No 
Srinivasa et 
al. 2014 
HIV positive cases & 
controls CS 
142 
M NS 45-59 Blood MB 
qPCR 
7 No Cont No 
Steer et al. 
2007 
Rheumatoid arthritis 
cases & controls CS 
1327 
MF 25-49 45-59 Blood PC 
TRF 
0.92 NS Cat No 
Suraweera 
et al. 2016 
Colorectal cancer & 
colorectal adenoma 
cases CS 
324 
MF  25-49 60+ 
Tumour, 
normal gut 
mucosa Column 
qPCR 
7.5, 8.4 NS Cat No 
Tentolouris 
et al. 2007 Type 2 DM cases CS 
84 
M <25 60+ Blood NS 
TRF 
NS Yes Cat No 
Tomita et 
al. 2010 
COPD cases & 
controls CS 
44 
MF 50+ 45-59 
Lung 
biopsies, 
alveolar 
macrophages n/a 
qFISH 
NS NS Both Yes -ve 
Unryn et al. 
2006 
Head & neck cancer 
cases & controls CS 
110 
MF NS NS Blood PC 
TRF 
NS NS Both Yes -ve 
442 
 
 
 
Verde et al. 
2016 
Recruited from 
Occupational 
Medicine Committee CS 
145 
MF 50+ <45 Blood PC 
qPCR 
NS Yes Cont Yes -ve 
Verde et al. 
2015 
Recruited from 
Occupational 
Medicine Committee CS 
147 
MF 50+ <45 Blood NS 
qPCR 
NS No Cont Yes -ve 
Wang et al. 
2014 
Glioma cases & 
controls CS 
934 
MF <25 <45 Blood IP 
qPCR 
NS Yes Cat No 
Xiao et al. 
2011 
Type 2 DM cases & 
controls CS 1797 <25 60+ Blood NS 
qPCR 
NS Yes Cat Yes -ve 
Zhou et al. 
2015 Type 2 DM cases CS 556 <25 45-59 Blood Column 
qPCR 
7 No Cat No 
 
As part of larger study 
 
Study 
CS/ 
Lo # Sex 
% 
Smoker Age  Healthy? Tissue  
Extra- 
ction 
Method 
COV % 
Relation 
with age 
Smoking 
measure Effect  
Mui et al. 
2009 
Advair Biomarker 
in COPD study CS 283 MF NS 60+ All COPD cases Blood NS 
qPCR 
NS Yes Both No 
Andreotti et 
al. 2015 
Agricultural 
Health Study CS 568 M <25 
45-
59 Yes Blood Unclear 
qPCR 
6.2 Yes Cat No 
443 
 
 
 
Hou et al. 
2013 
 
CS 1234 M <25 NS Yes Buccal IP 
qPCR 
NS Yes Both No 
Shen et al. 
2011 
Alpha- 
Tocopherol, Beta-
Carotene Cancer 
Prevention study CS 458 M 50+ 
45-
59 
Lung cancer 
cases & 
controls Blood PC 
qPCR 
7 No Cont Yes -ve 
Bekaert et al. 
2007 
Asklepios cohort 
study CS 
2509 
MF <25 
45-
59 Yes Blood SO 
TRF 
2.76 Yes Both No 
Sen et al. 2014 
Austrian Stroke 
Prevention Study CS 786 MF <25 60+ Yes Blood PC 
qPCR 
NS Yes Cat No 
Saßenroth et 
al. 2015 
Berlin Aging Study 
II CS 809 MF <25 60+ Yes Blood IP 
qPCR 
NS No Cat No 
Aviv et al. 
2009 Bogalusa Heart 
Study 
 
Lo 635 MF 25-49 <45 Yes Blood SO 
TRF  
1.4 Yes Cat Yes -ve 
Chen et al. 
2011 Lo 271 MF 25-49 <45 Yes Blood NS 
TRF  
NS Yes Cat Yes -ve 
Shen et al 
2007 
Breast Cancer 
Family Registry CS 637 F 25-49 
45-
59 
Breast cancer 
cases & 
controls Blood SO 
qPCR 
28 No Both No 
Ehrlenbach et Bruneck Study Lo 510 MF <25 60+ Yes Blood IP qPCR At 1 TP Cat No 
444 
 
 
 
al. 2009 NS out of 3 
Fitzpatrick et 
al. 2007 
Cardiovascular 
Health Study 
CS 419 MF <25 60+ Yes Blood NS 
TRF  
1.5 Yes Cat No 
Fitzpatrick et 
al. 2011 CS 
1136 
MF <25 60+ Yes Blood NS 
TRF  
1.7 Yes Cat 
Yes 
(former 
shortest) 
Sanders et al. 
2012 CS 419 MF <25 60+ Yes Blood NS 
TRF  
1.5 Yes Cat Yes -ve 
Zanet et al. 
2014 
Children and 
women: 
AntiRetrovirals 
and the 
Mechanisms of 
Aging study CS 395 MF 25-49 <45 
HIV positive 
cases & 
controls Blood NS 
qPCR 
NS Yes Both Yes -ve 
Chen et al. 
2015 
Chile Pediatric and 
Adult Sleep and 
Stress study CS 89 MF 25-49 <45 Yes Saliva NS 
qPCR 
<12 Yes Cat Yes -ve 
Osler et al. 
2016 
Copenhagen 
Ageing Midlife 
Biobank study CS 324 M <25 NS Yes Blood Auto 
qPCR 
5.8 NS Cat No 
445 
 
 
 
Weischer et al. 
2014 
Copenhagen City 
Heart study Lo 
4576 
MF 25-49 
45-
59 Yes Blood Column 
qPCR 
9.3 Yes Both Yes -ve 
Rode et al. 
2013 
Copenhagen City 
Heart Study, 
Copenhagen 
General 
Population Study 
CS 
46396 
MF <25 
45-
59 Yes Blood NS 
qPCR 
NS Yes Both Yes -ve 
Rode et al. 
2015 CS 
64637 
MF 50+ 
45-
59 Yes Blood Column 
qPCR 
NS Yes Both Yes -ve 
Weischer et al. 
2012 CS 
9765 
MF 25-49 
45-
59 Yes Blood NS 
qPCR 
9 Yes Cat Yes -ve 
Weischer et al. 
2013 CS 
47102 
MF 25-49 60+ Yes Blood NS 
qPCR 
9.3 Yes Both Yes -ve 
Rode et al. 
2014 
Copenhagen 
General 
Population Study CS 
55568 
MF 50+ 
45-
59 Yes Blood Column 
qPCR 
9 Yes Both Yes -ve 
Panayiotou et 
al. 2010 Cyprus Study CS 762 MF <25 60+ Yes Blood Column 
qPCR 
NS No Cat No 
Kozlitina & 
Garcia 2012 Dallas Heart Study CS 
3157 
MF <25 
45-
59 Yes Blood Auto 
qPCR 
4.09 Yes Both Yes -ve 
Pellatt et al. 
2012 
Diet, Activity and 
Lifestyle Study CS 
1260 
NS NS 60+ 
Cancer cases & 
controls Blood NS 
qPCR 
NS Yes Cont Yes -ve 
Müezzinler et Epidemiological Lo 961 MF <25 NS Yes Blood SO qPCR Yes Both Yes -ve 
446 
 
 
 
al. 2015 Study on the 
Chances of 
Prevention, Early 
Recognition, and 
Optimised 
Treatment of 
Chronic Diseases 
in the Older 
Population  
NS 
Salpea et al. 
2008 
European 
Atherosclerosis 
Research Study II CS 765 M 25-49 <45 Yes Blood SO 
qPCR 
5.6 No Cat No 
Surtees et al. 
2011 
European 
Prospective 
Investigation into 
Cancer Norfolk 
Population Study 
CS 4441 F <25 60+ Yes Blood NS 
qPCR 
15 Yes Cat Yes -ve 
Surtees et al. 
2012 CS 4441 F <25 60+ Yes Blood NS 
qPCR 
NS Yes Cat Yes -ve 
Marcon et al. 
2012 
European 
Prospective 
Project into CS 56 MF <25 NS Yes Blood NS 
TRF 
NS Yes Cat No 
447 
 
 
 
Cancer and 
Nutrition 
Nawrot et al. 
2004 
Flemish Study on 
Environment, 
Genes and Health 
Outcomes 
 
CS 271 MF 25-49 <45 Yes Blood NS 
TRF 
<5 Yes Cat Yes -ve 
Nawrot et al. 
2010 CS 305 MF 25-49 <45 Yes Blood NS 
TRF 
1.7 Yes Both Yes -ve 
Demissie et al. 
2006 Framingham 
Heart Study 
 
CS 327 M <25 60+ 
Hypertensive 
cases & 
controls Blood NS 
TRF 
NS Yes Cat No 
O’Donnell et 
al. 2008 CS 
1062 
MF <25 
45-
59 Yes Blood NS 
TRF 
2.4 Yes Cat Yes -ve 
Vasan et al. 
2008 CS 
1203 
MF <25 
45-
59 Yes Blood NS 
TRF 
2.4 Yes Cat Yes -ve 
Verhulst et al. 
2016 
Genes, Familiar 
and Common 
Environment for 
the Development 
of Insulin 
Resistance, Lo 676 MF 25-49 <45 Yes Blood NS 
TRF 
1.3 Yes Cat No 
448 
 
 
 
Abdominal 
Adiposity, and 
Cardiovascular 
Risk Factors Study 
Wong et al. 
2014 
Harvard 
Boilermakers 
Longitudinal Study CS 87 M 25-49 <45 Yes Blood NS 
qPCR 
NS NS Cat No 
Ahola et al. 
2012 
Health 2000 Study 
CS 
2911 
MF 25-49 <45 Yes Blood NS 
qPCR 
8.1 Yes Cat No 
Kananen et al. 
2010 CS 939 MF NS 
45-
59 
Anxiety 
disorder & 
controls Blood NS 
qPCR 
NS Yes Cat Yes -ve 
Julin et al. 
2015 
Health 
Professionals 
Follow-up Study CS 2483 M 50+ 60+ Yes Blood Column 
qPCR 
11.8-16 Yes Both Yes -ve 
Adler et al. 
2013 
Health, Aging and 
Body Composition 
Study 
 
CS 
2599 
MF 50+ 60+ Yes Blood NS 
qPCR 
NS Yes Cat Yes -ve 
O’Donovan et 
al. 2011 CS 
1962 
MF <25 60+ Yes Blood NS 
qPCR 
4 Yes Cat Yes -ve 
Sanders et al. CS 2750 NS NS Yes Blood NS qPCR Yes Cat Yes -ve 
449 
 
 
 
2009 MF 5.8 
Sanders et al. 
2011 
Health, Aging and 
Body Composition 
study; ARMA 
study CS 
4208 
MF <25 60+ Cataract Blood NS 
qPCR 
5.8 Yes Cat Yes -ve 
Strandberg et 
al. 2011 
Helsinki 
Businessmen 
Study CS 622 M <25 60+ Yes Blood NS 
TRF 
3.7 No Cat Yes -ve 
Kark et al. 
2012 
Jerusalem Lipid 
Research Clinic 
Prevalence Study Lo 609 MF 25-49 <45 Yes Blood SO 
TRF 
2.1-2.2 NS Both Yes -ve 
Benetos et al. 
2013 
Jerusalem Lipid 
Research Clinic, 
Bogalusa Heart 
Study, Evolution 
de la Rigidite 
Arterielle, 
Longitudinal Study 
of Aging Danish 
Twins Lo 
1156 
MF 25-49 <45 Yes Blood NS 
TRF 
2.3 NS Cat Yes -ve 
450 
 
 
 
Shin et al. 
2015 
Korean Genome 
Epidemiology 
Study CS 
2128 
MF <25 
45-
59 Yes Blood Column 
qPCR 
NS Yes Cat No 
Fyhrquist et al. 
2011 
Lifestyle 
Interventions and 
Independence for 
Elders study 
CS 
1271 
MF NS 60+ 
Hypertension 
& left 
ventricular 
hypertrophy 
Hypertension 
& left 
ventricular 
hypertrophy 
cases 
Blood SO 
TRF  
NS In males NS No 
Fyhrquist et al. 
2013 CS 
1249 
MF 25-49 60+ Blood SO 
TRF 
NS Yes Cat Yes -ve 
Shen et al. 
2009 
Long Island Breast 
Cancer Study 
Project  CS 2169 F NS NS 
Breast ca 
patients Blood PC 
qPCR 
NS Yes Both No 
Bischoff et al. 
2006 
Longitudinal 
Danish 
Centenarian study CS 812 MF NS 60+ Yes Blood NS 
TRF 
12 NS Cat No 
Bendix et al. 
2014 
Longitudinal Study 
of Aging Danish CS 439 MF 25-49 60+ Yes Blood NS 
TRF 
3.4 Yes Cat Yes -ve 
451 
 
 
 
Twins 
Lee et al. 2012 Lung Health study CS 
4271 
MF 50+ 
45-
59 
No- airflow 
limitation 
smokers Blood NS 
qPCR 
NS No Both No 
Epel et al. 
2009 
MacArthur Health 
Aging Study Lo 236 MF <25 60+ Yes Blood SO 
qPCR 
NS No Cont No 
Nordfjäll et al. 
2008 
Malmo Diet and 
Cancer Cohort, 
MONICA project CS 
1502 
MF <25 
45-
59 Yes Blood NS 
qPCR 
NS Yes Cont No 
van der Harst 
et al. 2007 
Metoprolol CR/XL 
Randomized 
Intervention Trial 
in Congestive 
Heart Failure plus 
additional CHF 
patients & 
controls CS 620 MF <25 60+ No- CHF Blood NS 
qPCR 
NS Yes Cat No 
Raschenberger 
et al. 2015 
Mild to Moderate 
Kidney Disease 
Study & Chronic CS 
1055 
MF <25 60+ No- CKD Blood Auto 
qPCR 
7.6-7.9 Yes Cat Yes -ve 
452 
 
 
 
Renal 
Insufficiency 
Standards 
Implementation 
Study 
Bendix et al. 
2013 MONICA 1 Lo 
1765 
MF 50+ <45 Yes Blood Column 
qPCR 
7.8 Yes Cat Yes -ve 
Ellehoj et al. 
2016 MONICA project CS 
1397 
MF 50+ <45 
CVD, IHD, 
stroke patients Blood NS 
qPCR 
5.8 NS Cat No 
Carroll et al. 
2013 
Multi-ethnic study 
of atherosclerosis 
 
CS 963 MF NS 60+ Yes Blood NS 
qPCR 
7 Yes Cont Yes -ve 
Carroll et al. 
2013 CS 948 MF NS 60+ Yes Blood NS 
qPCR 
7 Yes Cont Yes -ve 
Needham et 
al. 2014 CS 851 MF NS 60+ CVD Blood NS 
qPCR 
7 NS Cont Yes -ve 
Roux et al. 
2009 CS 981 MF NS 60+ Yes Blood NS 
qPCR 
7 Yes Cont Yes -ve 
Ahrens et al. 
2016 
National Health 
and Nutrition 
Examination study 
CS 1503 F <25 NS Yes Blood NS 
qPCR 
NS NS Cat No 
Loprinzi 2015 Lo 1764 NS <45 Yes Blood NS qPCR Yes Cat No 
453 
 
 
 
 MF <7 
Needham et 
al. 2013 CS 
5360 
MF 25-49 
45-
59 Yes Blood NS 
qPCR 
4.4 Yes Cont Yes -ve 
Needham et 
al. 2015 CS 
3091 
MF <25 NS Yes Blood NS 
qPCR 
NS Yes Cat No 
Patel et al. 
2016 CS 
3567 
MF 25-49 
45-
59 Yes Blood NS 
qPCR 
NS Yes Both Yes -ve 
Wulaningsih 
et al. 2016 CS 
6456 
MF <25 
45-
59 Yes Blood NS 
qPCR 
6.5 Yes Both Yes -ve 
Zota et al. 
2014 CS 
6796 
MF 25-49 NS Yes Blood SO 
qPCR 
NS Yes Cont Yes -ve 
Risques et al. 
2010 
National Long 
Term Care Survey CS 624 MF <25 60+ Some disabled Blood Auto 
qPCR 
7 No Cat No 
Révész et al. 
2016 
Netherlands Study 
of Depression and 
Anxiety  
CS 
2750 
MF NS <45 
Depression, 
anxiety Blood NS 
qPCR 
NS NS Cont Yes -ve 
Park et al. 
2015 CS 
2901 
MF 25-49 <45 Yes Blood NS 
qPCR 
NS NS Cat Yes -ve 
Dóra Révész et 
al. 2016 Lo 
2921 
MF NS <45 
No- mental 
healthcare 
recipients Blood NS 
qPCR 
NS Yes Cont Yes -ve 
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Verhoeven et 
al. 2015 CS 
2936 
MF 25-49 <45 
Depression, 
anxiety Blood NS 
qPCR 
4.6 Yes Cat Yes -ve 
Verhoeven et 
al. 2016 Lo 
2936 
MF 25-49 <45 
Depression, 
anxiety Blood NS 
qPCR 
4.6 Yes Cat Yes -ve 
Terry et al. 
2012 
New England 
case-control 
study; Nurses’ 
Health study CS 947 F <25 NS Yes (controls) Blood NS 
qPCR 
NS Yes Cat 
Yes, 
former 
smokers 
shorter 
Collerton et al. 
2007 
Newcastle 85+ 
Study CS 84 MF <25 60+ Yes Blood NS 
qPCR 
NS No Cat No 
Adams et al. 
2007 
Newcastle 
Thousand Families 
Study 
CS 318 MF NS 
45-
59 Yes Blood NS 
qPCR 
NS NS Cont No 
Pearce et al. 
2012 CS 318 MF 25-49 NS Yes Blood NS 
qPCR 
6.2 NS Cat Yes -ve 
Hou et al. 
2015 
Normative Aging 
Study Lo 579 M <25 60+ Yes Buccal NS 
qPCR 
NS Yes Both No 
Cassidy et al. 
2010 Nurses' Health 
Study 
CS 2284 F <25 
45-
59 Yes Blood NS 
qPCR 
14-16 Yes Both No 
Crous-Bou et 
al. 2014 CS 4676 F NS 
45-
59 Yes Blood Column 
qPCR 
<18 Yes Cont Yes -ve 
455 
 
 
 
De Vivo et al. 
2009 CS 2269 F NS 
45-
59 
Breast ca 
cases, controls Blood Column 
qPCR 
16.3 Yes Cont No 
Du et al. 2012 CS 7684 F <25 
45-
59 Yes Blood Column 
qPCR 
<17 Yes Cat Yes -ve 
Liang et al. 
2011 CS 4117 F <25 
45-
59 Yes Blood Column 
qPCR 
NS Yes Both No 
Liu et al. 2013 CS 4604 F NS 
45-
59 Yes Blood NS 
qPCR 
14-16.3 Yes Cont No 
Schürks et al. 
2013 CS 1008 F <25 60+ 
Ischaemic 
stroke  Blood Column 
qPCR 
22 No Cat No 
Sun et al. 2012 CS 5862 F <25 
45-
59 Yes Blood Column 
qPCR 
10.8-16 Yes Cat Yes -ve 
Liu et al. 2016 CS 4780 F 
 
45-
59 Yes Blood NS 
qPCR 
<18 Yes Cont Yes -ve 
McGrath et al. 
2007 
Nurses' Health 
Study and Health 
Professionals 
Follow-up Study CS 376 MF <25 60+ 
Bladder cancer 
in 184 subjects Blood Column 
qPCR 
NS No Both 
Yes -ve 
(HPFS 
only) 
Prescott et al. 
2010 
Nurses' Health 
Study and CS 1181 F NS 
45-
59 Yes Blood NS 
qPCR 
14 Yes Both No 
456 
 
 
 
Women's Health 
Study 
Mason et al. 
2015 
Nurses' Health 
Study II CS 1135 F NS 
45-
59 Yes Blood Column 
qPCR 
11.5 NS Cat Yes -ve 
Svensson et al. 
2014 Osteoporotic 
Fractures in Men 
Study 
CS 
2744  
M <25 60+ Yes Blood NS 
qPCR 
10.7 No Cat No 
Yu et al. 2015 CS 
2006 
MF <25 60+ Yes Blood PC 
qPCR 
11.1 
Yes, in 
men Cat No 
Mather et al. 
2010 
PATH Through Life 
Project CS 646 MF <25 
45-
59 Yes Blood Column 
qPCR 
3.44, 
8.82 
No, but 
diff 
between 
2 age 
cohorts Cat No 
Zee et al. 2009 Physicians Health 
Study 
 
CS 497 M <25 
45-
59 Colorectal ca Blood Column 
qPCR 
<2 Yes Cat No 
Zee et al. 2010 CS 518 M <25 60+ 
Stroke 
patients Blood Column 
qPCR 
<2 Yes Cat No 
Huzen et al. 
2014 
Prevention of 
Renal and 
Vascular End-
Lo 
8074 
MF 25-49 
45-
59 Yes Blood Column 
qPCR 
4.5 Yes Both Yes -ve 
Kingma et al. Lo 895 MF <25 45- Yes Blood Column qPCR Yes Cont No 
457 
 
 
 
2012 Stage Disease 
study 
 
59 3.9 
van 
Ockenburg et 
al. 2014 Lo 
2156 
MF 25-49 
45-
59 Yes Blood NS 
qPCR 
4.5 Yes Both No 
van 
Ockenburg et 
al. 2015 Lo 
1094 
MF <25 
45-
59 Yes Blood Column 
qPCR 
4.5 Yes Both 
Yes -ve 
(16-20 
CPD) 
Fernández-
Alvira et al. 
2016 
Progression of 
Early Subclinical 
Atherosclerosis 
study CS 
1459 
MF NS 
45-
59 
Subclinical 
atherosclerosis Blood n/a 
HT-
QFISH 
5.6 Yes Both No 
Baragetti et al. 
2015 
Progressione della 
Lesione Intimale 
Corotidea Study Lo 768 MF 25-49 
45-
59 Yes Blood SO 
qPCR 
7.3 Yes Cat Yes -ve 
Mirabello et 
al. 2009 
Prostate, Lung, 
Colorectal, and 
Ovarian Cancer 
Screening Trial CS 1661 M 50+ NS 
Prostate 
cancer pts and 
controls Blood Column 
qPCR 
NS Yes Cont Yes -ve 
Shiels et al. 
2011 
Psychological, 
social and CS 382 NS NS NS Yes Blood NS 
qPCR 
NS Yes Cat Yes -ve 
458 
 
 
 
biological 
determinants of ill 
health study 
Hardikar et al. 
2015 Seattle Barrett's 
esophagus study 
CS 295 MF 50+ 60+ 
Barrett's 
oesophagus 
patients Blood NS 
qPCR 
7 Yes Both Yes -ve 
Risques et al. 
2007 CS 287 MF 50+ NS 
Metaplasia in 
oesophageal 
biopsies Blood SO 
qPCR 
7 Yes Cat No 
Rane et al. 
2015 
Singapore Chinese 
Health Study CS 90 MF 25-49 
45-
59 Yes Blood Column 
TRF  
NS No Cat No 
Aviv et al. 
2006 
St. Thomas' (Twins 
UK) Adult Twin 
Registry 
CS 1517 F <25 
45-
59 Yes Blood NS 
TRF 
NS Yes Cat Yes -ve 
Barwell et al. 
2007 CS 1768 F NS 
45-
59 
Breast cancer 
cases & 
controls Blood NS 
TRF 
1.4 NS Cat Yes -ve 
Cherkas et al. 
2006 CS 1552 F <25 
45-
59 Yes Blood NS 
TRF 
NS Yes Cat Yes -ve 
Cherkas et al. 
2008 CS 
2401 
MF <25 
45-
59 Yes Blood NS 
TRF 
NS Yes Cat Yes -ve 
459 
 
 
 
Valdes et al. 
2005 CS 1103 F <25 
45-
59 Yes Blood NS 
TRF 
NS Yes Both Yes -ve 
Chen et al. 
2014 Strong Heart 
Family study 
CS 
3256 
MF 25-49 <45 Yes Blood NS 
qPCR 
6.9 Yes Cat No 
Zhao et al. 
2014 CS 
2328 
MF 25-49 <45 Yes Blood NS 
qPCR 
6.9 Yes Cat No 
Borghini et al. 
2016 
Studies on 
exposures to 
inorganic arsenic CS 241 MF 25-49 <45 Yes Blood Column 
qPCR 
NS Yes Cat No 
Bakaysa et al. 
2007 
Swedish Twin 
Registry CS 350 MF <25 60+ Yes Blood NS 
TRF 
NS Yes Cat No 
von Känel et 
al. 2015 
Sympathetic 
Activity and 
Ambulatory Blood 
Pressure in 
Africans study CS 341 MF <25 
45-
59 Yes Blood Column 
qPCR 
4.8 Yes Cat No 
Masi et al. 
2012 
Ten Towns Heart 
Health study CS 
1080 
MF <25 <45 Yes Blood SO 
qPCR 
3.27 Yes Cat No 
Farzaneh-Far 
et al. 2010 
The Heart and 
Soul study Lo 608 MF <25 60+ CVD patients Blood IP 
qPCR 
3.7 Yes Cat No 
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Harris et al. 
2006 
The Lothian Birth 
Cohort 1921 CS 190 MF <25 60+ Yes Blood NS 
qPCR 
NS NS Both No 
Harris et al. 
2012 
The Lothian Birth 
Cohort 1936 CS 
1048 
MF <25 60+ Yes Blood NS 
qPCR 
5.12 No Both No 
Kim et al. 2011 
The Sister Study 
CS 1077 F <25 
45-
59 
Breast cancer 
cases & 
controls Blood Auto 
qPCR 
11 Yes Cat No 
Parks et al. 
2009 CS 740 F <25 NS Yes Blood NS 
qPCR 
8.5 Yes Cat Yes -ve 
Parks et al. 
2011 CS 647 F <25 
45-
59 Yes Blood NS 
qPCR 
8.5 NS Cat Yes -ve 
Masi et al. 
2016 
University College 
Diabetes and 
Cardiovascular 
Disease Study CS 489 MF <25 60+ 
Diabetic clinic 
attendees Blood SO 
qPCR 
5.6 Yes Cat No 
Salpea et al. 
2010 
University College 
Diabetes and 
Cardiovascular 
Disease Study, 
European CS 
1017 
MF 
cases  
M 
controls 50+ 
45-
59 
Cases type 2 
DM Blood SO 
qPCR 
5.6 Yes Cat No 
461 
 
 
 
Atherosclerosis 
Research Study II, 
Hypercoagulability 
and Impaired 
Fibrinolytic 
Function 
Mechanisms 
predisposing to 
myocardial 
infarction study 
Gu et al. 2015 
Washington 
Heights-Inwood 
Community Aging 
Project CS 
1743 
MF 25-49 60+ Yes Blood NS 
qPCR 
5-8 Yes Cat No 
Batty et al. 
2009 
West of Scotland 
Coronary 
Prevention Study CS 1542 M NS NS 
High risk for 
coronary heart 
disease Blood NS 
qPCR 
NS Yes Cat No 
Brouilette et 
al. 2007 
West of Scotland 
Primary 
Prevention Study  CS 1542 M 50+ 
45-
59 
Coronary 
heart disease 
cases & Blood NS 
qPCR 
NS 
Only in 
controls Cat No 
462 
 
 
 
controls 
Phillips et al. 
2013 
West of Scotland 
Twenty-07 Study Lo 
1063 
MF <25 
45-
59 Yes Blood NS 
qPCR 
NS Yes Cat No 
Jackowska et 
al. 2012 
Whitehall II 
epidemiological 
study 
CS 434 MF <25 60+ Yes Blood NS 
qPCR 
NS No Cat 
Yes -ve 
in men 
Steptoe et al. 
2011 CS 448 MF <25 60+ Yes Blood Auto 
qPCR 
3.3 NS Cat No 
Song et al. 
2013 
Women’s’ Health 
Initiative 
Observational 
Study CS 4029 F <25 60+ Yes Blood NS 
qPCR 
5.7 Yes Cat No 
Houben et al. 
2011 
Zutphen Elderly 
Study Lo 203 M 25-49 60+ Yes Blood Column 
qPCR 
NS No Cat No 
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Weight was significantly positively associated with LRTL1 (F=10.1(1,39), R2=0.21, 
p=0.003) and BRTL2 (F=19.37(1,18), R2=0.52, p<0.001), less strongly with BRTL1 
(F=6.75(1,38), R2=0.15, p=0.01) and not significantly related to LRTL2 (F=1.71(1,22), 
R2=0.07, p=0.21) (Figure A10.1).  Interestingly, there was a strong positive 
relationship between CMRTL and dog weight (F=159.6(1,34), R2=0.84, p<0.001, 
Figure A10.2A).  Linear models of weight to ERTL and VDRTL were also significant 
with positive beta coefficients (ERTL F=33.19(1,32), R2=0.51, p<0.001; VDRTL 
F=9.01(1,33), R2=0.21, p=0.005; Figure A10.2B/C).  There were also negative 
relationships between the difference in LTRL1 and CMRTL, and dog weight 
(AIC=112.68, p<0.001, Figure A10.3A) and the difference between LRTL2 and 
CMRTL and dog weight (F=20.9(1,21), R2=0.50, p<0.001, Figure A10.3B), indicating 
larger dogs had an increased difference between their CMRTL and LRTL measures.  
In addition, there was a positive relationship between the rate of change between 
CMRTL and LRTL1 and weight (AIC=−32.56, p=0.002, Figure A10.3C), as well as the 
rate of change between CMRTL and LRTL2 and dog weight (F=13.06(1,21), R2=0.38, 
p=0.002, Figure A10.3D), indicating a faster rate of change in larger dogs.  In terms 
of excess body weight, there was a significant negative relationship between the 
difference in LRTL2 and CMRTL and kilogram weight gain (adjusted for weight gain 
due to growth) (F=11.04(1,21), R2=0.34, p=0.003, Figure A10.4B).  In addition, BRTL2 
increased with additional weight gain above weight gain due to growth 
(F=10.25(1,18), R2=0.36, p=0.005, Figure A10.4A). 
   
 
Like weight, height was positively associated with both LRTL1 (F=11.39(1,39), 
R2=0.23, p=0.002), BRTL1 (F=7.73(1,38), R2=0.17, p=0.008) and BRTL2 (F=20.2(1,18), 
R2=0.53, p<0.001), but not LRTL2 (F=1.85(1,22), R2=0.08, p=0.19).  Height was also 
positively associated with CMRTL (F=169.8(1,34), R2=0.83, p<0.001), ERTL 
(F=35.47(1,32), R2=0.53, p<0.001) and VDRTL (R2=0.20, p=0.006).  Likewise, with 
weight, taller dogs had a greater difference between LRTL1 and CMRTL 
(AIC=111.51, p<0.001) and LRTL2 and CMRTL (R2=0.53, p<0.001), as well as a faster 
rate of change between CMRTL and LRTL1 (AIC=-35.33, p<0.001) and CMRTL and 
LRTL2 (R2=0.41, p<0.001) in taller dogs. 
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The associations between sex and LRTL1 and sex and BRTL1 were only briefly 
examined, with there being just 5 females at time point 1 and 1 female returning 
for follow up.  Paired t-tests showed there was no difference in LRTL1 or BRTL1 
between the sexes (p=0.67 and p=0.52, respectively) (Figure A10.5). 
 
 
Breed was a difficult variable to examine given the small numbers of each breed.  
Initially, the dogs were divided into 4 groups: spaniel/spaniel cross, terrier/terrier 
cross, collie/collie cross and other.  The “other” group was excluded and one-way 
ANOVAs performed which showed no significant difference in LRTL1 (p=0.07), 
BRTL1 (p=0.13), CMRTL (p=0.47), and LRTL2 (p=0.08), but there was a significant 
difference in BRTL2 between the groups (p=0.03) (Figures A10.6 & A10.7).  It was 
noted during the analyses that the collie group seemed to have longer LRTL and 
BRTL measures, and thus all the dogs were divided into 2 groups: collie/collie cross 
and other.  Paired t-tests indicated a statistically significant difference in LRTL1 
(p=0.03) and BRTL1 (p=0.04) between the 2 groups, but while mean LRTL2 and 
BRTL2 were longer in the collie group, the differences were not statistically 
significant (p=0.23 and p=0.14, respectively).  There were also no statistically 
significant differences in CMRTL (p=0.27), ERTL (p=0.18) or VDRTL (p=0.17), 
however, in the collie group the mean value was higher for all these tissues as 
well. 
 
 
CMRTL was positively associated with breed life expectancy (F=100.5(1,24), R2=0.81, 
p<0.001, Figure A10.8C), despite there being a strong positive relationship 
between weight and CMRTL, and there being a negative trend between lifespan 
and weight (Spearman’s rho=−0.21, p=0.25).  As with increasing weight, there was 
a larger difference between LRTL1 and CMRTL with increasing life expectancy 
(AIC=78.0, p<0.001, Figure A10.8D).  Breed life expectancy was also significantly 
related to both LRTL1 (F=6.26(1,29), R2=0.18, p=0.02) and LRTL2 (F=6.97(1,13), 
R2=0.35, 0.02) (Figure A10.8A&B). 
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Dogs were divided into two groups based upon whether their LRTL measurements 
lengthened (L) or shortened (S) between time points 1 and 2.  The dog which was 
classed as a maintainer was not included in this analysis.  Table A10-1 shows the 
results of a series of statistical tests examining whether biochemical and 
haematological measures were different in groups L or S, and also if the changes in 
the biochemical and haematological measures between the two time points were 
different between the two groups.  Mean cell haemoglobin concentration was 
significantly higher in dogs in the S group than the L group at time point 1 
(p<0.001).  In addition, mean cell volume was significantly different between the 
groups at both time points, with the L group having higher average values at both 
points.  The change in monocyte count between the two time points was 
significantly different between the two groups, with the L group having little 
change and the S group having higher monocyte counts at time point 1 than 2.    
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Table A10-1 P values of pairwise testing between LRTL shorteners and elongators of 
measures at time point 1 (TP1), time point 2 (TP2) and the change in measures between the 
two time points.   
Significance level denoted by * <0.05, **<0.01, ***<0.001 
 
TP 1 TP2 TP1 – TP2 
Sodium concentration 0.37 0.40 0.79 
Potassium concentration 0.22 0.92 1 
Sodium:potassium ratio 0.15 0.67 0.27 
Chloride concentration 0.89 0.11 0.33 
Calcium concentration 0.21 0.71 0.83 
Phosphate concentration 0.73 0.08 0.17 
Urea concentration 0.89 0.54 0.49 
Creatinine concentration 0.78 0.77 0.53 
Cholesterol concentration 0.29 0.54 0.86 
Triglyceride concentration 0.08 0.22 0.74 
Total bilirubin concentration 0.26 0.17 0.53 
ALK Phosphatase concentration 0.76 0.86 0.90 
AST concentration 0.37 0.54 0.85 
ALT concentration 0.91 0.06 0.29 
GGT concentration 0.19 0.09 0.36 
Total protein concentration 0.47 0.37 0.82 
Albumin concentration 0.40 0.06 0.90 
Globulin concentration 0.79 0.75 0.57 
Albumin:globulin ratio 0.57 0.23 0.48 
Red cell count 0.85 0.27 0.28 
Haemoglobin concentration 0.63 0.58 0.43 
Haematocrit 0.35 0.69 0.32 
Mean cell volume 0.03* 0.02* 0.76 
Mean cell haemoglobin 0.54 0.05* 0.19 
Mean cell haemoglobin 
concentration 
<0.001*** 
0.49 0.06 
Red cell distribution width 0.08 0.56 0.08 
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White cell count 0.73 0.53 0.66 
Neutrophil count 0.37 0.79 0.32 
Lymphocyte count 0.40 0.21 0.60 
Neutrophil:lymphocyte ratio 0.30 0.60 0.40 
Monocyte count 0.22 0.21 0.02* 
Lymphocyte:monocyte ratio 0.83 0.19 0.10 
Eosinophil count 0.57 0.24 0.19 
Platelet count 0.59 0.24 0.28 
Mean platelet volume 0.91 0.92 0.97 
Plateletcrit 0.35 0.06 0.49 
Platelet distribution width 0.81 0.87 0.61 
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Figure A10.1 Scatterplots with regression line of leukocyte and buccal RTL by dog weight 
Natural log of leukocyte RTL and natural log of dog weight at time point 1 (A) (R2=0.21, 
p=0.003); natural log of leukocyte RTL and natural log of dog weight at time point 2 (B) 
(R2=0.07, p=0.21); natural log of buccal RTL and dog weight at time point 1 (C) (R2=0.15, 
p=0.01); natural log of buccal RTL and dog weight at time point 2 (D) (R2=0.52, p<0.001)  
 
  
A 
C D 
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Figure A10.2 Scatterplots with regression line of cremaster muscle, epididymis and vas 
deferens RTL by dog weight 
Cremaster muscle RTL and natural log of dog weight (A) (R2=0.82, p<0.001); natural log of 
epididymis RTL and natural log of dog weight (B) (R2=0.51, p<0.001); and natural log of vas 
deferens RTL and natural log of dog weight (C) (R2=0.13, p=0.005)  
A 
C 
B 
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Figure A10.3 Scatterplots with regression line of differences in tissue RTL by dog weight 
The difference in leukocyte RTL and cremaster muscle and natural log of dog weight at time 
point 1 (A) (AIC=112.68, p<0.001); difference in leukocyte RTL and cremaster muscle and dog 
weight at time point 2 (B) (R2=0.50, p<0.001); change in difference between cremaster muscle 
RTL and leukocyte RTL from time point 1 per month and dog weight at time point 1 (C) 
(AIC=−32.56, p=0.002); change in difference between cremaster muscle RTL and leukocyte RTL 
from time point 2 per month and dog weight at time point 2 (D) (R2=0.38, p=0.002) 
  
B 
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Figure A10.4 Scatterplots with regression line of buccal RTL and the difference between 
leukocyte and cremaster RTL at time point 2 by change in dog weight 
Natural log of buccal RTL at time point 2 and weight change between the two time points, 
adjusted for expected weight gain due to growth (A) (R2=0.36, p=0.005); leukocyte RTL 2 minus 
cremaster muscle RTL and adjusted weight change (B) (R2=0.34, p=0.003) 
  
A 
B 
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Figure A10.5 Dot plots of natural log of buccal RTL1 (A) and leukocyte RTL1 (B) by sex 
The orange squares represent the mean value and green dashes the 95% confidence intervals.  
No significant difference was found in buccal RTL1 (p=0.52) or leukocyte RTL1 (p=0.67) 
between the sexes. 
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Figure A10.6 Dot plots of natural log of leukocyte RTL1 (A) and leukocyte RTL2 (B) by breed 
groups 
“Collie/CX”= collie and collie cross breeds, “Spaniel/SX”= spaniels and spaniel cross breeds 
and “Terrier/TX”= terrier and terrier cross breeds.  The orange squares represent the mean 
value and green dashes the 95% confidence intervals.  No significant difference was found in 
leukocyte RTL1 (p=0.07) or leukocyte RTL2 (p=0.08) between the groups. 
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Figure A10.7 Dot plots of natural log of buccal RTL1 (A) and buccal RTL2 (B) by breed groups 
“Collie/CX”= collie and collie cross breeds, “Spaniel/SX”= spaniels and spaniel cross breeds 
and “Terrier/TX”= terrier and terrier cross breeds.  The orange squares represent the mean 
value and green dashes the 95% confidence intervals.  No significant difference was found in 
buccal RTL1 (p=0.13) between the groups, but a significant difference was observed in buccal 
RTL2 (p=0.03). 
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Figure A10.8 Scatterplots with regression line of leukocyte RTL, cremaster muscle RTL and 
the difference between leukocyte and cremaster muscle RTL by breed life expectancy 
Natural log of leukocyte RTL1 and breed life expectancy (A) (R2=0.18, p=0.02); natural log of 
leukocyte RTL2 and breed life expectancy (B) (R2=0.35, p=0.02); cremaster muscle RTL and 
breed life expectancy (C) (R2=0.81, p<0.001); difference between leukocyte RTL1 and cremaster 
muscle RTL and breed life expectancy (D) (AIC=78.0, p<0.001)  
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11 
Appendix 11: CDKN2A Western blot 
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Western blot measurement of CDKN2A protein 
 
A subset of the dogs had CDKN2A protein level measured using the same sample of 
testis from which RNA was extracted, to check concordance between mRNA and 
protein level measurements.  In order to achieve this, a Western blotting protocol 
needed to be optimised.  This technique was selected as it was possible to 
measure protein in the same tissue sample.  Immunohistochemistry could have 
been performed on the other testis, which had been placed in formalin, but 
CDKN2A levels could have varied between testes within the same dog. 
 
 
Table A11-1 Reagents, solutions, consumables & equipment for protein extraction & Western 
blotting 
Anti-CDKN2A antibody Abcam, Cambridge UK 
Anti-histone H3 antibody Abcam, Cambridge UK 
Guanidine hydrochloride Sigma Aldrich, Gillingham UK 
Isopropanol Sigma Aldrich, Gillingham UK 
Non-fat skimmed milk powder  
Nupage LDS Sample Buffer Invitrogen, Paisley UK 
Nupage MOPS SDS Running buffer 20X Invitrogen, Paisley UK 
SeeBlue Plus2 pre-stained standard Life Technologies, Paisley UK 
Tween 20 Sigma Aldrich, Gillingham UK 
PBST 0.1% v/v Tween-20 was added to 1X 
PBS solution 
1X MOPS running buffer To make 900ml running buffer, 45ml 
of 20X running buffer was added to 
855ml dH2O 
iBlot Transfer Stack Invitrogen, Paisley UK 
Novex BT Gel 4-12% 1.0MM 12W Invitrogen, Paisley UK 
Gel documentation system Syngene, Cambridge UK 
Gel tank for WB gels Invitrogen, Paisley UK 
iBlot dry blotting system ThermoFisher, Paisley UK 
Sonicating water bath Guyson International, Skipton UK 
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Protein extraction 
 
Protein was isolated from tissue using the phenol-chloroform phase obtained in the 
RNA extraction process.  2 phases remained after removing the upper phase for 
RNA extraction: the interphase and phenol-chloroform phase.  The interphase can 
be used for DNA extraction and the DNA was pelleted first prior to protein 
extraction.  300μl of 100% molecular biology grade ethanol was added to each 
sample and the sample inverted several times to mix, followed by a 3-minute 
incubation at room temperature.  The tubes were centrifuged at 2000 x g for 5 
minutes at 4°C to pellet the DNA.  The supernatant was removed and placed in a 
15ml tube, and protein extracted from the supernatant.  1.5ml isopropanol was 
added, the tubes mixed by inversion and incubated at room temperature for 10 
minutes.  The tubes were centrifuged at 10,000 x g for 10 minutes at 4°C to pellet 
the protein.  The supernatant was removed and discarded.  The pellet was then 
washed 3 times, each time by adding 2ml of protein extraction wash solution, 
incubating for 20 minutes, centrifuging at 7500 x g for 5 minutes at 4°C and then 
the wash solution removed and discarded.  A further wash was performed using 
ethanol.  2ml of 100% ethanol was added to the protein pellet, the tubes vortexed 
and then incubated at room temperature for 20 minutes.  The tubes were 
centrifuged at 7500 x g for 5 minutes at 4°C.  The pellet was air dried for 10 
minutes.  200μl of 1% SDS solution was added to the pellet and pipetted up and 
down until the protein was resuspended.  The tubes were centrifuged at 10,000 x g 
for 10 minutes at 4°C to sediment any insoluble material and the supernatant 
transferred to a 1.5ml microcentrifuge tube.  The concentration of protein was 
measured, then stored at −80°C.  
 
 
Protein quantification 
 
For the protein extraction samples, absorbance was measured at 280nm to 
calculate the concentration in mg/ml.  1% SDS was used as the blank. 
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MDCK and HeLa cell lines were used as comparative and control samples.  Cells 
were grown in 10cm dishes (section 2.2).  When the cells reached 80% confluency, 
the dish was removed from the incubator and placed on ice to avoid protein 
degradation.  The media was removed and the cells washed with 8ml PBS.  500μl 
Nupage LDS sample buffer (Invitrogen, Paisley UK) was added.  The cells were 
scraped off and placed in a 1.5ml screw top microcentrifuge tube.  The tube was 
placed on ice.  The cells were then physically disrupted using a 21 Gauge needle 
and 1ml syringe, by drawing in the fluid and ejecting it back out into the 
microcentrifuge tube 20 times.   The sample was then sonicated in a 4°C 
sonicating water bath 5 times for 30 seconds each time, with a one-minute gap 
between each sonication, during which the tube was on ice. 
 
 
Western blotting 
 
An antibody to canine CDKN2A to purchase could not be found.  However, the dog 
and human protein show similar sequences between 60 and 120 amino acids, so an 
antibody against this region was selected (Anti-CDKN2A/p16INK4a antibody 
[2D9A12], abcam Cambridge UK).  The expected band size was 40kDa.  A loading 
control antibody with predicted band size of 15kDa was selected, anti-histone H3 
antibody (abcam, Cambridge UK), which was listed as reacting to dog samples.  
Dot blots were performed in order to establish the concentration of the primary 
antibodies required.  Briefly, a dot of testis protein sample with 1:4 NuPAGE LDS 
sample buffer (Invitrogen, Paisley UK) was spotted onto a square of nitrocellulose 
membrane and allowed to air dry.  One square per primary antibody concentration 
to be tested was prepared.  The membranes were incubated in 10% skimmed milk 
powder in PBS for 1 hour at room temperature with agitation.  Each membrane was 
then incubated in an antibody dilution at 4°C overnight with agitation.  From the 
information provided with the primary antibodies, anti-CDKN2A antibody was 
tested at a range of concentrations from 1:500 to 1:2000, and anti-histone H3 was 
tested at concentrations from 1:1000 to 1:5000.  The membranes were washed 
with PBST and incubated in 1:5000 secondary antibodies (detailed below) and 
incubated for one hour.  The membranes were washed with PBST, PBS and ddH2O 
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and scanned using an Odyssey system (LI-COR, Nebraska USA).  The primary 
antibody concentration was decided by determining the lowest concentration at 
which the protein was detected.  
 
 
The samples were prepared by diluting to 2μg/μl (so 30μg would be loaded onto 
the gel) and adding 5μl NuPage LDS sample buffer to 15μl of the diluted sample.  
The samples were then placed in a heat block at 70°C for 10 minutes.  The 
samples to be tested were loaded onto the gels alongside MDCK and HeLa protein 
samples.  The HeLa sample was used as control to calculate the relative expression 
to, and MDCK was used to calculate the inter-assay variation.  Precast 4-12% 
gradient gels (Novex Bt Gel 1.0MM 12w, Invitrogen Paisley UK) were rinsed twice 
with ddH2O and once with 1X MOPS running buffer (Invitrogen, Paisley UK) and set 
up in a gel tank.  The tank was filled with 1X MOPS running buffer.  20μl of samples 
were loaded into wells, alongside 10μl SeeBlu Plus 2 pre-stained standard (Life 
Technologies, Paisley UK).  The gel was run at 200V for 50 minutes.  The gel was 
placed in an iBlot system and transfer set up using an iBlot transfer stack 
(Invitrogen, Paisley UK).  Transfer was completed and the resulting membrane 
placed in PBS for 2 minutes.  Blocking was undertaken for 1 hour with agitation at 
room temperature using 10% skimmed milk powder in PBS.  The membrane was 
then incubated in 1:1000 anti-CDKN2A and 1:5000 anti-HH3 antibodies diluted in 
5% skimmed milk powder in PBS overnight with gentle agitation at 4°C.  The 
antibody solution was discarded and the membrane washed with PBST 5 times for 5 
minutes each time with agitation.  The membrane was then incubated in 1:5000 
goat anti-rabbit IgG DyLight 680 and 1:5000 goat anti-mouse DyLight 800 secondary 
antibodies (Thermo Scientific, Loughborough UK) diluted in 5% skimmed milk 
power in PBST for one hour at room temperature.  The membranes were protected 
from light from the secondary antibody incubation step onward, as the secondary 
antibodies were light sensitive.  Following the incubation in secondary antibodies, 
the solution was discarded and the membrane washed with agitation using the 
following: PBST 5 times for 5 minutes each time, PBS 3 times for 5 minutes each 
time and ddH2O 3 times for 5 minutes each time.  The membrane was then 
scanned using an Odyssey system.  The intensities of the bands were obtained 
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using Image Studio Lite v5.0 software (LI-COR, Nebraska USA).  The intensity of 
CDKN2A was adjusted using the histone H3 loading control and then expression 
relative to that of HeLa cells calculated. 
 
 
Unfortunately, the anti-CDKN2A antibody generated multiple bands, and in fact, 
abcam subsequently were in contact to say the antibody was no longer to be 
deemed suitable for Western blotting.  However, using the band at the expected 
position, the relative expression was calculated, as the data generated were to 
support the evidence provided in the main body of work, rather than to stand 
alone.  Using this method, the values generated were plotted against the qRT-PCR 
generated values in the same dog (Figure A11.1).  Correlation testing showed the 
methods showed good agreement (Pearson’s correlation coefficient=0.70, 
p=0.001). 
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Figure A11.1 Natural log of relative protein expression of CDKN2A and natural log of mRNA 
expression of CDKN2A in the same testis samples 
(correlation p=0.001)  
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Glossary- General terms 
 
Biological age An individual’s physiological function relative to 
the normal physiological progression throughout 
lifespan 
 
Cross-sectional study A study of a population using data collected at a 
single time point 
 
Environmental tobacco smoke A combination of exhaled smoke from a smoker, 
sidestream smoke from a lit cigarette and tobacco 
smoke which lingers in the environment after the 
cigarette is extinguished 
 
Longitudinal study A study in which data is gathered from 
participants on multiple occasions 
 
Pack-years A numerical value calculated by the number of 
packs of 20 cigarettes smoked per day by the 
number of years a person has smoked for 
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Glossary- Statistical terms 
 
95% confidence interval An interval constructed from the data, with a 95% 
chance that the true value lies within that range 
 
Akaike information criterion 
 
A measure of quality of a model relative to other 
models for a given set of data 
 
Bland Altman plot A graphical method of comparing two 
measurement techniques 
 
Coefficient of variation The ratio of the standard deviation to the mean 
Shows the extent of variability relative to the 
mean of the population 
 
F ratio A ratio of the explained to the unexplained 
variance in a model 
 
General linear model A framework for testing how different variables 
affect different continuous variables 
 
Generalised linear model As with general linear model, however allows for 
the response variable having a non-normal 
distribution 
 
Holm p value correction Used to reduce the chance of obtaining a 
statistically significant result when performing 
multiple tests 
 
Interquartile range The difference between the upper and lower 
quartiles of the data 
Gives a measure of spread 
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Kruskal Wallis test A rank-based non-parametric method of testing 
for differences between two or more groups 
 
Mean The sum of the data, divided by the number of 
elements in the set 
 
Median The value halfway through an ordered data set 
 
Non-parametric Assumptions are not made regarding the 
distribution of the data, the data are not normally 
distributed 
 
One-way analysis of variance A test to determine if there is a difference in the 
means of two or more independent groups 
 
p value The probability of getting a value of the test 
statistic more extreme than by chance alone 
 
Parametric Where assumptions are made regarding the 
parameters of the data 
Parametric statistics are used for normally 
distributed data 
 
Pearson’s product moment 
correlation 
The strength of linear association between two 
variables 
 
R2 The coefficient of determination 
The proportion of variance in the outcome 
variable explained by the input variable(s) 
 
Receiver operating 
characteristic curve 
A graph used to determine the diagnostic ability of 
a test at different cut-off points  
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Shapiro-Wilk test 
 
 
A test of normality of data 
 
Spearman’s rank correlation A measure of the strength and direction of 
association between two ranked variables 
 
Standard deviation A value describing how much the data vary from 
the mean 
 
Standard error A measure of precision of the sample mean 
 
Test sensitivity The ability of a test to correctly identify those 
with the exposure/disease/etc 
 
Test specificity The ability of a test to correctly identify those 
without the exposure/disease/etc as not having it 
 
t-test A test of whether the means of two groups 
significantly differ from one another 
 
Wilcoxon rank-sum test A test of whether the median of a group is 
significantly different from another value 
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